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Chapter 5. Systematic Review Results by 
Biomarker Classifications 
5.1 Markers of Absorption and Permeability: 
Overview 
Tests of gut permeability and of absorption often overlap in concept, and are frequently 
performed simultaneously. For this reason, it is appropriate to provide background in tandem. 
Proper functioning of the intestine depends on sufficient absorptive surface area and 
maintaining the barrier function and structural integrity of the lining of this organ. Absorptive 
surface is a function of individual villous surface area, as depicted in the photos below [3], and 
of gut length, which is probably not compromised in post-natally-acquired enteropathic 
syndromes. Absorption depends on the ability of various cellular mechanisms to assimilate 
nutrients from food that is ingested, using processes that rely on specialized pumps, pathways, 
and degradation. Integrity reflects 
sieve size, and presumably passive 
diffusion of large molecules across 
non-intact epithelia. To varying 
extents, these functionalities are 
hindered in EED, celiac disease, and 
small bowel Crohn’s disease, among 
other disorders.  
To perform its functions, the 
intestinal epithelium utilizes a layer of 
 
Microvilli of the small bowel, as seen with a magifying lens 
[3]. Normal finger-like projections are presented in the top 
panel. Enteropathy is characterized by flattened villi (bottom 
panel).  Reproduced from Gut, Booth, C.C., Vol. 5, p. 46, 
1964 with permission from BMJ Publishing Group Ltd. 
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 highly specialized columnar epithelial cells connected by the apical junctional complex of tight 
junctions and adherens junctions. Theoretically, specific molecules can be chosen strategically 
to interrogate these various attributes. For example, breaches in integrity that enable passive 
diffusion into the host could be measured by ingesting a substance that is not found in the diet, 
and measuring its concentration in the blood or urine. Another detection strategy would be to 
use a molecule that is easily absorbed in health and disease, but where absorption is limited 
only by mucosal surface availability, and, similarly, measure this tracer in urine and blood. The 
optimal challenge substances would resist digestion in the gut, be nontoxic, and be easily 
measured. Ideally, one attribute (surface area) can and should be measured in parallel with the 
other (specific uptake). Lastly, it might be difficult to separate one function (i.e., permeability) 
from the other (absorption); therefore these two processes are discussed in tandem in this 
section.  
5.1.1 Sugars as Tracers of Intestinal Function 
Historically, sugars have served well as tracers of intestinal function. These substances 
are nontoxic, easily detected in blood or urine, and, most importantly, neither made, nor 
degraded, by the host, so their presence in the body reflects gut uptake. Most of these sugars 
are assayed after ingestion of a load. Some of these sugars are “endomolecular,” i.e., 
consumed as part of a normal diet, but most are “xenomolecular,” i.e., foreign to natural diets, 
not metabolically necessary for the host, and absorbed without the benefit of specific 
transporters. Because they are foreign to the human diet, their use as a marker of intestinal 
function requires administration of a load to assay presence in body fluids. Moreover, depending 
on their size and the physiology of their assimilation, these sugars can be used to probe either 
amalgamated function, or specific processes or lesions (see Table 13).  
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 Sugar Molecular weight Molecular structure  Chemical (IUPAC) name Formula 
Endo- vs. 
Xeno-
molecular1 
Primary function 
assessed when found 
in blood and/or urine / 
Other comments 
D-xylose 150.13  [174] 
 
 
D-xylose HOCH2 
(CH 
(OH))3CHO 
Xeno-
molecular 
Measure of small bowel 
(perhaps primarily 
jejunal) absorptive 
capacity. Sugar 
synthesized by wood. 
Lactose 342.3 [175] 
 
β-D-galactopyranosyl-(1→4)-
D-glucose 
C12H22O11 Endo-
molecular 
Measure of small bowel 
permeability, although 
might also reflect lactase 
deficiency. 
Lactulose 342.30  [176]
 
4-0-β-D-galactopyranosyl-D-
fructofuranose 
 
 
 
C12H22-011 
 
Xeno-
molecular 
Measure of small bowel 
permeability. Usually 
normalized to mannitol. 
                                                          
1 We use the term xenomolecular for probes that would not be ingested in a normal dietary environment, while endomolecular probes are common 
and/or necessary dietary constituents. Therefore, endomolecular probes or their breakdown products are typical constituents in body analytes. 
Table 13. Sugar probes.
Sugar Molecular weight Molecular structure  Chemical (IUPAC) name Formula 
Endo- vs. 
Xeno-
molecular1 
Primary function 
assessed when found 
in blood and/or urine / 
Other comments 
Mannitol 182.17 [177]   (2R,3R,4R,5R)-Hexan-
1,2,3,4,5,6-hexol  
C6H14O6 Xeno-
molecular 
Measure of total small 
bowel absorptive 
capacity. 
Rhamnose 164.16  [178]
 
 2R,3R,4R,5R,6S)-6-
methyloxane-2,3,4,5-tetrol 
C6H12O5 · 
H2O 
Xeno-
molecular 
Has been used in lieu of 
mannitol as a measure of 
total small bowel 
absorptive capacity. 
Sucralose 397.64 
[179] 
1,6-Dichloro-1,6-dideoxy-β-D-
fructofuranosyl-4-chloro-4-
deoxy-α-D-galactopyranoside 
C12H19-Cl3O8 Xeno-
molecular 
Measure of colonic 
permeability. Active 
ingredient in SplendaR. 
Sucrose 342.30 [180]
 
Structural α-D-glucopyranosyl-
(1→2)-β-D-fructofuranoside 
C12H22-O11 Endo-
molecular 
Measure of gastric 
permeability. 
 
Table 13. Sugar probes.
 An early sugar that was employed as an indicator of intestinal function was D-xylose 
[181, 182], a pentose, which remains a standard for single sugar absorption testing worldwide. 
Humans do not synthesize D-xylose isomerase. Following an enteral challenge, the molecule is 
eliminated intact by renal clearance, after circulating in the blood. It is largely passively 
absorbed in the small bowel. The mechanism of clearance is glomerular filtration without 
demonstrated tubular reabsorption or renal tubular excretion. Hence, uptake of D-xylose can be 
assayed by seeking the peak in the serum or by collecting urine for assay. The assay for D-
xylose currently relies on isotopic or photometric assays [183]. Its main limitation is that a single 
sugar cannot differentiate loss of absorptive function from loss of absorptive area (e.g., due to 
shortened bowel length). Other single sugars that indicate absorptive function include mannitol 
and rhamnose. Sugars that are not absorbed by an intact healthy gastrointestinal tract better 
reflect porosity including lactose and lactulose in the small intestine, sucrose in the stomach, 
and sucralose in the large intestine. 
The second class of sugar absorption tests utilizes two sugars. One sugar reflects total 
small bowel absorptive capacity, and is most often mannitol or, occasionally, rhamnose. This 
"denominator" sugar requires no specific uptake mechanisms or host attributes except for 
available surface area. The “numerator” sugar in these dual tests is most often lactulose 
although lactose, sucrose, and sucralose have also been used. These large molecules enter the 
host by passive diffusion in the presence of alterations of the integrity of the small bowel 
(lactulose and lactose), stomach (sucrose), or colon (sucralose).  
Dual sugar tests have additional advantages. A single molecule might be affected by 
factors that are not related to the permeability process, e.g., rates of gastric emptying and 
intestinal transit, bacterial degradation, or the sufficiency of urine collection. In contrast, a ratio 
of excretion of two molecules is not susceptible to these factors, because such processes act on 
both molecules similarly, and the ratio is the key retained metric. However, absolute values 
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 might be low in these situations, and dynamic ranges for uptake are not well established. 
Finally, in adults, some data suggest that the use of hyperosmolar fluids (i.e., lactulose and 
mannitol) might affect absorption via solvent drag [184]. For purposes of comparison, the four 
grams of lactulose and one gram of mannitol dissolved in five milliliters of water, a commonly 
employed formulation [185] produces a solution that is 4,629 mOsm/kg as compared to normal 
plasma osmolality of 270-285 mOsm/kg.  
Variations on the challenge and recover motif used in the classic sugar absorption 
studies warrant discussion. Some studies use indirect assessments of uptake. For example, 
non-absorbed D-xylose can be metabolized by microbes in the bacteria-rich colon, and possibly 
also in small bowel bacterial overgrowth, and measured as exhaled carbon dioxide.  
We reviewed 36 studies that assessed small intestinal absorption or permeability using 
sugars as absorbed probes. Three studies measured lactose, an endomolecular sugar, either in 
the serum (n=1) or urine (n=2) among breastfeeding children. Of the 36 studies, 35 assessed 
malabsorption/permeability deficits by administering xenomolecular sugar challenges using 
lactulose, mannitol, rhamnose, or xylose (including one study each that also measured serum 
and urinary lactose). We reviewed five studies that reported xenomolecular probe results 
of single-only sugar tests, and 30 studies that reported results of dual sugar tests. The dual 
sugar tests included urinary L:M (n=25 studies), urinary or serum L:R (n=5), and urinary 
lactose:lactulose (n=1). The single sugar assay was used in six studies: urinary lactose (n=1) 
and D-xylose (two using serum measures, one using urine as a substrate, and two in which the 
body fluid from which the sugar was measured was not reported).  
5.1.2 Endomolecular Nutrients as Tracers of Intestinal Function  
Essential nutrients that are absorbed by healthy small intestine provide another 
opportunity to assess gut absorptive function. These types of marker assessments can provide 
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 especially valuable information regarding the role of derangement of gut function among 
children with nutrient deficiencies, i.e., how much of the deficiency is because of lack of intake 
rather than malabsorption. Since these molecules are naturally found in body analytes, load 
administration requires tagging such as with the use of radiolabeled molecules, quantification of 
which can then be assessed in breath, blood, urine, and/or stool as surrogate markers of 
absorptive capacity. We reviewed six studies that utilized such methodologies including 
assessments of zinc (n=3), lipid (n=2) and iron (n=1) absorption.  
We present in Evidence Tables 1 and 2 data from publications that utilized markers of 
absorption and permeability, respectively. Evidence Table 1 depicts data related to the 
systematic review from the articles that reported results of markers that were principally related 
to absorptive functions (such as D-xylose and fecal fat). Evidence Table 2 contains data on 
markers related to porosity or permeability. However, tests of gut permeability are often 
assessed simultaneously with markers of absorption. For example, the lactulose:mannitol ratio 
(L:M) and lactulose:rhamnose ratio (L:R) are often described as tests of permeability; however, 
by their nature they do include measures of absorption (via mannitol and rhamnose, 
respectively). For this reason, we present markers of permeability with or without concomitant 
assessment of absorption in Evidence Table 2. We identified 44 publications that assessed 
small intestinal absorption (13 studies) or permeability (primarily, sometimes also with some 
assessment of absorption based on dual sugar testing; 31 studies) in children in resource-poor 
settings. 
5.2 Markers of Absorption 
Data regarding markers of absorption are presented in Evidence Table 1. 
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Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
2002 
 
Dini E et al. 
 
Sudan III and 
steatocrit in the 
detection of fecal fat 
in malnourished 
children 
 
Fecal fat by four 
different testing 
methods as a 
marker of 
malabsorption 
among children with 
varying nutritional 
status and well-
nourished controls 
 
Caracas, Venezuela 
 
6 mo-9 yr olds with 
recruited from an 
outpatient nutrition 
center and well-
nourished controls. 
Case-control 
 
n=129; 
 
n=99 cases: 
• 30 with 
subclinical 
malnutrition 
• 34 with mild 
malnutrition  
• 30 with 
moderate 
malnutrition  
• 5 with severe 
malnutrition  
 
n=30 controls 
Stool Test: 
Fecal fat, by method: 
• Sudan III 
classic 
• Sudan III 
modified 
• Steatocrit 
classic 
• Steatocrit acid 
 
 
Each subject 
underwent testing for 
all four methods. 
 
Proportions testing positive for 
fecal fat ranged from 33%-41% 
overall, depending on test 
method used. 
 
The proportion testing positive 
varied by nutritional status 
across testing methods: 
• 80%-100% of severely 
malnourished subjects had a 
positive test 
• Similar proportions of subjects 
with subclinical, mild or 
moderate malnutrition tested 
positive, ranging from 30%-
47%  
• 13%-27% of controls tested 
positive 
These differences appeared to 
be significant, but statistical 
comparison results were not 
entirely clear. 
 
Fecal fat did not vary based on 
quantity of fat intake. 
  
By all four methods, a high 
percentage of children with 
parasites tested positive (~60%) 
compared to children without 
parasites (25%).  
 
Associations were observed 
between infection with Giardia 
lamblia or Blastocystis hominis 
and fecal fat (p<0.05); this held 
true across diagnostic methods.  
 
The presence of diarrhea at time 
of testing was positively 
associated with fecal fat by all 
test methods (p<0.02 for all 
except steatocrit classic, 
A majority of children 
studied tested negative 
for fecal fat.  
 
The highest percent 
testing positive was in 
those with severe 
malnutrition, followed by 
those with subclinical-
moderate malnutrition. 
Controls had the lowest 
percent testing positive.  
 
Subjects with enteric 
parasites or those 
experiencing diarrhea at 
time of testing excreted 
fat significantly more 
often than uninfected 
children without 
diarrhea, although the 
magnitude of difference 
was not reported.  
 
There was some 
variation between the 
different testing 
methods, for example 
their relationship with a 
history of diarrhea in the 
year prior to testing. 
Spanish language 
article. 
 
Control recruitment 
strategy was not 
well described. 
 
Proportions positive 
for fecal fat by 
history of diarrhea 
(current or 
previous) were not 
provided.  
Authors reported 
percent agreement 
between tests but 
did not report 
results of statistical 
testing of these 
estimates.  
 
Test results varied 
by subject 
characteristics; 
however, 
assessments 
adjusting for 
potential 
confounding were 
not reported. 
Evidence Table 1. Markers of absorption. 
Biomarkers in bold are primarily markers of malabsorption.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
p=0.06).  
 
The relationship between fecal 
fat and history of diarrhea in the 
year prior to testing varied by 
test method:  
• Sudan III classic: p=0.134 
• Sudan III modified: p<0.001 
• Steatocrit classic: p=0.14 
• Steatocrit acid: p=0.015  
 
Agreement between all four 
methods was 72%. Agreement 
between at least three was 
91.5%. 
2006 
 
Leite CA et al. 
 
Functional, 
microbiological and 
morphological 
intestinal findings 
among human 
immunodeficiency 
virus infected 
children 
 
Small intestinal and 
rectal biopsy to 
assess morphology 
and D-xylose as a 
marker of 
malabsorption 
among HIV-infected 
children 
Sao Paulo, Brazil 
 
5 mo-12 yr old 
(median 24 mo) HIV-
infected subjects 
recruited from a 
hospital and clinic. 
 
All subjects had 
some degree of 
protein-energy 
malnutrition. 
Cohort 
 
n=11; 
 
n=5 patients with 
current or recent 
episode of 
diarrhea  
 
n=6 patients with 
no diarrhea in the 
30 days 
preceding 
enrollment 
 
 
Blood Test: 
D-xylose 
(9 tested) 
 
 
Biopsy of small 
intestine by tethered 
capsule or 
endoscopy: 
Histopathology 
(10 tested)  
 
 
Rectal biopsy: 
Histopathology 
(6 tested) 
100% had low D-xylose 
absorption: 
• Mean: 15.6 mg/dL 
• SD: 5 
• Range: 8.9-24.4 
• Median: 14.2  
 
Small intestinal biopsy:  
• 100% had some degree of 
villous atrophy based on a I-IV 
grading system: 
• Grade I: 3 
• Grade I/II: 2  
• Grade II: 1 
• Grade II/III: 1 
• Grade III/IV: 1 
• 2 samples were too 
superficial to assess 
• Intraepithelial lymphocytes 
were increased in half of the 
biopsies. 
• Lymphocytic and 
polymorphonuclear (PMN) 
infiltration of the lamina 
propria were present in 10/10 
and 7/10 biopsies, 
respectively. 
 
There was a high 
prevalence (100%) of 
abnormal D-xylose 
results among HIV-
infected children, 
regardless of diarrhea 
status.  
 
All patients also had 
cellular infiltration of the 
lamina propria and 
varying degrees of 
villous atrophy. 
 
There was no correlation 
between D-xylose and 
degree of villous atrophy 
on biopsy.  
 
 
Portuguese 
language article.  
 
D-xylose <25 mg/dL 
was defined as 
indicative of 
malabsorption. This 
value is higher than 
what some 
references have 
noted as a cut-point 
[186] 
Investigators used 
a well-articulated 
system of grading 
villous atrophy.  
 
Results were not 
presented by 
diarrhea status, 
perhaps due to 
small sample size. 
Evidence Table 1. Markers of absorption. 
Biomarkers in bold are primarily markers of malabsorption.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
Rectal biopsy: 
• 100% had normal architecture 
Lymphocytic and PMN infiltration 
were present in 6/6 and 4/6, 
respectively. 
2005 
 
López de Romaña D 
et al. 
 
Longitudinal 
measurements of 
zinc absorption in 
Peruvian children 
consuming wheat 
products fortified 
with iron only or iron 
and 1 of 2 amounts 
of zinc 
 
Zinc absorption 
among stunted, 
anemic children 
receiving zinc as 
well as iron and/or 
iron/zinc-fortified 
foods 
 
Lima, Peru 
 
3-4 yr olds residing 
in a poor community 
at the periphery of 
Lima with stunting 
and moderate 
anemia as a 
surrogate risk factor 
for zinc deficiency.  
 
RCT 
 
n=41; 
(31 completed 
both initial and 
follow-up 
absorption assay 
at 2 mo) 
 
Group 1: 
n=14 received 
wheat flour with 
iron fortification 
only  
(10 completed 
follow-up) 
 
Group 2: 
n=12 received 
wheat flour with 
iron and 3mg 
zinc/100g flour  
(9 completed 
follow-up) 
 
Group 3: 
n=15 wheat flour 
with iron and 9mg 
zinc/100g flour  
(12 completed 
follow-up)  
 
Urine Test: 
Zinc excretion to 
measure fractional 
absorption of zinc 
(FAZ) and total 
absorbed zinc (TAZ) 
following 
radiolabeled zinc 
administration  
 
Mean zinc parameters (SD) at 
initial assessment: 
• FAZ:  
• Group 1: 0.34 (0.11) 
• Group 2: 0.24 (0.05) 
• Group 3: 0.13 (0.04) 
• TAZ (mg/d):  
• Group 1: 0.71 (0.18) 
• Group 2: 1.11 (0.21) 
• Group 3: 1.34 (0.47) 
 
Neither mean FAZ nor TAZ 
changed significantly at 
subsequent assessments in any 
treatment group. 
 
In both the initial and 
subsequent assays, mean TAZ 
from zinc-fortified meals 
increased with increasing 
amounts of fortification (p< 
0.001). However mean FAZ was 
inversely related to zinc intake 
from these meals (p<0.001). 
 
Non-fortified dinner FAZ and 
TAZ were significantly lower in 
the group receiving the most 
zinc-supplementation at the 
initial assay (p=0.015 and 
p=0.012, respectively) despite 
no difference in zinc intakes 
from the unfortified dinner by 
treatment group. This 
relationship between groups was 
not observed at the second 
assay; however, a significant 
decrease of 16% in mean FAZ 
Despite a reduction in 
FAZ with increasing 
fortification, TAZ 
increased as more zinc 
was consumed and with 
increasing 
concentrations of zinc 
fortification. 
 
Authors speculate that 
reduction in FAZ with 
increasing fortification 
could be due to factors 
such as saturation 
kinetics.  
 
Authors described a 
unexpected finding:  
subjects consuming 
more zinc from the zinc-
fortified breakfast 
and lunch meals 
absorbed less zinc from 
the unfortified 
dinners during the initial 
absorption assay.  
 
Intestinal function 
could play a role in 
zinc (or other 
micronutrient) 
absorption; such 
factors were not 
explored in this 
study. 
 
The principal aim of 
this study was to 
determine 
appropriate extent 
of zinc fortification 
of a staple food in a 
specific community; 
we present only 
results relevant to 
this review. 
Evidence Table 1. Markers of absorption. 
Biomarkers in bold are primarily markers of malabsorption.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
and TAZ from the unfortified 
dinners was observed between 
initial and subsequent assays 
(p<0.001).  
 
Mean plasma zinc 
concentrations did not differ 
between treatment groups 
throughout the study period. The 
proportion with low fasting 
plasma zinc concentrations 
(<65μg/dL) was lower at the end 
of the study (3.3% vs. 20.5% 
initially, p=0.046). 
2002 
 
Manary ML et al. 
 
Zinc homeostasis in 
Malawian children 
consuming a high-
phytate, maize-
based diet 
 
Zinc absorption in a 
sample of 10 
asymptomatic 
children 
 
Blantyre, Malawi 
 
2–5 yr olds (mean 
age 43.6 mo, SD 
7.7) from rural area 
attending 
immunization clinic.  
 
There was a high 
prevalence of 
stunting and low 
plasma zinc in this 
series. 
Case-series 
 
n=10  
 
 
Stool Test: 
Endogenous fecal 
zinc (EFZ) 
 
 
Urine Test: 
Zinc excretion to 
measure fractional 
absorption (FAZ) 
and total absorption 
(TAZ) following 
radiolabeled zinc 
administration 
 
Mean (SD): 
• FAZ: 0.24 (0.04) 
• TAZ (mg/d): 1.30 (0.33)  
• EFZ (mg/d): 1.15 (0.33) 
 
Language in the discussion 
section strongly suggests, but 
does not explicitly state, that 
TAZ and EFZ were not 
correlated. Correlation analysis 
for these parameters was not 
reported. 
 
EFZ was higher than 
would be expected for a 
zinc deficient cohort, and 
EFZ was not correlated 
with TAZ as would have 
been expected. While 
high-phytate diets 
leading to poor zinc 
absorption might explain 
these findings, the 
authors note that in a 
previous study (among a 
somewhat older age 
group) there were no 
differences in EFZ 
among children 
consuming high- or low-
phytate diets [187]. They 
note that such 
perturbations in EFZ 
have also been reported 
in children with 
enteropathy due to 
cystic fibrosis [188] and 
suggest that a similar 
process could be going 
on in these Malawian 
children due to TE.  
 
Authors note that 
the lack of 
comparable 
data from children 
of the age range in 
this study limits 
data interpretation. 
They also provide 
results per body 
weight due to 
presumed 
relationship; validity 
of such measures 
has not been 
established. 
 
Authors comment 
that the methods 
used for calculating 
absorption 
measures are 
sensitive and 
accurate, but quite 
difficult to conduct, 
especially among 
children. 
Evidence Table 1. Markers of absorption. 
Biomarkers in bold are primarily markers of malabsorption.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
2001 
 
Mittal SK et al. 
 
Tropical sprue in 
north Indian children 
 
D-xylose and 
duodenal biopsy as 
markers of TS  
New Delhi, 
India 
 
0-15 yr old 
gastroenterology 
clinic patients with 
PD.  
 
Those with abnormal 
morphology on 
biopsy, abnormal D-
xylose test, and 
clinical response to 
antibiotics were 
diagnosed as having 
TS.  
 
Those with abnormal 
morphology and 
response to gluten-
free diet were 
diagnosed with CD. 
We include data on 
these subjects for 
comparative 
reasons. 
 
 
Case-series 
 
n=94; 
(38 with repeat 
biopsies) 
 
<5 yr old: n=44  
Duodenal biopsy, 
method not specified: 
Histopathology 
 
 
Blood Tests: 
• Hemoglobin 
• D-xylose*  
 
 
* Not specified 
whether from urine or 
serum, and units of 
measurement not 
provided. 
 
36 (38.3%) were diagnosed with 
TS including 14/44 (31.8%) who 
were under 5 years of age.  
 
18 (19.1%) were diagnosed with 
CD.  
 
Degree of villous atrophy among 
TS vs. CD patients:  
• Mild in 8/36 (22.2%) vs. 0 
• Moderate in 23/36 (63.9%) vs. 
4/18 (22.2%) 
• Severe in 5/36 (13.9%) vs. 
14/18 (77.8%)  
 
Mean hemoglobin concentration 
(range) among TS patients was 
8.3 g/dL (5.5-11) and did not 
differ from values of those with 
CD.  
 
Among the 22 TS patients, 
repeat biopsies showed: 
• 16 with normalization 
• 5 with improvement  
• 1 worsened despite marked 
clinical improvement  
 
The D-xylose test was abnormal 
in all TS patients by diagnostic 
definition. 
More than half of the GI 
clinic patients with PD 
had some degree of 
villous atrophy.  
 
More than one-third and 
almost one-fifth of 
subjects were diagnosed 
with TS and CD, 
respectively.  
 
By study diagnostic 
definition, all TS patients 
improved with treatment.  
Among those who had 
repeat biopsies, almost 
three-quarters showed 
normalization of 
histology, while 23% had 
partial improvement and 
1 patient had worsened 
pathology. 
 
Biopsy results were 
not provided for 
patients without TS 
or CD.  
 
It was unclear if 
there were patients 
with abnormal D-
xylose and 
histology who did 
not respond to 
antibiotic therapy 
and therefore were 
not diagnosed with 
TS. 
 
Cut-off points used 
to define abnormal 
D-xylose tests were 
not provided. 
2002 
 
Moya-Camarena SY 
et al. 
 
Effects of 
asymptomatic 
Giardia intestinalis 
infection on 
carbohydrate 
Hermosillo, Sonora, 
Mexico 
 
3-6 yr olds in a 
periurban setting 
attending preschool 
centers meeting 
inclusion criteria of 
no GI symptoms, no 
antibiotics in the 
Case-control 
 
n=13; 
 
<5 yr old:  
n=5 
 
n=7 
asymptomatic 
cases infected 
Breath Tests*: 
• Lactose HBT  
• D-Xylose HBT** 
 
 
Urine Test: 
D-xylose**,1  
 
 
* Reported as parts 
Mean lactose HBT (SE): 
• Cases pre-treatment: 3.6 
(0.75) ppm  
• Cases post-treatment:  -0.85 
(0.75) ppm (p<0.05 compared 
to pre-treatment) 
• Controls: 0.19 (0.81) ppm 
(p<0.05 compared to pre-
treatment cases) 
 
Lactose HBT 
concentrations were 
normal according to 
established cut-points 
among all subjects.  
 
However, lactose HBT 
was significantly higher 
among cases compared 
to controls and there 
Statistical methods 
might not have 
been adequate to 
account for intra-
subject correlation 
when comparing 
the same group of 
subjects (cases) 
before and after 
treatment.  
1 D-xylose results were expressed as % of dose administered. 
Evidence Table 1. Markers of absorption. 
Biomarkers in bold are primarily markers of malabsorption.
Reference and 
Study Outcomes of  
Diagnostic Interest 
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absorption in well-
nourished Mexican 
children 
 
Lactose hydrogen 
breath test (HBT) as 
a marker of lactose 
absorption, and 
xylose breath test 
and urinary excretion 
as markers of xylose 
absorption in well-
nourished children 
with asymptomatic 
giardiasis and non-
infected controls 
 
preceding 3 wk, and 
no SBBO by 
lactulose HBT and 
Indican test. 
 
 
only with G. 
intestinalis  
 
n=6 controls 
without Giardia 
 
 
Cases were 
evaluated before 
and 3 wk after 
treatment with 
tinidazole. Post-
treatment stools 
were verified for 
absence of 
parasites. 
per million (ppm) 
post-substrate 
ingestion after 
subtraction of 
baseline, pre-
substrate H2 
concentrations. A 
positive HBT is 
considered to be a 
rise of >20ppm in 
breath H2 above 
baseline H2 
concentration. 
 
** Investigators did 
not specify the xylose 
enantiomer used, 
however test 
functionality 
characteristics lead 
us to assume that it 
was the dextrorotary 
(D) enantiomer. 
 
Mean xylose HBT (SE): 
• Cases pre-treatment: 2.2 
(0.69) ppm for infected group  
• Cases post-treatment:   -4.16 
(0.69) ppm (p<0.05 compared 
to pre-treatment) 
• Controls: 1.13 (0.74) ppm (NS 
compared to pre-treatment 
cases) 
 
Mean urinary excretion of xylose 
(SE) among cases pre-treatment 
and post- treatment was 34% (3) 
and 46% (11), respectively (NS), 
well above cut-offs indicative of 
malabsorption. 
  
 
 
was also a significant 
decrease in lactose HBT 
among cases after 
treatment. The clinical 
relevance of such mildly 
elevated HBT results in 
asymptomatically 
infected children is 
unclear.  
 
Results did not 
demonstrate xylose 
malabsorption by either 
urinary or breath 
measures among any 
group. While urinary 
results did not differ 
before and after 
treatment, case xylose 
HBT was significantly 
lower after treatment; 
again the clinical 
significance of such 
results is not apparent. 
  
Investigators 
wished to exclude 
children with SBBO. 
As such, inclusion 
criteria restricted 
participants to 
those with 
adequate 
production of H2 
following ingestion 
of lactulose and 
with minimal urinary 
indoxyl sulfate 
excretion. The 
number of children 
excluded due to 
failure to meet 
these criteria was 
not reported. 
2002 
 
Murphy JL et al. 
 
Maldigestion and 
malabsorption of 
dietary lipid during 
severe childhood 
malnutrition 
 
Stool recovery of 
radiolabeled 
products as markers 
of lipid digestion and 
absorption, and bile 
salt deconjugation 
as a marker of 
SBBO among 
children with severe 
Kingston, Jamaica 
 
5-23 mo olds 
admitted to the 
Tropical Metabolism 
Research Unit of the 
University of the 
West Indies with 
severe malnutrition. 
 
Case-series 
 
n=24 
 
Subjects were 
divided into 3 
groups of 8 
children, each 
group receiving a 
different labeled 
triglyceride. 
 
Data were 
collected in three 
separate phases 
as described 
above in JL 
Murphy et al. 
2001 [149].   
Stool Tests: 
• Total and 
fractionated 13C 
following 
ingestion of one 
of three 13C 
labeled 
triglycerides (TG): 
trilaurin, triolein, 
or trilinolein* 
• 13C stool assay 
following 
administration of 
labeled fatty acid 
13C glycocholate** 
 
 
* To assess fat 
excretion as a % of 
Median total stool excretion of 
13C in phase 1 was 9% (range: 
1%-29%) and did not vary 
between TG groups.  
Median 13C excretion dropped 
33%-99% in phase 2 and 86%-
95% in phase 3 compared to 
phase 1 (p<0.05 each). 
 
Over the study period, there 
were significant associations 
between total lipid and the 
amount of 13C labeled TGs in 
stool for some groups, but not 
for others. 
 
Median 13C in TG and FA was 
similar across TG groups in all 
phases. 13C FA recovery was 
High concentrations of 
13C (compared to 
healthy UK children) 
[190] were observed in 
half of the subjects at 
admission, reflecting 
impaired digestion or 
absorption.  
 
The differences in stool 
13C were wide but not as 
extreme as in a previous 
study by same 
investigators (also 
examined in this review) 
using a different TG 
(tripalmitin) substrate 
[149].  
 
Authors state that 
the study was not 
powered to 
compare the 
different TGs, but 
they contend that 
medium chain 
trilaurin did not 
appear to be 
processed 
differently than the 
longer chain TGs 
triolein and 
trilinolein. 
 
Authors did not 
describe the 
method used to 
assign subjects to 
Evidence Table 1. Markers of absorption. 
Biomarkers in bold are primarily markers of malabsorption.
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Study Outcomes of  
Diagnostic Interest 
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Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
malnutrition  
 
 
dose administered. 
Also assessed 
proportion of 13C in 
triglyceride (TG) and 
fatty acid (FA) 
fractions to 
distinguish excretion 
caused impaired 
digestion (presence 
of TG) vs. poor 
absorption (presence 
of FA). 
 
** To assess bile salt 
deconjugation in the 
bowel caused by 
SBBO; conducted 
after the TG 
assessment and a 3 
day washout period. 
similar and reduced by ~2/3 
compared to Phase 1. 13C TG 
was not detectable in Phases 2 
or 3. Statistical comparisons 
between phases were not 
reported.  
 
13C after radiolabeled 
glycocholate administration was 
detected in stool at quantities 
considered to be in excess of 
the 7% recovery of dose 
administered upper limit of 
normal in U.S. adults in [189]: 
• Phase 1: 13/24 (54%) 
• Phase 2: 5/24 (20.8%)  
Phase 3: 3/24 (12.5%) 
13C excretion did not 
significantly differ 
between TG groups and 
declined with improving 
clinical course. 
 
Similar to their previous 
study, significantly more 
13C in stool was 
recovered as FA than 
TG, reflecting impaired 
absorption over poor 
lipid digestion/ 
hydrolysis. Unlike in their 
previous study, there 
was evidence of SBBO 
as measured post-
ingestion of 13C 
glycocholate. 
different TG groups.  
 
While it was noted 
that some subjects 
had positive stool 
cultures, details 
were not provided 
on the nature of the 
enteric infections. 
2001 
 
Murphy JL et al. 
 
Gastrointestinal 
handling and 
metabolic disposal of 
13C-labelled 
tripalmitin during 
rehabilitation from 
childhood 
malnutrition 
 
Fecal fat, stool 
recovery of 
radiolabeled 
products, and breath 
tests as markers of 
lipid digestion and 
absorption and bile 
salt deconjugation 
as a marker of 
SBBO among 
Kingston, Jamaica 
 
7-23 mo olds with 
malnutrition admitted 
to the University of 
the West Indies. 
 
Case-series 
 
n=8  
 
 
Data were 
collected in three 
separate phases 
(each lasting 9 
days): 
1. Within 48 hours 
of admission 
2. During early 
rehabilitation 
3. During late 
rehabilitation 
Stool Tests: 
• Fecal fat* 
• Total and 
fractionated 13C 
assay after 
administration of 
13C tripalmitin 
(TP)** 
• 13C assay after 
administration of 
13C glycocholate 
(GCA)*** 
 
Breath Tests: 
• 13CO2 after 
administration of 
13C glycocholate 
(GCA)*** or 13C 
TP**** 
 
* In 72 hour stool 
collection (measured 
as total grams and as 
Mean fecal fat (SD): 
• Phase 1: 2.4 g/day (3.6) or 
5.9% (9.4) of dietary lipid 
intake 
• Phase 2: 1.7 (0.9) g/day, or 
3.3% (2.4) of intake  
• Phase 3: 0.9 (0.6) g/day, or 
1.4% (0.7) of intake 
• Differences between phases 
were not statistically 
significant. 
 
Total excretion of 13C in stool 
also varied widely across 
patients (0%-44%) and did not 
differ between study phases.  
 
Correlation between fecal fat 
and 13C (r=0.48; p<0.05) was 
observed.  
 
Lack of lipid digestion and 
absorption were assessed by 
Mean fecal fat was not 
elevated compared to 
published norms [191, 
192], during any study 
phase.  
 
There was wide variation 
in fecal fat at 
presentation, and wide 
variations in stool 13C 
across subjects. Authors 
indicate that this is the 
first such assessment in 
malnourished children; 
previous studies on 
healthy children from the 
UK demonstrated 
average excretion of 6% 
[190]. 
 
The majority of excreted 
13C was in the form of 
FA rather than TG. 
Statistical methods 
might be 
inappropriate for a 
small sample. 
 
All subjects were 
treated with 
antibiotics including 
metronidazole for 
presumptive SBBO; 
this might have 
affected GCA 
testing. 
Evidence Table 1. Markers of absorption. 
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children with severe 
malnutrition 
% of dietary fat 
intake). 
 
** To assess fat 
excretion as a % of 
dose administered. 
Also assessed 
proportion of 13C in 
triglyceride (TG) and 
fatty acid (FA) 
fractions to 
distinguish excretion 
caused by impaired  
digestion (presence 
of TG) vs. poor 
absorption (presence 
of FA). 
 
*** To assess bile 
salt deconjugation in 
the bowel caused by 
SBBO; conducted 
after the TG 
assessment and a 3 
day washout period. 
 
**** Expressed as a 
percentage of 
absorbed label (dose 
administered - label 
recovered in stool) to 
assess oxidation for 
acute energy needs. 
measuring TG and FA fractions, 
respectively. Mean 13C TG 
recovery (SD) (% of 
administered dose), number of 
patients excreting TG: 
• Phase 1: 0.7% (1.6), n=3 
• Phase 2: 0.9% (2.8), n=1  
• Phase 3: no recovery from 
any subjects, differences 
between phases were NS 
 
13C FA fraction in stool declined 
during rehabilitation. 
Mean 13C FA recovery (SD): 
• Phase 1: 6.0% (7.3)  
• Phase 2: 4.8% (3.7)  
• Phase 3: 3.3% (3.8),  
differences between phases 
were NS 
  
Mean FA values were ~9x (NS), 
5x (p<0.001), and 3x (p<0.05) 
higher than mean TG values in 
Phases 1, 2, and 3, respectively. 
  
Following administration of 
labeled TP, absorbed 13C label 
by breath analysis was ~5% 
(range 0%-21.2%) and similar 
across study phases.  
 
Following the administration of 
labeled GCA, there was either 
no or minimal recovery of 13C in 
stool and 13CO2 on breath (as % 
of dose administered) in all 
phases. 
Authors interpreted this 
to reflect failure of lipid 
absorption in the face of 
adequate digestion/ 
hydrolysis. Each form 
(FA and TG) was found 
in decreasing values as 
the study phases 
progressed, suggesting 
improved digestion and 
absorption, although 
results did not differ 
significantly.  
 
Fecal fat was correlated 
with concentrations of 
13C in stool.  
There was no evidence 
of SBBO or bile acid 
malabsorption.  
 
13CO2 excretion following 
administration of 13C TP 
was minimal, suggesting 
a propensity for 
deposition in adipose 
tissues rather than 
oxidation for immediate 
energy needs. The 
authors report that this 
breath test has not been 
widely used, but that 
healthy UK children 
have breath excretion 
values from 15%-43% 
[190], compared to a 
mean of 5% and range 
0%-21% in this cohort; 
the latter findings were 
more similar to results 
from kwashiorkor 
patients where 13C-
labeled oleic acid was 
Evidence Table 1. Markers of absorption. 
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used as substrate [193]. 
2000 
 
Nichols B et al. 
 
Contribution of 
villous atrophy to 
reduced intestinal 
maltase in infants 
with malnutrition 
 
Jejunal biopsy, 
maltase activity, and 
enzyme messenger 
RNAs among 
malnourished and 
well-nourished 
children. Assessed 
association between 
maltase and villous 
atrophy and other 
mucosal intestinal 
markers indicative of 
loss of enterocytes 
and enterocytic 
function. 
Sao Paulo, Brazil 
 
Cases were children 
(mean age 9.9 mo, 
SD 8.1) hospitalized 
with malnutrition 
refractory to dietary 
rehabilitation.  
 
Controls were 
children (mean age 
3.6 mo, SD 1.0) with 
HAZ and WAZ 
scores >-2 and 
normal intestinal 
mucosa on biopsy, 
hospitalized for 
Kasai procedure for 
biliary atresia. 
Case-control 
 
n=33; 
 
n=24 cases  
 
n=9 controls  
 
 
Subjects were 
matched on 
height and 
weight; ages 
differed within 
matched sets. 
Jejunal capsule 
biopsy: 
• Histopathology* 
• Maltase activity  
• Intestinal 
messenger RNA 
(mRNA) 
abundances: 
• Maltase-
glucoamylase 
(MGA) 
• Sucrase-
isomaltase (SI) 
• Villin, a 
structural 
protein 
expressed 
only in 
enterocytes 
• Sodium-
activated 
luminal 
glucose-
galactose 
transporter 1 
(SGLT), a 
functional 
protein 
expressed 
only in 
enterocytes 
• β-actin 
 
 
* Mucosal atrophy 
was scored on a 
scale of 1 (absence 
of atrophy compared 
to an organ donor) to 
4 (similar to children 
with active CD). 
 
Mean villous atrophy score (SD): 
• Cases: 2.6 (0.8) 
• Controls: 1.2 (0.5), p=0.006) 
 
WAZ score was correlated with 
villous atrophy (r=0.65, p- value 
not reported).  
 
13/25 [sic] cases and 0/5 
controls had subnormal (defined 
as <94U/g protein) of maltase 
activity; mean maltase was 34% 
lower among cases (p=0.11). 
Maltase activity did not appear 
to decrease with WAZ score 
(further details not provided). 
 
However, in sub-analyses 
among those samples with an 
adequate β-actin, a 
housekeeping gene message, 
(n=10 cases, n=9 controls), 
cases’ findings expressed as a 
mean percent of controls' (SD) 
included: 
• Villous length (reciprocal of 
atrophy score): 38.9 (41.6), 
p=0.004 
• Maltase activity: 37.1 (23.2), 
p=0.001 
• MGA mRNA: 45.1 (36.4), 
p=0.016 
• Villin mRNA: 52.5 (22.6), 
p=0.003 
• SGLT mRNA: 66.6 (23.1), 
p=0.057 
• β-actin: 88.2 (15.8), p=0.189 
 
Both villous length and maltase 
activity in a subset of cases 
were less than 40% of control 
values.  
The malnourished 
children had significantly 
greater villous atrophy 
than the younger 
controls. 
 
Among the subset tested 
for mRNA messages, 
maltase activity as well 
as the mRNA 
abundances for MGA, 
villin and SGLT were 
significantly correlated 
with case status and 
were correlated with 
villous atrophy. 
 
While maltase deficiency 
has been reported in 
malnutrition in other 
studies, authors assert 
that these are the first 
results that directly 
support the hypothesis 
that reductions in 
maltase activity are due 
to villous atrophy. This 
study also nicely 
correlates mRNA 
relative abundance with 
function.   
 
 
Tissue from 
patients requiring 
intestinal resection 
as part of their 
biliary atresia 
management 
provides an 
opportunity to 
assess presumably 
“normal” intestinal 
architecture.  
However, unless 
they mocked up ex 
vivo mucosal 
biopsies in these 
controls, resections 
will have lower 
proportions of 
villous to 
submucosa tissue 
compared to cases’ 
samples derived 
from mucosal 
biopsies. While this 
probably doesn’t 
affect histology, it 
might affect 
enterocyte 
functional assays 
and mRNA 
determination, as 
transmural tissue 
will bring in more 
diverse populations 
of cells; only some 
of them might have 
transcripts of 
interest. However, 
the bias is likely in a 
direction that would 
reduce effect size. 
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Histology among 
controls was on 
surgically resected 
tissue. 
 
MGA, villin, and SGLT mRNA 
abundances were correlated 
with villous atrophy score 
(r=0.73), (r=0.76), and (r=0.54), 
respectively (p-values not 
reported)1.  
 
MGA mRNA abundance was 
correlated with maltase activity 
(r=0.32). 
It was unclear if 
control inclusion 
criteria included 
absence of atrophy 
or if all potential 
controls lacked 
atrophy.  
 
Statistical methods 
might not have 
adequately taken 
into account the 
small sample size 
and matching 
scheme.  
 
Subsets of subjects 
were investigated 
for various tests. 
For example, 10 
cases had mRNA 
analyses based on 
β-actin adequacy. 
Another instance of 
selected testing 
was the subset of 
22 and 15 cases 
that had WAZ score 
to histology and 
mRNA correlation 
analyses, 
respectively. 
Rationale for subset 
selection was not 
thoroughly 
described. 
2001 
 
Perin NM et al. 
 
Intestinal absorption 
Florianopolis, Brazil 
 
18 mo-14 yr old HIV-
infected children with 
GI and non-GI 
Cross-sectional 
 
n=104 
 
Blood Test: 
D-xylose  
 
 
Prevalence of an abnormal D-
xylose result was 7.7%.  
 
Mean D-xylose (SD, range): 
42.8mg/dL (14.4mg/dL, 16-73 
D-xylose showed 
substantial variation 
across individuals.  
 
 
Portuguese 
language article. 
 
D-xylose <25 mg/dL 
was defined as 
1 Villin and SGLT1 were assessed as a ratio with housekeeper gene β-actin. 
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of D-xylose in 
children infected with 
the human 
immunodeficiency 
virus 
 
D-xylose as a 
marker of intestinal 
absorption among 
HIV-infected children 
with and without GI 
symptoms 
symptoms of HIV 
infection recruited 
from a pediatric 
AIDS center.  
mg/dL)  
 
D-xylose was not associated 
with age. 
 
Of the 8 children with abnormal 
results, 1 had diarrhea. Of 19 
with diarrhea, 1 had an 
abnormal result. 
 
Of those with abnormal results, 
50% had Cryptosporidium 
infection. Of the 33 subjects with 
Cryptosporidium infection, 4 had 
abnormal D-xylose results. 
 
 
 
indicative of 
malabsorption. 
2002 
 
Poddar U et al. 
 
Celiac disease in 
India: Are they true 
cases of celiac 
disease? 
 
Duodenal biopsy, D-
xylose, and fecal fat 
in children with 
symptoms of CD but 
normal mucosal 
biopsy results 
Chandigarh, India 
 
18 mo-14 yr olds 
with PD, FTT, or 
pallor from a hospital 
pediatric 
gastroenterology 
unit.  
Subjects with normal 
crypt:villous ratio on 
biopsy were of 
interest for this 
review.  
Case-control 
 
n=47     
Endoscopic duodenal 
biopsy: 
Histopathology  
 
 
Stool Tests: 
• Fecal fat* 
• D-xylose** 
 
 
* In 72-hour stool 
collection. 
 
** Not specified 
whether from urine or 
serum, and units of 
measurement not 
provided. 
38% had chronic inflammatory 
cell infiltrates in the lamina 
propria.  
 
55% had abnormal D-xylose 
concentrations. 
 
20% had abnormal fecal fat test. 
 
No results beyond proportion 
positive were reported for any of 
the above markers. 
 
Among controls with 
normal mucosal 
architecture by biopsy, 
more than one-third had 
PD. 
 
D-xylose and fecal fat 
might not correlate well 
with duodenal biopsy 
results. 
Relationships 
between fecal fat, 
D-xylose and 
biopsy results were 
not reported. 
 
While 38% of 
controls had PD, 
results for the 
markers studied 
were not stratified 
by PD for this 
group.  
 
Seven children with 
biopsies consistent 
with CD did not 
respond to gluten-
free diet and were 
excluded from the 
study.  
 
Cut-off points used 
to define abnormal 
D-xylose tests were 
not provided. 
Evidence Table 1. Markers of absorption. 
Biomarkers in bold are primarily markers of malabsorption.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
2004 
 
Sarker SA et al. 
 
Helicobacter pylori 
infection, iron 
absorption, and 
gastric acid 
secretion in 
Bangladeshi children 
 
Iron absorption 
among children with 
iron deficiency 
anemia with and 
without H. pylori 
infection 
Dhaka, Bangladesh 
 
 2-5 yr old apparently 
healthy children from 
a periurban setting, 
screened for iron 
deficiency and H. 
pylori. 
 
  
 
 
Case-control 
 
n=25: 
 
n=13 cases 
infected with H. 
pylori 
 
n=12 controls not 
infected with H. 
pylori  
 
 
Blood Test: 
Iron (absorption 
test) 
Mean1 iron absorption from 
ferrous (Fe) sulfate and Fe 
fumarate:  
• Uninfected children: 15.6% 
and 5.4%, (p<0.001) 
• Infected children before 
treatment: 19.7% and 5.3%, 
(p<0.0001)  
• Infected children after 
treatment: 22.5% and 6.4%, 
(p<0.0001)  
• H. pylori treatment did not 
significantly affect absorption 
(Fe sulfate or fumarate), 
p=0.3 
 
Iron absorption from Fe 
fumarate was 
significantly lower than 
from Fe sulfate. 
  
Results do not support 
the hypothesis that H. 
pylori infection 
influences absorption of 
water-soluble (Fe 
sulfate) or non-water-
soluble (Fe fumarate) 
iron compounds.   
 
 
Data on iron 
absorption among 
2-5 yr olds are 
limited, making 
comparison of 
results from this 
study setting 
difficult. 
2006 
 
Sheng XY et al. 
 
Major variables of 
zinc homeostasis in 
Chinese toddlers 
 
Differences in zinc 
absorption in healthy 
toddlers with a high 
prevalence of zinc 
deficiency. 
Xi-Chou (town) & 
Yun-Nan (province), 
China 
 
19-25 mo olds 
recruited from a 
remote small town 
and 2 surrounding 
rural villages.  
 
48% of children had 
plasma zinc 
concentrations below 
2.5th percentile. 
Dietary zinc intake 
was low.  
 
There was a high 
prevalence of 
stunting among the 
subjects. 
Cross-sectional 
 
n=43 
 
 
 
Stool Test: 
Endogenous fecal 
zinc (EFZ) 
 
 
Urine Test: 
Zinc excretion to 
measure fractional 
absorption of zinc 
(FAZ) and total 
absorbed zinc (TAZ) 
following 
radiolabeled zinc 
administration 
 
 
Mean (SD): 
• FAZ: 0.35 (0.12) 
• AZ (mg/d): 0.63 (0.24) 
• EFZ (mg/d): 0.67 (0.23) 
 
The quantity of absorbed zinc 
was lower than physiologic 
requirements. 
 
There was no statistically 
significant difference in any 
laboratory value between the 
town and village groups. 
 
Zinc absorption was ~80% of 
estimated physiologic 
requirement and equivalent to 
the amount of endogenous zinc 
excreted via the intestine; it was 
expected that absorbed zinc 
would exceed excreted zinc 
[144, 187, 194, 195] 
Zinc absorption was 
lower than physiologic 
requirements and EFZ 
was higher than 
expected. 
 
The authors note that 
the results are difficult to 
explain and specifically 
state that they do not 
think (though without 
clear justification) that 
enteropathy is prevalent 
in the population and 
therefore could not be a 
contributing factor. 
 
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. 
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s. 
1 Geometric mean. 
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All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting. 
 
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval, 
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins, 
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G, 
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent 
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium 
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score), 
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s) 
 
 
Evidence Table 1. Markers of absorption. 
Biomarkers in bold are primarily markers of malabsorption.
Thirteen studies used markers of intestinal absorption among children in resource-
limited settings. The range of markers included urinary, breath and serum markers of sugar 
absorption, fecal fat as a marker of lipid absorption, measures of endomolecular absorption, and 
presence of messenger RNAs in intestinal tissue as markers of intestinal surface area, and, by 
inference, absorptive capacity.  
5.2.1 D-Xylose 
While single molecule tests have disadvantages compared with dual molecule tests, as 
discussed above, the D-xylose test has been commonly used to assess malabsorption in 
developing settings. There has been further criticism of this test, including its potential hepatic 
metabolism of the sugar [196] and jejunal absorption [197].  
D-Xylose was the most commonly reported measure of small bowel absorption in the 
literature that we reviewed and was employed in five studies. It was assessed either in serum 
(n=2) [136, 152] or urine (n=1) [147], although in two studies the substrate from which D-xylose 
was measured was not reported [146, 155]. Although one of these reports did not specify the 
xylose enantiomer [147], test functionality characteristics led us to assume it was the 
dextrorotary (D) enantiomer, as was used in the other studies. This study, in addition to 
assessment of urinary excretion of the sugar, also measured hydrogen excretion in breath 
before and after administration of the xylose. Three of the studies [136, 146, 147] provided 
demographic information stratified by age group and together included 58 children under five 
years of age. However, none of the studies presented D-xylose data by age group. Overall, the 
five studies included D-xylose results for 267 children up to the age of 14 years.  
Two of the studies investigated the association of D-xylose with degree of villous atrophy 
on biopsy. One of these studies performed D-xylose tests in children with symptoms of celiac 
disease and normal architecture on duodenal biopsy, although approximately one-third had 
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chronic inflammatory cell infiltrates in the lamina propria [155]. This publication reported 
abnormal D-xylose results in 55% of these subjects (but did not provide information on the 
range of normal and abnormal concentrations, sampling site, or units of measure of D-xylose). 
Their results suggested that the D-xylose test might not correlate well with intestinal 
histopathology, especially crypt:villous architecture. The other study was among HIV-infected 
children with protein-energy malnutrition in Brazil [136]. All subjects’ tissue had cellular 
infiltration of the lamina propria and varying degrees of villous atrophy on biopsy, and all 
subjects also had abnormally low D-xylose absorption (based on authors’ reported cutoff value 
of <25 mg/dL). However, there was no correlation between the proportion of serum D-xylose 
absorption and the degree of villous atrophy on biopsy. 
Another Brazilian study used the same definition of normal range for serum D-xylose 
among HIV-infected children with and without gastrointestinal symptoms. Eight percent of the 
children had D-xylose below the “normal” range in their blood following challenge [152]. The 
authors also examined the relationships between D-xylose absorption and history of diarrhea 
and Cryptosporidium infection. Of the eight children with abnormal D-xylose, one had diarrhea, 
and of 19 subjects with diarrhea, one had an abnormal result for D-xylose. Among subjects with 
abnormal results, 50% had Cryptosporidium infection, and of the 33 with Cryptosporidium 
infection (many of whom did not have diarrhea), four had an abnormal D-xylose test. They did 
not report statistical testing of association, but these clinical factors do not appear to be 
associated with D-xylose absorption in this cohort.  
Moya-Camarena et al. performed urinary D-xylose and xylose breath hydrogen tests in 
well-nourished children with asymptomatic Giardia intestinalis infection and healthy controls 
recruited from preschool centers [147]. Results did not demonstrate any disturbance in urinary 
xylose absorption among infected cases or healthy controls. Urinary results did not differ before 
and after treatment for Giardia. Breath hydrogen levels decreased significantly with treatment, 
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indicating improvement. The clinical and physiologic implications of this difference, in the face of 
hydrogen breath test results well within the range of normal, are not apparent. The investigators 
did not report on the relationship between breath and urinary D-xylose results. 
Finally, Mittal et al. used the D-xylose absorption test as part of their diagnostic criteria 
for tropical sprue among gastroenterology clinic patients presenting with persistent diarrhea. By 
definition, all of the children had abnormal xylose absorption results; however, information about 
the D-xylose dose, units of measure, cutoff point for normal, and even the identity of the 
sampled fluid (urine or serum) were not provided [146]. 
Methods of test performance and cutoff points were often not described adequately to 
enable comparing results across studies. For example, in two instances D-xylose abnormal cut 
points were specifically defined as <25 mg/dL [136, 152], This is higher than some references 
suggest as a cutoff point among infants and children [186]. Insufficient data were reported in 
these two studies for readers to assess how the proportion of those with D-xylose malabsorption 
might have shifted with differing cut points. In two other studies D-xylose results were only 
reported as normal or abnormal without defining a cutoff point [146, 155].  
5.2.2 Endomolecular Challenge Absorption Tests 
Six studies assessed absorption after administering labelled endomolecules (zinc (n=3), 
iron (n=1), and lipids (n=2)). These investigations rely on challenge with the molecule of interest, 
which is generally a stable isotope, and measure urinary excretion as an indicator of absorption, 
or fecal excretion, as an indicator of non-absorption. When examining stool, it is important to 
note that the fecal concentration could potentially represent uptake and subsequent excretion by 
the host. In one Peruvian study, there appeared to be saturation kinetics at high doses of zinc, 
and zinc dosing early in the day was related to diminished absorption of this divalent cation from 
unfortified foods later in the day [141]. Manary et al. identified an unexpectedly high fractional 
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excretion of the challenge zinc in children in Malawi [144]. In China, Sheng et al. demonstrated 
unexpectedly high fractional excretion of zinc in stool, and inferred diminished uptake of this 
nutrient, but also speculated that their population of children were not suffering from enteropathy 
[164]. Murphy et al. used 13C labeled triglycerides (TG) as trilaurin, triolein, or trilinolein, and 
determined that in a group of Jamaican children, many of whom had bacterial overgrowth, the 
uptake of challenge lipids was impaired, but that the defect was not related to impaired intestinal 
lipolysis [148] Earlier, Murphy et al. demonstrated that during acute malnutrition, there is 
impaired lipid uptake from the gut, and that this defect improved during rehabilitation [149]. 
Unlike in the cohort in their later study, small bowel bacterial overgrowth was not an issue in this 
cohort. Sarker et al. studied labeled iron uptake in children with and without Helicobacter pylori 
infection, and found no evidence for diminished uptake among the infected children [163]. 
Similarly, treatment of the H. pylori infection did not improve uptake. They inferred that this 
gastric infection did not play a role in diminished uptake of iron by children in Bangladesh, but 
did note that there are limited data on the physiology of normal iron uptake in children in the age 
group studied (2-5 year olds). 
5.2.3 Enterocyte-specific Proteins 
Nichols et al. assessed intestinal tissue markers of digestion (see Evidence Table 3) as 
well as two markers of absorption: intestinal messenger RNA (mRNA) abundances of villin and 
sodium-activated luminal glucose-galactose transporter 1 transcripts [53]. These are structural 
proteins expressed only in enterocytes. mRNAs for these proteins are found in reduced 
quantities if intestinal surface area is diminished and hence reflect absorptive capacity. Nichols 
et al. compared the mRNA abundances in intestinal biopsies of children with refractory 
malnutrition to values found in controls that were neither stunted nor wasted, and found a 
reduction of more than 50% in mRNA abundances for both proteins among cases. It is 
important to note that the controls were children with biliary atresia who, as part of their 
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management for the condition, underwent intestinal resection. Without having performed an ex 
vivo mucosal biopsy in the control subjects, it is not possible to rule out a lower ratio of villous to 
submucosa tissue present in resected tissue which might affect mRNA determinations, as 
transmural tissue can be expected to contain a more diverse population of cells, only some of 
which might contain the transcripts of interest. However, the bias, if any, is likely in the direction 
that would reduce effect size.  
5.2.4 Fecal Fat 
Data on fecal fat was reported in three studies as a marker of malabsorption, including 
one study that measured the fat by four different methods, with a high degree of consistency in 
results across techniques [116]. That study, conducted among children with varying nutritional 
status in Venezuela, and another study conducted in India among children with symptoms 
consistent with and being evaluated for celiac disease [155], reported results as percent of 
subjects that tested positive while another study of severely malnourished Jamaican children 
[149] presented results as mean fecal fat excretion in grams per day and as percent of intake; 
hence, the results of this third study could not be compared to the other two. Positive results 
among the Venezuelan children varied from 13-27% (depending on laboratory method) among 
well-nourished children to 80-100% (again, depending on method) among the most severely 
malnourished children [116], while the Indian study detected fat in the stools of 20% of the 
children [155].  
 The Jamaican study found the fecal fat results to correlate with recovery of radiolabeled 
lipids in the stool after administration of 13C tripalmitin. The Indian study found that 55% of 
subjects with symptoms of celiac disease but a negative serologic evaluation for that disorder 
had abnormal D-xylose absorption (although the authors did not report the units of measure, 
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cutoff point of normal-abnormal results, or whether or not they measured the sugar in the urine 
or serum) and 20% had abnormal fecal fat results; correlation testing was not reported. 
 5.2.5 Summary of Markers of Absorption 
The assessed markers demonstrated normal and abnormal enteric function, depending 
on the marker and the study. The proportion of abnormal urinary D-xylose excretion results 
ranged from none among well-nourished children with asymptomatic Giardia intestinalis 
infection and healthy controls [147] to 100% among HIV-infected children in Brazil with protein-
energy malnutrition [136]. Endomolecular markers also yielded varying results in different study 
populations. Apparent malabsorption was observed based on lipid uptake in a cohort of 
Jamaican children, some of whom had small bowel bacterial overgrowth [149]. In contrast, a 
study of iron uptake among children with and without Helicobacter pylori infection found no 
evidence of impaired absorption [163]. Malnourished children had reduced absorptive capacity 
relative to controls as inferred from reduced abundance of messenger RNA in biopsies for 
enterocyte-specific proteins [53]. Similarly malnourished children showed absorptive 
derangement by fecal fat test, with a notably higher proportion of positive tests than among well-
nourished children [116]. 
Two of the fecal fat studies were the only ones that assessed more than one marker that 
is primarily a measure of absorptive capacity. The Jamaican study was the only one that 
reported testing for correlation between these tests of absorption [149]. Several studies 
compared the relationship of markers of absorption to biopsy. D-xylose [136, 146, 155] and 
fecal fat [155] corresponded poorly with histopathology. The papers suggested that there was 
only a short interval between the performance of these tests and the biopsies, but the exact 
length of time was not provided. Abundance of messenger RNA for two enterocyte-specific 
proteins, villin and sodium-activated luminal glucose-galactose transporter 1, did correlate with 
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villous atrophy in a study examining biopsy-derived markers [53]. None of the studies compared 
markers of absorption to other types of markers of enteric dysfunction (i.e., other than to biopsy 
or other measures of absorptive function). 
Only one study reported data on an absorption marker in relation to the presence of 
diarrhea, finding no apparent association with D-xylose absorption, although this was not 
analyzed statistically [152]. None of the studies examined the association between absorption 
markers and growth outcomes. A Peruvian study was the only one to report an absorption 
marker as a clinical endpoint of an intervention trial, in this case a randomized, controlled trial of 
zinc supplementation [141]. It was also the only study to measure intra-individual longitudinal 
change outside of the context of intervention or convalescence. These investigators assessed 
zinc absorption longitudinally in controls without zinc supplementation and observed no change 
in absorption of this pentose sugar.  
 These absorption tests showed a range of logistical challenges for deployment in 
resource-limited settings. When methods were described, the D-xylose test was conducted by 
colorimetric or spectrophotometric means, whereas the tests of endomolecules involved more 
complex laboratory methods and the intestinal tissue markers, requiring biopsy, were most 
technically complicated and invasive. The D-xylose studies generally did not cite reference 
standards or compare their results to those from other studies. Two studies compared their fecal 
fat results to those in other published studies [116, 149]. One of these studies also conducted a 
lipid breath test and compared results to those previously published [149]. All of the zinc 
absorption studies discussed results in relation to expected values based on reference indices 
and other studies of zinc homeostasis [141, 144, 164]. In the iron absorption study, authors 
cited a lack of data available in the literature for subjects of similar age for comparison [163]. 
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5.3 Markers of Permeability 
Data regarding markers of permeability are presented in Evidence Table 2. As discussed 
above, many of the tests that assess permeability also entail a test component that assesses 
absorptive function.  
Thirty-one studies assessed markers of intestinal permeability. All but one of these 
included assessments of dual sugar tests as either lactulose:mannitol (L:M) (n=25) or 
lactulose:rhamnose (L:R) (n=5); the other reported measures of lactose in the urine as 
lactose:creatinine. Two studies reporting L:M test results also reported other markers of 
permeability, either urinary lactose and lactose:lactulose or plasma endotoxin and IgG 
endotoxin-core antibody. 
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This category includes markers with dual assessment of absorption and permeability. Biomarkers in bold are primarily markers of permeability (with or without dual 
assessment of absorption). 
Reference and Study 
Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
2004 
 
Campbell DI et al. 
 
Intestinal inflammation 
measured by fecal 
neopterin in Gambian 
children with 
enteropathy: 
association with 
growth failure, Giardia 
lamblia, and intestinal 
permeability 
 
Fecal neopterin and 
L:M as markers of 
intestinal inflammation 
and permeability, 
respectively, and their 
correlation with growth 
status and Giardia 
recovery in the stool  
Keneba, Gambia 
 
2 mo olds from 
rural area followed 
until 15 mo of age.  
Cohort 
 
n=72 
 
Subjects were 
evaluated with 
twice-weekly 
questionnaire to 
determine 
diarrhea 
morbidity, clinic 
assessments of 
growth, and 
screening 
laboratory tests 
every 2 mo. 
Stool Test: 
Neopterin  
 
 
Urine Tests: 
• Lactulose1  
• Mannitol 
• L:M 
 
 
Mean neopterin concentration was 
negatively correlated with long-term 
height (r=-0.29, p<0.009) and weight 
(r=-0.36, p<0.007) gain, but not with 
giardiasis. 
 
Mean2 L:M (CI): 0.31 (0.26, 0.34). 
 
Mean excretion of lactulose (CI): 
0.20 (0.18, 0.23).  
 
Mean excretion of mannitol (CI): 3.0 
(2.8, 3.2).  
 
Mean L:M was negatively correlated 
with long-term height gain (r value 
not provided, p<0.0001), but was not 
correlated with presence of Giardia. 
 
L:M and fecal neopterin were not 
correlated (p=0.11). 
L:M and mean fecal 
neopterin 
concentration were 
not correlated. 
 
Mean L:M in the 
Gambian children 
was substantially 
higher than normal 
values in children in 
the UK. These high 
L:M ratios appear to 
be driven by 
mannitol excretion. 
Study population 
might have some 
overlap with that of 
Campbell et al. also 
included in this 
review [110]. 
2003 
 
Campbell DI et al. 
 
Growth faltering in 
rural Gambian infants 
is associated with 
impaired small 
intestinal barrier 
function, leading to 
endotoxemia and 
systemic inflammation 
 
L:M as a marker of 
Keneba, The 
Gambia 
 
All 2-11 mo olds 
were recruited 
from this rural 
village and 
followed up to 14 
mo of age. 
Cohort 
 
n=71 
 
 
Urine Tests: 
• Lactulose3  
(53 tested) 
• Mannitol 
(52 tested) 
• L:M 
(52 tested) 
 
 
Blood tests: 
• Albumin 
• CBC 
• C-reactive  
protein (CRP) 
At 8 wk of age:  
• Mean4 L:M: 0.169 (CI: 0.145, 
0.198; range: 0.058-0.657) 
• Mean lactulose recovery: 0.202 
(SD=0.159; range: 0.009-0.640) 
• Mean mannitol recovery: 3.80 
(SD=2.35; range: 0.52-8.58) 
 
L:M more than doubled between 12 
wk-1 yr of age (r=0.44, p<0.001) and 
was driven by both increasing 
lactulose (r=0.18, p<0.001) and 
decreasing mannitol (r=-0.14, 
p<0.01) excretion with age.  
Mean L:M ratios 
were elevated at 8 
weeks of age, and 
more than doubled 
in the first year of 
life. 
 
Many markers of 
inflammation and 
endotoxin release 
were significantly 
correlated with L:M 
and lactulose 
recovery.  
Presence of malaria 
parasites was 
assessed by blood 
smear at each 
study visit; the only 
parameter 
associated with 
malaria was CRP.  
 
Authors did not 
report investigating 
relationships 
between certain 
serum parameters 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 Type of mean not specified. 
3 For lactulose and mannitol results, excretion measurement was not specified. 
4 Geometric mean. 
Evidence Table 2. Markers of permeability.
Reference and Study 
Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
intestinal permeability 
and its relationship 
with various 
inflammatory markers 
and endotoxin  
• IgA 
• IgM  
• IgG 
• Plasma endotoxin 
• IgG endotoxin-core 
antibody 
 
 
WAZ and HAZ scores were 
negatively correlated with L:M (r=-
0.41, p<0.001), and primarily driven 
by lactulose excretion (r=-0.39, 
p<0.001). 
 
Laboratory values were consistent 
with chronic, low level 
immunostimulation: 
• 50% of platelet and 39% of 
leukocyte counts were elevated, 
especially mean lymphocyte 
counts which were almost twice 
expected values [198]. 
• While the mean1 CRP was within 
the normal range, 25% of values 
were above the upper limit of 
normal (5 mg/L), and 17% were 
>10 mg/L [198]. 
• Mean IgG, IgA and IgM 
concentrations were near normal 
at 8 wk of age, but increased 
rapidly; all three were elevated 
above expected values in all other 
age groups [198, 199]  
• Mean2 free plasma endotoxin 
concentration was twice the upper 
limit of normal [200] and IgG 
endotoxin-core antibody 
concentrations were also elevated 
[198]  
• However, mean albumin 
concentrations (and 
concentrations within SD) were 
generally within normal range 
[198]. 
 
L:M was correlated with 
IgG and IgA (r=0.41 and 0.41, 
 
Poor growth was 
significantly 
correlated with L:M 
ratios, primarily due 
to lactulose 
excretion. 
 
 
 
(blood counts, CRP 
concentrations) and 
L:M. 
 
Authors postulate 
that while general 
markers of 
inflammation 
cannot 
be specifically 
ascribed to a gut 
source, endotoxin 
and its related core 
antibody are 
potentially a direct 
measure of 
intestinal 
inflammation due to 
gut gram negatives 
as a primary source 
of endotoxin 
release among 
subjects without 
sources of extra-
intestinal gram 
negative infection.  
 
Study population 
might have overlap 
with that of 
Campbell et al. 
2004 also included 
in this review [15]. 
                                                          
1 Geometric mean. 
2 Geometric mean. 
Evidence Table 2. Markers of permeability.
Reference and Study 
Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
respectively, p<0.001), and IgM 
(r=0.28, p<0.02). 
IgG and IgA were also correlated 
with lactulose recovery (r=0.26 and 
0.25, respectively, p<0.02). 
 
IgG endotoxin core antibody 
concentration was correlated with 
L:M and driven by lactulose 
recovery, (r=0.35, p<0.005 for both).  
 
Endotoxin concentrations were 
correlated with lactulose recovery 
(r=0.36, p<0.02) only. 
2003 
 
Campbell DI et al. 
 
Chronic T cell-
mediated enteropathy 
in rural west African 
children: relationship 
with nutritional status 
and small bowel 
function 
 
 
L:M as a marker of 
intestinal permeability, 
small bowl biopsy with 
assessment of 
intestinal immune 
markers, and 
computerized 
morphometric analysis 
among rural Gambian 
children with differing 
degrees of malnutrition 
and compared to well-
nourished UK children  
 
Fajara and 
Sibanar, The 
Gambia 
 
6 mo-3 yr old 
hospital- and 
clinic-based cases 
from rural 
communities. 
 
Case groups 
based on 
differences in 
nutritional status:  
1. WAZ score >-2, 
with GI 
complaints other 
than diarrhea  
2. Grade I protein 
energy 
malnutrition 
(PEM) (WAZ 
score -2 to -4) 
and 
unresponsive to 
nutritional 
supplements, 
Case-control 
  
n=40 cases: 
• Group 1: n=4  
• Group 2: n=11 
(7 with diarrhea) 
• Group 3: n=25 
(18 with 
diarrhea) 
 
n=34 with case 
tissue samples 
sufficient for 
cytokine 
immuno-
reactivity tests:  
• Group 1: n=3 
• Group 2: n=8 
• Group 3: n=23 
 
 
Endoscopic 
small bowel biopsy, 
site not specified: 
• Histopathology 
• Morphometric 
assessment by 
computer analysis*  
• Intestinal tissue 
cytokines and 
immune markers:  
• CD-3  
• CD-4 
• CD-8 
• CD-19 
• CD-25 
• HLA-DR 
• Perforin 
• γδ T-cell 
receptor 
• Syndecan-1 
• TNF-α 
• IFN-γ 
• TGF-β 
• IL-10 
 
 
Crypt-hyperplasia and villous 
atrophy were observed among all 
Gambian subjects, and the degree of 
histopathology did not differ among 
cases with differing nutritional status, 
nor was there a correlation with 
diarrhea. 
 
IEL1 means were ~3-fold higher in 
Gambian than UK children. 
 
Median CD3, CD4, CD8, CD19, and 
CD25 cell counts were significantly 
higher (2-5x higher) among each 
case group compared to the UK 
controls.  
 
IEL, γδ, syndecan-1, HLA-DR, and 
perforin were detected among the 
Gambian children in varying degrees 
but were not reported for UK 
controls. Syndecan, CD3, and CD8 
displayed a gradient proportional to 
malnutrition severity. 
 
All Gambian groups showed higher 
lamina propria cytokine-
All Gambian 
subjects had 
evidence of 
enteropathy with 
crypt-hyperplasia 
and villous atrophy, 
and mean IELs >2 
SD above UK 
norms, independent 
of nutritional status 
and diarrhea history. 
 
Elevation of cell-
mediated intestinal 
markers and 
mucosal 
proinflammatory 
cytokines was 
present across the 3 
Gambian groups, 
variably correlated 
with nutritional 
status. 
 
L:M ratios were 
elevated in all 
Gambian groups, 
Statistical 
methodology was 
not sufficiently 
detailed to 
determine what was 
compared (e.g. type 
of central tendency 
measure and 
variance 
calculations for L:M 
not stated).  
 
Duration of diarrhea 
not specified, but 
assumed to be 
persistent.  
 
Mucosal 
lymphocyte 
densities, cytokine 
immuno-reactivity, 
and L:M results 
were not stratified 
by history of 
diarrhea. 
 
                                                          
1 These figures are presumed to represent IEL means; however, this was not explicitly stated. 
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Reference and Study 
Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
with or without 
diarrhea 
3. Grade II PEM 
(WAZ score <-4) 
with or without 
diarrhea  
 
Controls from UK* 
who were well 
nourished children 
with GI complaints 
other than diarrhea 
and with normal 
endoscopy results 
were also studied. 
 
 
* UK subjects are 
presented in this 
table due to 
comparisons of 
interest made in 
the review. 
However we do 
not include these 
subjects in the 
sample size for 
this review. 
 
 
Urine Tests: 
• Lactulose2 
• Mannitol 
• L:M 
 
 
* Biopsy involved 
morphometric 
assessment by 
computer analysis of 
villous height, crypt 
depth, villous:crypt 
ratio, and 
intraepithelial 
lymphocyte (IEL) 
density (per 100 
epithelial cells).  
 
immunoreactive mononuclear cell 
density (~200-450/mm2) than UK 
controls (30-80/mm2). 
 
Among subjects with elevated 
cytokines, similar densities were 
seen for both pro-inflammatory (IFN-
γ and TNF-α) and putative regulatory 
(IL-10 and TGF-β) cytokines. 
Epithelial expression of TGF-β was 
also enhanced compared to UK 
controls, but subjects with poorer 
nutritional status had lower densities 
of mucosal TGF-β+ cells, with 
median densities of 420 and 250 
cells/mm2 in the grade I and grade II 
PEM groups, respectively. 
 
L:M values1:  
• Group 1: 0.53 (0.4-1.3)  
• Group 2: 0.47 (0.02-2.20) 
• Group 3: 0.73 (0.14-2.2) 
• Not assessed among the UK 
controls 
 
Nutritional status was not associated 
with L:M, recoveries of lactulose or 
mannitol.  
 
L:M was correlated with mucosal B 
lymphocyte density (r=0.57, p<0.05), 
IEL (r=0.51, p<0.02), and perforin+ 
IEL (r=-0.64, p<0.03). 
without apparent 
correlation to host 
nutritional status.  
 
2002 
 
Campbell DI et al. 
 
Age-related 
association of small 
Keneba, The 
Gambia and 
surrounding 
villages 
 
2-60 yr olds 
Cohort  
 
n=162; 
 
<5 yr old:  
n=26 
Urine Tests: 
• Lactulose2 
• Mannitol 
• L:M 
 
 
Mean3 L:M (SE) in 2-5 yr old group: 
0.353 (0.022).  
 
Mean lactulose and mannitol % 
recovery was ~0.45 and ~0.65, 
respectively. 
Mean L:M in 
asymptomatic 2 to 5 
yr olds was high and 
decreased 
significantly with 
increasing age, but 
Subjects were free 
from diarrhea 
symptoms for at 
least one week 
prior to urinary 
assessments. 
                                                          
1 Not clearly indicated if these figures represent mean (CI) or another measure of central tendency. 
2 Lactulose and mannitol results were expressed as % of dose administered. 
3 Type of mean not specified. 
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Reference and Study 
Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
intestinal mucosal 
enteropathy with 
nutritional status in 
rural Gambian children 
 
L:M and urinary 
lactulose and mannitol 
recovery as a marker 
of intestinal 
permeability and its 
association with 
nutritional status at 
varying ages. Also 
assessed correlation 
of change in L:M with 
nutritional status at 3.5 
mo re-visit. 
 
randomly selected 
from rural 
communities. 
 (23 were re-
assessed) 
  
L:M was highest in 2-5 yr age group 
and decreased with increasing age 
(up to age 20) (p<0.001), but never 
fell within referenced UK normal 
ranges [201]. 
 
Most of the improvement in L:M was 
driven by a reduction in lactulose 
excretion (p<0.001), which fell within 
expected UK ranges by age 10 yr. 
 
In contrast, although mannitol 
excretion slightly decreased with 
age, this trend did not reach 
statistical significance. In fact, 
excretion proportions were at all 
times ½ - ⅓ of expected UK values 
[201]. 
 
L:M was inversely correlated with 
HAZ score1 (r=-0.31, p<0.001), but 
not with WAZ or body mass index 
(BMI) Z- scores. The correlation with 
HAZ score was mainly due to the 
higher lactulose excretion in subjects 
with poorer HAZ scores (r=-0.22, 
p=0.001) and held across all age 
groups.  
 
There was a small improvement in 
mean L:M (SE) between the two 
study time points from 0.198 (0.018) 
to 0.172 (0.010) (p=0.026 for change 
in L:M), driven by an improvement in 
mannitol recovery with no change in 
lactulose excretion.  
 
Indices of intestinal permeability 
within subjects showed a high  
 
never fell within 
expected range of 
values. 
 
Among all age 
groups, L:M showed 
significant intra-
subject correlation 
between tests 
conducted 3.5 
months apart.  
 
Among all age 
groups, L:M was 
significantly 
inversely correlated 
with HAZ score, 
primarily driven by 
lactulose excretion.  
 
 
The authors sought 
correlation between 
the mean L:M of the 
two visits and 
∆BMIZ, ∆HAZ and 
∆WAZ scores, but 
statistical 
calculations were 
not provided.  
 
                                                          
1 Reported results were adjusted for age, sex, and visit. 
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degree of correlation between the 
two visits:  
• Lactulose: r=0.55, p<0.001 
• Mannitol: r=0.24, p<0.05 
• L:M: r=0.66, p<0.001 
 
Change in measures between visits 
(analysis not stratified by age): 
• Mean L:M (SD):  
• Visit 1: -1.62 (0.66) 
• Visit 2: -1.76 (0.55), 
(p=0.026) 
• Mean mannitol recovery (SD): 
• Visit 1: 5.25 (2.69) 
• Visit 2: 6.28 (3.03), 
(p=0.006) 
• Mean lactulose recovery (SD):  
• Visit 1: 0.28 (0.20)  
• Visit 2: 0.29 (0.18),  
NS (p-value not specified) 
2003 
 
Chen P et al. 
 
Association of vitamin 
A and zinc status with 
altered intestinal 
permeability: analyses 
of cohort data from 
northeastern Brazil 
 
L:M as a marker of 
intestinal permeability 
pre- and post-vitamin 
A and zinc 
supplementation 
among children with 
history of PD or low 
WAZ score  
Goncalves Dias 
favela in Fortaleza, 
Brazil  
 
2-97 mo olds 
recruited from an 
urban shantytown.  
 
 
Cohort 
 
n=75 with pre-
supplement L:M 
and retinol 
concentrations 
measured: 
• 51 with pre-
supplement 
circulating zinc 
concentrations 
measured 
• 20 with post-
intervention* 
longitudinal 
follow-up of 
subset with 
history of PD or 
low WAZ score 
 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M 
 
 
Baseline mean (SD): 
• L:M2: 0.29 (0.16) 
• Lactulose: 0.54 (0.29) 
• Mannitol: 2.07 (0.88) 
 
L:M was not correlated with age. L:M 
was inversely correlated with retinol 
(r=-0.55, p<0.0005), including after 
adjustment for zinc concentration 
and stratification on retinol 
concentrations.  
 
Retinol was correlated with mannitol 
(r=0.28, p=0.017) and lactulose (r=-
0.22, p<0.063) excretion.  
 
Lactulose, mannitol and their 
combined ratio were not correlated 
with zinc concentrations.  
  
Supplementation of 
vitamin A and zinc 
resulted in 
significant 
improvements in L:M 
among the cohort of 
children with a 
history of PD or low 
WAZ score who 
received post-
supplementation 
assessment. Less 
than one-third of the 
subjects had post-
intervention L:M 
assessments. 
 
Longitudinal data 
were not reported 
stratifying on 
underlying condition 
(i.e. PD history vs. 
WAZ score). 
 
Follow-up data on 
L:M were not 
provided for the 
children with normal 
WAZ score or no 
history of PD.  
 
Unclear how long 
after 
supplementation 
the L:M testing was 
done.  
 
                                                          
1 For lactulose and mannitol results, excretion measurement was not specified. 
2 Type of mean not specified. 
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* These subjects 
received a single 
oral dose of 
vitamin A and a 2-
wk course of daily 
zinc supplements. 
 
L:M improved after supplementation 
for the cohort of 20 children followed 
longitudinally with PD or low WAZ 
score: 
L:M mean (SD):  
• Pre-treatment: 0.28 (0.12) 
• Post-treatment: 0.19 (0.07) 
However, lactulose and mannitol 
excretion did not change 
significantly. 
Post-
supplementation 
L:M results in the 
text of the 
publication differed 
somewhat from 
what was reported 
in the publication 
table. 
2007 
 
Darboe MK et al. 
 
Effectiveness of an 
early supplementation 
scheme of high-dose 
vitamin A versus 
standard WHO 
protocol in Gambian 
mothers and infants: a 
randomised controlled 
trial 
 
L:M as a marker of 
intestinal epithelial 
integrity among infants 
receiving high-dose 
vitamin A or standard 
vitamin A protocol  
Keneba, The 
Gambia 
 
Subjects recruited 
at birth from rural 
community. Age 
range during study 
was 0-12 mo. 
 
 
RCT 
 
n=197 
 
n=99 received 
high dose vitamin 
A protocol 
 
n=98 received 
standard dose 
vitamin A protocol 
 
Urine Test: 
L:M 
 
 
Mean1 L:M and proportion with 
values >0.30 among those receiving 
standard doses of vitamin A, by age: 
• 2 mo: 0.195, 12% 
• 5 mo: 0.197, 13% 
• 7 mo: 0.212, 22% 
• 9 mo: 0.286, 30% 
• 12 mo: 0.322, 34% 
 
Mean L:M differed between the two 
groups only at 7 mo (0.276 in high-
dose vitamin A group, p=0.014), 
although there was no difference in 
percentages with L:M >0.30.  
 
 
L:M values rose by 
~50% from age 2 
mo to 1 yr and were 
not affected by 
dosing of vitamin A.  
The L:M normal 
cutoff was defined 
higher than for most 
other L:M studies, 
as 0.30. This was 
derived from the 
mean plus 2 SD 
from a study of UK 
infants [202]. 
2001 
 
Filteau SM et al. 
 
The effect of antenatal 
vitamin A and (beta)-
carotene 
supplementation on 
gut integrity of infants 
Durban, 
South Africa 
 
Pregnant, HIV-
infected women 
between 28-32 wk 
gestation recruited 
from antenatal 
clinic. Infants were 
RCT  
 
n=238 
 
n=119 received 
vitamin A 
supplements 
(26 with HIV 
infection) 
Urine Tests: 
• Lactulose2  
• Mannitol  
• L:M 
 
 
Subjects tested: 
• 1 wk: 
• Treatment: 
Mean L:M3 (CI) at 1 wk among 
infants without reports of illness was 
0.12 (0.08, 0.17). L:M did not change 
with increasing age and did not 
significantly increase with reported 
morbidity. 
 
While a history of ever having been 
breastfed was an important 
Mean L:M overall 
was within normal 
range. However, 
mean L:M for 
placebo-treated, 
HIV-infected infants 
by 14 weeks was 
significantly elevated 
to almost 0.5.  
Specific sugar 
excretion was 
normalized to 
urinary creatinine to 
control for variation 
in renal function.  
                                                          
1 Geometric mean. 
2 For lactulose and mannitol results, excretion measurement was not specified. 
3 Geometric mean. 
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of HIV-infected South 
African women 
 
L:M as a marker of 
intestinal permeability 
among infants of HIV-
infected mothers 
enrolled in a vitamin A 
trial 
 
 
 
followed until 14 
wk of age. 
 
n=119 received 
placebo 
(29 with HIV 
infection) 
 
 
Treatment 
involved maternal 
vitamin A 
supplements 
during pregnancy 
and at delivery.   
n=104 
• Placebo: n=104 
• 6 wk: 
• Treatment: 
n=100 
• Placebo: n=105 
• 14 wk: 
• Treatment: n=99 
• Placebo: n=95 
 
contributor to L:M at 1 wk (ΔR2=0.22, 
p=0.008), a significant effect was not 
seen at 6 and 14 weeks1. Current 
feeding status had a modest effect 
on L:M only at 14 wk (ΔR2=0.06, 
p=0.04).  
 
Birth weight contributed significantly 
at 1 wk (ΔR2=0.07, p=0.02), but 
current weight did not contribute 
significantly to L:M at any time point.  
 
HIV infection status by 14 wk was 
the major factor contributing to L:M 
at 6 wk (ΔR2=0.22, p=0.008) and 14 
wk (ΔR2=0.21, p=0.01). 
 
Maternal HIV viral load during 
pregnancy was not consistently 
significantly correlated with infant 
L:M. Maternal lymphocyte counts 
and plasma retinol concentrations 
were not associated with infant L:M. 
 
While maternal vitamin A 
supplementation had no effect on 
L:M of uninfected infants, it 
appeared to prevent the increase in 
L:M of HIV-infected infants2: 
Mean L:M (CI):  
• Uninfected: 
• Vitamin A group: 0.11 (0.08, 
0.15)  
• Placebo group: 0.09 (0.06, 
0.12)  
• HIV-infected: 
• Vitamin A group: 0.17 (0.13, 
0.23) 
• Placebo group: 0.50 (0.37, 
0.68)  
 
While HIV infection 
did not affect 
mannitol excretion, it 
was associated with 
increased lactulose 
excretion. 
 
                                                          
1 Reported results were adjusted for confounding variables, unless otherwise noted. 
2 Reported results were adjusted for confounding variables included an interaction with HIV infection. 
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Mannitol was not affected by vitamin 
A. HIV infection was not consistently 
significantly associated with mannitol 
across age groups. 
 
Lactulose also did not consistently 
differ between treatment groups or 
by HIV-status, although vitamin A 
prevention of increase in lactulose 
among HIV-infected infants neared 
significance at 14 wk (p=0.058)1.   
2005 
 
Galpin L et al. 
 
Effect of Lactobacillus 
GG on intestinal 
integrity in Malawian 
children at risk of 
tropical enteropathy 
 
L:M and sucrose: 
lactulose ratio (SUC:L) 
as markers of 
intestinal and gastric 
permeability, 
respectively, in 
asymptomatic children 
presumed at risk of 
EED 
Mwenye, Malawi  
 
36-60 mo olds 
recruited from a 
rural community, 
excluding children 
with severe acute 
malnutrition or 
severe chronic 
illnesses. 
 
Subjects were 
considered at risk 
for EED due to 
residence in a 
location with high 
prevalence of 
EED. 
 
Presumed that if 
SBBO is etiology 
for EED, treatment 
with Lactobacillus 
will result in 
improved gut 
integrity. 
RCT 
 
n=164;  
 
n=81 received 
Lactobacillus GG 
(80 completed the 
study) 
 
n=83 received 
placebo 
(81 completed the 
study) 
 
 
Subjects received 
30-days of 
Lactobacillus GG 
or placebo. Only 
the 161 subjects 
who completed 
the study had 
repeat testing. 
Urine Tests: 
• Lactulose2 
• Mannitol 
• Sucrose (SUC) 
• L:M  
• SUC:L 
 
  
At enrollment: 
• 73% had L:M >0.10  
• 40% had L:M >0.20 
• Mean3 L:M (SD): 
• Treatment: 0.18 (0.16) 
• Placebo: 0.22 (0.20)  
• Mean lactulose (SD) in treatment 
group: 0.25 (0.17) 
• Mean mannitol (SD) in treatment 
group: 8.0 (4.5)  
• Mean SUC:L (SD):  
• Treatment: 0.58 (0.64)  
• Placebo: 0.60 (0.64) 
 
Mean excretion of sucrose (SD) 
increased from 0.057 (0.042) to 
0.078 (0.058) in the treatment group 
(p=0.01), but similar results were 
observed in the placebo group. 
Otherwise there were no changes in 
lactulose, mannitol, L:M, or SUC:L 
after treatment or placebo. 
A high baseline 
prevalence of 
abnormal L:M was 
observed, with no 
change after 
intervention. 
  
High mannitol 
excretion (relative to 
UK norms) drove the 
abnormal L:M. 
 
There was little 
effect on SUC:L with 
intervention; sucrose 
excretion increased 
in both treatment 
and control groups.  
Difficult to interpret 
sucrose tests 
because there are 
limited data on 
laboratory values 
for these tests in 
young children. 
2008 
 
Dhamrai Upazila, 
Bangladesh 
RCT 
 
Urine Test: Mean L:M1 (SD) at baseline was 
0.18 (0.24) in treatment groups, with 
High L:M ratios 
overall with 
High L:M ratios 
were defined as 
                                                          
1 P-values are from reported results that were adjusted for confounding variables. 
2 Lactulose, mannitol, and sucrose results were expressed as % of dose administered. 
3 Arithmetic mean.  
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Goto R et al. 
 
Impact of anti-Giardia 
and anthelminthic 
treatment on infant 
growth and intestinal 
permeability in rural 
Bangladesh: a 
randomised double-
blind controlled study 
 
L:M as a marker of 
intestinal permeability, 
IgG as a marker of 
chronic immune 
stimulation, and α-1-
acid glycoprotein as an 
acute phase reactant 
among children 
undergoing anti-
parasitic presumptive 
treatment vs. placebo. 
Also assessed 
markers’ associations 
with growth 
parameters. 
 
3-15 mo olds from 
a rural area were 
enrolled and 
followed in a 9-mo 
trial.  
 
There was a high 
prevalence of 
malnutrition in the 
study population. 
n=222* 
 
n=75 received 
anti-Giardia and 
anthelminthic 
treatment 
 
n=59 received 
anti-Giardia 
treatment only 
 
n=88 received 
placebo 
 
 
* Those who fully 
participated and 
for whom data 
were analyzed 
are included in 
this review. 
• L:M  
 
 
Blood Tests:  
• α-1-acid 
glycoprotein (AGP) 
• IgG 
• Albumin 
 
no significant difference in placebo 
group or in testing post-intervention. 
 
Proportion with elevated L:M at any 
study time point varied between 
58%-74%. >57% consistently 
elevated L:M ratios. 
 
Seasonal variation in L:M was 
observed (p <0.001), with highest 
mean values in the monsoon 
season.  
 
L:M was associated with ∆WAZ and 
∆WHZ scores at 24 weeks (p=0.001 
and p<0.001, respectively, point 
estimates not provided.) 
 
Serum immune marker values were 
similar in all groups and did not 
change substantially with 
interventions. 
 
AGP concentrations were negatively 
associated with ∆WAZ score at 24 
weeks (p=0.004, point estimate not 
provided), and were associated with 
∆WHZ score at 12 weeks but not at 
24 weeks. 
substantial seasonal 
and within-infant 
variability.  
 
Interventions did not 
impact L:M or serum 
immune markers. 
 
There was 
improvement in 
weight with better 
L:M values, the 
degree to which this 
occurred was not 
reported.   
 
 
greater than the 
upper CI for UK 
infants. 
 
Same study 
population as 
reported by this 
group in another 
study also included 
in this review [123]. 
2008 
 
Goto R et al. 
 
Impact of intestinal 
permeability, 
inflammation status 
and parasitic infections 
on infant growth 
faltering in rural 
Bangladesh 
Dhamrai Upazila, 
Bangladesh 
 
3-15 mo olds from 
a rural area were 
enrolled and 
followed in a 9-mo 
trial.  
 
There was a high 
prevalence of 
Longitudinal data 
extracted from an 
RCT [122].  
 
n=298 
 
 
Urine and blood 
samples were 
collected every 3 
mo and 
Urine Test: 
L:M 
 
 
Blood Tests: 
• α-1-acid 
glycoprotein (AGP) 
• IgG 
• Albumin 
• Hemoglobin 
 
Mean2 L:M: 0.15 
 
L:M showed a decreasing trend with 
age (p=0.003), and was associated 
with female gender (p=0.004), HAZ 
score (p=0.039), and WAZ score 
(p=0.019), but not with giardiasis or 
any of the serum immune markers. 
 
IgG, AGP, and albumin were 
associated with giardiasis, but 
Mean L:M was 
elevated. L:M was 
not associated with 
any of the tested 
serum markers of 
inflammation or with 
giardiasis. 
 
IgG rose with 
increasing age at the 
rate expected 
Helminthiasis 
prevalence was 
very low; testing for 
association with 
markers was not 
performed.  
 
Giardiasis was 
defined as 
presence of a 
Giardia-specific IgM 
                                                                                                                                                                                                                                                                                               
1 Geometric mean. 
2 Geometric mean. 
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L:M as a marker of 
intestinal permeability, 
IgG as a marker of 
chronic immune 
stimulation, and α-1-
acid glycoprotein as an 
acute phase reactant. 
Also assessed 
laboratory values’ 
associations with 
giardiasis and growth 
parameters.   
malnutrition in the 
study population. 
anthropometric 
measurements 
were collected 
monthly. 
 
 
 
 
hemoglobin was not. 
 
Mean circulating albumin 
concentration was normal for age 
[203]. Compared to UK age-matched 
reference [199], rate of rise in IgG 
with increasing age was similar, but 
concentrations were consistently 
~3g/L higher.  
 
IgG was not associated with growth 
parameters. Albumin was associated 
with HAZ score only (p=0.016). AGP 
was inversely associated with HAZ 
(p=0.011) and WAZ (p=0.005) 
scores. 
(compared to UK 
norms) [199] but at 
higher 
concentrations 
across all ages. 
 
 
 
 
 
response. 
 
Same study 
population as 
reported by this 
group in another 
study also included 
in this review [122]. 
 
Cut-off values 
representing 
elevated 
concentrations 
have not been 
determined for 
AGP. UK norms for 
10 mo olds-adults 
are 0.88 g/L mean 
(0.21 SD) [204]. 
2002  
 
Goto R et al. 
 
Poor intestinal 
permeability in mildly 
stunted Nepali 
children: Associations 
with weaning practices 
and Giardia lamblia 
infection 
 
L:M as a marker of 
intestinal permeability, 
and assessment of 
association with 
giardiasis, 
helminthiasis, 
nutritional practices, 
and growth status. 
Kathmandu, Nepal 
 
0-5 yr olds (mean 
age 3.8 yr) from 
two urban squatter 
settlements.  
 
37% and 33% of 
subjects were 
stunted and 
underweight, 
respectively.   
Cross-sectional 
 
n=210 
Urine Tests: 
• Lactulose1 
• Mannitol 
• Lactose2 
(168 tested) 
• L:M   
(158 tested) 
• Lactose:lactulose 
ratio 
(157 tested) 
 
L:M: 
• 92% had values >UK norms 
• Mean3 L:M (SD, range): 0.26 (0.21, 
0.04-1.71).  
• Giardia-infected versus uninfected 
means: 0.43 vs. 0.25, p=0.014 
 
The duration of ingestion of solid 
foods (with or without concurrent 
breastfeeding) was not associated 
with L:M in multivariate analysis.  
 
L:M was correlated with longer 
duration of breastfeeding (r=0.27, 
p<0.019). Specifically, children who 
breastfed for >2 yr had higher L:M 
ratios than children who breastfed 
for shorter times (data not provided).  
 
L:M was not associated with:  
L:M ratios were high 
overall. 
 
Wide individual 
variation was 
observed in L:M 
ratios. 
 
L:M was associated 
with giardiasis but 
not helminthiasis.  
 
Urinary lactose 
concentrations and 
lactose:lactulose 
ratios were 
significantly higher in 
breastfed subjects 
than in those that 
were not breastfed, 
Low lactase activity 
was defined as 
lactose:lactulose 
ratio >0.4.  
 
Specific L:M data 
by WAZ and HAZ 
scores were not 
reported, although 
authors state that 
L:M was not 
associated with 
“growth status.” 
 
 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 Lactose results were expressed in mg/L. 
3 Geometric mean. 
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• History of diarrhea in the week 
preceding testing 
• Helminthiasis 
• Age 
• WAZ or HAZ scores 
 
Lactulose excretion ranged from 
0.02–15.00. Mannitol excretion 
ranged from 0.5–15.00. 
 
47% showed low lactase activity. 
Lactose values and lactose:lactulose 
ratios decreased with age (R2=28%, 
p<0.0001), but were not associated 
with sex, ethnicity, and location nor 
were they associated with L:M.  
 
Mean1 urinary lactose 
concentrations (mg/L) by feeding 
mode: 
• Breastfed: 172.5  
• Non-breastfed: 44.5, p<0.0001 
corrected for infant age  
 
Mean2 lactose:lactulose ratio by 
feeding mode:  
• Breastfed: 2.76 
• Non-breastfed: 0.31,  
p<0.0001 corrected for infant age 
 
Mean L:M by feeding mode: 
• Breastfed: 0.23 
Non-breastfed: 0.28, non-significant, 
p-value not specified 
despite similar 
intestinal 
permeability values.  
 
There were some 
unexpected findings: 
the duration of 
breastfeeding, and 
not the timing of 
introduction of solid 
foods, was 
correlated with L:M, 
and the correlation 
was direct, not 
inverse. Authors 
speculate that this 
could be due to 
higher mean age of 
their cohort 
compared to another 
study that 
demonstrated 
beneficial effect of 
duration of 
breastfeeding on 
reduced L:M in 
Guatemala [205]. 
2000 
 
Haase A et al. 
 
Dual sugar 
Darwin, Australia 
 
Cases were >4 mo 
olds admitted to 
Royal Darwin 
Case-control 
 
n=264; 
 
n=150 cases with 
Blood Test: 
L:R 
 
 
Urine Test: 
Among the subset with both blood 
and urine specimens: 
• Urine L:R: 
• Mean3 (CI): 
• Cases: 12.4 (9.3, 16.5) 
Children with 
diarrhea had 
significantly higher 
L:R ratios by both 
blood and urine 
Authors used data 
from non-diarrheal 
controls from their 
clinical practice to 
derive cut-points for 
                                                          
1 Geometric mean. 
2 Geometric mean. 
3 Geometric mean. 
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permeability testing in 
diarrheal disease 
 
Lactulose:rhamnose 
ratio (L:R) as a marker 
of intestinal 
permeability in children 
with or without 
diarrhea. Also directly 
compared blood and 
urine methods of L:R 
testing in a subset of 
subjects. 
 
 
Hospital with 
diarrhea. Controls 
were patients 
admitted with non-
GI illness.  
 
More than 75% of 
cases and controls 
were Aboriginal. 
 
  
 
 
AD 
 
n=114 controls 
with no diarrhea 
 
 
 
L:R 
 
 
Among cases: 
• 24 had both blood 
and urine L:R 
• 98 had blood L:R 
only 
• 28 had urine L:R 
only 
  
Among controls: 
• 25 had both blood 
and urine L:R 
• 36 had blood L:R 
only 
• 53 had urine L:R 
only 
 
A total of 49 subjects 
were tested with both 
blood and urine L:R 
methods to allow 
direct comparison of 
values. 
• Controls: 6.7 (5.0, 8.8), 
p=0.004 
• Distribution across ratios:  
• Low: n=31 
• Intermediate: n=9 
• High: n=9 
• Blood L:R: 
• Mean1 (CI): 
• Cases: 9.4 (6.7, 13.1) 
• Controls: 5.9 (4.4, 7.8), 
p=0.04  
• Distribution across ratios: 
• Low: n=27 
• Intermediate: n=11 
• High: n=11 
 
Among subjects with only urine 
tested: 
Mean2 urine L:R (CI):  
• Cases: 15.7 (12.6, 19.6)  
• Controls: 6.7 (5.7, 8.0), p<0.0001  
 
Among subjects with only blood 
tested: 
Mean3 blood L:R (CI):  
• Cases: 12.8 (10.3, 16.0) 
• Controls: 3.7 (2.8, 4.9), p<0.0001   
 
Even though blood L:R was 
consistently lower than urine L:R by 
a geometric mean (CI) of 1.09 (1.02, 
1.16), there was strong correlation 
between L:R ratios in blood and 
urine as measured by:  
• Concordance correlation coefficient 
for agreement (CI) of 0.76 (0.64, 
0.88) 
• Kappa statistic (CI) of 0.71 (0.51, 
testing compared 
with controls without 
GI illness. 
 
There was 
substantial 
agreement between 
urine and blood L:R 
tests in the same 
subjects. 
 
Urine has been an 
established 
substrate for sugar 
excretion 
assessment as an 
indication of 
intestinal 
permeability. 
However, timed 
collection of urine is 
not a trivial task, 
especially among 
female children, and 
contamination with 
stool is problematic, 
especially in children 
with diarrhea. 
However, the much 
lower concentrations 
of probe sugars in 
blood compared to 
urine had posed a 
challenge to 
sensitive detection in 
blood. High 
performance liquid 
chromatography 
(HPLC) methods, as 
L:R ratios used in 
this study:  
• Blood L:R: 
• Low= <7 
• Intermediate= 
7-12.5 
• High= >12.5 
• Urinary L:R: 
• Low= <10 
• Intermediate= 
10-18 
• High= >18 
 
Controls were 
significantly older 
than the cases, but 
authors suggest 
that age differences 
do not impact L:R 
test performance. 
 
Numbers of 
subjects do not 
always match up 
(e.g. numerator in 
test failure rate 
calculations does 
not match other 
such reported 
numbers). 
 
Analyses of those 
subjects who had 
both blood and 
urine testing were 
conducted on 
combined cases 
and controls. 
Analyses of those 
                                                          
1 Geometric mean. 
2 Geometric mean. 
3 Geometric mean. 
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0.92) (when L:R ratios are divided 
into 3 ordered categories) 
• Sensitivity and specificity of blood 
tests of 81% (25/31) and 89% 
(16/18), respectively, when using 
the urine testing as the standard. 
 
The failure rate* for serum L:R 
testing (20/197, 10%) was lower 
than for urine testing (86/234, 37%) 
(p<0.0001).  
 
 
* Defined as emesis with 
rhamnose/lactulose oral challenge 
(same dose for urine and serum 
testing), urine leakage or 
contamination with stool, or plasma 
quantity from blood draw of 
insufficient quantity for analysis. 
used in this study, 
now provide a more 
sensitive method of 
assessing blood 
specimens. 
 
The failure rate of 
L:R blood testing 
was significantly 
lower than that of 
urine testing.   
 
 
with and without 
diarrhea would 
have been of 
interest. One would 
expect children with 
diarrhea to have 
higher rates of urine 
test failure due to 
contamination with 
stool and to have 
higher failure rates 
using either 
analytes due to 
higher rates of 
emesis.  
 
Spot blood testing 
might be more 
feasible than timed 
urine collections, 
but HPLC might not 
be feasible in 
resource-poor 
settings.  
 
This study appears 
to report on the 
same population as 
two other studies in 
this review which 
also assessed 
serum L:R as a 
marker of intestinal 
permeability [43, 
58]. 
2003 
 
Kukuruzovic R et al. 
 
Increased nitric oxide 
production in acute 
diarrhea is associated 
with abnormal gut 
Darwin, 
Australia 
 
1-6 yr old 
Aboriginal and 
non-Aboriginal 
hospital inpatients.  
 
Case-control  
 
n=318; 
 
n=169 cases with 
AD  
(154 Aboriginal) 
 
Urine Test: 
Nitric Oxide (NO)* 
 
 
Blood Tests: 
• L:R 
• Mean corpuscular 
volume (MCV) 
NO among Aboriginal children with 
diarrhea was >3x higher than any 
other group and >5x higher than in 
non-Aboriginal controls. 
• NO was >3x and >2x higher 
among Aboriginal than non-
Aboriginal children in the diarrhea 
(p<0.001) and no infections groups 
NO2 + NO3:Cr ratio, 
as a measure of 
endogenous nitric 
oxide production, 
was used as a 
marker of gut 
permeability and 
inflammation, with 
Positive stool RS 
was defined as 
>0.5%.  
 
Abnormal L:R was 
defined as >7.6; no 
reference or 
derivation was 
Evidence Table 2. Markers of permeability.
Reference and Study 
Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
permeability, 
hypokalemia and 
malnutrition in tropical 
Australian aboriginal 
children 
 
Nitric oxide (NO) as a 
marker of intestinal 
permeability and 
inflammation, and 
lactulose:rhamnose 
ratio (L:R) as a marker 
of intestinal 
permeability and the 
relationship between 
NO and L:R, growth 
parameters, mean 
corpuscular volume 
(as a surrogate of iron 
deficiency), and stool 
reducing substances 
among children with 
and without diarrhea 
Subjects were 
grouped as 
follows: 
1. Children with 
AD 
2. Children with no 
diarrhea but with 
non-GI 
infectious 
conditions  
3. Children without 
GI or infectious 
conditions 
 
 
n=149 controls: 
• 73 with non-GI 
infections (49 
Aboriginal) 
• 76 with no 
infections (29 
Aboriginal) 
 
 
Stool Test: 
Reducing substances 
(RS)**  
(169 cases tested)  
 
 
* NO is an unstable 
free radical and is 
converted to nitrite 
and nitrate. Urine 
nitrate (NO3)+ nitrite 
(NO2) was expressed 
as a ratio with urine 
creatinine (NO2 + 
NO3:Cr) in order to 
account for 
differences in urine 
concentration. 
 
** Measured only 
among children with 
profuse diarrhea. 
 
 
(p<0.001), respectively, but there 
was no difference between them in 
the non-GI infections group.  
• NO was >3x and ~2x higher in the 
diarrhea compared to the no 
infections group among 
Aboriginals (p<0.001) and non-
Aboriginals (p<0.03), respectively.  
• NO was virtually the same among 
the Aboriginal non-GI infections 
and no infections groups, as well 
as among the non-Aboriginal 
diarrhea and non-GI infections 
groups.  
 
112/152 (74%) and 31/169 (18%) of 
children with AD had abnormal L:R 
ratios1 and positive stool RS, 
respectively. 
 
NO and L:R were measured at 
“convalescence” on Day 5 among 
those with diarrhea: the mean 
improvement in NO was 21.7% 
compared with 54.6% for L:R 
(p=0.01). 
 
NO and L:R were correlated (n=193, 
r=0.37, p<0.001)1; the correlation 
was stronger for lactulose (effect 
ratio=1.47, p<0.001) than for 
rhamnose (effect ratio=0.80, 
p=0.022).  
 
NO was not correlated with stool 
RS3 or MCV, but was correlated with 
lower WAZ score (effect ratio=0.88, 
p=0.05). 
an attempt to identify 
how much more it 
reflects as response 
to inflammation from 
GI vs. non-GI 
infections. 
 
Among non-
Aboriginal controls, 
NO production was 
the same among 
those with diarrhea 
and non-GI 
infections (and 
higher compared to 
controls). NO was 
highest by far 
among Aboriginal 
children with 
diarrhea compared 
to any other group. 
Authors suggest that 
high basal 
concentrations of 
NO among 
Aboriginal children 
due to (clinically 
silent) enteropathy 
could explain the 
concentrations seen 
among Aboriginal 
controls in this 
study. 
 
NO appeared to 
decrease 
significantly more 
slowly than L:R 
among children 
provided for this 
cut-point. 
 
Study population 
appears to be the 
same as in another 
Kukuruzovic, et al. 
study also included 
in this review which 
assessed serum 
lactulose:rhamnose 
as a marker of 
intestinal 
permeability [58]. 
                                                          
 
1 Reported results appear to have been adjusted for age and race. 
2 Reported results were adjusted for age and race. 
3 Reported results among children with diarrhea were adjusted for age and race. 
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Location and  
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recovering from 
diarrhea. 
NO was found to 
correlate with L:R. 
NO was more 
strongly correlated 
with lactulose than 
rhamnose. 
2002 
 
Kukuruzovic RH et al. 
 
Milk formulas in acute 
gastroenteritis and 
malnutrition: a 
randomized trial 
 
Lactulose:rhamnose 
ratio (L:R) as a marker 
of intestinal 
permeability among 
children with diarrhea 
and/or malnutrition 
treated with milk 
formulas of varying 
composition and 
osmolality 
Darwin, Australia 
 
Inpatient 
Aboriginal children 
<3 yr old with AD 
and/or WAZ score 
<-2. 
 
60% of subjects 
had low WAZ 
score and 90% 
had diarrhea. 
 
 
 
RCT 
 
n=177; 
 
n=60 received 
De-Lact formula 
 
n=65 received O-
Lac formula 
 
n=52 received 
Alfaré formula 
 
 
Subjects were 
treated with one 
of three low-
lactose formulas: 
• De-Lact, low-
osmolality 
lactose-free 
formula 
• O-Lac, lactose-
free formula 
• Alfaré, partially 
hydrolyzed 
formula 
Blood Test: 
L:R 
 
 
L:R testing was 
repeated in 150 
subjects at day 5: 
• De-Lact: n=48  
• O-Lac: n=52 
• Alfaré: n=50 
Baseline mean1 L:R (CI) in De-Lact 
group was 14.9 (10.4, 21.5), with no 
difference between groups. 
 
The mean improvement* in L:R (CI) 
was 13.0 (9.3, 16.6) with some 
significant differences between the 
various formulas: 
• De-Lact: 18.6 (10.6, 26.6)  
• O-Lac: 12.0 (7.5, 16.6), p=0.15 
compared to De-Lact  
• Alfaré: 8.5 (2.1, 14.9), p=0.049 
compared to De-Lact  
 
 
* Improvement in L:R was calculated 
as baseline L:R minus repeat L:R. 
 
 
 
Authors noted that 
treatment with all of 
the low-lactose 
formulas studied 
resulted in improved 
L:R among this 
population at risk for 
enteropathy and 
growth failure. 
Improvement was 
most marked with 
the low osmolality 
formula, De-Lact. 
 
 
Reported results 
did not appear to be 
harmonized with 
the method 
described for 
calculating 
improvement in 
L:R. 
 
Fully breastfed 
children were 
excluded. 
 
The study did not 
include a control 
arm (of standard 
care) to which 
change in L:R could 
be compared. 
 
Authors reiterate 
the advantages of 
serum over timed 
urine collection for 
assessment of L:R 
as discussed in 
another publication 
in this review [125]. 
2002 
 
Kukuruzovic RH et al.  
 
Darwin, Australia 
 
Cases were 
Aboriginal and 
Case-control 
 
n=375 admissions 
for 306 children; 
Blood Tests: 
• Lactose 
• Lactulose2 
• Rhamnose 
27/75 (36%) of Aboriginal controls 
and 0 non-Aboriginal controls had 
abnormal L:R ratios. 
 
Mean L:R ratios of 
Aboriginal children 
were approximately 
double those of non-
Positive stool RS 
was defined as 
>0.5%.  
 
                                                          
1 Geometric mean. 
2 Lactulose and rhamnose results were expressed as % of dose administered. 
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Small bowel intestinal 
permeability in 
Australian Aboriginal 
children 
 
Serum lactulose: 
rhamnose ratio (L:R), 
serum lactose, and 
stool reducing 
substances as 
markers of intestinal 
permeability among 
Aboriginal and non-
Aboriginal children 
with and without 
diarrhea  
non-Aboriginal 
children admitted 
to hospital with 
diarrhea. Controls 
were Aboriginal 
and non-Aboriginal 
children admitted 
without GI 
illnesses. 
 
 
 
n=285 case 
admissions for 
AD (264 
Aboriginal) 
 
n=90 control 
admissions with 
no diarrhea (74 
Aboriginal) 
 
 
• L:R  
• Hemoglobin  
• Mean corpuscular 
volume (MCV) 
 
 
Stool Test: 
Reducing substances 
(RS)*  
 
 
L:R testing was 
repeated on day 5 for 
a subset of Aboriginal 
subjects: 
• 174/264 admissions 
for acute diarrhea  
• 25/74 control 
admissions 
 
 
* Measured only 
among children with 
profuse diarrhea 
when “clinically 
indicated." Number 
tested not provided. 
 
 
 
Mean1 L:R at baseline: 
Cases: 
• Aboriginal: 16.4  
• Non-Aboriginal: 7.9, p=0.002 
compared to Aboriginal cases 
Controls: 
• Aboriginal: 4.6 
• Non-Aboriginal: 2.5, p=0.02 
compared to Aboriginal controls  
 
Mean improvement2 in L:R (CI) at 
day 5 among those with repeat 
testing: 
• Aboriginal cases: 14.6 (11.2, 18.0)  
• Aboriginal controls: -0.63 (-4.0, 
2.7)  
 
Mean lactulose recovery3: 
• Cases day 1: 0.085 (0.070–0.103)  
• Cases day 5: 0.039 (0.033–0.046) 
• Controls: 0.024 (0.019–0.029) 
All 3 values significantly differed 
from one another. 
 
Mean rhamnose recovery: 
• Cases day 1: 0.479 (0.424–0.542) 
• Cases day 5: 0.555 (0.498–0.616) 
• Controls: 0.585 (0.500–0.685) 
These values did not significantly 
differ from one another. 
 
Confidence intervals (CIs) in the 
authors' graphical representation of 
mean L:R at admission did not 
overlap, and the difference in means 
was particularly evident between 
Aboriginal and non-Aboriginal 
subjects. 
 
Aboriginal children 
both among those 
with and without 
diarrhea, consistent 
with authors’ 
suggestion that 
clinically silent 
enteropathy is 
prevalent among 
Aboriginal children.  
 
Mean L:R 
significantly 
improved over 5 
days among 
Aboriginal cases. 
Children with severe 
diarrhea had higher 
mean L:R. 
 
Higher case L:R was 
driven more by high 
lactulose than by low 
rhamnose.  
Similarly, 
improvement in L:R 
among cases was 
primarily due to 
decreased lactulose.  
 
Stool RS and serum 
lactose were found 
in approximately 
one-quarter and 
one-third of 
Aboriginal cases, 
respectively. The 
latter was weakly 
associated with 
Abnormal L:R was 
defined as >5.6, 
derived from 2 SD 
above the 
arithmetic mean for 
non-Aboriginal 
controls in this 
study. The rationale 
for the choice of 2 
SD above the 
arithmetic, instead 
of the geometric, 
mean is not clear. 
Proportions of 
cases with 
abnormal 
concentrations 
were not reported. 
 
Analysis included 
data for 69 children 
with repeat 
admissions; this 
might violate 
independence 
assumptions for 
their statistical 
analysis methods.  
Repeat L:R testing 
was conducted on 
controls of both 
racial groups, but 
among cases it was 
only conducted on 
Aboriginal cases. 
 
This study appears 
to report on the 
                                                          
1 Geometric mean. 
2 Improvement in L:R appears to have been calculated as baseline L:R minus repeat L:R, as described in another publication in this review; however, this was not expressly stated. 
Reference 134. Kukuruzovic RH, Brewster DR. Milk formulas in acute gastroenteritis and malnutrition: a randomized trial. J Paediatr Child Health, 2002. 38(6):571-577.  
3 Figures reported parenthetically after the mean percent recoveries of lactulose and rhamnose were not specified as ranges or CIs. 
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Factors associated with L:R among 
cases were1:  
• Acidosis (p=0.007) 
• Hypokalemia (p=0.035) 
• Diarrhea severity (p=0.001)  
 
Age and malnutrition were not 
associated with L:R. 
 
38% and 27% of Aboriginal cases 
had positive serum lactose and stool 
RS, respectively. 12% of Aboriginal 
and non-Aboriginal controls 
combined had lactosemia.  
 
Presence of lactosemia was 
associated with L:R, adjusted 
relative risk (CI)=1.06 (1.03, 1.10)2. 
Stool RS, anemia, and MCV were 
not associated with L:R. 
increased lactulose. same population as 
in the Kukuruzovic, 
et al. 2003 
reference also 
included in this 
review, which 
assessed nitric 
oxide excretion 
[43].  
 
Authors reiterate 
the advantages of 
serum over timed 
urine collection for 
assessment of L:R, 
as discussed in 
another publication 
in this review [125]. 
2010 
 
Lima AA et al.  
 
Effects of vitamin A 
supplementation on 
intestinal barrier 
function, growth, total 
parasitic, and specific 
Giardia spp infections 
in Brazilian children: a 
prospective 
randomized, double-
blind, placebo-
controlled trial 
 
L:M as a marker of 
intestinal barrier 
function, and stool 
Fortaleza, Brazil 
 
2 mo-9 yr olds 
(mean 43 mo) from 
an impoverished 
urban community, 
eligible if HAZ 
score was 
<median for their 
community. 
 
Subjects were 
screened for 
intestinal 
parasites, and 
longitudinal 
anthropometrics 
were assessed. 
RCT 
 
n=79;  
 
n=40 received 
placebo 
(tocopherol)  
 
n=39 received 
vitamin A (retinyl 
palmitate)  
 
 
Subjects were 
treated every 4 
mo.  
Urine Tests: 
• Lactulose3 
• Mannitol 
• L:M  
 
Stool Tests: 
• Lactoferrin 
• Cytokines: 
• IFN-γ 
• TNF-α 
• IL-4 
• IL-10 
Median L:M at baseline was 0.089. 
There was no significant change in 
L:M at 4 mo follow-up within either 
treatment group.  
 
No significant difference in L:M was 
observed between treatment groups. 
 
Both median lactulose and mannitol 
excretions decreased at 4 mo follow-
up among the vitamin A compared to 
the placebo group: 
• Lactulose: 0.21 to 0.74, p=0.042  
• Mannitol: 3.06 to 8.25, p=0.008  
 
Overall proportion of lactoferrin was 
23% initially. At 1 mo follow-up, there 
was no difference in prevalence 
between vitamin A (33%) and 
Frequency of stool 
lactoferrin varied 
between 23%-32%. 
 
While vitamin A 
supplementation 
was associated with 
reduced lactulose 
excretion, it was also 
associated with 
reduced mannitol 
excretion, with no 
overall effect on L:M.  
 
Vitamin A 
supplementation 
was not associated 
with presence of 
lactoferrin or 
Authors did not 
report testing for 
associations 
between urinary 
markers of 
intestinal 
permeability and 
concentrations of 
fecal cytokines, or 
between these 
markers and growth 
parameters or 
parasitosis. 
 
Cut-point values for 
lactoferrin positivity 
and abnormal L:M 
were not described.  
 
                                                          
1 Reported results were adjusted for confounding variables, unless otherwise noted. 
2 Reported results were adjusted for severity of diarrhea, acidosis, hypokalemia, and age. 
3 For lactulose and mannitol results, excretion measurement was not specified. 
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lactoferrin and specific 
intestinal 
immunological 
cytokines as markers 
of intestinal 
inflammation among 
nutritionally at-risk 
children who received 
either vitamin A or 
placebo  
placebo (31%) groups. 
 
Cytokine concentrations did not 
significantly differ between placebo 
and vitamin A groups. 
intestinal cytokine 
response. 
Exclusively 
breastfed children 
were excluded from 
study participation 
due to assessment 
of stool lactoferrin. 
 
2005 
 
Lima AA et al. 
 
Intestinal barrier 
function and weight 
gain in malnourished 
children taking 
glutamine-
supplemented enteral 
formula 
 
L:M as a marker of 
intestinal permeability 
and various stool tests 
among children with 
malnutrition or PD who 
received either glycine 
or glutamine 
supplemented formula 
or placebo 
Fortaleza, Brazil 
 
2-60 mo olds 
hospitalized with 
WAZ score <-2, 
~70% of whom 
had PD.  
RCT 
 
n=80;         
 
n=53 received 
supplemented 
formula 
• 27 with glycine 
• 26 with 
glutamine 
 
n=27 received 
nonsupplemented 
formula 
 
 
Urine Tests*: 
• Lactulose1 
• Mannitol 
• L:M  
 
 
Stool Tests**: 
• Lactoferrin  
• Leukocytes  
• Occult blood 
• Reducing 
substances (RS) 
 
 
* n=80 tested at 
enrollment, n=65 
tested at day 10. 
 
** n=60 tested. 
Mean2 L:M (SE):  
• Glutamine group: 
• Baseline: 0.31 (0.10) (similar in 
all three groups) 
• Day 10: 0.10 (0.02); significant 
decrease, (p=0.01) 
• No significant decrease in L:M in 
glycine and nonsupplemented 
formula groups at day 10 
 
Mean lactulose (SE):  
• Glutamine group: 
• Baseline: 0.97 (0.46) (similar in 
all three groups) 
• Day 10: NS decrease in all 3 
groups 
 
Mean mannitol (SE):  
• Glutamine group: 
• Baseline: 3.42 (0.64) (similar in 
all three groups) 
• Day 10: NS decrease in all 3 
groups 
 
Proportion of stool markers at 
baseline among all subjects:  
• Lactoferrin: 53.3% 
• Leukocytes: 11.7% 
• RS: 3.3% 
• Occult blood: 5.0%  
L:M significantly 
improved in the 
glutamine group 
only. 
 
>50% of subjects 
had intestinal 
inflammation by 
stool lactoferrin. 
Fecal leukocytes, 
RS, and occult blood 
were detected in 
fewer subjects than 
lactoferrin. 
The relationship 
between stool 
markers and L:M 
was not reported.  
 
Data were not 
stratified by history 
of PD. 
 
Fecal fat was 
assessed, but 
results were not 
reported. 
 
Cut-off values for 
lactoferrin positivity 
were not described.  
 
Exclusively 
breastfed children 
were excluded from 
study participation 
due to assessment 
of stool lactoferrin. 
 
 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 Type of mean not specified. 
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2007 
 
Lima NL et al. 
 
Wasting and intestinal 
barrier function in 
children taking alanyl-
glutamine-
supplemented enteral 
formula 
 
L:M as a marker of 
intestinal permeability 
in assessing alanyl-
glutamine supplement 
to improve intestinal 
barrier function in 
malnourished children 
compared to glycine-
containing placebo 
supplement 
Parque 
Universitario, 
Fortaleza, Brazil 
 
6 mo-8 yr olds 
(mean age 3.5 yr) 
from an urban 
setting with HAZ, 
WAZ, or WHZ 
scores <-1. 
 
RCT 
 
n=107; 
 
n=51 received 
alanyl-glutamine 
treatment  
 
n=56 received 
glycine placebo 
 
 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M 
 
L:M median (range) at baseline: 
• Treatment: 0.0385 (0.8922 [sic])  
• Placebo: 0.0302 (5.5812 [sic]) 
 
Lactulose and mannitol excretion 
both significantly decreased in the 
treatment group only (p=0.05 for 
both sugars)2. L:M did not change 
significantly within or across groups 
days after treatment. 
 
Lactulose excretion was not 
associated with WHZ, WAZ or HAZ 
scores in either group3. Mannitol 
was not associated with growth 
parameters in the control group, but 
was associated with WHZ (r2=-
0.386, p=0.027) and WAZ (r2=-
0.385, p=0.027) scores in the 
supplemented group. Data for L:M 
and growth parameter association 
was not provided. 
Even though 
lactulose excretion 
improved in the 
treatment group, 
mannitol excretion 
worsened with 
overall L:M not 
changing.  
 
Lactulose, mannitol 
and L:M did not 
change significantly 
in the placebo 
group. 
Authors state that 
L:M median and 
range values were 
within the 
confidence interval 
for values of 
healthy children in 
the study 
community; no 
reference was 
cited. 
 
Although the 
authors defined 
persistent and 
chronic diarrhea in 
their methods, they 
did not report data 
stratified according 
to these conditions. 
 
Authors provide 
negative R2 values 
when reporting 
Pearson’s 
correlation analysis 
results; these likely 
actually represent r 
values. 
2001 
 
Northrop-Clewes CA 
et al. 
 
Anthelmintic treatment 
of rural Bangladeshi 
children: effect on host 
physiology, growth, 
and biochemical status 
Jamalpur district, 
northern 
Bangladesh 
 
2-5 yr olds from 
poor rural villages, 
sampled randomly 
from a larger 
cohort study. 
 
RCT* 
 
n=109; 
 
n=54 received 
bimonthly empiric 
antihelminthic 
treatment 
 
n=55 received 
Blood Tests 
• α 1-
antichymotrypsin 
• Albumin 
• Total protein  
 
Urine Test: 
L:M  
 
Mean L:M4 at baseline: 
• Treatment: 0.22 
• Placebo: 0.25 
 
Seasonal variation in L:M was 
observed, with highest values 
following the monsoon season.  
 
Within-subject L:M analysis showed 
L:M ratios were high 
overall and 
demonstrated 
seasonal variation.  
 
Intra-individual L:M 
values did not 
change significantly 
over time, nor were 
they associated with 
Baseline study data 
were lost, so 
analysis began with 
samples taken at 
month 2. 
 
The relationship 
between the serum 
markers and 
intestinal 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 Reported results were adjusted for age and season. 
3 Reported results were adjusted for age and season. 
4 Geometric mean. 
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L:M as a marker of 
intestinal permeability, 
and α 1-
antichymotrypsin as a 
marker of inflammation 
and immune activation 
to treatment among 
children randomized to 
bimonthly 
antihelminthics or 
placebo. 
Stools were 
assessed for 
helminthiasis and 
giardiasis. Growth 
was followed 
longitudinally. 
placebo 
 
 
* Randomized at 
the village level. 
 
 
 
Among 93 subjects 
with L:M at baseline:  
• 46 received 
treatment 
• 47 received 
placebo 
 
Among 66 subjects 
with repeated L:M 
testing: 
• 34 received 
treatment 
• 32 received 
placebo 
no significant association with 
intestinal helminthiasis and no 
significant improvement in treatment 
or placebo groups over 1 yr. L:M 
was generally not associated with 
giardiasis (with the exception of one 
group at one study interval). 
 
L:M was inversely correlated with 
∆HAZ and ∆WAZ scores at some of 
the follow-up intervals (r=-0.22, 
p<0.02 and r=-0.21, p<0.05, 
respectively, at 12 mo follow-up 
visit). 
 
Mean serum ACT, albumin and total 
protein were within normal ranges 
and were not associated with growth 
parameters. ACT and albumin 
concentrations did not significantly 
change with treatment, whereas total 
protein concentrations did (p<0.001). 
helminthiasis or 
consistently 
associated with 
giardiasis.  
 
Inverse correlations 
were seen between 
L:M and growth 
parameters. 
 
Serum markers were 
within normal range. 
The only significant 
change in these 
markers was a 
decrease in total 
protein in the 
treatment group 
without concomitant 
change in albumin; 
this suggested a 
decrease in 
globulins (not 
directly measured), 
perhaps due to 
decreased 
inflammation. 
permeability was 
not reported. 
2009 
 
Panter-Brick C et al. 
 
Pathways leading to 
early growth faltering: 
An investigation into 
the importance of 
mucosal damage and 
immunostimulation in 
different socio-
economic groups in 
Nepal 
 
Kathmandu, Nepal 
 
3-18 mo olds in 
two cohorts: 
1. All children in 
target age range 
from four 
squatter 
settlements  
Randomly 
selected, age-
matched cohort 
from lower middle-
class, periurban 
Cohort 
 
n=86; 
 
n=48 in squatter 
cohort  
 
n=38 in lower 
middle-class 
cohort 
Urine Test: 
Lactose:Cr  
 
 
Blood Test: 
Hemoglobin 
 
Mean1 Lactose:Cr (CI): 
• Squatter: 0.14 (0.12, 0.16) 
• Middle Class: 0.08 (0.07, 0.10) 
• Statistically significant difference 
between the 2 groups among the 
6-12 mo olds (p=0.007) and 18-24 
mo olds (p=0.002), but not among 
12-18 mo olds.  
• For both SES groups, Lactose:Cr 
values decreased with increasing 
age (p<0.001). 
 
HAZ, WAZ, WHZ, and ∆WAZ scores 
were strongly associated with mean 
Authors speculate 
that Lactose:Cr 
accounted for less of 
the deterioration in 
nutritional status 
among the squatter 
children because of 
several factors, 
including poorer 
nutritional intake, 
that impact the 
nutritional status of 
children with lower 
socio-economic 
Specific sugar 
excretion was 
normalized to 
urinary creatinine to 
control for variation 
in renal function.  
 
Authors suggest 
that while 
Lactose:Cr might 
not be as accurate 
as L:M, it might be 
a more field-friendly 
assessment of 
                                                          
1 Geometric mean. 
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Design and 
Sample Size Biomarker Results Conclusion Comments 
Lactose:creatinine 
ratio (Lactose:Cr) as a 
marker of intestinal 
permeability and 
hemoglobin, albumin, 
α-1-acid glycoprotein, 
and IgG as markers of 
immunostimulation. 
The latter were also 
assessed for their 
relationship to 
nutritional status. 
households Lactose:Cr (p<0.001 each) as was 
∆HAZ score (p=0.004); ∆WHZ score 
was not. The strength and 
magnitude of association between 
∆WAZ score and Lactose:Cr was 
most pronounced among the 
wealthier cohort and there was no 
association between ∆HAZ score 
and Lactose:Cr among the squatter 
children.  
 
Hemoglobin concentrations were 
inversely related to Lactose:Cr 
(r2=0.018, p<0.001). 
 
 
 
status. mucosal damage 
compared to L:M, 
requiring only spot 
urine collection and 
no substrate 
dosing. However, 
L:M was not 
assessed in this 
study; direct 
comparison of the 
two tests was not 
possible.  
 
While hemoglobin 
concentration was 
inversely related to 
Lactose:Cr, testing 
for associations of 
other measured 
blood markers (IgG, 
AGP and albumin) 
with Lactose:Cr 
was not reported. 
2000 
 
Quadro L et al. 
 
Retinol and retinol-
binding protein: gut 
integrity and circulating 
immunoglobulins 
 
L:M as a marker of 
small intestinal 
permeability, and its 
correlation with serum 
retinol among mildly 
malnourished children 
Goncalves Dias 
favela in Fortaleza, 
Brazil 
  
1-9 yr olds with 
mild malnutrition 
selected from a 
large cohort of 
children from an 
urban slum. They 
were recruited at 
birth and followed 
longitudinally. 
 
19 (63%) had 
some degree of 
vitamin A 
deficiency—all of 
Cross-sectional 
 
 n =30 
 
  
 Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M  
 
 
 
 
 
 
80% of subjects had abnormal L:M, 
defined as >=0.030.  
 
Serum retinol was:  
• Inversely correlated with L:M 
(r=0.46, p=0.012) 
• Directly correlated with mannitol 
(r=0.66, p<0.01)  
Not correlated with lactulose (data 
not reported) 
Children with low 
serum retinol had 
higher L:M, 
apparently mediated 
by mannitol 
excretion. 
The L:M normal 
cutoff was defined 
lower than for most 
other L:M studies, 
as 0.030. The 
authors reference 
several studies 
regarding use of 
this cut point. 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
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Sample Size Biomarker Results Conclusion Comments 
these had mild 
deficiency, except 
for 2 with 
moderately low 
concentrations. 
2004 
 
Rabbani GH et al. 
 
Green banana and 
pectin improve small 
intestinal permeability 
and reduce fluid loss in 
Bangladeshi children 
with persistent 
diarrhea 
 
L:M as a marker of 
intestinal permeability 
among infants with PD 
who are treated with 
green banana, pectin, 
or rice diet  
  
 
Dhaka, 
Bangladesh 
 
5-12 mo old males 
admitted to the 
hospital of the 
International  
Centre for  
Diarrhoeal Disease 
Research with PD 
but without other 
concurrent 
illnesses. 
 
 
RCT 
 
n=57; 
 
n=19 received 
green banana 
and rice 
 
n=17 received 
pectin and rice 
 
n=21 received 
rice alone 
(placebo) 
 
 
 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M  
 
 
 
Mean L:M (SD) by treatment group, 
pre- and post-treatment:  
• Banana: pre=0.50 (0.14), 
post=0.21 (0.12), p<0.01 
• Pectin: pre=0.54 (0.17), post=0.23 
(0.09), p<0.01 
• Placebo: pre=0.41 (0.11), 
post=0.45 (0.13), p>0.6 
 
Lactulose and mannitol excretion did 
not differ between groups at 
baseline.  
 
Lactulose excretion was not 
significantly reduced after 
intervention in the placebo group. 
Mean (SD): 
• Pre-treatment: 1.45 (0.12) 
• Post-treatment: 1.35 (0.15) 
 
Both treatment groups had 70-80% 
reduced lactulose excretion following 
treatment (p<0.01). 
 
Mannitol excretion increased in all 
groups compared to their pre-
treatment values, but only 
significantly so in the banana and 
pectin groups (p<0.05).  
 
Mean mannitol % excretion (SD), 
pre- vs. post-treatment:  
• Banana: 1.82 (0.13) vs. 3.21 
(0.16) 
• Pectin: 1.91 (0.12) vs. 3.2 (0.18) 
• Placebo: 2.10 (0.11) vs. 2.33 
L:M values were 
high at baseline 
among the study 
population of 
inpatient young 
children with PD. 
Mean L:M 
significantly 
improved with the 
green banana or 
pectin intervention 
but were still above 
normal range 
following 7 days of 
treatment. The 
improvements in L:M 
were driven by both 
mannitol and 
lactulose, with the 
latter having an 
impact of greater 
magnitude.  
 
Authors cite studies 
postulating that the 
effectiveness of 
green banana in 
reducing diarrheal 
fluid loss is due to its 
high content of 
amylase-resistant 
starch, which 
undergoes 
bacterial 
fermentation into 
short-chain fatty 
 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
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(0.18) 
 
The banana and pectin groups 
stopped having diarrhea more often 
compared to controls (e.g. p<0.01 by 
day 4). Among the banana and 
pectin groups, stool reductions were 
associated with percent change in 
L:M before and after treatment 
(R2=0.84 for pectin and R2=0.86 for 
banana; p<0.05 for each). 
acids in the colon, 
stimulating colonic 
salt and water 
absorption. Pectin is 
thought to work by a 
similar mechanism. 
Authors also 
suggest that short 
chain fatty acids 
might affect entero-
hormones and 
growth factors, 
resulting in the 
observed changes in 
intestinal 
permeability [206].  
2009 
 
Ritchie BK et al. 
 
13C-sucrose breath 
test: novel use of a 
noninvasive biomarker 
of environmental gut 
health 
 
Sucrose breath test 
(SBT) as a marker of 
small bowel mucosal 
damage vis a vis 
sucrase activity among 
an Australian 
Aboriginal population. 
Also compared SBT 
with serum 
lactulose:rhamnose 
ratio (L:R) 
Darwin and 
Adelaide, Australia 
 
4 mo-5 yr old 
Aboriginal children 
admitted to 
hospital with 
diarrhea. 
 
Two control 
groups: 
1. Aboriginal 
controls 
admitted to 
hospital with 
non-GI 
symptoms (50% 
had pneumonia) 
2. Healthy, non-
Aboriginal 
controls 
recruited from 
community 
Case-control 
 
n=43;  
 
n=18 Aboriginal 
cases with AD 
 
n=25 controls: 
• 18 Aboriginal, 
without diarrhea 
• 7 non-
Aboriginal, 
healthy 
Blood Tests: 
• L:R 
(32 Aboriginal cases 
and controls tested) 
• C-reactive protein 
(CRP) 
• Mean Corpuscular 
Volume (MCV) 
• Hemoglobin 
 
 
Breath Test: 
13C sucrose breath 
test (SBT) 
 
  
20/32 (63%) of Aboriginal children 
had abnormal L:R ratios. 
 
Mean1 L:R (CI): 
• Diarrhea cases: 31.8 (24.9, 40.7)  
• Aboriginal controls without 
diarrhea: 11.4 (8.5, 15.5),  
significant difference (p<0.0001) 
 
SBT Mean (CI): 
• Diarrhea cases: 1.9% (0.9, 3.0), 
p<0.0001 compared to non-
Aboriginal controls and p=0.004 
compared to Aboriginal controls 
• Aboriginal controls: 4.1% (3.0, 
5.2), p=0.032 compared to non-
Aboriginal controls 
• Non-Aboriginal controls: 6.1% 
(4.8, 7.3) 
Significant differences were 
observed between all three groups.  
 
SBT results were not associated with 
wasting or with patient age or 
breastfeeding status. 
SBT values were 
significantly lower 
and L:R values were 
significantly higher 
among Aboriginal 
children with 
diarrhea than among 
those without GI 
symptoms. SBT was 
also significantly 
lower among 
Aboriginal controls 
than among non-
Aboriginal children 
without diarrhea. 
This is consistent 
with previous reports 
of high prevalence of 
clinically silent TE in 
this population.  
 
SBT was 
significantly 
inversely correlated 
with L:R.  
Abnormal L:R ratios 
were defined as 
>16; no reference 
or derivation was 
provided for this 
cut-point.  
 
L:R test was not 
conducted among 
the non-Aboriginal 
controls. 
 
SBT/L:R correlation 
analysis was based 
on data for 
Aboriginal cases 
and controls 
combined; stratified 
analysis was not 
reported and could 
be of interest 
considering the 
large difference in 
L:R observed 
between these 
                                                          
1 Geometric mean. 
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SBT and L:R were inversely 
correlated (r=0.67; CI: 0.42, 0.62; 
p<0.0001). L:R explained 45% of the 
variance in SBT; diarrhea explained 
28% of variance. 
 
SBT was associated with increased 
MCV, relative risk (CI)=3.9 (2.8, 5.0). 
SBT was not associated with 
hemoglobin or CRP. 
groups. 
 
Associations of 
MCV, CRP, and 
hemoglobin with 
SBT after adjusting 
for potentially 
confounding 
variables were not 
reported.  
2001 
 
Rollins NC et al. 
 
Feeding mode, 
intestinal permeability, 
and neopterin 
excretion: A 
longitudinal study in 
infants of HIV-infected 
South African women 
 
L:M as a marker of gut 
mucosal integrity and 
urinary neopterin 
excretion as a marker 
of cell-mediated 
immunity in infants 
with and without HIV 
infection 
 
Durban, South 
Africa 
 
1, 6, and 14 wk old 
infants born to 
HIV-infected 
mothers. 
Cohort 
 
n=272  
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M  
• Neopterin  
Mean2 L:M (CI): 
• HIV-infected subjects: 
• 1 wk: 0.12 (0.06, 0.27)  
• 6 wk: 0.24 (0.15, 0.38) 
• 14 wk: 0.24 (0.14, 0.44) 
• Uninfected subjects:  
• 1 wk: 0.13 (0.09, 0.19) 
• 6 wk: 0.08 (0.06, 0.11) 
• 14 wk: 0.09 ( 0.07, 0.13) 
 
HIV-infection by 14 wk of age was 
significantly associated with 
increased L:M. 
 
A non-significant, positive trend in 
neopterin excretion was observed 
among HIV-infected infants.  
L:M was generally 
normal (compared to 
UK values) for non-
HIV-infected infants, 
but significantly 
increased among 
HIV-infected 
subjects, especially 
after 6 weeks. 
 
The increased L:M 
in HIV-infected 
infants was primarily 
driven by lactulose 
rather than mannitol. 
 
Higher neopterin 
excretion by HIV-
infected infants was 
observed but this 
was not statistically 
significant. 
Assessment of 
association 
between L:M and 
neopterin was not 
reported. 
2000 
 
Rollins NC et al. 
 
Vitamin A 
Durban, South 
Africa 
 
6-60 mo old 
inpatients or 
RCT 
 
n=139; 
 
n=66 received 
Urine Tests: 
• Lactulose3 
• Mannitol 
• L:M  
• Neopterin  
Mean4 L:M: 
• Group 1:  
• Day 0: ~1.8 
• Day 3: ~2.4  
• Group 2:  
Mean L:M ratios 
were very high 
(~10x) (at baseline 
and at day 3 in both 
groups) compared to 
Urine testing could 
only be conducted 
in the laboratory on 
certain days; hence 
only a subset of 
                                                          
1 Lactulose and mannitol results were expressed in mg. 
2 Geometric mean. 
3 For lactulose, mannitol, and neopterin results, excretion measurement was not specified. 
4 Geometric mean. 
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supplementation of 
South African children 
with diarrhea: optimum 
timing for improving 
biochemical and 
clinical recovery and 
subsequent vitamin A 
status 
 
L:M as a marker of 
intestinal permeability 
and urinary neopterin, 
serum α-1 acid 
glycoprotein, and C-
reactive protein as 
markers of 
inflammation among 
children with severe 
diarrhea  
 
 
 
outpatients with 
severe diarrhea. 
 
vitamin A on 
admission (group 
1) 
 
n=73 received 
vitamin A after 
clinical 
improvement 
(group 2) 
 
 
Treatment 
involved vitamin A 
supplementation 
either on the day 
of 
admission or after 
acute diarrheal 
symptoms had 
resolved.  
 
 
Blood Tests: 
• C-reactive protein 
(CRP) 
• α-1 acid 
glycoprotein (AGP) 
 
49 subjects received 
urine testing: 
• Group 1: n=25 
• Group 2: n=24  
 
 
Blood and urine were 
tested on days 0 and 
3. 
 
• Day 0: ~1.2 
• Day 3: ~0.7 
 
There were no differences in mean 
L:M between groups or within groups 
between days 0 and 3, although 
there was a significant difference in 
paired analysis within individuals at 
the two time points (data not 
presented, and direction, magnitude 
and degree of significance not 
reported). 
  
Lactulose and mannitol excretion 
were assessed only in the paired 
analysis. Lactulose excretion 
decreased between days 0 and 3 
(magnitude of effect and degree of 
significance not reported), while 
mannitol excretion showed no 
change.  
 
Mean1 neopterin and AGP 
concentrations did not differ between 
groups or within groups on the 
different study days or in the paired 
analysis. When initial CRP (~2x 
higher in Group 2 compared to 
Group 1, p<0.004) was taken into 
account, mean CRP on day 3 did not 
differ between the 2 groups. 
However in the paired analysis, CRP 
concentrations were significantly 
different between days 0 and 3.  
other studies in this 
review. Study 
authors suggested 
(via personal 
correspondence) 
that this could have 
been due to the 
severity of illness in 
the sample 
population (children 
hospitalized for 
diarrhea). 
 
Vitamin A 
administration did 
not result in 
significant 
improvement in L:M, 
neopterin, or AGP 
regardless of timing 
of vitamin A 
administration.  
 
 
 
subjects underwent 
those tests.  
 
Group 2 patients 
had significantly 
higher CRP, non-
significantly higher 
WBCs and AGP, 
and lower retinol 
and retinol-binding 
protein 
concentration 
compared to group 
1 at baseline. 
Authors note that 
these parameters 
suggest that Group 
2 patients might 
have been more ill 
at baseline. For the 
subset of 49 
patients undergoing 
urine testing, the 
mean L:M and 
neopterin 
concentrations 
were lower among 
Group 2 than Group 
1 subjects (NS). 
However, baseline 
differences in acute 
phase and vitamin 
A markers at 
baseline were not 
reported separately 
for these 49 
subjects. 
 
Data for lactulose 
and mannitol 
excretion were not 
                                                          
1 Geometric mean. 
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reported separately. 
Rationale for 
additional analyses 
of these molecules 
expressed as ratios 
with creatinine was 
not explained.  
 
Authors suggest 
that their 3-day 
testing period 
(based on their 
previous work in a 
different setting 
[207] might have 
been too short to 
identify effect as 
demonstrated by 
McCullough et al. at 
10 days after 
presentation [208]. 
2000 
 
Thurnham DI et al. 
 
Innate immunity, gut 
integrity, and vitamin A 
in Gambian and Indian 
infants 
 
L:M as a marker of 
intestinal integrity 
among children 
receiving vitamin A 
supplementation 
 
Orissa State, India 
 
Subjects were 
recruited from 2 
sources: 
1. Hospital-based 
infants admitted 
for “diarrheal or 
respiratory 
disease,” mean 
age 9 mo 
2. Clinic-based 
infants with 
“minor 
ailments”, age 
not specified  
 
RCT 
 
n=174; 
 
n=94 hospital-
based 
• 31 received 
vitamin A at day 
1 
• 32 received 
vitamin A at 
discharge (up to 
day 5) 
• 31 received 
placebo 
 
n=80 clinic-
based* 
 
 
Clinic-based 
subjects were 
Urine Test: 
L:M  
 
 
For hospital-based 
subjects, L:M was 
assessed at baseline, 
discharge from 
hospital, and 10 or 30 
days after discharge. 
 
For clinic-based 
subjects, L:M was 
assessed at baseline, 
4, and 8 wk. 
Mean L:M was ~3-fold higher among 
hospitalized compared to clinic 
patients at baseline. Within the 
allocation groups, mean baseline 
L:M did not differ for either the 
hospitalized or clinic subjects. 
 
Among the hospital cohort, mean 
L:M declined significantly in the two 
vitamin A groups compared to the 
placebo group, and remained lower 
at day 30 among the treatment 
groups, but the difference was no 
longer significant compared to the 
placebo group. 
 
Among the clinic cohort, mean L:M 
reduction was accelerated in vitamin 
A-supplemented children. However, 
mean L:M did not significantly differ 
between treatment groups at any 
time point.  
Mean L:M values, 
including post-
intervention values, 
were 2-5 times 
higher than those 
observed in the UK 
[209]. 
 
L:M reduction was 
accelerated among 
vitamin A- 
supplemented 
children, but end-of-
study mean values 
did not differ 
statistically between 
allocation groups in 
either the clinic or 
the hospital cohorts.  
 
 
Precise numerical 
values were not 
reported, rather L:M 
results were 
portrayed in figures 
with units 
expressed in mg, 
making it difficult to 
compare these 
results to those of 
other studies.  
 
Information on 
study design, such 
as randomization 
scheme, was 
limited. 
 
The article also 
reported re-
analyzed data from 
a 1991 report from 
Evidence Table 2. Markers of permeability.
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randomized to 
receive vitamin A 
weekly for 8 wk or 
placebo.  
 
 
* Number of 
subjects in each 
treatment group 
was not specified. 
 
 
 
The rate of decline in L:M was most 
steep among the vitamin A-treated 
hospitalized patients, in whom the 
mean L:M value decreased by 63% 
over 30 days, followed by placebo-
treated hospitalized patients, with a 
decrease of 38% over 30 days. 
Mean L:M decreased by 57% in the 
vitamin A-treated clinic patients, 
while there was no change in L:M 
among the clinic placebo group. 
The Gambia [209]. 
2009  
 
Trehan I et al. 
 
A randomized, double-
blind, placebo-
controlled trial of 
rifaximin, a 
nonabsorbable 
antibiotic, in the 
treatment of tropical 
enteropathy 
 
L:M,  
sucrose:lactulose, and  
sucralose:lactulose as 
markers of small 
intestinal, gastric, and 
colonic permeability, 
respectively, among 
those receiving 
rifaximin or placebo  
Limela, Malawi 
 
All 3-5 yr olds from 
the village were 
recruited. 
 
 
RCT 
 
n=144;  
 
n=72 received 
rifaximin for 7 
days 
 
n=72 received 
placebo  
 
It was presumed 
that if SBBO is 
the etiology for 
enteropathy, 
treatment with 
rifaximin would 
result in improved 
intestinal integrity. 
Urine Tests 
• Lactulose1 
• Mannitol 
• Sucrose (SUC) 
• Sucralose (SCL) 
• L:M2  
• Sucrose:lactulose 
ratio (SUC:L) 
• Sucralose:lactulose 
ratio (SCL:L)  
 
 
Subjects were tested 
before and after 
treatment. 
At enrollment: 
• Mean mannitol (SD):  
• Treatment: 9.57 (5.24)  
• Placebo: 10.29 (6.62) 
• Mean lactulose (SD): 
• Treatment: 0.30 (0.18) 
• Placebo: 0.34 (0.25) 
• Mean SUC (SD):  
• Treatment: 0.062 (0.04)  
• Placebo: 0.074 (0.058) 
• Mean SCL (SD):  
• Treatment: 0.51 (0.29)  
• Placebo: 0.58 (0.53) 
• Mean L:M (SD): 
• Treatment: 0.18 (0.12) 
• Placebo: 0.17 (0.09) 
• Mean SUC:L (SD): 
• Treatment: 0.50 (0.34) 
• Placebo: 0.64 (0.90) 
• Mean SCL:L (SD): 
• Treatment: 0.42 (0.32) 
• Placebo: 0.39 (0.23) 
• For both groups combined:  
• 76% had L:M >0.10 
• 34% had L:M >0.20 
 
No significant post- intervention 
There was a high 
proportion with 
elevated L:M which 
did not change with 
rifaximin treatment. 
 
Baseline L:M 
measurements in 
this study resembled 
those of another 
Malawian population 
in similar 
environmental 
conditions [120]. 
 
SCL excretion in this 
population was 
similar to that found 
in healthy American 
children (0.4%), 
while SCL:L was 
comparatively lower 
(0.8) and driven by 
lactulose [210]. 
SCL:L might be a 
better marker of 
colonic permeability 
[211-213]. Results 
Methodological 
differences in 
specimen collection 
and testing, in 
particular for SCL 
excretion, might 
account for some 
differences in 
values compared to 
other studies.  
 
This was the first 
use of SCL for site-
specific absorption 
testing in a 
developing country 
setting.  
                                                          
1 Lactulose, mannitol, SUC, and SCL results were expressed as % of dose administered. 
2 Type of mean for sugar ratios not specified. 
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differences were observed in any 
fractional sugar excretion or dual 
sugar test, including among children 
with elevated pre-intervention L:M. 
 
from this study 
potentially indicate 
that colonic 
permeability was 
normal. 
  
Few data exist on 
SUC excretion. 
Results in this trial 
are similar to those 
found in another 
Malawian population 
(0.06% SUC 
excretion) [120] 
and high compared 
to healthy older 
children from 
developed country 
settings (0.02-
0.03%) [210, 212]. 
2008 
 
Vieira MM et al. 
 
Carotenoids, retinol, 
and intestinal barrier 
function in children 
from northeastern 
Brazil 
 
L:M as marker of 
intestinal barrier 
function, fecal 
lactoferrin and 
leukocytes as markers 
of intestinal 
inflammation, and 
CRP and AGP as 
acute phase reactants 
among children with 
varying vitamin A 
Fortaleza, Brazil 
 
2 mo-9 yr olds 
(mean age 41 mo) 
from an 
impoverished 
urban community, 
eligible if HAZ 
score <median  
for their 
community. 
Cross-sectional 
 
n=102 
 
 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M  
(97 tested) 
 
 
Stool Tests: 
• Lactoferrin 
(93 tested) 
• Leukocytes 
 
 
Blood Tests: 
• C-reactive protein 
(CRP)  
• α-1-acid 
glycoprotein (AGP) 
 
48.5% had abnormal L:M.  
 
L:M and excretion of each sugar 
separately did not vary with retinol 
concentration. 
 
L:M was associated with levels of 
common dietary carotenoids, 
primarily driven by lactulose. 
However, the association was not 
always statistically significant, and 
the direction of association varied 
depending on precursor.  
 
40% of stool samples were positive 
for lactoferrin. 
 
1% of stool samples were positive 
for fecal leukocytes. 
 
30% of stool samples were positive 
Almost half of 
subjects had 
increased L:M, and 
~40% of subjects 
had increased 
lactoferrin. 
 
While serum retinol 
concentrations were 
not associated with 
L:M, serum 
carotenoids were; 
authors suggest that 
these retinol 
precursors might be 
more sensitive 
predictors of 
impaired intestinal 
function. However, 
the reported 
direction of 
L:M threshold for 
abnormal values 
was defined as 
>0.0864 [214]. Cut-
off values for 
lactoferrin positivity 
were not described.  
 
Relationships 
between acute 
phase proteins and 
measures of 
intestinal 
permeability or 
inflammation were 
not reported. 
Relationships 
between L:M and 
lactoferrin or fecal 
leukocytes as well 
as those between 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
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status  for parasites but this had no impact 
on L:M results, lactoferrin, or acute 
phase reactants.  
association varied, 
making 
interpretation of 
these results 
unclear.  
retinol or 
carotenoids and 
lactoferrin or fecal 
leukocytes were not 
reported.  
 
Exclusively 
breastfed children 
were excluded from 
study participation 
due to assessment 
of stool lactoferrin. 
2007 
 
Williams EA et al. 
 
A double-blind, 
placebo-controlled, 
glutamine-
supplementation trial 
in growth-faltering 
Gambian infants 
 
L:M and plasma 
immunoglobulins and 
acute phase reactant 
proteins (albumin, C-
reactive protein, and 
alpha-1-
antichymotrypsin) in 
community-based 
Gambian infants 
enrolled in a glutamine 
trial 
 
 
West Kiang region, 
Gambia 
 
4-10 mo olds from 
a rural area 
followed during the 
5-month rainy 
season and for 6 
months afterward. 
Cohort 
 
n=72 
 
Glutamine or 
placebo of 
nonessential 
amino acids was 
orally 
administered 
twice daily during 
rainy season; L:M 
ratio was 
measured 
monthly, and 
plasma samples 
were collected 3 
times. 
 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M  
 
Blood markers 
• C-reactive protein 
(CRP) 
• Alpha-1 
antichymotrypsin 
(ACT) 
• IgA 
• IgG 
• IgM 
• Albumin 
 
Mean2 L:M (CI):  
• Baseline:  
• Glutamine group: 0.33 (0.25, 
0.43) 
• Placebo group: 0.33 (0.26, 
0.41) 
• Post-intervention: 
• Glutamine group: 0.29 (0.23, 
0.35) 
• Placebo group: 0.26 (0.21, 
0.32) 
 
Mean excretion of lactulose (CI):  
• Baseline:  
• Glutamine group: 0.21 (0.16, 
0.28) 
• Placebo group: 0.20 (0.15, 
0.26) 
• Post-intervention: 
• Glutamine group: 0.17 (0.13, 
0.21) 
• Placebo group: 0.14 (0.11, 
0.18) 
 
Mean excretion of mannitol (CI):  
• Baseline:  
• Glutamine group: 2.65 (2.02, 
L:M values were 
elevated in this 
population, with no 
significant change 
after the 
intervention.  
None of the plasma 
markers differed 
significantly between 
treatment and 
placebo groups, 
either at baseline or 
at the end of 
supplementation. 
Growth outcomes 
did not differ 
significantly across 
treatment groups. 
 
The relationships 
between L:M and 
growth parameters, 
immuno-globulins, 
and acute phase 
proteins were not 
reported. 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 Geometric mean. 
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Reference and Study 
Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
3.48) 
• Placebo group: 2.50 (1.87, 
3.36) 
• Post-intervention: 
• Glutamine group: 2.48 (1.99, 
3.11) 
• Placebo group: 2.14 (1.62, 
2.82) 
 
L:M values did not differ significantly 
between treatment groups before or 
following intervention. However, a 
repeated measures ANOVA showed 
that during supplementation, L:M 
values were borderline elevated 
among the glutamine-supplemented 
group relative to the placebo group 
(p=0.05), counter to expectation. 
 
Neither ACT, CRP, albumin, nor 
immunoglobulins IgA, IgG, or IgM 
differed significantly between 
treatment and placebo groups, either 
at baseline or at the end of 
supplementation. 
 
Mean levels of IgA and IgG 
increased during the study (p 
<0.001), while IgM levels did not. 
Concentrations of each of these 
immunoglobulins did not differ 
between treatment and placebo 
groups. 
 
Plasma albumin, ACT, and CRP 
values showed no change over the 
course of the study. 
 
Proportions of children with elevated 
CRP ranged from 30-41% at 
different collection time points. The 
glutamine intervention had no effect 
on proportion of children with 
Evidence Table 2. Markers of permeability.
Reference and Study 
Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
elevated CRP. 
 
Treatment and placebo groups 
experienced decreases in WAZ, 
HAZ, and MUAC coinciding with the 
rainy season; however, there was no 
significant difference observed 
between the groups for any of these 
parameters. 
  
Treatment and placebo groups did 
not differ in morbidity indices (i.e. 
percentage of time reported with a 
particular illness or illness overall). 
2000 
 
Willumsen JF et al. 
 
Subclinical mastitis as 
a risk factor for 
mother-infant HIV 
transmission 
 
L:M as a marker of 
infant intestinal 
permeability and its 
relationship with 
subclinical maternal 
mastitis 
Durban, South 
Africa 
 
HIV-infected 
breastfeeding 
mothers and their 
infants followed up 
to 14 wk of age.  
 
Women recruited 
from antenatal 
clinic via a vitamin 
A supplementation 
trial to reduce 
mother-to-child 
HIV transmission. 
Cross-sectional 
analysis of 
baseline data 
prior to 
randomization for 
an RCT  
 
n=104 mothers  
 
n=108 infants (4 
pairs of twins), 
(26 were HIV-
infected by 3 mo 
of age) 
Urine Test: 
L:M  
 
 
There was no significant association 
between L:M and subclinical mastitis 
as measured by milk Na/K.  
 
 
Subclinical mastitis 
was not associated 
with magnitude of 
L:M. 
 
Actual L:M values 
were not reported 
but are found in a 
companion study, 
also included in this 
review [119].The 
study group in 
Willumsen, et al. 
represents a 
subsample of the 
study population 
reported in the 
companion study. 
2000 
 
Zhang Y et al. 
 
Lactulose-mannitol 
intestinal permeability 
test in children with 
diarrhea caused by 
rotavirus and 
Cryptosporidium  
 
Lima, Peru 
 
0-36 mo olds with 
watery diarrhea 
admitted to oral 
rehydration unit of 
hospital. 
Case-control  
 
n=36; 
 
n=29 cases: 
• 15 with C. 
parvum alone 
• 7 with rotavirus 
alone 
• 7 with bacteria 
(alone or with 
Urine Test: 
L:M  
 
 
Enrollment and 
convalescent (at day 
20) L:M ratios were 
assessed. 
Mean1 L:M (SE) at day 1, day 20: 
• Rotavirus only: 0.67 (0.38), 0.19 
(0.09) 
• Cryptosporidium only: 0.76 (0.43), 
0.28 (0.14) 
• Bacterial infection: ranged from 
0.2-0.87, 0.11-0.99 
• Unknown etiology: 0.26 (0.12), 
0.29 (0.18) 
 
Mean L:M ratios significantly 
L:M ratios were 
significantly 
elevated in children 
with rotavirus or 
Cryptosporidium 
infection compared 
to those with 
diarrhea not caused 
by rotavirus, 
Cryptosporidium, or 
identifiable bacteria.  
 
                                                          
1 Arithmetic mean. 
Evidence Table 2. Markers of permeability.
Reference and Study 
Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
L:M as a marker of 
intestinal permeability 
in children with 
diarrhea  
 
 
 
rotavirus or 
Cryptosporidium
) 
 
n=7 controls with 
unknown etiology 
 
differed between the unknown 
etiology and both the rotavirus (p< 
0.01) and Cryptosporidium groups 
(p<0.05) at baseline, but not at day 
20.  
 
Mean L:M ratios decreased between 
baseline and day 20 for both the 
rotavirus (p<0.001) and 
Cryptosporidium (p<0.05) groups. 
 
Among the group of subjects with 
enteric bacterial infections, the 
causative agents identified and 
mean L:M ratios (baseline, day 20) 
were: Campylobacter jejuni and 
rotavirus infection (0.86, 0.18), C. 
jejuni and 
Cryptosporidium infection (0.87, 
0.53), Salmonella sp. (0.2, 0.11), C. 
jejuni (0.69, 
0.99), and Aeromonas sp. (0.38, 
0.11). The L:M ratios of this group of 
seven infants were not included in 
the statistical analyses. 
 
Mean L:M did not 
change significantly 
among those with 
diarrhea of unknown 
etiology, but did 
significantly 
decrease among 
those infected with 
rotavirus or 
Cryptosporidium, 
reaching ratios 
similar to those with 
diarrhea of unknown 
etiology. 
 
 
 
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. Where these studies 
did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s. 
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting. 
Further details on L:M studies can be found in Table 19.  
 
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval, 
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins, 
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G, 
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent 
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium 
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score), 
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s) 
 
 
Evidence Table 2. Markers of permeability.
5.3.1 The Urinary Lactulose:Mannitol Ratio (L:M) 
The urine L:M test is the permeability test that has been most extensively used to 
measure gut function in children in the literature identified for this review. This noninvasive test 
involves oral administration of a dose of both sugars (i.e., lactulose and mannitol), followed by a 
timed urine collection. As reviewed above, lactulose is a large sugar (a disaccharide) that is 
minimally absorbed from an intact small intestine. However, if permeability is altered, this 
disaccharide traverses intracellular spaces of the gut, is then cleared by glomerular filtration 
without renal tubular reabsorption, and becomes measurable in the urine. Mannitol is a sugar 
alcohol that is absorbed (via transcellular pathways) proportional to the small bowel absorptive 
capacity (i.e. surface area). Shortened microvilli diminish uptake and subsequent urinary 
excretion of mannitol, which, like lactulose, is filtered and not reabsorbed.  
5.3.1.1 Technical Issues with the L:M Test 
Prior to delving into the results of the L:M tests, it is important to note that all of the 
biomarkers examined in this review have particular and general performance considerations, 
perhaps none more so than the L:M test. These considerations for the L:M test are summarized 
in Table 14, which demonstrates the tremendous variability in methods, citation of methods, 
ranges of purported normal values of abnormal cutoff points, and the way that results were 
reported across the 25 studies that we reviewed that used L:M as a marker. 
124
Reference
1
 Population Exclusion/ 
Inclusion 
Criteria 
Fasting Loading 
Doses of 
Lactulose 
and 
Mannitol
2 
Urine 
Collection 
Post 
Loading 
Dose Time 
Interval
3
 
Laboratory 
Analysis Method
4
 
Central 
Tendency 
Measure for 
L:M 
Comparisons to 
Other Studies
5
 
2004  
Campbell DI et al. 
Intestinal inflammation 
measured by fecal neopterin in 
Gambian children with 
enteropathy 
2 mo olds from a 
rural area followed 
until 15 mo of age. 
 
Not specified 
 
1 hr after 
loading dose  
A 5 hr Enzymatic assay 
per Northrop CA et 
al. [215] and Lunn 
PG et al. [216]  
Mean, type 
not specified, 
(CI) 
 
Normal value cut points
6
: <0.10 based on UK norm. Campbell DI et al. cited Travis & Menzies et al. [201] but it was unclear if the citation was related to normal values 
for lactulose and mannitol individually or also for L:M. Travis & Menzies did not report primary L:M data, but cited a mean (type not specified) of 0.016 (SEM 0.002), per 
Juby et al. [217], as normal. 
 
2003  
Campbell DI et al. 
Growth faltering in rural 
Gambian infants is associated 
with impaired small intestinal 
barrier function 
2-11 mo olds from 
a rural village 
followed up to 14 
mo of age. 
Not specified 2 hr after 
loading dose  
A  5 hr Enzymatic assay  
per Northrop CA et 
al. [215] and Lunn 
& Northrop-Clewes 
[218] 
Geometric 
mean (CI, 
range) 
Gambian children 
[209]  
Normal value cut points: Based on UK norms, value was not specified, per Freeman JV et al. [219], Weaver [220], Lunn PG et al. [202], and Lunn [52]. Freeman JV et 
al. [219] reported no data relevant to L:M. Weaver reported data for breastfed English infants and a derived median L:M from this data of ~0.2. Lunn PG et al. [202] 
reported a mean (SEM) L:M for UK 3-15 mo olds of 0.12 (0.02) based on “data from [their] laboratory”, but did not portray the data or cite another reference. Text suggests 
this was a geometric mean, but this was not clearly stated. Lunn [52] described L:M patterns, but not specific values. 
                                                             
1
 Some titles are abbreviated. 
2
 A = 400 mg/kg of lactulose, 100 mg/kg of mannitol, B = not reported, C = 4 g lactulose, 1 g mannitol, D = 5 g lactulose, 1 g mannitol, E = 200 mg/kg of lactulose, 
50 mg/kg of mannitol, F = 400 mg/kg of lactulose, 100 mg/kg of mannitol, G = 400 mg/kg of lactulose (maximum 4 g), 100 mg/kg of mannitol (maximum 1 g), H = 
500 mg/kg of lactulose (maximum 5 g), 100 mg/kg of mannitol (maximum 1 g). 
3
 Where authors cited references for these parameters, they are provided. 
4
 Where authors cited references for these parameters, they are provided. 
5
 Other than studies presented within the “Normal value cut points” row. 
6
 Where authors cited references for normal value cut-points, they are provided along with the relevant information from those citations. 
Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference
1
 Population Exclusion/ 
Inclusion 
Criteria 
Fasting Loading 
Doses of 
Lactulose 
and 
Mannitol
2 
Urine 
Collection 
Post 
Loading 
Dose Time 
Interval
3
 
Laboratory 
Analysis Method
4
 
Central 
Tendency 
Measure for 
L:M 
Comparisons to 
Other Studies
5
 
2003 
Campbell DI et al. 
Chronic T cell-mediated 
enteropathy in rural west African 
children: relationship with 
nutritional status and small 
bowel function 
6 mo-3 yr old 
malnourished in- 
and out-patients 
from rural areas. 
Compared to well-
nourished UK 
children with GI 
complaints other 
than diarrhea. 
Not specified Not reported B 5 hr Enzymatic assay  
per Sullivan PB et 
al. [221] and Lunn 
PG et al. [209] 
Not clearly 
indicated  
Asymptomatic 
Gambian children 
[209]  
 
Normal value cut points: <0.10 based on UK norms, per Fagundes-Neto U et al. [17] and Beattie RM et al. [222]. We were unable to obtain the article by Fagundes-Neto 
U et al. to verify. No relevant L:M data were found in Beattie RM et al. 
 
 
2002  
Campbell DI et al. 
Age-related association of small 
intestinal mucosal enteropathy 
with nutritional status in rural 
Gambian children 
2-60 yr olds from 
rural communities.  
Not specified Not reported C 5 hr Enzymatic assay 
per Northrop CA et 
al. [215], and Lunn 
& Northrop-Clewes 
[218] 
Mean, type 
not specified, 
(SE) 
Adults in UK & 
tropics [57] and 
previous results in 
Gambian & UK 
subjects [202]  
Normal value cut points: <0.10 based on UK norm per Freeman JV et al. [219] and Travis & Menzies [201]. Freeman JV et al. reported no relevant data. Travis & 
Menzies cited a mean (type not specified) L:M ratio of 0.016 (SEM 0.002), per Juby LD et al. [217], as normal.  
 
2003 
Chen P et al. 
Association of vitamin A and 
zinc status with altered intestinal 
permeability 
2-97 mo olds from 
an urban 
shantytown.  
 
Not specified Not reported D 5 hr HPLC 
per Barboza MS et 
al. [214] 
Mean, type 
not specified 
(SD) 
 
Normal value cut points: Not reported. 
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5
 
2007  
Darboe MK et al. 
Effectiveness of an early 
supplementation scheme of 
high-dose vitamin A versus 
standard WHO protocol in 
Gambian mothers and infants 
0-12 mo olds from 
a rural community.  
 
Inclusion: 
successfully 
obtained cord 
blood sample  
Exclusion: birth 
weight <2.2 kg, 
<37 wk gestation, 
congenital 
anomalies or 
severe  
peripartum illness 
Not reported E 5 hr Enzymatic assay 
per Lunn PG et al. 
[209] 
Geometric 
mean 
 
 
Normal value cut points: <0.30, authors derived this from Lunn PG et al. [202] UK infants’ mean plus 2 SD. Lunn PG et al. stated a mean (type not specified) (SE) of 
0.12 (0.02) based on “most recent data from this laboratory”, data not shown or cited. 
 
 
2001 
Filteau SM et al. 
The effect of antenatal vitamin A 
and (beta)-carotene 
supplementation on gut integrity 
of infants of HIV-infected South 
African women 
Infants of HIV-
infected women 
recruited from 
antenatal clinic and 
followed until 14 wk 
of age.  
Not specified Not reported A 5 hr Enzymatic assay 
per Lunn PG et al. 
[209] and 
Willumsen JF et al. 
[207] 
Geometric 
mean (CI) 
 
Normal value cut points: Based on norms, values not specified, per Catassi C et al. [223] and Lunn PG et al. [209]. Catassi C et al. reported data from 72 Italian infants. 
Their L:M values were calculated in two ways: 1) absolute ratio of lactulose and mannitol in mg/dl with L:M mean (type not specified) (SD) ranging from 1.27 (0.73)-0.22 
(0.21) and 2) ratio of lactulose and mannitol as percent dose ingested with L:M mean (type not specified) (SD) of 0.09 (0.08). Lunn PG et al. stated that UK infants’ norm 
as a mean (type not specified) (SD) of 0.12 (0.09), but did not portray the related data or cite another reference for this UK norm.  
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3
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Analysis Method
4
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Tendency 
Measure for 
L:M 
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5
 
2005 
Galpin L et al. 
Effect of Lactobacillus GG on 
intestinal integrity in Malawian 
children at risk of tropical 
enteropathy 
 
36-60 mo olds from 
a rural community. 
 
Exclusion: 
evidence of 
severe acute 
malnutrition or 
severe chronic 
illness  
Overnight D 3 hr Cation-exchange 
column and 
refractometer by 
modified method of 
Catassi C et al. 
[224] and Shulman 
RJ et al. [225] 
Arithmetic 
mean (SD) 
 
Normal value cut points: <0.10 based on developed world norms between 0.03-0.12, per Goto R et al. [205], van Elburg RM et al. [226], Campbell DI et al. [112]. Goto R 
et al. reported data based on 158 Guatemalan infants aged 0-11 mo without diarrhea in preceding week; the L:M median ranged from 0.41-0.54. They also used 0.07 as a 
cut point for normal L:M based on another reference by Ford RP et al. [227] which did not report data relevant to L:M. van Elburg RM et al. reported L:M based on 30 
Dutch 0-16 yr olds. L:M was calculated in two ways: 1) absolute ratio of lactulose and mannitol in mmol/mol creatinine with L:M mean (type not specified) (SD) 0.043 
(0.045) and 2) ratio of lactulose and mannitol as percent dose ingested with L:M mean (type not specified) (SD) 0.034 (0.033). Campbell DI et al. reported mean (type not 
specified) (SE) L:M of 0.353 (0.022) based on 26 Gambian 2-5 yr olds without diarrhea. They also reference UK norms but do not report specific values (see above). 
 
 
2008 
Goto R et al. 
Impact of anti-Giardia and 
anthelminthic treatment on infant 
growth and intestinal 
permeability in rural Bangladesh 
3-15 mo olds from 
a rural community 
followed over 9 
mos. Malnutrition 
was prevalent. 
Not specified Not reported  A 
  
Usually 3 
hr, but up 
to 5-6 hr if 
no urine 
output 
within 3 hr 
per Akram 
S et al. 
[228] 
Enzymatic assay 
per Lunn PG et al. 
[216] and Northrop 
CA et al. [215]. 
Geometric 
mean (SD) 
Gambian and 
Bangladeshi 
subjects per Lunn 
PG et al. [209] and 
Rousham EK et al. 
[229] 
Normal value cut points: < upper CI for UK infants, value not specified, per Lunn PG et al. [209]. Lunn PG et al. stated that UK infants’ norm as a mean (type not 
specified) (SD) of 0.12 (0.09), but did not portray the related data or cite another reference for this UK norm.  
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Measure for 
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2008 
Goto R et al. 
Impact of intestinal permeability, 
inflammation status and 
parasitic infections on infant 
growth faltering in rural 
Bangladesh 
 
3-15 mo olds from 
a rural community 
followed over 9 
mos. Malnutrition 
was prevalent. 
Not specified 1 hr before 
load 
A  5 hr for 
first exam. 
Reduced 
to 3 hr 
subseque
ntly if 
subject 
voided 
within first 
90 
minutes 
per Akram 
S et al. 
[228] 
Enzymatic assay 
per Lunn PG et al. 
[216] and Northrop 
CA et al. [215] 
Geometric 
mean, mean 
log L:M
7
 (SD 
reported for 
logged value) 
Gambian and 
Bangladeshi 
subjects per Lunn 
PG et al. [209] and 
Rousham EK et al. 
[229] 
Normal value cut points: Geometric mean 0.12 for UK infants per Lunn PG et al. [209]. Lunn PG et al. stated that UK infants’ norm as a mean (type not specified) (SD) 
of 0.12 (0.09), but did not portray the related data or cite another reference for this UK norm.  
2002  
Goto R et al. 
Poor intestinal permeability in 
mildly stunted Nepali children: 
Associations with weaning 
practices and Giardia lamblia 
infection 
 
0-5 yr olds from two 
urban squatter 
settlements. 
Malnutrition was 
prevalent.  
 
Not specified 1 hr after 
load (with 
the 
exception of 
breastfeedin
g) 
A 
  
5 hr Enzymatic assay 
per Lunn PG et al. 
[216]; 
Northrop CA et al. 
[215]; Blood et al. 
[230]; Lunn & 
Northrop-Clewes 
[218] 
Geometric 
mean (range, 
geometric 
SE
8
) 
Bangladeshi 
subjects per  
Northrop-Clewes 
CA et al. [150] and 
Rousham EK et al. 
[229]. Gambian 
subjects per  
Lunn PG et al. [202] 
and Behrens RH et 
al. [231]. 
Guatemalan 
subjects
9
 per 
Goto R et al. [205] 
 
Normal value cut points: <0.12 based on UK geometric mean per Lunn PG et al. [202]. Lunn et al. stated that UK infants’ norm as a mean (type not specified) (SD) of 
0.12 (0.09), but did not portray the related data or cite another reference for this UK norm.  
                                                             
7
 Authors present positive log L:M values, however, logged values would be expected to be negative for ratios between 0-1 as is the case for L:M ratios. 
8
 Authors calculated the geometric standard error using the formula: antilog (mean + standard error of logged values) - geometric mean. 
9
 For this study, medians were reported rather than means. 
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Other Studies
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2010 
Lima AA et al. 
Effects of vitamin A 
supplementation on intestinal 
barrier function, growth, total 
parasitic, and specific Giardia 
spp infections in Brazilian 
children 
2 mo-9 yr olds from 
an impoverished 
urban community. 
 
 
Inclusion: HAZ 
score 
<community 
median 
Exclusion: 
exclusively 
breast-fed, 
participant in 
another study in 
past 2 yr, or 
febrile illness at 
enrollment 
Not reported F Per 
Barboza 
MS et al. 
[214] 
Per Lunn PG et al. 
[216] and Northrop 
CA et al. [215] 
Median 
(range
10
) 
 
Normal value cut points: Not reported. 
2005 
Lima AA et al. 
Intestinal barrier function and 
weight gain in malnourished 
children taking glutamine-
supplemented enteral formula 
 
2-60 mo olds 
hospitalized with 
malnutrition, ~70% 
of whom had PD. 
Inclusion: history 
of PD or WAZ 
score <-2 and 
consent to 10-day 
hospital stay 
Exclusion: 
exclusively 
breast-fed, 
intolerant to 
cow's milk, 
participant in 
another study in 
past 2 yr, illness 
at enrollment 
3 hr before 
load 
G 5 hr HPLC per Barboza 
MS et al. [214] 
Mean, type 
not specified, 
(SE) 
 
Normal value cut points: Not reported. 
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 Authors used the term "range," but for some of the L:M medians, only one value was reported, apparently the maximum L:M value observed. 
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Fasting Loading 
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and 
Mannitol
2 
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Collection 
Post 
Loading 
Dose Time 
Interval
3
 
Laboratory 
Analysis Method
4
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Tendency 
Measure for 
L:M 
Comparisons to 
Other Studies
5
 
2007 
Lima NL et al. 
Wasting and intestinal barrier 
function in children taking alanyl-
glutamine-supplemented enteral 
formula 
6 mo-8 yr olds from 
an urban setting 
with HAZ, WAZ, or 
WHZ scores <-1. 
 
Exclusion: 
exclusively 
breast-fed, 
participant in 
another study in 
the past 2 yr, 
sibling enrolled in 
this study, 
chronic or severe 
or febrile illness 
at enrollment 
3 hr before 
load 
D 5 hr HPLC per Barboza 
MS et al. [214] 
Median 
(range
i
) 
 
 
Normal value cut points: Within the CI for values of healthy children in the community, values were not reported and no reference was provided. 
2001 
Northrop-Clewes CA et al. 
Anthelmintic treatment of rural 
Bangladeshi children: effect on 
host physiology, growth, and 
biochemical status 
2-5 yr olds from 
poor rural villages. 
 
 
Not specified 2 hr before 
and after 
load 
C 
 
5 hr Enzymatic assay  
per Northrop CA et 
al. [215], and Lunn 
& 
Northrop-Clewes 
[218] 
Geometric 
mean, mean 
log L:M (SE 
reported for 
logged value) 
Bangladeshi 
subjects per 
Northrop CA et al. 
[232] 
Normal value cut points: <~0.15 based on UK norm per Lunn PG et al. [209]. Lunn PG et al. stated that UK infants’ norm as a mean (type not specified) (SD) of 0.12 
(0.09), but did not portray the related data or cite another reference for this UK norm. 
2000  
Quadro L et al. 
Retinol and retinol-binding 
protein: gut integrity and 
circulating immunoglobulins 
1-9 yr olds with mild 
malnutrition from an 
urban slum. Vitamin 
A deficiency was 
prevalent. 
Inclusion: no sign 
of infection or 
other obvious 
illness 
 
Overnight D 
 
 
5 hr 
 
HPLC 
per Bao Y et al. 
[233]  
None 
reported 
 
Normal value cut points: <0.030 based on norms per Lima AA et al. [234], Deitch [235], Ukabam & Cooper [236],Wyatt J et al. [237], Pearson AD et al. [238], and Ford 
RP et al. [227] Lima AA et al. reported mean L:M (type not specified) (SE) of 0.017 (0.002) based on data from 13 Brazilian adults without HIV infection. Deitch reported 
mean L:M from 8 healthy American adult controls. Mean L:M was 1.7; SE was only presented graphically. L:M was expressed as lactulose/mannitol x 100 and the ratio 
was calculated as units rather than % dose administered; type of mean was not otherwise specified. Baseline values of mannitol (from pre-test samples) were subtracted 
from test samples. Ukabam & Cooper reported separate lactulose and mannitol excretion means for 25 healthy adult controls, presumably from the UK based on address 
of corresponding author. They did not report data on the L:M ratio. Wyatt J et al. reported mean (type not specified) L:M (SE) of 0.018 (0.002) based on data from 30 
healthy adults (presumably in Austria based on corresponding author’s address.) They defined a normal cutoff of 0.030 based on mean L:M + 2 SD. Pearson AD et al. 
reported mean L:M (type not specified) (range) of 0.018 (0.005-0.028) based on data from 31 healthy 2-13 yr olds (presumably in UK based on corresponding author’s 
address.) Ford RP et al. reported no data relevant to L:M.  
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2004 
Rabbani GH et al. 
Green banana and pectin 
improve small intestinal 
permeability and reduce fluid 
loss in Bangladeshi children with 
persistent diarrhea 
5-12 mo old males 
admitted to hospital 
with PD but without 
other concurrent 
illnesses. 
 
Inclusion: male, 
PD  
Exclusion: 
concurrent illness 
3 hr before 
load 
D 
 
5 hr Enzymatic assay  
per Behrens et al. 
[239], and 
Yamanaka [240] 
Mean, type 
not specified 
(SD) 
 
Normal value cut points: Based on norms, value not specified, per Lunn PG et al. [209], Barboza MS et al. [214], Behrens RH et al. [231], Roy SK et al. [241], Ford RP 
et al. [227]. Lunn PG et al. stated that UK infants’ normal values are: mean (type not specified) (SD) 0.12 (0.09), but did not portray the related data or cite another 
reference for this UK value. Barboza MS et al. reported mean L:M (type not specified) (SD) of 0.0394 (0.0235) based on 15 Brazilian under-5s from a low SES area 
without diarrhea in the preceding 2 weeks. Behrens RH et al. reported mean L:M (type not specified) (+/-2SD) of 0.42 (0.2, 1.4) and 0.52 (0.2, 2.2) based on 255 tests on 
60 healthy Gambian 0-18 mo olds with HFA >80% of NCHS median and 45 tests on 15 Gambian 0-18 mo olds with HFA between 60-80% of NCHS median. Roy SK et al. 
reported geometric mean L:M (CI) of 0.13 (0.1, 0.16) based on 53 asymptomatic Bangladeshi controls. Ages of controls were not described but diarrheal cases were aged 
3-24 mo. Ford RP et al. reported no data relevant to L:M. 
2001 
Rollins NC et al. 
Feeding mode, intestinal 
permeability, and neopterin 
excretion: A longitudinal study in 
infants of HIV-infected South 
African women 
1, 6, and 14 wk old 
infants born to HIV-
infected mothers. 
Not specified  Not reported A 5 hr 
 
  
Enzymatic assay  
per Willumsen JF et 
al. [207] 
Geometric 
mean (CI) 
 
Normal value cut points: Based on norms, value not specified, per Catassi C et al. [223] and Behrens RH et al. [231]. Catassi C et al. reported mean L:M based on data 
from 72 Italian infants. Their L:M values were calculated in two ways: 1) absolute ratio of lactulose and mannitol in mg/dl with L:M mean (type not specified) (SD) ranging 
from 1.27 (0.73)-0.22 (0.21) and 2) ratio of lactulose and mannitol as percent dose ingested with L:M mean (type not specified) (SD) of 0.09 (0.08). Behrens RH et al. 
reported mean L:M (type not specified) (+/-2SD) of 0.42 (0.2, 1.4) and 0.52 (0.2, 2.2) based on 255 tests on 60 healthy Gambian 0-18 mo olds with HFA >80% of NCHS 
median and 45 tests on 15 Gambian 0-18 mo olds with HFA between 60-80% of NCHS median.  
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2000  
Rollins NC et al. 
Vitamin A supplementation of 
South African children with 
diarrhea: optimum timing for 
improving biochemical and 
clinical recovery and subsequent 
vitamin A status 
6-60 mo old in- or 
out-patients with 
severe diarrhea. 
Intestinal 
permeability tests 
could be performed 
only for a subset of 
inpatients.  
Exclusion: 
children with 
dysentery, 
metabolic 
acidosis, 
circulatory 
impairment, 
severe 
electrolyte 
disturbances, or 
inability to take 
oral fluids 
Not reported A  
  
5 hr 
 
Enzymatic assay  
per Willumsen JF et 
al. [207] 
 
Geometric 
mean (CI) 
 
 
Normal value cut points: Not reported. 
2000 
Thurnham DI et al. 
Innate immunity, gut integrity, 
and vitamin A in Gambian and 
Indian infants 
Inpatients with 
diarrheal or 
respiratory disease, 
mean age 9 mos. 
And out-patients 
with “minor 
ailments”, age not 
specified.  
Not specified Not reported B 5 hr Not specified per 
Lunn PG et al. 
[209] 
Mean, type 
not specified 
(SE) 
 
Normal value cut points: <0.12 based on UK norm per Lunn PG et al. [209]. Lunn PG et al. stated that UK infants’ norm as a mean (type not specified) (SD) of 0.12 
(0.09), but did not portray the related data or cite another reference for this UK norm. 
2009 
Trehan I et al. 
A randomized, double-blind, 
placebo-controlled trial of 
rifaximin, a nonabsorbable 
antibiotic, in the treatment of 
tropical enteropathy 
3-5 yr olds from a 
rural village. 
 
Exclusion: 
chronic 
debilitating 
illness, congenital 
abnormalities, or 
severe acute 
malnutrition  
Overnight D 
 
4 hr HPLC per Shulman 
RJ et al. [212] and 
Scarpignato C et al. 
[242] 
Mean, type 
not specified 
(SD) 
 
Normal value cut points: <0.10 based on norms of 0.03-0.12 per Campbell DI et al. [112], Goto R et al. [205], and Galpin L et al. [120]. Campbell DI et al. reported mean 
(type not specified) (SE) L:M of 0.353 (0.022) based on 26 Gambian 2-5 yr olds without diarrhea. They also reference UK norms but do not report specific values (see 
above). Goto R et al. reported L:M values based on 158 Guatemalan infants aged 0-11 mo without diarrhea in preceding week. L:M median ranged from 0.41-0.54. They 
also used 0.07 as a cut point for normal L:M based on another reference by Ford RP et al. [227] which did not report data relevant to L:M. Galpin L et al. reported 
arithmetic mean (SD) L:M of 0.18 (0.16) and 0.22 (0.20) based on 2 groups of 80 and 81 healthy Malawian 3-5 yr old children, respectively.  
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2008 
Vieira MM et al. 
Carotenoids, retinol, and 
intestinal barrier function in 
children from northeastern Brazil 
2 mo-9 yr olds from 
an impoverished 
urban community. 
Inclusion: HAZ 
score 
<community 
median  
Exclusion: 
exclusively 
breast-fed, 
participants in 
another study in 
past 2 yr or 
febrile illness at 
enrollment 
1 hr after 
load, fasted 
prior as well, 
but duration 
not 
specified.  
H 
 
5 hr HPLC per Bao Y et 
al. 
 [233], Lima, et al. 
[234], and Barboza 
MS et al. [214] 
Mean 
(SD); 
however, only 
the 
proportion of 
normal 
values was 
reported 
rather than 
the mean 
 
Normal value cut points: <0.0864, calculated as mean + 2SD based on data from Barboza MS et al. [214]: mean L:M (type not specified) (SD) of 0.0394 (0.0235) based 
on 15 Brazilian under-5s from low SES area without diarrhea in preceding 2 weeks. 
2007 
Williams EA et al. 
A double-blind, placebo-
controlled, glutamine-
supplementation trial 
in growth-faltering Gambian 
infants 
 
4-10 mo olds from 
a rural area 
followed during the 
5-month rainy 
season and for 6 
months afterward 
All age-eligible 
children in the 
study villages 
were included 
None pre-
dose 
(stating 
ethical 
considera-
tions); 
2 hr post-
dose 
(exception 
of water 
allowed) 
 
F 5 hr Not specified. 
Williams et al. cited 
Travis and Menzies 
[201] generally 
regarding L:M 
assessment of 
intestinal 
permeability; it was 
unclear which 
aspects of Travis 
and Menzies’ 
methods were 
being referenced. 
Geometric 
mean, (CI) 
 
Normal value cut points: Not reported. 
Normal value cut points: Not reported. 
2000  
Willumsen JF et al. 
Subclinical mastitis as a risk 
factor for mother-infant HIV 
transmission 
Infants of HIV-
infected 
breastfeeding 
mothers, followed 
up to 14 wk of age.  
Inclusion: 
breastfeeding 
Not 
reported 
B Not 
specified 
Enzymatic assay  
per Willumsen JF et 
al. [207] 
None 
reported 
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2000  
Zhang Y et al. 
Lactulose-mannitol intestinal 
permeability test in children with 
diarrhea caused by rotavirus 
and Cryptosporidium  
0-36 mo olds with 
watery diarrhea 
admitted to a 
hospital oral 
rehydration unit. 
Inclusion: watery 
diarrhea and 
stool positive for 
rotavirus or 
Cryptosporidium  
Exclusion: 
dysentery, history 
of renal disease, 
or current 
antibiotic use 
Not reported A  
 
5 hr Enzymatic assay 
and 
spectrophotometer.  
 
Arithmetic 
mean (SE). 
Also reported 
raw data 
allowing for 
further 
analysis by 
the reader. 
 
Normal value cut points: Not reported. 
 
Abbreviations: AIDS=Acquired immune deficiency syndrome, CI=95% confidence interval, GI=Gastrointestinal, HAZ=Height-for-age Z (score), HFA=Height-for-age, 
HIV=Human immunodeficiency virus, HPLC=High performance liquid chromatography, hr=Hour(s), L=Lactulose, L:M=lactulose:mannitol, M=Mannitol, mo=Month(s), 
PD=Persistent diarrhea, SD=Standard deviation, SE=Standard error, TB=Tuberculosis, UK=United Kingdom, WAZ=Weight-for-age Z (score), WFA=Weight-for-age, 
WHZ=Weight-for-height Z (score), wk=Week(s), yr=Year(s) 
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An important initial methodological consideration is that administration of a loading dose 
is required; dosing among the studies we reviewed varied. Ideally, the dosing should be related 
to body mass, or at least to body weight, in view of the large range in body size and composition 
of the subjects to whom it is administered. Such dosing was reported to have been performed in 
only 13 of the 25 L:M studies we reviewed. It should be noted that either or both of these 
molecules can cause diarrhea via their hyperosmolar properties, and that sometimes the load 
causes vomiting. These side effects, although not serious, might be more prominent among 
children with certain characteristics thus skewing results. Indeed, the hyperosmolar effect is 
proposed to potentially interfere with absorption by causing solvent drag (retention of the 
measured solute in the gut), and has prompted consideration of a liquid meal with which to 
administer these exomolecular probes of intestinal absorption and permeability [184].  
Because gastric emptying could delay kinetics of absorption, a standard and perhaps 
prolonged fasting interval should be employed. This presents a challenge when testing infants 
who cannot tolerate fasts of greater than 3-6 hours depending on age, especially if exclusively 
breastfed since breastmilk is easily and relatively quickly digested. Furthermore, even a three-
hour fasting interval may not be tolerated among acutely malnourished children. However, 
fasting is most important for assessment of individual component measurements. Twelve of the 
25 reviewed studies reported that the children were fasted prior to challenge, but the duration of 
fasting differed across studies.  
There are additional theoretical concerns with hyperosmolar sugar absorption tests. 
First, there is evidence in humans that intestinal permeability can be altered by the 
administration of such solutes [243, 244]. Second, there is a small degree of endogenous 
mannitol production and excretion [243]. Third, the use of lactulose can accelerate orocecal 
transit time [245]. None of these factors were mentioned by any of these studies. These 
potential technical limitations have also not received much attention outside of the field of 
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environmental enteric dysfunction in the last two decades. Both the individual mannitol and 
lactulose component measures provide unique information as mentioned above, and thus 
should be reported separately; nearly three-quarters of the studies we reviewed did so. Ideally, 
the individual components should be presented as percent of dose administered, and also as an 
(ideally standardized) osmolarity of the ingested probe. Of the 18 studies reporting that 
components were measured separately, 11 presented results as such. Indeed, the report of 
Lima et al. exemplifies the merit of reporting such metadata, as a paradoxically inverse 
relationship between mannitol uptake and poor growth was identified [139]. 
Five-hour timed urine collections are considered standard. Timed urine collection among 
infants and young children presents a challenge in the best of circumstances and it can be even 
more challenging when subjects have loose stools, as is often the case among the very cohort 
of children for whom assessment of intestinal permeability is desired. Urine collection times 
varied across the studies in this review, and two did not report the information. Additionally, 
urinary bacteria, either representing clinical bacteriuria or contamination and replication prior to 
freezing, could alter sugar concentrations [246].  
Laboratory detection method varied as described in Table 14. Limits of normal results 
have not been determined for populations in resource-limited settings. Comparisons are made 
to those derived from developed-country settings. Table 14 demonstrates the various norms, 
primarily from the United Kingdom (UK), that were cited and referenced within the studies that 
we reviewed. Furthermore, the results were reported in varying ways. For example, L:M values 
can change with age of the subject, and in the setting of low urinary flow, as in dehydration, the 
impermeability of the proximal tubule has not been adequately assessed in children. 
Stratification of results based on age was often non-existent or suboptimal for determining its 
contribution to high L:M values. Also, it was difficult to compare the same age groups between 
studies. Perhaps the most striking deficiency was the lack of standard reporting of central 
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tendency measures, which were variably provided as medians or means. The latter were 
calculated as arithmetic or geometric means; the geometric method is more appropriate for ratio 
measures such as L:M. Some studies did not report central tendency measures but only the 
proportion with abnormal results. Among the 25 L:M studies we reviewed, three reported no 
central tendency values, two reported medians, and 20 reported means. Of the studies reporting 
means, 10 reported the geometric mean, which is a mathematically preferred expression of a 
mean for ratios, while two reported arithmetic means, and eight reported means without 
specifying their type. Clearly, despite the relative abundance of recent L:M data, the wide 
variation in study and reporting methods hamper our ability to make inter-study comparisons.  
5.3.1.2 Range of L:M Values Reported 
The majority of studies that we reviewed found elevated L:M values in their subjects, 
consistent with reports from before the interval of publication of papers that we assessed for this 
systematic review (i.e., studies published prior to 2000). These elevated L:M values were largely 
compared to norms reported for Western (primarily from the UK) childhood values [201, 217, 
220, 223, 226, 235, 237, 238] and less often related to presumed norms of children in 
developing-country settings [112, 120, 205, 214, 231, 234, 241].  
Delineation of normal values is a challenge for several reasons. Normative curves are 
often established based on assessments among a small sample of children in a developed 
country. Two standard deviations are frequently used as cutoff point to define normal/abnormal 
levels. However, this may not always be an appropriate method for a variety of reasons. Genetic 
factors might or might not influence test results. Marker response to environmental exposures 
might, at least initially, reflect adaptive rather than pathologic responses.  
As noted above, comparison of L:M values across the 25 studies that we reviewed was 
also challenged by differences in the way the values were reported (see Table 14). Among 
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studies reporting the ratio results as geometric means, the values (ratios) ranged from 0.08 to 
2.4 and both extremes were published by the same author group in two different studies, 
although among different populations. The lowest (i.e. least abnormal) values were reported 
among HIV-negative South African infants under four months of age born to HIV-infected 
mothers [160, 161], while the highest values were found in children aged six to 60 months 
hospitalized with severe diarrhea, also in South Africa [161]. The fact that the highest values 
were an order of magnitude higher than in other studies reviewed led us to speculate that L:M 
values might have been expressed as a multiple for portrayal on the same graph with urinary 
neopterin and serum retinol-binding data. 
Among children in rural Bangladesh, one study found a geometric mean L:M value of 
0.15 [123]. In two different rural Bangladesh intervention trials, baseline L:M values were 0.18 in 
each of the anti-helminthic treatment groups and 0.16 in the placebo group in the same setting 
[122], but were 0.22 and 0.25 in a different rural setting also among anti-helminthic treatment 
and placebo groups, respectively [150].  
In Nepal, the mean L:M value among mildly stunted children aged 0-60 months was 
0.26, but did significantly differ between those infected with Giardia (0.43) vs. those without 
evidence of giardiasis (0.25) [124]. A series of studies conducted in The Gambia reported L:M 
geometric mean values of 0.169 [110], 0.353 [112], and 0.31 [15]. Another study demonstrated 
similar results, ranging from 0.26 to 0.37 in placebo-treated children, depending on month of the 
study [170]. These studies support the concept of widespread intestinal permeability issues 
among children in developing settings with considerable variation between studies, generally 
finding a greater degree of permeability in central African settings.  
However, in contrast to the Asian and central African studies, some South African [119, 
160] studies found L:M values that were similar to established norms (i.e., mean values from 
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healthy children in developed settings). These apparent contradictions could reflect the 
emergence of the economies in which these children reside, with concomitant improvement in 
gut health. Three [119, 160, 161] of the four L:M studies from South Africa presented geometric 
means (notably, each of these four studies were performed by the same investigator group). 
The fourth study [171] presented a subset of data published by Filteau et al. [119]. Filteau et al. 
[119] and Rollins et al. [160] assessed L:M among infants born to HIV-infected mothers and 
generally found normal values that did not increase with age. Filteau et al. also noted no change 
in L:M measures with increasing morbidity. However, in both studies the mean value of L:M for 
the infants who became infected with HIV was increased; the Rollins et al. observational study 
reported a mean of 0.24 and the Filteau et al. intervention trial reported a mean of almost 0.5 
among those whose mothers had not received vitamin A supplementation.  
Similarly, some South American [137, 139] studies found L:M values that were similar to 
mean values for healthy children. Six L:M studies from Brazil were conducted by one team of 
investigators [113, 137-139, 156, 169]. Three of the studies reported baseline L:M values but 
did not classify them as normal or abnormal [113, 137, 138]. Two studies assessing similar 
populations of mildly malnourished children from an impoverished urban community in Brazil 
[156, 169] reported that a high proportion of their subjects had abnormal L:M values. L:M 
median and range data collected a few years later in the same setting and with the same 
inclusion criteria were noted by the authors to be within the confidence interval for values of 
healthy children in the study community [139] (the reference for this confidence interval was not 
cited).  
Several studies measured the variability of L:M values between and within individuals. 
Some of these identified wide ranges [122, 124], and Campbell et al. [112] found that L:M 
showed significant intra-subject correlation between tests conducted 3.5 months apart. In 
contrast, Northrop-Clewes et al. [150] observed that intra-individual L:M values in the placebo 
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group of an anti-helminthic trial did not change significantly over 12 months. Of note, L:M values 
might change with increasing age because of normal changes of physiologic maturation. 
However, the studies that we reviewed rarely reported data stratified by age, thereby prohibiting 
rigorous comparisons from one study to the next. 
Very few studies investigated longitudinal change in a measure of central tendency of 
L:M values for their study sample. Campbell et al. found a small but significant improvement in 
mean L:M value between the two study time points (from 0.198 to 0.172, type of mean not 
mentioned), driven by an improvement in mannitol recovery with no change in lactulose 
excretion [112]. The interval between sampling was 3.5 months.  
Three studies observed seasonal variation in L:M values. Two of these studies were 
conducted in rural Bangladesh; the timing of peak L:M values differed slightly between them. In 
one study [122], the highest values were observed during the monsoon season while in the 
other [150], the peak followed the monsoon season. A study in The Gambia reported monthly 
variation in geometric mean L:M values, ranging from 0.37 in July to 0.26 in October in placebo-
treated children [170]. 
5.3.1.3 Associations between L:M and Growth Outcomes 
The L:M test has been used extensively to assess small intestinal function in relation to 
nutritional status in children in resource-limited settings. Several studies have found inverse 
relationships between L:M and growth parameters, while others have not (Table 15). Goto et al. 
[123] and Campbell et al. [110] found that L:M was inversely associated with height-for-age Z-
scores (HAZ) and weight-for-age Z-scores (WAZ). A longitudinal study by Goto et al. [122] 
found associations between change in L:M and changes in weight-for-age Z-scores (∆WAZ) and 
weight-for-height Z-scores (∆WHZ),showing improvement in growth parameters with decreased 
L:M values. A later study by Campbell et al. [15] found that long-term height gain was negatively 
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associated with mean L:M value. Northrop-Clewes et al. [150] observed that L:M was inversely 
correlated with change in height-for-age Z- (∆HAZ) and ∆WAZ scores at 12 months of follow-up. 
However, several studies did not find an association between L:M and growth 
parameters. Goto et al. [124] reported no association between L:M values and growth status, 
although they did not specify which of the assessed growth measures (HAZ and WAZ) were 
used to evaluate this. A 2003 study by Campbell et al. similarly found no association between 
L:M and grade of protein energy malnutrition [111]. The same group earlier demonstrated that 
L:M was inversely associated with HAZ after correcting for age, gender, and study visit, but not 
with WAZ or body mass index z-scores [112]. In these studies, the association with HAZ was 
mainly attributed to the greater lactulose excretion in subjects with poorer HAZ scores and was 
constant across all age groups. There was no significant association between L:M calculated as 
the mean of the two data collection points and change in nutritional status parameters.  
Several factors complicate comparison of the relationship between L:M and growth 
parameters across studies. Anthropometric indices used in these assessments varied. Markers 
were sometimes associated with different anthropometric measures within the same study. In 
one instance [112], a relationship was identified between L:M and HAZ score but not WAZ 
score. When the relationship between L:M values and growth parameters is not reported, it is 
not clear if the anthropometric indicator was either not evaluated or whether a significant 
relationship was not identified (i.e., only positive results were presented). One study assessed 
association with single sugar excretion only, reporting no significant associations between HAZ, 
WAZ, or weight-for-height Z- (WHZ) scores and lactulose, but significant associations with both 
WAZ and WHZ scores and mannitol [139]. The article did not mention HAZ score when 
reporting the results of mannitol analyses, leaving unspecified whether the relationship was 
assessed and found to be nonsignificant, or not assessed at all.
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Table 15. Associations between anthropometric indicators and biomarkers of EED. 
Data presented are from one study unless otherwise indicated in parentheses. 
 
Anthropometric 
Z- score L:M Lactulose Mannitol Lactose:creatinine 
Stool 
lactoferrin 
Stool 
neopterin 
Urine 
nitric 
oxide 
Intestinal 
maltase 
activity 
Intestinal 
lactase 
activity 
Histopathology 
HAZ Y (3) 
N (1) 
N  Y     Y By 2 of 3 digital 
morphometric 
measures1: Y 
∆HAZ Y (2)   Y N Y     
WAZ Y (2) 
N (3) 
N Y Y   N N Y By 2 of 3 digital 
morphometric 
measures*: Y 
Endoscopy: N 
Histopathology: 
N (2) 
Y (1) 
∆WAZ Y (2)   Y  Y     
WHZ Y N Y Y      By 2 of 3 digital 
morphometric 
measures1: Y 
∆WHZ    Y       
BMI N          
Y=yes, a statistically significant relationship was found. 
N=no, a statistically significant relationship was not found. 
                                                             
1 The three digital morphometry measures included enterocyte height, enterocyte brush border, and enterocyte nucleus height. The two measures 
that were significantly associated with anthropometric indicators differed for each type of anthropometric indicator assessed.  
5.3.1.4 Associations between L:M and Other Outcomes 
Four studies assessed the potential association between L:M values and Giardia 
infection. Two found no association [15, 123]. A Bangladeshi antihelmintic trial [150] found that 
L:M and giardiasis were not associated overall; they only identified an association among the 
treatment group in their intervention trial at a single time point over the course of the 12-month 
study period. In the fourth study, the geometric mean L:M among mildly stunted Nepalese 
children from urban squatter settlements aged five years and under was 0.26, but statistically 
significantly differed between Giardia-infected and non-infected children (0.43 vs. 0.25, 
respectively) [124].  
Several studies investigated the relationship between subject age and L:M values; three 
found no association [113, 119, 124]. Goto et al. demonstrated a decreasing L:M trend with age 
among a cohort of Bangladeshi 3-15 month olds [123]. Campbell et al. [112] compared 
Gambian 2-5 year olds with older children and found a significant association between age and 
L:M values as well as a small but statistically significant improvement in mean L:M over 3.5 
months driven by improved mannitol excretion without change in lactulose excretion. They later 
[110] reported study results among another cohort of Gambian children that showed that L:M 
values showed a large and statistically significant increase between 12 weeks and one year of 
age, a change driven by both increasing lactulose and decreasing mannitol excretion. Darboe et 
al. [115] observed that L:M values rose by about 50% from age two months to one year, but did 
not analyze the trend statistically.  
Various studies examined the L:M marker in the context of other conditions. No 
association was found between L:M and diarrhea history [124] or helminthiasis [150, 205]. 
Associations were found between L:M and infection with HIV [119, 160] and Cryptosporidium 
and rotavirus [172]. Two studies reported seasonal L:M variation in rural Bangladesh, with 
peaks during [122] or following [150] monsoon season. 
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5.3.1.5 Use of the L:M Test as an Endpoint for Intervention Trials 
Multiple studies have used the L:M marker as an endpoint to assess intestinal 
permeability in randomized, controlled trials. The specific interventions varied widely, including 
micronutrient supplementation, probiotics, therapeutic diets, and antibiotic and anti-helminthic 
drug administration. 
Four studies utilized L:M as an outcome in vitamin A supplementation intervention trials 
and found no association with L:M overall [115, 119, 137, 168] although Filteau et al. did identify 
a significant reduction in L:M values among HIV-infected children treated with vitamin A [119]. 
While Darboe et al. noted that a vitamin A-supplemented group experienced a reduction in 
lactulose uptake, they also observed an accompanying decrease in mannitol absorption; 
therefore the ratio of the two sugars did not change [115]. This finding demonstrates the value 
of reporting the absorption of the two sugars separately, in addition to reporting the ratio. In 
contrast, Chen et al. observed improved L:M values after treating a cohort with persistent 
diarrhea or low WAZ with a single dose of vitamin A and a two-week course of daily zinc [113]. 
Lima et al. conducted two studies using L:M as an outcome to assess the beneficial 
effects of formulas of different compositions used in therapeutic rehabilitation of children with 
persistent diarrhea and/or malnutrition. In the study assessing glycine-supplemented formula, 
L:M values improved in the treatment group [138]. However in a trial in which this group 
examined alanyl-glutamine-supplemented formula, even though lactulose excretion improved, 
mannitol excretion worsened and therefore L:M values did not change after the intervention 
[139]. In another trial of glutamine supplementation, conducted by Williams et al. in The 
Gambia, the intervention did not improve L:M values; in fact, analysis by repeated measures 
analysis of variance (ANOVA) indicated that L:M values were borderline elevated in the 
glutamine-supplemented group (p=0.05), contrary to what was expected [170].  
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Another dietary intervention trial examined the efficacy of green banana and pectin 
among children with persistent diarrhea [157]. While post-intervention L:M values were still 
elevated, both lactulose and mannitol excretion improved after treatment, with lactulose being 
the primary driver of the improvements seen in the ratio of these two sugars.  
Four other trials examined the degree to which L:M values improved as a result of 
various interventions, with no effect observed: probiotics [120] and antibiotics (rifaximin) [13] to 
target small bowel bacterial overgrowth as a potential cause of impaired intestinal integrity in 
Malawi, and various anti-helminthic and anti-Giardia treatments in Bangladesh [122, 150]. 
Interestingly, a Brazilian vitamin A trial demonstrated reduced lactulose as well as mannitol 
excretion, but an unchanged overall ratio [137], thereby highlighting the value of reporting 
absorption of the sugars separately. 
In many of these studies, power considerations were not addressed at all, or 
incompletely addressed, and were often subordinated to study realities. Several examples 
illustrate the issue. Goto et al. recruited 222 children, into two treatment groups and one 
placebo group [122]. They estimated their sample size based on baseline recent Bangladeshi 
infant data [247]. They calculated that to improve HAZ by 33%, a sample size of 68 was needed 
(using an α of 0.05, and 80% power). For WAZ, the sample size needed was 73. So, after 
allowing for attrition, they aimed to recruit approximately 100 infants in each group. The anti-
Giardia treatment used in this study, secnidazole, is unpalatable, so there was concern that 
there might be more attrition in those receiving this treatment. Therefore the treatment groups 
were increased by about 10% relative to the control group (n = 142, 141 and 127, respectively). 
However, because of large loss of subjects to follow-up as well as other methodological issues, 
including inaccurate dosing by many subjects and switching to analysis on actual treatment 
received rather than on an "intent-to-treat" basis, the final group sizes were 75 (secnidazole & 
albendazole), 59 (secnidazole only), and 88 (control). Hence, the size of the second group fell 
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below sample size targets for adequate power, while the other groups were still of sufficient size 
for projected HAZ and WAZ outcomes. 
Northrop-Clewes et al. [150] did not report sample size calculations, indicating that their 
target sample size of 120 was based on logistical reasons. They went on to state “the null effect 
of deworming in this study could perhaps have stemmed from an inadequate sample size or 
duration of follow-up. However, significant improvements were observed in studies with smaller 
samples (e.g., n = 23, n = 55, and n = 72; 42, 10, 11) and of much shorter duration (seven and 
nine weeks) [248-250]". This comparison draws attention to the potential role of publication bias 
in any review of the literature. 
5.3.1.6 Associations between L:M and Other Markers 
Five of the 25 publications examined L:M results in relation to other potential markers of 
intestinal dysfunction, including one study that found that it was not correlated with urinary 
lactose or lactose:lactulose [124]. Two studies assessed L:M and markers of systemic 
inflammation and found differing results [110, 123]. A fourth study found no correlation with stool 
neopterin [15]. The only study that we reviewed that examined L:M in relation to intestinal tissue 
reported a variety of intestinal tissue measurements by morphometry and reported positive 
correlation with mucosal B-lymphocyte density, intraepithelial lymphocytes (IEL), and IELs 
staining positive for perforin [111]. It is not clear if the other intestinal markers were not 
correlated or merely not assessed for correlation. 
5.3.2 The Lactulose:Rhamnose Ratio (L:R) 
Similar to the L:M, the lactulose:rhamnose ratio (L:R) has been used as an index of gut 
mucosal function. As in the L:M test, lactulose is used as the measure of barrier function, but 
rhamnose replaces mannitol as the marker of absorptive capacity. L:M is performed on urine 
samples and, as mentioned above, in timed collections, ranging from three to six hours. The L:R 
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test had been performed on similarly timed urine specimens as well. To our knowledge, there 
are no published data comparing rhamnose directly to mannitol in children with enteric 
dysfunction, but in adults with inflammatory bowel disease the two sugars are absorbed 
comparably [251].  
5.3.2.1 The L:R Test as a Reflection of Issues in Serum or Urine Sugar 
Testing in Children 
Recent advances in high-performance liquid chromatography (HPLC) now permit 
sensitive detection of lactulose, mannitol and rhamnose in the blood. While timed blood 
specimens have been evaluated in animals and human adults [252-256], the invasiveness of 
repeated phlebotomies presents practical and ethical challenges in pediatric research. However, 
collection of urine over a period of time in young children, while less invasive, is not a trivial task 
either. While application of urine “bag” collectors permits noninvasive capture of urine, loss of 
urine because of leakage around the bag is common, as is contamination by stool, especially 
among children with diarrhea. Indeed, it should be noted that the children in most need of 
intestinal function testing often have diarrhea, and the ingestion of the sugar loads themselves 
can lead to osmotic diarrhea.  
Haase et al. compared the validity of L:R testing on one-time collections of blood to 5-
hour urine collections [125] in children. They found that blood L:R values were consistently 
lower than urine L:R values by a geometric mean (95% confidence interval (CI)) of 1.09 (1.02, 
1.16). There was substantial agreement between the two tests as measured by a kappa statistic 
of concordance (95% CIs) of 0.71 (0.51, 0.92). Assuming urine L:R as a gold standard, Haase 
et al. calculated sensitivity and specificity of blood L:R as 81% and 89% respectively. 
As discussed above, test failure can occur for various reasons when tests rely on urine 
samples, particularly timed samples. However, test failure can also occur with blood specimens 
because of insufficient volumes collected to run the assay, and potentially from edema if blood 
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is obtained by finger stick [257]. In addition, the assay cannot be performed using either analyte 
if children vomit, or refuse to ingest, the sugars. Haase et al. defined test “failure” as emesis of 
the sugar load, urine leakage or contamination with stool, or blood collection insufficient for 
analysis (<0.25 mL of plasma). While they did not delineate the reasons for failure among the 
blood vs. the urine collections, they did observe a significantly higher failure rate for the urine 
(37%) compared to the blood assays (10%) (p<0.0001). Interestingly, a study published in 1999 
(and therefore not included in the analysis of this systematic review) by the same authors also 
reported a 37% failure rate for urine L:R testing and in this earlier study they specified the 
proportions by cause of failure. They noted that the failure rate for a five-hour urine collection 
varied between 47% (32 of 68) in girls with acute diarrhea to 17% (14 of 82) in non-diarrheal 
controls. They also noted that causes of test failure consisted of vomiting or refusal to drink the 
probe sugar solution in 21 (9%) of the tests [258]. 
The remaining four studies that used L:R as a marker of gut permeability measured 
these ratios in blood specimens. We found that rates of technical failure of testing were not 
often reported in the sugar absorption/permeability studies that we reviewed. Of the four studies 
using serum L:R, two discussed failure to complete testing. One study specifically reported 
difficulty with venipuncture in two of 34 subjects [159]. In the other study, L:R was measured at 
baseline as well as following an intervention with specific milk formulas [134]. It was not entirely 
clear, but it did seem that baseline L:R testing was successfully completed on all subjects while 
there was a reported “failure” of post-intervention testing among 10 of 150 children. Reasons for 
test failure in the second determination were not reported. Among the five studies that used D-
xylose (either urine or serum) [136, 146, 147, 152, 155] no mention was made of lack of 
completion of testing among the subjects enrolled. Only seven [124, 138, 139, 150, 161, 169, 
172] of the 25 urinary L:M studies included in this review specifically mentioned the number of 
children who completed L:M testing compared to the number recruited into the study. It was not 
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always clear why incomplete L:M testing occurred, but it appears that in five of these studies 
there was a failure in testing because of improper compounding of the sugar solution, inability to 
collect urine during the testing period, urine leakage or stool contamination, or refusal to ingest 
the sugar solution. Similar to the study that expressly measured and reported failure rates in L:R 
testing [125], Goto et al. reported in 1999 (and therefore not included in this review) that the L:M 
test failure rates were 32% [205]. 
It should be noted that each of the five L:R studies in this review was conducted by the 
same researchers in Darwin, Northern Territories, Australia (one of their studies also included 
subjects from Adelaide, South Australia, Australia). It appears that some of the studies might 
represent data from overlapping cohorts of children. It should also be noted that while Australia 
clearly falls within the classification of a high income country, our inclusion definition of children 
in “developing-country setting” included marginalized or indigenous populations in a developed 
country who are plausibly exposed to the same environmental and/or infectious risks for EED as 
children in developed-country settings. In fact, research among Aboriginal populations in 
Australia has contributed a great deal to the EED field [58, 258].  
5.3.2.2 Range of L:R Values Reported and Associations with Growth 
Outcomes 
Many investigators report the L:R value multiplied by 100 for ease of reporting; this 
convention was followed within the articles examined for this review. The geometric mean was 
the measure of central tendency consistently used in these studies, facilitating comparison of 
results. However, while the L:M studies referenced various ranges of normal standards, none of 
the L:R studies cited such reference standards. Furthermore, the three studies that reported the 
proportion of children with abnormal L:R results used different cutoff points and did not cite 
references for these demarcations of normal and abnormal values that they employed. One 
study defined an abnormal L:R value as >16, with 20 of 32 children (63%) exhibiting values 
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above this threshold [159], another used 7.2 as their defined cutoff point with 112 of 152 
subjects (74%) above that threshold [43], and a third explained the derivation of its cutoff point 
of >5.6 as two standard deviations above the arithmetic mean for non-Aboriginal children 
without diarrhea [58]. No citation was given for this standard value, implying that it might have 
been derived from the data collected in this study. However, the authors reported that none of 
the study’s non-Aboriginal children without diarrhea had abnormal permeability values, 
suggesting that perhaps the cutoff point was derived from a different study. While their study 
included Aboriginal children with diarrhea, they did not report proportions of children with L:R 
values >5.6 for this group. 
Three studies compared serum L:R values among primarily Aboriginal cases with 
diarrhea and controls without this disorder. Baseline geometric means for L:R (95% CIs) in the 
two studies ranged from 3.7 (2.8, 4.9) [134] to 5.9 (4.4, 7.8) [125] to 11.4 (8.5, 15.5) [159] 
among controls and 9.4 (6.7, 13.1) [125] to 12.8 (10.3, 16.0) [134] to 31.8 (24.9, 40.7) [159] 
among cases.  
In a randomized trial of three different milk formulas in Aboriginal children with 
malnutrition and/or diarrhea, baseline geometric mean L:R values (95% CIs) were 14.9 (10.4, 
21.5) in one treatment group; baseline values were similar in the other groups [134]. Although 
subjects were randomized to treatment groups, the study did not include a control arm of 
standard care to which change in L:R could be compared. Mean improvement in L:R (95% CIs) 
was 13.0 (9.3, 16.6) with some significant differences across treatment groups. This was the 
only study in this review using L:R as an outcome measure in an intervention trial.  
A similar study reported that mean L:R values among Aboriginal children were 
approximately double those of non-Aboriginal children, whether examining across groups of 
subjects either with or without diarrhea, consistent with the authors’ suggestion that clinically 
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silent enteric dysfunction is prevalent among Aboriginal children [58]. Geometric mean L:R 
among the children without diarrhea was 2.5 and 4.6 among non-Aboriginal and Aboriginals, 
respectively (p=0.02). Geometric mean L:R among those with diarrhea was 7.9 and 16.4 among 
non-Aboriginals and Aboriginals, respectively (p=0.002).  
One study examined the relationship between L:R and growth and found no association 
with nutritional status or age. Associations were, however, found between high L:R and acidosis 
(p=0.007), hypokalemia (p=0.035) and diarrhea severity (p=0.001) among children with diarrhea 
[58]. 
5.3.2.3 Associations between L:R and Other Markers 
Serum L:R was compared to other biomarkers for EED in three of the other four studies. 
Ritchie et al. found L:R to be significantly inversely correlated with the 13C sucrose breath test 
(r=0.67; CI: 0.42, 0.62; p<0.0001) [159]. Kukuruzovic et al. studied urinary nitric oxide excretion 
in relation to L:R in Aboriginal and non-Aboriginal in-patients with acute diarrhea, non-
gastrointestinal infections, or without infections or diarrhea [43]. They found that 
NO2/NO3:creatinine and L:R were correlated (r=0.37, p<0.001), after adjusting for age and race. 
The association was stronger for lactulose permeability, with an effect ratio (95% CIs) of 1.47 
(1.29, 1.66), than it was for rhamnose malabsorption, with an effect ratio (95% CIs) of 0.80, 
(0.67, 0.97). NO2/NO3 concentrations decreased significantly less rapidly than L:R values 
among children recovering from diarrhea. Another study by Kukuruzovic et al. assessed the 
association between L:R and red cell indices, stool reducing substances, and lactosemia and 
identified an association only with the latter, but the degree of correlation was minimal [58]. 
5.3.2.4 Methodological Issues with the L:R Test 
Overall, there were fewer issues with consistency in reporting of L:R results across 
studies, perhaps because all of the L:R studies in our review were performed by the same group 
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of investigators. Four of the five studies reported a measure of central tendency for L:R and it 
was consistently in the form of a geometric mean multiplied by 100. Dosing of the sugars was 
the same across the studies. The timing for serum sampling was similar, with most using a 
collection time of 90 minutes following administration of the dose; only one study differed 
slightly, with testing occurring in a range between 90 to 120 minutes. HPLC was the test method 
for the serum L:R throughout. However, in striking contrast to the L:M studies, reference 
standards for L:R values were not cited. The three studies that reported proportions with 
abnormal L:R values used markedly different cutoff values that were either not defined or given 
insufficient explanation. 
The urinary L:R test has disadvantages typical of any urinary method for dual-sugar 
permeability testing; the serum method avoids these issues, and, indeed, Haase et al. found a 
lower test failure rate with this method. 
5.3.3 Serum and Urinary Lactose 
As mentioned above, we assigned markers to categories based on their best fit, 
recognizing that biomarkers could indicate derangement of more than one function. For 
example, lactose is not normally absorbed across the intestine, but rather requires breakdown 
to products that are absorbed, namely galactose and glucose. This digestion is catalyzed by 
lactase, an intestinal brush border enzyme. While the presence of lactose in the serum or urine 
would in most instances indicate a lack of lactase (as opposed to presence of lactose excessive 
to lactase saturation), it also, and primarily, reflects a permeability defect, because even if 
lactose is not broken down, its size should preclude traversing the mucosa unless a porosity 
defect also exists.  
We identified three studies that measured lactose in the blood (n=1) or urine (n=2) in the 
context of putative intestinal injury. Kukuruzovic et al. tested markers of intestinal permeability, 
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including serum lactose, among hospitalized Aboriginal and non-Aboriginal children with and 
without diarrhea [58]. Circulating lactose was detected in 38% of Aboriginal cases and 12% of 
controls (Aboriginal and non-Aboriginal combined). Lactosemia was weakly associated with an 
abnormal L:R. Another study of children from two urban squatter settlements with high rates of 
malnutrition primarily focused on identifying lactase deficiency via urinary lactose:lactulose, 
finding that nearly half of subjects had low lactase activity [124]. Urinary lactose concentration, 
as well as lactose:lactulose ratio, decreased with increasing age, but neither was associated 
with the L:M. The authors noted that lactose concentrations and lactose:lactulose ratios were 
significantly higher in breastfed subjects than those not breastfed, despite similar L:M values. 
However, the paper did not specify the nature of the dietary lactose sources in the non-
breastfed babies. That is to say, if the bioavailability of the lactose or the quantity ingested is 
low, mucosal function could appear to be inappropriately normal. The final study measured the 
lactose:creatinine (L:Cr) ratio in Nepali children living either in squatter settlements or lower 
middle-class periurban households [151]. Mean L:Cr was significantly higher among the 
squatter compared to the lower-middle class group. For both SES groups, L:Cr values 
decreased with increasing age (p<0.001). HAZ, WAZ, WHZ, and ∆WAZ scores were strongly 
associated with mean L:Cr (p<0.001 for each parameter) as was ∆HAZ score (p=0.004); ∆WHZ 
score was not. Interestingly, the strength and magnitude of association between ∆WAZ score 
and L:Cr was most pronounced among the wealthier cohort and there was no association 
between ∆HAZ score and L:Cr among the squatter children, perhaps because of poor diets 
accounting for more of an effect among the squatter children.  
5.3.4 Summary of Markers of Permeability 
Despite logistical challenges, the L:M and L:R tests and other tests of permeability have 
been utilized extensively to assess intestinal function in children in resource-limited settings. 
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L:M values were often, but not always, elevated above published developed country 
norms in community-based studies of asymptomatic children in resource-limited settings. The 
other tests of permeability generally were not compared to a reference standard, limiting 
comparison of results across studies and different settings. 
The L:M test was more extensively studied than the other permeability markers and was 
used more widely as an endpoint for intervention trials, including evaluation of micronutrient 
supplementation, dietary interventions and probiotics, and anti-bacterial and anti-parasitic drug 
treatments. L:R was used as an outcome measure for one intervention study. With new HPLC 
laboratory methods that are sufficiently sensitive to detect lactulose, rhamnose and other 
sugars, dual sugar tests might become more widely used.  
While we identified two studies that compared serum L:R to serum lactose [58] and L:M 
to urinary lactose and lactose:lactulose [124], we did not find comparisons of L:M and L:R test 
results; a head-to-head comparison of the two most extensively used permeability tests would 
be informative.  
The relationship between L:M and age varied across studies; some observed an 
association [110, 112, 115, 123], while others did not [113, 119, 124]. The single study that 
investigated the relationship between L:R and age did not find an association [58]. Furthermore, 
while most studies found an inverse association between L:M and anthropometric status, results 
were mixed. One study investigated the relationship between L:R and growth, and did not 
observe an association [58].  
As with the D-xylose and endomolecular tests of absorption, lack of consistency in what 
was used as a cutoff point for normal (or what was reported to have been used) in the dual 
sugar permeability tests made it very difficult to compare results from one study to the next. 
Across permeability tests, we found a wide spectrum of depth of reporting and insufficient 
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details were often provided. The L:M studies best portrayed issues with methodology, reporting, 
and poor comparability caused by wide differences in how the test was performed across 
studies, differences in subject preparation and feeding mode, dosage of test sugars, and timing 
of urine collection, all of which can influence test results. Further complicating comparability, the 
measures of central tendency for reporting L:M varied. 
While L:R tests have been conducted by evaluating the different biological sampling 
media of urine or serum, the serum test was used much more widely in the last decade and 
serum tests have been conducted in a much more standard manner than the urinary L:M test. 
Urinary L:R has disadvantages typical of any urinary method for dual-sugar permeability testing; 
the serum method avoids these, and Haase et al. [125] found fewer test failures with this 
method.  
We found only one example of the urinary lactose:creatinine test having been employed 
in a pediatric population in a resource-limited setting [151]. The lactose in the urine is waste 
from endogenous metabolism of ingested material, and the creatinine is also a waste product 
naturally present in the urine. Testing endogenous metabolites eliminates the need for a loading 
dose as well as a post-dose delay of multiple hours for sample collection, which are inherent 
parameters of dual-sugar tests. These aspects of the L:Cr test could provide advantages 
compared to dual-sugar tests in resource-limited settings. However, in comparing the tests, it 
will be important to consider other parameters such as sample processing, as well as the 
comparative accuracy and reproducibility of the different tests. Recent data on the use of the 
L:Cr ratio to assess intestinal permeability in pediatric populations in resource-limited settings is 
scarce. None of the studies from our review assessed both L:M and L:Cr ratios in the same 
individuals, so it is not possible to compare the tests directly from the available data. 
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It should be noted that many elements of this chapter, especially pertaining to the L:M 
test, were published in 2014 [185]. 
5.4 Markers of Digestion 
Twelve studies [43, 53, 58, 102, 109, 124, 132, 138, 147-149, 159] utilized a variety of 
markers that reflect intestinal digestive function. The particular data relevant to this review are 
listed for each of these studies in Evidence Table 3. Thirteen markers were assessed across the 
studies: eleven and two were markers of carbohydrate and lipid digestion, respectively. Testing 
for reducing substances in the stool was used in four studies as a marker of nonspecific poor 
digestion of sugars [43, 58, 132, 138]. Two other studies used biopsied intestinal tissue to 
measure specific disaccharidase activity or mRNA abundances [53, 109]. Three studies tested 
exhaled breath to assess maldigestion of lactose or sucrose [102, 147, 159]. 
One study employed urine lactose:lactulose ratio as a marker of lactase function [124]. 
Lastly, two studies, both by the same investigators, assessed intestinal lipid digestive capacity 
by measuring total triglyceride compared to fatty acids in the stool [148, 149].
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Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
2002 
 
Alves GM et al. 
 
Nutritional status 
and breath hydrogen 
test with lactose and 
lactulose in Terena 
Indian children 
Lactose hydrogen 
breath test (HBT) as 
a marker of lactase 
activity, and 
lactulose HBT as a 
marker of SBBO 
Limão Verde and 
Córrego Seco, Mato 
Grosso du Sul, Brazil 
 
All children <10 yr 
old were recruited 
from these rural 
villages. 
Cross-sectional 
 
n=264;  
 
<5 yr old: n=145  
 
(However results 
were provided by 
<4 and >4 yr old 
age groups.) 
Breath Tests: 
• Lactose HBT 
(251 tested) 
• Lactulose HBT  
(252 tested) 
 
Lactose HBT: 
• Elevated: 27.1% among all 
subjects 
• Borderline: 43.0% among all 
subjects 
• 0% of subjects <4 yr had 
elevated or borderline results 
 
Lactulose HBT positive: 
• 11.5% of all subjects 
8.6% of subjects <4 yr 
The prevalence of 
lactase deficiency as 
measured by lactose 
HBT was >25%, but 
non-existent among 
those <4 yr of age. 
 
Prevalence of SBBO as 
assessed by lactulose 
HBT was ~10%. 
Assessment of 
association 
between lactulose 
and lactose 
absorption was not 
reported. 
2003 
 
Bustos M et al. 
 
Disaccharidase 
deficiency in Bolivian 
children with 
persistent diarrhea 
 
Jejunal biopsy and 
disaccharidase 
activities in children 
with PD and different 
forms of malnutrition 
Cochabamba, 
Bolivia 
 
3-34 mo old 
Amerindians 
hospitalized with PD 
and moderate or 
severe malnutrition 
in an urban setting. 
Cohort 
 
n=42 cases with 
PD and 
malnutrition: 
• 2 with 
kwashiorkor 
• 20 with 
marasmus 
• 20 with 
marasmic- 
kwashiorkor  
 
 
Children were 
assessed on 
admission and at 
three weeks, after 
diarrhea had 
resolved and 
anthropometrics 
were improving. 
 
Jejunal tethered 
capsule biopsy: 
• Histopathology 
• Disaccharidase 
activity:  
• Lactase 
• Sucrose-
Isomaltase 
• Maltase 
 
 
Histology was scored 
on a scale of 1 
(normal) to 4 (severe 
morphological 
damage or flat 
mucosa). 
 
Most subjects had mild to 
moderate (score of 2-3) 
histological abnormalities, with 
one kwashiorkor patient having 
completely flat villi.  
 
Second biopsy showed a trend 
of improved mucosa, but 
difference was not significant 
based on histology score, 
intraepithelial lymphocyte 
density, or degree of infiltration 
of lamina propria. 
 
Percentages with enzymatic 
activity below normal at 
baseline, discharge:  
• Lactase: 64%, 59% 
• Sucrase-isomaltase: 97%, 
90% 
• Maltase: 45%, 52% 
All changes were statistically 
significant.  
 
Lactase recovery was 
associated with admission HAZ 
(p=0.05) and WAZ (p=0.03) 
scores.  
Patients had diminished 
intestinal disaccharidase 
activity and substantial 
pathology on biopsy at 
admission and at three 
weeks, despite clinical 
improvements and 
tolerance of lactose-
containing formula. 
  
 
 
Spanish language 
article. 
 
Values for 
subnormal 
disaccharidase 
activity were not 
provided. 
 
The magnitude of 
lactase inverse 
association with 
growth parameters 
was not reported. 
Authors did not 
report whether they 
had tested for 
associations 
between maltase or 
sucrose-isomaltase 
and growth 
parameters. 
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Despite continued high 
disaccharidase deficiency 
prevalence at discharge, all 
children tolerated the lactose-
containing formula challenge. 
2002  
 
Goto R et al. 
 
Poor intestinal 
permeability in mildly 
stunted Nepali 
children: 
Associations with 
weaning practices 
and Giardia lamblia 
infection 
 
L:M as a marker of 
intestinal 
permeability, and 
assessment of 
association with 
giardiasis, 
helminthiasis, 
nutritional practices, 
and growth status. 
 
Kathmandu, Nepal 
 
0-5 yr olds (mean 
age 3.8 yr) from two 
urban squatter 
settlements.  
 
37% and 33% of 
subjects were 
stunted and 
underweight, 
respectively. 
 
Cross-sectional 
 
n=210 
 
Urine Tests: 
• Lactulose1 
• Mannitol 
• Lactose2 
(168 tested) 
• L:M  
(158 tested) 
• Lactose:lactulose 
ratio 
(157 tested) 
 
L:M: 
• 92% had values >UK norms 
• Mean3 L:M (SD, range): 0.26 
(0.21, 0.04-1.71).  
• Giardia-infected versus 
uninfected means: 0.43 vs. 
0.25, p=0.014 
 
The duration of ingestion of solid 
foods (with or without concurrent 
breastfeeding) was not 
associated with L:M in 
multivariate analysis.  
 
L:M was correlated with longer 
duration of breastfeeding 
(r=0.27, p<0.019). Specifically, 
children who breastfed for >2 yr 
had higher L:M ratios than 
children who breastfed for 
shorter times (data not 
provided).  
 
L:M was not associated with:  
• History of diarrhea in the week 
preceding testing 
• Helminthiasis 
• Age 
• WAZ or HAZ scores 
 
Lactulose excretion ranged from 
0.02–15.00. Mannitol excretion 
ranged from 0.5–15.00. 
L:M ratios were high 
overall. 
 
Wide individual variation 
was observed in L:M 
ratios. 
 
L:M was associated with 
giardiasis but not 
helminthiasis.  
 
Urinary lactose 
concentrations and 
lactose:lactulose ratios 
were significantly higher 
in breastfed subjects 
than in those that were 
not breastfed, despite 
similar intestinal 
permeability values.  
 
There were some 
unexpected findings: the 
duration of 
breastfeeding, and not 
the timing of introduction 
of solid foods, was 
correlated with L:M, and 
the correlation was 
direct, not inverse. 
Authors speculate that 
this could be due to 
higher mean age of their 
Low lactase activity 
was defined as 
lactose:lactulose 
ratio >0.4.  
 
Specific L:M data 
by WAZ and HAZ 
scores were not 
reported, although 
authors state that 
L:M was not 
associated with 
“growth status.” 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 Lactose results were expressed in mg/L. 
3 Geometric mean. 
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47% showed low lactase activity. 
Lactose values and 
lactose:lactulose ratios 
decreased with age (R2=28%, 
p<0.0001), but were not 
associated with sex, ethnicity, 
and location nor were they 
associated with L:M.  
 
Mean1 urinary lactose 
concentrations (mg/L) by feeding 
mode: 
• Breastfed: 172.5  
• Non-breastfed: 44.5, p<0.0001 
corrected for infant age  
 
Mean2 lactose:lactulose ratio by 
feeding mode:  
• Breastfed: 2.76 
• Non-breastfed: 0.31,  
p<0.0001 corrected for infant 
age 
 
Mean L:M by feeding mode: 
• Breastfed: 0.23 
Non-breastfed: 0.28, non-
significant, p-value not specified 
cohort compared to 
another study that 
demonstrated beneficial 
effect of duration of 
breastfeeding on 
reduced L:M in 
Guatemala [205].  
 
2002 
 
Kirkpatrick BD et al. 
 
Cryptosporidiosis 
stimulates an 
inflammatory 
intestinal response 
in malnourished 
Haitian children 
 
Port-au-Prince, Haiti 
 
<18 mo olds from a 
low SES setting 
recruited from the 
rehydration unit of 
GHESKIO HIV 
Center3 with 
diarrhea and 
Cryptosporidium 
infection. Controls 
Case-control 
 
n=49; 
 
n=17 cases with 
Cryptosporidium 
and diarrhea (5 
with PD)  
 
n=32 controls 
without 
Stool Tests: 
• Reducing 
substances (RS) 
• Lactoferrin 
• Cytokines: 
• TNF-α receptor 
I  
• IL-4 
• IL-8 
• IL-10 
• IL-13 
Proportion RS-positive:  
• 33.3% cases 
• 64.7% diarrhea controls 
• 46.7% healthy controls, (p=0.2) 
 
Proportion lactoferrin-positive:  
• 83.3% cases  
• 60.0% diarrhea controls 
• 28.6% healthy controls, 
(p=0.01) 
 
Fecal lactoferrin was 
identified most often in 
children with diarrhea, 
especially in those with 
Cryptosporidium. While 
some fecal cytokines 
were detected in as 
many as 40% of healthy 
controls and 70% of 
controls with diarrhea, 
they were generally 
Reported results 
were not stratified 
by persistent vs. 
acute diarrhea 
status.  
 
Cut-off values for 
lactoferrin positivity 
were not described.  
 
Stools from children 
                                                          
1 Geometric mean. 
2 Geometric mean. 
3 The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections. 
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Stool lactoferrin, 
reducing 
substances, 
leukocytes and 
cytokines as 
markers of intestinal 
inflammation of 
children with and 
without 
Cryptosporidium 
infection 
recruited from an 
outpatient clinic 
without 
Cryptosporidium 
infection included 
those with and 
without diarrhea. 
Cryptosporidium; 
• 17 with diarrhea 
(5 with PD)  
• 15 healthy 
• IFN- γ  
 
 
Blood Test: 
WBC 
IFN-γ was not recovered in any 
stools. 
 
All other fecal cytokines were 
significantly associated with 
Cryptosporidium cases 
compared to diarrhea and 
healthy controls.  
 
Additionally, TNF-α receptor I, 
IL-8, IL-13 were found in 
diarrhea and healthy controls, 
while IL-4 and IL-10 were not.  
 
Fecal lactoferrin was associated 
with the presence of TNF-α 
receptor I (point estimate not 
provided, p=0.03). 
 
Mean WBC counts were within 
normal range in all 3 groups. 
associated with 
Cryptosporidium 
infection. The other stool 
tests did not discriminate 
by diarrhea or 
Cryptosporidium status. 
who were 
breastfeeding were 
not tested for 
lactoferrin. 
2003 
 
Kukuruzovic R et al. 
 
Increased nitric 
oxide production in 
acute diarrhea is 
associated with 
abnormal gut 
permeability, 
hypokalemia and 
malnutrition in 
tropical Australian 
aboriginal children 
 
Nitric oxide (NO) as 
a marker of intestinal 
permeability and 
inflammation, and 
lactulose:rhamnose 
ratio (L:R) as a 
marker of intestinal 
Darwin, 
Australia 
 
1-6 yr old Aboriginal 
and non-Aboriginal 
hospital inpatients.  
 
Subjects were 
grouped as follows: 
1. Children with AD 
2. Children with no 
diarrhea but with 
non-GI infectious 
conditions 
3. Children without 
GI or infectious 
conditions 
Case-control  
 
n=318; 
 
n=169 cases with 
AD  
(154 Aboriginal) 
 
n=149 controls: 
• 73 with non-GI 
infections (49 
Aboriginal)  
• 76 with no 
infections (29 
Aboriginal) 
Urine Test: 
Nitric Oxide (NO)* 
 
 
Blood Tests: 
• L:R  
• Mean corpuscular 
volume (MCV)  
 
 
Stool Test: 
Reducing 
substances (RS)**  
(169 cases tested)  
 
 
* NO is an unstable 
free radical and is 
converted to nitrite 
and nitrate. Urine 
nitrate (NO3)+ nitrite 
(NO2) was expressed 
NO among Aboriginal children 
with diarrhea was >3x higher 
than any other group and >5x 
higher than in non-Aboriginal 
controls. 
• NO was >3x and >2x higher 
among Aboriginal than non-
Aboriginal children in the 
diarrhea (p<0.001) and no 
infections groups (p<0.001), 
respectively, but there was 
no difference between them 
in the non-GI infections 
group.  
• NO was >3x and ~2x higher 
in the diarrhea compared to 
the no infections group 
among Aboriginals 
(p<0.001) and non-
Aboriginals (p<0.03), 
respectively.  
• NO was virtually the same 
NO2 + NO3:Cr ratio, as a 
measure of endogenous 
nitric oxide production, 
was used as a marker of 
gut permeability and 
inflammation, with an 
attempt to identify how 
much more it reflects as 
response to 
inflammation from GI vs. 
non-GI infections. 
 
Among non-Aboriginal 
controls, NO production 
was the same among 
those with diarrhea and 
non-GI infections (and 
higher compared to 
controls). NO was 
highest by far among 
Aboriginal children with 
diarrhea compared to 
Positive stool RS 
was defined as 
>0.5%.  
 
Abnormal L:R was 
defined as >7.6; no 
reference or 
derivation was 
provided for this 
cut-point. 
 
Study population 
appears to be the 
same as in another 
Kukuruzovic, et al. 
study also included 
in this review which 
assessed serum 
lactulose:rhamnose 
as a marker of 
intestinal 
permeability [58]. 
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permeability and the 
relationship between 
NO and L:R, growth 
parameters, mean 
corpuscular volume 
(as a surrogate of 
iron deficiency), and 
stool reducing 
substances among 
children with and 
without diarrhea 
as a ratio with urine 
creatinine (NO2 + 
NO3:Cr) in order to 
account for 
differences in urine 
concentration. 
 
** Measured only 
among children with 
profuse diarrhea. 
among the Aboriginal non-GI 
infections and no infections 
groups, as well as among 
the non-Aboriginal diarrhea 
and non-GI infections 
groups.  
 
112/152 (74%) and 31/169 
(18%) of children with AD had 
abnormal L:R ratios and positive 
stool RS, respectively. 
 
NO and L:R were measured at 
“convalescence” on Day 5 
among those with diarrhea: the 
mean improvement in NO was 
21.7% compared with 54.6% for 
L:R (p=0.01). 
 
NO and L:R were correlated 
(n=193, r=0.37, p<0.001)1; the 
correlation was stronger for 
lactulose (effect ratio=1.47, 
p<0.001) than for rhamnose 
(effect ratio=0.80, p=0.022).  
 
NO was not correlated with stool 
RS3 or MCV, but was correlated 
with lower WAZ score (effect 
ratio=0.88, p=0.05). 
any other group. Authors 
suggest that high basal 
concentrations of NO 
among Aboriginal 
children due to (clinically 
silent) enteropathy could 
explain the 
concentrations seen 
among Aboriginal 
controls in this study. 
 
NO appeared to 
decrease significantly 
more slowly than L:R 
among children 
recovering from 
diarrhea. 
NO was found to 
correlate with L:R. NO 
was more strongly 
correlated with lactulose 
than rhamnose. 
 
2002 
 
Kukuruzovic RH et 
al.  
 
Small bowel 
intestinal 
permeability in 
Darwin, Australia 
 
Cases were 
Aboriginal and non-
Aboriginal children 
admitted to hospital 
with diarrhea. 
Controls were 
Case-control 
 
n=375 admissions 
for 306 children; 
 
n=285 case 
admissions for 
AD (264 
Blood Tests: 
• Lactose 
• Lactulose4 
• Rhamnose 
• L:R  
• Hemoglobin  
• Mean corpuscular 
27/75 (36%) of Aboriginal 
controls and 0 non-Aboriginal 
controls had abnormal L:R 
ratios. 
 
Mean5 L:R at baseline: 
Cases: 
• Aboriginal: 16.4  
Mean L:R ratios of 
Aboriginal children were 
approximately double 
those of non-Aboriginal 
children both among 
those with and without 
diarrhea, consistent with 
authors’ suggestion that 
Positive stool RS 
was defined as 
>0.5%.  
 
Abnormal L:R was 
defined as >5.6, 
derived from 2 SD 
above the 
                                                          
1 Reported results appear to have been adjusted for age and race. 
2 Reported results were adjusted for age and race. 
3 Reported results among children with diarrhea were adjusted for age and race. 
4 Lactulose and rhamnose results were expressed as % of dose administered. 
5 Geometric mean. 
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Australian Aboriginal 
children 
 
Serum lactulose: 
rhamnose ratio 
(L:R), serum lactose, 
and stool reducing 
substances as 
markers of intestinal 
permeability among 
Aboriginal and non-
Aboriginal children 
with and without 
diarrhea 
 
Aboriginal and non-
Aboriginal children 
admitted without GI 
illnesses. 
 
Aboriginal) 
 
n=90 control 
admissions with 
no diarrhea (74 
Aboriginal) 
volume (MCV) 
 
 
Stool Test: 
Reducing 
substances (RS)*  
 
 
L:R testing was 
repeated on day 5 for 
a subset of Aboriginal 
subjects: 
• 174/264 admissions 
for acute diarrhea  
• 25/74 control 
admissions 
 
 
* Measured only 
among children with 
profuse diarrhea 
when “clinically 
indicated". Number 
tested not provided. 
• Non-Aboriginal: 7.9, p=0.002 
compared to Aboriginal cases 
Controls: 
• Aboriginal: 4.6 
• Non-Aboriginal: 2.5, p=0.02 
compared to Aboriginal 
controls  
 
Mean improvement1 in L:R (CI) 
at day 5 among those with 
repeat testing: 
• Aboriginal cases: 14.6 (11.2, 
18.0)  
• Aboriginal controls: -0.63 (-
4.0, 2.7)  
 
Mean lactulose recovery2: 
• Cases day 1: 0.085 (0.070–
0.103)  
• Cases day 5: 0.039 (0.033–
0.046) 
• Controls: 0.024 (0.019–0.029) 
All 3 values significantly differed 
from one another. 
 
Mean rhamnose recovery: 
• Cases day 1: 0.479 (0.424–
0.542) 
• Cases day 5: 0.555 (0.498–
0.616) 
• Controls: 0.585 (0.500–0.685) 
These values did not 
significantly differ from one 
another. 
 
Confidence intervals (CIs) in the 
authors' graphical representation 
of mean L:R at admission did 
not overlap, and the difference in 
clinically silent 
enteropathy is prevalent 
among Aboriginal 
children.  
 
Mean L:R significantly 
improved over 5 days 
among Aboriginal cases. 
Children with severe 
diarrhea had higher 
mean L:R. 
 
Higher case L:R was 
driven more by high 
lactulose than by low 
rhamnose.  
Similarly, improvement 
in L:R among cases was 
primarily due to 
decreased lactulose.  
 
Stool RS and serum 
lactose were found in 
approximately one-
quarter and one-third of 
Aboriginal cases, 
respectively. The latter 
was weakly associated 
with increased lactulose. 
arithmetic mean for 
non-Aboriginal 
controls in this 
study. The rationale 
for the choice of 2 
SD above the 
arithmetic, instead 
of the geometric, 
mean is not clear. 
Proportions of 
cases with 
abnormal 
concentrations 
were not reported. 
 
Analysis included 
data for 69 children 
with repeat 
admissions; this 
might violate 
independence 
assumptions for 
their statistical 
analysis methods.  
 
Repeat L:R testing 
was conducted on 
controls of both 
racial groups, but 
among cases it was 
only conducted on 
Aboriginal cases. 
 
This study appears 
to report on the 
same population as 
in the Kukuruzovic, 
et al. 2003 
reference also 
                                                          
1 Improvement in L:R appears to have been calculated as baseline L:R minus repeat L:R, as described in another publication in this review; however, this was not expressly stated. 
Reference 134. Kukuruzovic RH, Brewster DR. Milk formulas in acute gastroenteritis and malnutrition: a randomized trial. J Paediatr Child Health, 2002. 38(6):571-577. 
2 Figures reported parenthetically after the mean percent recoveries of lactulose and rhamnose were not specified as ranges or CIs. 
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means was particularly evident 
between Aboriginal and non-
Aboriginal subjects. 
 
Factors associated with L:R 
among cases were1:  
• Acidosis (p=0.007) 
• Hypokalemia (p=0.035) 
• Diarrhea severity (p=0.001)  
 
Age and malnutrition were not 
associated with L:R. 
 
38% and 27% of Aboriginal 
cases had positive serum 
lactose and stool RS, 
respectively. 12% of Aboriginal 
and non-Aboriginal controls 
combined had lactosemia.  
 
Presence of lactosemia was 
associated with L:R, adjusted 
relative risk (CI)=1.06 (1.03, 
1.10)2. Stool RS, anemia, and 
MCV were not associated with 
L:R. 
included in this 
review, which 
assessed nitric 
oxide excretion 
[43].  
Authors reiterate 
the advantages of 
serum over timed 
urine collection for 
assessment of L:R, 
as discussed in 
another publication 
in this review [125] 
2005 
 
Lima AA et al. 
 
Intestinal barrier 
function and weight 
gain in malnourished 
children taking 
glutamine-
supplemented 
enteral formula 
 
L:M as a marker of 
Fortaleza, Brazil 
 
2-60 mo olds 
hospitalized with 
WAZ score <-2, 
~70% of whom had 
PD. 
RCT 
 
n=80;         
 
n=53 received 
supplemented 
formula 
• 27 with glycine 
• 26 with 
glutamine 
 
n=27 received 
Urine Tests*: 
• Lactulose3 
• Mannitol 
• L:M  
 
 
Stool Tests**: 
• Lactoferrin 
• Leukocytes 
• Occult blood 
• Reducing 
substances (RS) 
Mean4 L:M (SE):  
• Glutamine group: 
• Baseline: 0.31 (0.10) 
(similar in all three groups) 
• Day 10: 0.10 (0.02); 
significant decrease, 
(p=0.01) 
• No significant decrease in L:M 
in glycine and 
nonsupplemented formula 
groups at day 10 
 
L:M significantly 
improved in the 
glutamine group only. 
 
>50% of subjects had 
intestinal inflammation 
by stool lactoferrin. 
Fecal leukocytes, RS, 
and occult blood were 
detected in fewer 
subjects than lactoferrin. 
The relationship 
between stool 
markers and L:M 
was not reported.  
 
Data were not 
stratified by history 
of PD. 
 
Fecal fat was 
assessed, but 
results were not 
reported. 
                                                          
1 Reported results were adjusted for confounding variables, unless otherwise noted. 
2 Reported results were adjusted for severity of diarrhea, acidosis, hypokalemia, and age. 
3 Lactulose and mannitol results were expressed as % of dose administered. 
4 Type of mean not specified. 
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intestinal 
permeability and 
various stool tests 
among children with 
malnutrition or PD 
who received either 
glycine or glutamine 
supplemented 
formula or placebo 
nonsupplemented 
formula 
 
 
* n=80 tested at 
enrollment, n=65 
tested at day 10. 
 
** n=60 tested. 
Mean lactulose (SE):  
• Glutamine group: 
• Baseline: 0.97 (0.46) 
(similar in all three groups) 
• Day 10: NS decrease in all 
3 groups 
 
Mean mannitol (SE):  
• Glutamine group: 
• Baseline: 3.42 (0.64) 
(similar in all three groups) 
• Day 10: NS decrease in all 
3 groups 
 
Proportion of stool markers at 
baseline among all subjects:  
• Lactoferrin: 53.3% 
• Leukocytes: 11.7% 
• RS: 3.3% 
Occult blood: 5.0% 
 
Cut-off values for 
lactoferrin positivity 
were not described.  
 
Exclusively 
breastfed children 
were excluded from 
study participation 
due to assessment 
of stool lactoferrin. 
 
2002 
 
Moya-Camarena SY 
et al. 
 
Effects of 
asymptomatic 
Giardia intestinalis 
infection on 
carbohydrate 
absorption in well-
nourished Mexican 
children 
 
Lactose hydrogen 
breath test (HBT) as 
a marker of lactose 
absorption, and 
xylose breath test 
and urinary excretion 
as markers of xylose 
Hermosillo, Sonora, 
Mexico 
 
3-6 yr olds in a 
periurban setting 
attending preschool 
centers meeting 
inclusion criteria of 
no GI symptoms, no 
antibiotics in the 
preceding 3 wk, and 
no SBBO by 
lactulose HBT and 
Indican test. 
 
Case-control 
 
n=13; 
 
<5 yr old:  
n=5 
 
n=7 
asymptomatic 
cases infected 
only with G. 
intestinalis  
 
n=6 controls 
without Giardia 
 
 
Cases were 
evaluated before 
and 3 wk after 
treatment with 
Breath Tests*: 
• Lactose HBT  
• D-Xylose HBT** 
 
 
Urine Test: 
D-xylose**,1  
 
 
* Reported as parts 
per million (ppm) 
post-substrate 
ingestion after 
subtraction of 
baseline, pre-
substrate H2 
concentrations. A 
positive HBT is 
considered to be a 
rise of >20ppm in 
breath H2 above 
Mean lactose HBT (SE): 
• Cases pre-treatment: 3.6 
(0.75) ppm  
• Cases post-treatment:  -0.85 
(0.75) ppm (p<0.05 compared 
to pre-treatment) 
• Controls: 0.19 (0.81) ppm 
(p<0.05 compared to pre-
treatment cases) 
 
Mean xylose HBT (SE): 
• Cases pre-treatment: 2.2 
(0.69) ppm for infected group  
• Cases post-treatment:   -4.16 
(0.69) ppm (p<0.05 compared 
to pre-treatment) 
• Controls: 1.13 (0.74) ppm (NS 
compared to pre-treatment 
cases) 
 
Mean urinary excretion of xylose 
Lactose HBT 
concentrations were 
normal according to 
established cut-points 
among all subjects.  
 
However, lactose HBT 
was significantly higher 
among cases compared 
to controls and there 
was also a significant 
decrease in lactose HBT 
among cases after 
treatment. The clinical 
relevance of such mildly 
elevated HBT results in 
asymptomatically 
infected children is 
unclear.  
 
Results did not 
Statistical methods 
might not have 
been adequate to 
account for intra-
subject correlation 
when comparing 
the same group of 
subjects (cases) 
before and after 
treatment.  
  
Investigators 
wished to exclude 
children with SBBO. 
As such, inclusion 
criteria restricted 
participants to 
those with 
adequate 
production of H2 
following ingestion 
                                                          
1 D-xylose results were expressed as % of dose administered. 
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absorption in well-
nourished children 
with asymptomatic 
giardiasis and non-
infected controls 
tinidazole. Post-
treatment stools 
were verified for 
absence of 
parasites. 
baseline H2 
concentration. 
 
** Investigators did 
not specify the xylose 
enantiomer used, 
however test 
functionality 
characteristics lead 
us to assume that it 
was the dextrorotary 
(D) enantiomer. 
(SE) among cases pre-treatment 
and post- treatment was 34% (3) 
and 46% (11), respectively (NS), 
well above cut-offs indicative of 
malabsorption. 
demonstrate xylose 
malabsorption by either 
urinary or breath 
measures among any 
group. While urinary 
results did not differ 
before and after 
treatment, case xylose 
HBT was significantly 
lower after treatment; 
again the clinical 
significance of such 
results is not apparent. 
of lactulose and 
with minimal urinary 
indoxyl sulfate 
excretion. The 
number of children 
excluded due to 
failure to meet 
these criteria was 
not reported. 
2002 
 
Murphy JL et al. 
 
Maldigestion and 
malabsorption of 
dietary lipid during 
severe childhood 
malnutrition 
 
Stool recovery of 
radiolabeled 
products as markers 
of lipid digestion and 
absorption, and bile 
salt deconjugation 
as a marker of 
SBBO among 
children with severe 
malnutrition  
Kingston, Jamaica 
 
5-23 mo olds 
admitted to the 
Tropical Metabolism 
Research Unit of the 
University of the 
West Indies with 
severe malnutrition. 
Case-series 
 
n=24 
 
 
Subjects were 
divided into 3 
groups of 8 
children, each 
group receiving a 
different labeled 
triglyceride. 
 
Data were 
collected in three 
separate phases 
as described 
above in JL 
Murphy et al. 
2001 [149]. 
Stool Tests: 
• Total and 
fractionated 13C 
following 
ingestion of one 
of three 13C 
labeled 
triglycerides (TG): 
trilaurin, triolein, 
or trilinolein*  
• 13C stool assay 
following 
administration of 
labeled fatty acid 
13C glycocholate** 
 
 
* To assess fat 
excretion as a % of 
dose administered. 
Also assessed 
proportion of 13C in 
triglyceride (TG) and 
fatty acid (FA) 
fractions to 
distinguish excretion 
caused impaired 
digestion (presence 
of TG) vs. poor 
absorption (presence 
Median total stool excretion of 
13C in phase 1 was 9% (range: 
1%-29%) and did not vary 
between TG groups.  
Median 13C excretion dropped 
33%-99% in phase 2 and 86%-
95% in phase 3 compared to 
phase 1 (p<0.05 each). 
 
Over the study period, there 
were significant associations 
between total lipid and the 
amount of 13C labeled TGs in 
stool for some groups, but not 
for others. 
 
Median 13C in TG and FA was 
similar across TG groups in all 
phases. 13C FA recovery was 
similar and reduced by ~2/3 
compared to Phase 1. 13C TG 
was not detectable in Phases 2 
or 3. Statistical comparisons 
between phases were not 
reported.  
 
13C after radiolabeled 
glycocholate administration was 
detected in stool at quantities 
considered to be in excess of 
High concentrations of 
13C (compared to 
healthy UK children) 
[190] were observed in 
half of the subjects at 
admission, reflecting 
impaired digestion or 
absorption.  
 
The differences in stool 
13C were wide but not as 
extreme as in a previous 
study by same 
investigators (also 
examined in this review) 
using a different TG 
(tripalmitin) substrate 
[149].  
 
13C excretion did not 
significantly differ 
between TG groups and 
declined with improving 
clinical course. 
 
Similar to their previous 
study, significantly more 
13C in stool was 
recovered as FA than 
TG, reflecting impaired 
Authors state that 
the study was not 
powered to 
compare the 
different TGs, but 
they contend that 
medium chain 
trilaurin did not 
appear to be 
processed 
differently than the 
longer chain TGs 
triolein and 
trilinolein. 
 
Authors did not 
describe the 
method used to 
assign subjects to 
different TG groups.  
 
While it was noted 
that some subjects 
had positive stool 
cultures, details 
were not provided 
on the nature of the 
enteric infections. 
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of FA). 
 
** To assess bile salt 
deconjugation in the 
bowel caused by 
SBBO; conducted 
after the TG 
assessment and a 3 
day washout period. 
the 7% recovery of dose 
administered upper limit of 
normal in U.S. adults in [189]: 
• Phase 1: 13/24 (54%) 
• Phase 2: 5/24 (20.8%)  
• Phase 3: 3/24 (12.5%) 
 
absorption over poor 
lipid digestion/ 
hydrolysis. Unlike in their 
previous study, there 
was evidence of SBBO 
as measured post-
ingestion of 13C 
glycocholate. 
2001 
 
Murphy JL et al. 
 
Gastrointestinal 
handling and 
metabolic disposal of 
13C-labelled 
tripalmitin during 
rehabilitation from 
childhood 
malnutrition 
 
Fecal fat, stool 
recovery of 
radiolabeled 
products, and breath 
tests as markers of 
lipid digestion and 
absorption and bile 
salt deconjugation 
as a marker of 
SBBO among 
children with severe 
malnutrition 
Kingston, Jamaica 
 
7-23 mo olds with 
malnutrition admitted 
to the University of 
the West Indies. 
Case-series 
 
n=8  
 
 
Data were 
collected in three 
separate phases 
(each lasting 9 
days): 
1. Within 48 hours 
of admission 
2. During early 
rehabilitation 
3. During late 
rehabilitation 
Stool Tests: 
• Fecal fat* 
• Total and 
fractionated 13C 
assay after 
administration of 
13C tripalmitin 
(TP)** 
• 13C assay after 
administration of 
13C glycocholate 
(GCA)*** 
 
 
Breath Tests: 
• 13CO2 after 
administration of 
13C glycocholate 
(GCA)*** 
• 13CO2 after 
administration of 
13C TP**** 
 
 
* In 72 hour stool 
collection (measured 
as total grams and as 
% of dietary fat 
intake). 
 
** To assess fat 
excretion as a % of 
dose administered. 
Also assessed 
Mean fecal fat (SD): 
• Phase 1: 2.4 g/day (3.6) or 
5.9% (9.4) of dietary lipid 
intake 
• Phase 2: 1.7 (0.9) g/day, or 
3.3% (2.4) of intake  
• Phase 3: 0.9 (0.6) g/day, or 
1.4% (0.7) of intake 
• Differences between phases 
were not statistically 
significant. 
 
Total excretion of 13C in stool 
also varied widely across 
patients (0%-44%) and did not 
differ between study phases.  
 
Correlation between fecal fat 
and 13C (r=0.48; p<0.05) was 
observed.  
 
Lack of lipid digestion and 
absorption were assessed by 
measuring TG and FA fractions, 
respectively. Mean 13C TG 
recovery (SD) (% of 
administered dose), number of 
patients excreting TG: 
• Phase 1: 0.7% (1.6), n=3 
• Phase 2: 0.9% (2.8), n=1  
• Phase 3: no recovery from 
any subjects, differences 
between phases were NS 
 
Mean fecal fat was not 
elevated compared to 
published norms [191, 
192] during any study 
phase.  
 
There was wide variation 
in fecal fat at 
presentation, and wide 
variations in stool 13C 
across subjects. Authors 
indicate that this is the 
first such assessment in 
malnourished children; 
previous studies on 
healthy children from the 
UK demonstrated 
average excretion of 6% 
[190]. 
 
The majority of excreted 
13C was in the form of 
FA rather than TG. 
Authors interpreted this 
to reflect failure of lipid 
absorption in the face of 
adequate digestion/ 
hydrolysis. Each form 
(FA and TG) was found 
in decreasing values as 
the study phases 
progressed, suggesting 
improved digestion and 
absorption, although 
Statistical methods 
might be 
inappropriate for a 
small sample. 
 
All subjects were 
treated with 
antibiotics including 
metronidazole for 
presumptive SBBO; 
this might have 
affected GCA 
testing. 
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proportion of 13C in 
triglyceride (TG) and 
fatty acid (FA) 
fractions to 
distinguish excretion 
caused by impaired 
digestion (presence 
of TG) vs. poor 
absorption (presence 
of FA). 
 
*** To assess bile 
salt deconjugation in 
the bowel caused by 
SBBO; conducted 
after the TG 
assessment and a 3 
day washout period. 
 
**** Expressed as a 
percentage of 
absorbed label (dose 
administered - label 
recovered in stool) to 
assess oxidation for 
acute energy needs. 
 
13C FA fraction in stool declined 
during rehabilitation. 
Mean 13C FA recovery (SD): 
• Phase 1: 6.0% (7.3)  
• Phase 2: 4.8% (3.7)  
• Phase 3: 3.3% (3.8),  
differences between phases 
were NS 
  
Mean FA values were ~9x (NS), 
5x (p<0.001), and 3x (p<0.05) 
higher than mean TG values in 
Phases 1, 2, and 3, respectively. 
  
Following administration of 
labeled TP, absorbed 13C label 
by breath analysis was ~5% 
(range 0%-21.2%) and similar 
across study phases.  
 
Following the administration of 
labeled GCA, there was either 
no or minimal recovery of 13C in 
stool and 13CO2 on breath (as % 
of dose administered) in all 
phases. 
results did not differ 
significantly.  
 
Fecal fat was correlated 
with concentrations of 
13C in stool.  
There was no evidence 
of SBBO or bile acid 
malabsorption.  
 
13CO2 excretion following 
administration of 13C TP 
was minimal, suggesting 
a propensity for 
deposition in adipose 
tissues rather than 
oxidation for immediate 
energy needs. The 
authors report that this 
breath test has not been 
widely used, but that 
healthy UK children 
have breath excretion 
values from 15%-43% 
[190], compared to a 
mean of 5% and range 
0%-21% in this cohort; 
the latter findings were 
more similar to results 
from kwashiorkor 
patients where 13C-
labeled oleic acid was 
used as substrate [193]. 
2000 
 
Nichols B et al. 
 
Contribution of 
villous atrophy to 
reduced intestinal 
maltase in infants 
with malnutrition 
 
Sao Paulo, Brazil 
 
Cases were children 
(mean age 9.9 mo, 
SD 8.1) hospitalized 
with malnutrition 
refractory to dietary 
rehabilitation.  
 
Controls were 
Case-control 
 
n=33; 
 
n=24 cases  
 
n=9 controls  
 
 
Subjects were 
Jejunal capsule 
biopsy: 
• Histopathology* 
• Maltase activity  
• Intestinal 
messenger RNA 
(mRNA) 
abundances: 
• Maltase-
glucoamylase 
Mean villous atrophy score (SD): 
• Cases: 2.6 (0.8) 
• Controls: 1.2 (0.5), p=0.006) 
 
WAZ score was correlated with 
villous atrophy (r=0.65, p- value 
not reported).  
 
13/25 [sic] cases and 0/5 
controls had subnormal (defined 
The malnourished 
children had significantly 
greater villous atrophy 
than the younger 
controls. 
 
Among the subset tested 
for mRNA messages, 
maltase activity as well 
as the mRNA 
Tissue from 
patients requiring 
intestinal resection 
as part of their 
biliary atresia 
management 
provides an 
opportunity to 
assess presumably 
“normal” intestinal 
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Jejunal biopsy, 
maltase activity, and 
enzyme messenger 
RNAs among 
malnourished and 
well-nourished 
children. Assessed 
association between 
maltase and villous 
atrophy and other 
mucosal intestinal 
markers indicative of 
loss of enterocytes 
and enterocytic 
function. 
children (mean age 
3.6 mo, SD 1.0) with 
HAZ and WAZ 
scores >-2 and 
normal intestinal 
mucosa on biopsy, 
hospitalized for 
Kasai procedure for 
biliary atresia. 
matched on 
height and 
weight; ages 
differed within 
matched sets. 
(MGA) 
• Sucrase-
isomaltase (SI) 
• Villin, a 
structural 
protein 
expressed only 
in enterocytes 
• Sodium-
activated 
luminal 
glucose-
galactose 
transporter 1 
(SGLT), a 
functional 
protein 
expressed only 
in enterocytes 
• β-actin 
 
 
* Mucosal atrophy 
was scored on a 
scale of 1 (absence 
of atrophy compared 
to an organ donor) to 
4 (similar to children 
with active CD). 
 
Histology among 
controls was on 
surgically resected 
tissue. 
as <94 U/g protein) of maltase 
activity; mean maltase was 34% 
lower among cases (p=0.11). 
Maltase activity did not appear 
to decrease with WAZ score 
(further details not provided). 
 
However, in sub-analyses 
among those samples with an 
adequate β-actin, a 
housekeeping gene message, 
(n=10 cases, n=9 controls), 
cases’ findings expressed as a 
mean percent of controls' (SD) 
included: 
• Villous length (reciprocal of 
atrophy score): 38.9 (41.6), 
p=0.004 
• Maltase activity: 37.1 (23.2), 
p=0.001 
• MGA mRNA: 45.1 (36.4), 
p=0.016 
• Villin mRNA: 52.5 (22.6), 
p=0.003 
• SGLT mRNA: 66.6 (23.1), 
p=0.057 
• β-actin: 88.2 (15.8), p=0.189 
 
Both villous length and maltase 
activity in a subset of cases 
were less than 40% of control 
values.  
 
MGA, villin, and SGLT mRNA 
abundances were correlated 
with villous atrophy score 
(r=0.73), (r=0.76), and (r=0.54), 
respectively (p-values not 
reported)1.  
 
MGA mRNA abundance was 
abundances for MGA, 
villin and SGLT were 
significantly correlated 
with case status and 
were correlated with 
villous atrophy. 
 
While maltase deficiency 
has been reported in 
malnutrition in other 
studies, authors assert 
that these are the first 
results that directly 
support the hypothesis 
that reductions in 
maltase activity are due 
to villous atrophy. This 
study also nicely 
correlates mRNA 
relative abundance with 
function.  
 
architecture.  
However, unless 
they mocked up ex 
vivo mucosal 
biopsies in these 
controls, resections 
will have lower 
proportions of 
villous to 
submucosa tissue 
compared to cases’ 
samples derived 
from mucosal 
biopsies. While this 
probably doesn’t 
affect histology, it 
might affect 
enterocyte 
functional assays 
and mRNA 
determination, as 
transmural tissue 
will bring in more 
diverse populations 
of cells; only some 
of them might have 
transcripts of 
interest. However, 
the bias is likely in a 
direction that would 
reduce effect size. 
 
It was unclear if 
control inclusion 
criteria included 
absence of atrophy 
or if all potential 
controls lacked 
atrophy.  
 
Statistical methods 
                                                          
1 Villin and SGLT1 were assessed as a ratio with housekeeper gene β-actin. 
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correlated with maltase activity 
(r=0.32). 
might not have 
adequately taken 
into account the 
small sample size 
and matching 
scheme.  
 
Subsets of subjects 
were investigated 
for various tests. 
For example, 10 
cases had mRNA 
analyses based on 
β-actin adequacy. 
Another instance of 
selected testing 
was the subset of 
22 and 15 cases 
that had WAZ score 
to histology and 
mRNA correlation 
analyses, 
respectively. 
Rationale for subset 
selection was not 
thoroughly 
described. 
2009 
 
Ritchie et al. 
 
13C-sucrose breath 
test: novel use of a 
noninvasive 
biomarker of 
environmental gut 
health 
 
Sucrose breath test 
(SBT) as a marker of 
small bowel mucosal 
Darwin and 
Adelaide, Australia 
 
4 mo-5 yr old 
Aboriginal children 
admitted to hospital 
with diarrhea. 
 
Two control groups: 
1. Aboriginal controls 
admitted to 
hospital with non-
GI symptoms 
(50% had 
Case-control 
 
n=43;  
 
n=18 Aboriginal 
cases with AD 
 
n=25 controls: 
• 18 Aboriginal, 
without diarrhea 
• 7 non-
Aboriginal, 
healthy 
Blood Tests: 
• L:R 
(32 Aboriginal 
cases and controls 
tested) 
• C-reactive protein 
(CRP) 
• Mean Corpuscular 
Volume (MCV) 
• Hemoglobin 
 
 
Breath Test: 
13C sucrose breath 
20/32 (63%) of Aboriginal 
children had abnormal L:R 
ratios. 
 
Mean1 L:R (CI): 
• Diarrhea cases: 31.8 (24.9, 
40.7)  
• Aboriginal controls without 
diarrhea: 11.4 (8.5, 15.5),  
significant difference 
(p<0.0001) 
 
SBT Mean (CI): 
• Diarrhea cases: 1.9% (0.9, 
SBT values were 
significantly lower and 
L:R values were 
significantly higher 
among Aboriginal 
children with diarrhea 
than among those 
without GI symptoms. 
SBT was also 
significantly lower 
among Aboriginal 
controls than among 
non-Aboriginal children 
without diarrhea. This is 
Abnormal L:R ratios 
were defined as 
>16; no reference 
or derivation was 
provided for this 
cut-point.  
 
L:R test was not 
conducted among 
the non-Aboriginal 
controls. 
 
SBT/ L:R 
correlation analysis 
                                                          
1 Geometric mean. 
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damage vis a vis 
sucrase activity 
among an Australian 
Aboriginal 
population. Also 
compared SBT with 
serum 
lactulose:rhamnose 
ratio (L:R) 
pneumonia) 
2. Healthy, non-
Aboriginal controls 
recruited from 
community 
test (SBT) 3.0), p<0.0001 compared to 
non-Aboriginal controls and 
p=0.004 compared to 
Aboriginal controls 
• Aboriginal controls: 4.1% (3.0, 
5.2), p=0.032 compared to 
non-Aboriginal controls 
• Non-Aboriginal controls: 6.1% 
(4.8, 7.3) 
Significant differences were 
observed between all three 
groups.  
 
SBT results were not associated 
with wasting or with patient age 
or breastfeeding status. 
 
SBT and L:R were inversely 
correlated (r=0.67; CI: 0.42, 
0.62; p<0.0001). L:R explained 
45% of the variance in SBT; 
diarrhea explained 28% of 
variance. 
 
SBT was associated with 
increased MCV, relative risk 
(CI)=3.9 (2.8, 5.0). SBT was not 
associated with hemoglobin or 
CRP. 
consistent with previous 
reports of high 
prevalence of clinically 
silent TE in this 
population.  
 
SBT was significantly 
inversely correlated with 
L:R. 
was based on data 
for Aboriginal cases 
and controls 
combined; stratified 
analysis was not 
reported and could 
be of interest 
considering the 
large difference in 
L:R observed 
between these 
groups. 
 
Associations of 
MCV, CRP, and 
hemoglobin with 
SBT after adjusting 
for potentially 
confounding 
variables were not 
reported. 
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. 
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s. 
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting. 
 
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval, 
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins, 
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G, 
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent 
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium 
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score), 
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s) 
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5.4.1 Sucrose and Lactose Breath Tests 
Three studies used breath tests to detect the presence of lactose (n=2) [102, 147] or sucrose 
(n=1) [159] in the intestines after administration of a loading dose activity. These disaccharides should, in 
normal intestinal health, be split by the brush border enzymes lactase or sucrase to glucose and 
galactose or fructose, respectively. While these breath tests also reflect intestinal capacity to absorb these 
monosaccharides, we classified them as markers of digestive function first and foremost, because 
enzymatic cleavage of the ingested sugars is a cardinal intestinal process required for absorption to take 
place. Breath tests can measure various molecules in exhaled breath, most commonly hydrogen. 
Normally, very little hydrogen is detected in breath after an overnight fast; however, hydrogen is produced 
when undigested substances such as lactose are fermented by intestinal bacteria. The sucrose breath 
test (SBT) assessed in this review measured exhaled CO2, a normal by-product of disaccharide 
metabolism which will be found in reduced amounts if there is reduced sucrase activity. Because 
genetically ordained age-associated lactose intolerance becomes common beyond infancy in many 
populations irrespective of intestinal mucosal health, the possibility exists that sucrase activity might serve 
as a better marker of overall intestinal function because such age-related decline in tolerances are not 
known to be associated with sucrose.  
CO2 exhalation in the SBT was significantly lower among Aboriginal children with diarrhea 
compared to those without gastrointestinal symptoms, as well as among Aboriginal controls compared to 
non-Aboriginal children without diarrhea. SBT results were not associated with age, breastfeeding status, 
or wasting [159]. SBT results were significantly inversely correlated with L:R values (r=0.67), but this was 
assessed among all Aboriginal subjects (cases and controls) combined. L:R values differed largely 
between these groups; it would be useful to investigate the relationship between SBT and L:R stratified on 
diarrhea status. SBT results were also associated with one other marker, mean corpuscular volume, but 
were not associated with blood C-reactive protein, an index of systemic inflammation, or with hemoglobin, 
concentrations of which can be reduced for a variety of reasons, including acute and chronic systemic 
inflammation. While this study suggests that SBT is a promising diagnostic test for EED, this was the only 
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publication that analyzed the SBT in children in a developing country setting or among marginalized 
populations during the time period under review.  
Two studies utilized hydrogen breath tests (HBT) to assess lactase function [102, 147]. Each study 
also assessed either lactulose or D-xylose as substrates using the HBT. These two substrates for breath 
hydrogen analyses are primarily used to identify small bowel bacterial overgrowth (SBBO) and 
malabsorption, respectively, and as such they are discussed in those sections. Prevalence of abnormal 
lactose absorption differed between these two studies. Lactose absorption among indigenous Brazilian 
children with mild malnutrition was abnormal in more than one fourth of the subjects [102]. In well-
nourished Mexican children, HBT values in cases with asymptomatic giardiasis were only mildly elevated 
but remained below concentrations that have been used as criteria for lactose malabsorption [147]. Cases 
had HBTs before and after anti-giardiasis treatment. The pre-treatment HBT excretion was significantly 
higher compared to controls without giardiasis and to post-treatment values. The clinical relevance of 
such mildly elevated HBT results in asymptomatically infected children remains unclear, however.  
The discrepancy in results between the studies was unexpected, and the reason for it remains 
unclear. Both studies used the same cutoff for normal values, but the proportions of children with lactase 
deficiency were quite different. The differences might reflect numerous factors including differences in 
age, nutritional status, and age-related lactose intolerance. Another potential contributing factor is the 
exclusion of children with SBBO from the Mexican study but not from the Brazilian study, in which greater 
than 10% of the subjects had SBBO by lactulose HBT. An additional complication in assessing mucosal 
function, at least in children four years of age and older, is that there is a high prevalence of genetic 
lactase deficiency in many of the populations at risk for enteropathy, including in Latin America, Africa and 
Asia [259] and among Native Americans [260]. 
Neither of the HBT studies assessed the relationship of the test with growth outcomes in a 
statistically interpretable manner. While the Mexican study found normal D-xylose absorption by breath 
hydrogen testing in case (and control) subjects, neither this study nor the Brazilian study statistically 
analyzed the association between growth and the lactose HBT.  
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5.4.2 Stool Reducing Substances 
Reducing substances are those that reduce copper salts in a hot solution to a chromogenic less 
oxidized state. These substances include glucose, lactose, fructose, galactose, and pentose. Like breath 
tests, reducing substances can indicate malabsorption, but also primarily identify maldigestion. This test 
has been used for decades to differentiate diarrhea secondary to infection from that caused by 
noninfectious intestinal dysfunction, particularly lactose intolerance. A condition of the test is that it must 
be performed on liquid stool.  
Four studies [43, 58, 132, 138] assessed the prevalence of stool reducing substances to 
investigate digestive pathology. The proportion of positive tests for stool reducing substances among 
subjects varied widely across studies. Only 3.3% of Brazilian children hospitalized with malnutrition or 
persistent diarrhea had positive tests for stool reducing substances (definition of positive not provided) 
[138]. In contrast, tests in Haitian children with and without diarrhea were positive for stool reducing 
substances in one-third of those with diarrhea and cryptosporidiosis, in two-thirds of those with diarrhea 
but no evidence of Cryptosporidium infection, and in nearly half of controls without diarrhea [132], though 
the accuracy of this test on non-diarrheal stools is assumed to be inadequate because the non-absorbed 
sugars reportedly partition to the aqueous phase [261]. Hence, finding these sugars in solid stools, while 
unexpected, probably indicates of some degree of maldigestion. Again, cutoff points defining positivity 
were not provided, and there was no statistical difference between groups for this parameter (p=0.2).  
Two studies investigated reducing substances among Aboriginal and non-Aboriginal Australian 
children with diarrhea; a positive result was defined as stool containing sugar concentrations >0.5 %. In 
the first of these, one-quarter of Aboriginal diarrheal cases tested positive for stool reducing substances 
[58]. In the subsequent study by the same authors almost one-fifth of children with profuse diarrhea tested 
positive [43].  
Only one study of reducing substances examined its association with clinical outcomes, and this 
study found that the marker was associated with severity of diarrheal illness [58]. The same study found 
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that among subjects with diarrhea, a positive test for reducing substances was associated with high L:R 
by univariate analysis, but the association did not hold up in their multivariate model. Another study also 
examined the association between reducing substances and urinary nitric oxide among Aboriginal and 
non-Aboriginal children with acute diarrhea, but found none [43]. 
5.4.3 Intestinal Disaccharidases 
Two studies assessed intestinal disaccharidase activity as a marker of digestive pathology on 
jejunal specimens obtained by capsule biopsy--Bolivian children with persistent diarrhea and malnutrition 
[109] and Brazilian children with refractory malnutrition [53]. Of note, the latter study utilized a unique 
control group, children without severe malnutrition undergoing intestinal resection as part of the 
management of their biliary atresia. Both studies assessed the proportion of children with maltase 
activities that were below normal, and the Bolivian study also measured sucrase-isomaltase and lactase 
activities. Both studies reported similar prevalences of abnormally low maltase activity in approximately 
half of the subjects with enteric dysfunction, but only one of these studies provided a defined cut point for 
abnormal (<94U/g protein) [53]. The deficiency in other disaccharidase activities was not as prevalent as 
that of maltase. In addition to maltase activity, the Brazilian study also measured abundance of 
messenger RNA for maltase-glucoamylase (MGA) and sucrase-isomaltase in small intestinal tissue, and 
found that they were correlated with the activity of maltase at the messenger RNA abundance.  
The Brazilian study found no association between WAZ score and tissue maltase activity (no other 
details were provided), while the Bolivian study found that intestinal lactase concentrations were 
significantly and positively associated with WAZ and less strongly associated with HAZ at admission. 
Unfortunately, they did not detail the magnitude of these associations or report if they assessed maltase 
and sucrase-isomaltase association with growth parameters. Because intestinal disaccharidase activity is, 
by its nature, measured on intestinal tissue, it was relatively straightforward for these studies to assess 
marker association with intestinal histopathology. Maltase-glucoamylase (MGA) mRNA abundances were 
strongly correlated with both maltase activity and villous atrophy. The Bolivian study did not attempt to 
correlate disaccharidase activity with histopathology. 
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5.4.4 13C Assessment in Stool after Lipid Administration 
Two studies by the same group of investigators in the same setting [148, 149] with a total sample 
size of 32 severely malnourished children assessed digestion by administering radiolabeled lipids. They 
then measured the amount of radiolabel excreted in the stool in the forms of triglyceride (TG) and fatty 
acid (FA), with recovery of fatty acids interpreted to indicate adequate lipid breakdown but poor absorption 
while recovery of triglycerides marked poor digestive function. Both studies found widely varying 13C in 
stool, although the variation was less marked in their later study; however the sample size was only eight 
patients [148].  
In both of these studies, the majority of excreted 13C was in the form of FA rather than TG, 
reflecting a failure of lipid absorption in the face of adequate digestion. Each labeled lipid form (FA and 
TG) was found in decreasing concentrations as the study progressed, suggesting improved digestion and 
absorption, although concentrations did not differ significantly with time.  
The two studies differed in their findings related to small bowel bacterial overgrowth; the first study 
[149] found no evidence for bacterial overgrowth while the second [148] did, as measured by the recovery 
of label in the stool after ingestion of 13C glycocholate.  
The first of these studies [149] additionally investigated fecal fat as a marker and found that it was 
associated with concentrations of 13C in stool. 
5.4.5 Urinary Lactose:Lactulose Ratio 
We considered serum and urinary lactose to be primarily measures of gut permeability, as 
described above. As a large molecule, lactose should not enter the system unless there is a permeability 
defect. It should be recognized, however, that presence of lactose in the serum or urine could be 
complicated by lactase deficiency. However, lactase deficiency without a permeability defect would not be 
expected to result in the presence of lactose in the blood or urine. When urinary lactose is normalized 
against another marker for permeability, the lactose:lactulose ratio is primarily a marker of lactose 
digestion. One study assessed this marker and found that nearly half of subjects had low lactase activity, 
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defined as lactose:lactulose ratio >0.4 [124]. Urinary lactose and lactose:lactulose ratios significantly 
decreased with age and were significantly elevated among breast-fed compared to non-breastfed infants, 
adjusting for age, despite similar intestinal permeability values as measured by L:M. The markers were 
not associated with sex, ethnicity, or location. Lactose and lactose:lactulose ratios were not associated 
with L:M.  
5.4.6 Summary of Markers of Digestion 
A broad range of markers was used to assess digestive function in children in resource-limited 
settings. Intestinal disaccharidases were affected in subjects with persistent diarrhea and/or malnutrition. 
The sucrose and lactose HBTs showed varying degrees of digestive disturbance across studies with 
subjects of differing health conditions. Results for maltase activities were consistent across the two 
studies in which they were sought in intestinal tissues. Several different methods were used to assess 
intestinal enzyme capacity, and results between methods were consistent where comparable.  
Few markers of digestion were investigated in relation to biopsy or tests of intestinal permeability. 
Breath tests in particular lacked comparison to other standard markers.  
Varying associations were observed between markers of digestion and growth parameters. The 
sucrose breath test was not associated with growth [159]. The studies of intestinal disaccharidases found 
different results for different enzymes; one study found no association between maltase and wasting while 
the other found an association between lactase and growth parameters [53, 109]. The relationship 
between abnormal markers of digestion and growth outcomes was not reported for either hydrogen breath 
tests or stool reducing substances. 
The sucrose breath test results were significantly associated with the L:R; the concentration of 
exhaled hydrogen was inversely associated with the L:R [159]. This test might be useful as a noninvasive 
marker of enteric dysfunction, although replication of these results is needed before a judgment as to their 
value can be made.  
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5.5 Markers of Intestinal Inflammation and Intestinal 
Immune Activation 
Eighteen studies utilized a variety of markers that reflect intestinal inflammation or immune 
activation among children in resource-limited settings. The data relevant to this review are listed for each 
of these studies in Evidence Table 4. Eight types of markers were assessed across the studies, most of 
which were examined in stool. Lactoferrin was the most commonly assessed marker among these 
reports; nine studies utilized it to assess intestinal inflammation. Additionally, fecal cytokines, leukocytes, 
and neopterin were measured in five [101, 131, 132, 137, 140], four [104, 138, 158, 169], and one [15] 
studies, respectively. Two studies by the same group of investigators assessed fecal IgE [142, 143]. 
Intestinal tissue cytokines, immune and inflammatory cell markers, and duodenal aspirate 
immunoglobulins were investigated in one study apiece. 
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Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
2003 
 
Alcantara CS et al. 
 
Interleukin-8, tumor 
necrosis factor-
alpha, and 
lactoferrin in 
immunocompetent 
hosts with 
experimental and 
Brazilian children 
with acquired 
cryptosporidiosis 
 
Fecal cytokines and 
lactoferrin as 
markers of intestinal 
inflammation among 
children with and 
without 
Cryptosporidium 
parvum. 
Fortaleza, 
Brazil  
 
3-43 mo olds 
recruited from a 
shantytown 
community who 
were screened for 
enteric pathogens. 
 
There was a high 
prevalence of 
malnutrition among 
the cases. 
 
(Adults 
experimentally 
exposed to C. 
parvum by 
ingestion were also 
studied; these data 
were not included 
in this review.) 
Case-control  
 
n=32; 
 
n=17 cases with C. 
parvum:  
• 4 with no 
diarrhea 
• 10 with AD 
• 3 with PD 
 
n=15 controls with 
no diarrhea or 
enteric pathogens 
and comparable 
HAZ and WAZ 
scores to cases 
Stool tests: 
• Lactoferrin  
(17 cases and 15 controls 
tested) 
• IL-8  
(13 cases and 15 controls 
tested) 
• TNF-α  
(10 cases and 0 controls 
tested)  
 
 
 
Lactoferrin positive: 
• 12/17 cases 
• 1/4 cases without 
diarrhea 
• 8/10 AD cases 
• 3/3 PD cases 
• 3/15 controls (p=0.006 
compared to cases) 
 
IL-8 detectable: 
• 3/13 all cases 
• 0/2 cases without 
diarrhea 
• 3/10 AD cases 
• 0/1 PD cases 
• 6/16 controls (p=0.435 
compared to cases) 
 
TNF-α detectable:  
• 0/10 cases 
The proportion of 
children who tested 
positive for fecal 
lactoferrin was 
greater in those 
with 
cryptosporidiosis, 
especially those 
symptomatic with 
diarrhea, than in 
uninfected controls, 
although 20% of 
the control group 
tested positive. 
 
Fecal IL-8 did not 
differ between 
those with and 
without 
Cryptosporidium 
infection. TNF-α 
was not elevated 
among children 
with 
Cryptosporidium 
infection. 
Direct comparisons 
between various 
stool tests were 
not reported.  
 
Lactoferrin results 
were graded based 
on agglutination 
reaction positivity 
with increasing 
dilution and were 
considered 
negative if there 
was no reaction at 
1:25.  
 
Four subjects were 
breastfed and were 
tested for 
lactoferrin. 
2009 
 
Amadi B et al. 
 
Reduced production 
of sulfated 
glycosaminoglycans 
occurs in Zambian 
children with 
kwashiorkor but not 
marasmus 
 
Duodenal biopsy 
including 
assessments of 
intestinal markers in 
children with PD and 
Lusaka, Zambia 
 
12.2-19.8 mo olds 
with PD and 
malnutrition 
admitted to the 
malnutrition ward of 
a teaching hospital. 
Case-control  
 
n=41*; 
 
n=41 cases with 
PD and 
malnutrition:  
• 18 with 
marasmus 
• 8 with marasmic 
kwashiorkor 
• 15 with 
kwashiorkor  
 
n=19 healthy 
control children 
from UK  
Endoscopic duodenal 
biopsy: 
• Histopathology 
• Densities in lamina propria 
and crypt epithelium: 
• Cell proteins:  
• Glycosaminoglycan 
(GAG) 
• Enterocyte heparan 
sulfate proteoglycan 
(HSPG) 
• Syndecan-1  
• Inflammatory cell 
markers: 
• CD3 IEL 
• Ki67 
• Human leukocyte 
Biopsy findings among the 
Zambian compared to the UK 
children: 
• Villous height reduced 
• Crypt depth increased  
• ~50% reduction in 
crypt:villous ratio 
• Values for lamina propria cell 
densities were not reported 
for UK subjects 
 
No significant differences in 
crypt or villous measures or 
lamina propria cell densities 
were observed between 
nutritional groups or after 
nutritional rehabilitation. 
Mucosal 
architecture was 
markedly abnormal 
compared to UK 
controls but did not 
vary between 
marasmus and 
kwashiorkor 
presentations of 
malnutrition.  
 
Inflammatory cell 
densities were 
generally higher 
compared to UK 
children and 
showed different 
27 subjects were 
HIV positive; 
incidence was 
lower in the 
kwashiorkor group. 
Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.  
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
different forms of 
malnutrition 
 
 
* UK subjects are 
presented in this 
table due to 
comparisons of 
interest made in 
the review. 
However we do not 
include these 
subjects in the 
sample size for this 
review. 
antigen DR-1 (HLA-
DR) 
 
Intestinal markers: 
• Inflammatory markers were 
seen in higher densities 
compared to the UK children. 
There were significant 
differences between the 
different nutritional groups in 
the specific types of 
inflammatory markers. 
• There was a significant 
reduction in GAGs and HSPG 
in the kwashiorkor group 
compared to UK children, but 
no significant differences 
between kwashiorkor and 
other presentations of 
malnutrition.  
• There was no difference in 
epithelial syndecan-1 protein 
expression between the 
malnutrition groups (data not 
available for UK controls). 
patterns across the 
malnutrition 
presentations.  
 
Tissue 
concentrations of 
HSPG and GAG 
were reduced 
especially amongst 
children with 
kwashiorkor. 
Intestinal protein 
markers did not 
differ amongst the 
malnutrition groups. 
2000 
 
Azim T et al. 
 
Immune response of 
Bangladeshi 
children with acute 
diarrhea who 
subsequently have 
persistent diarrhea 
 
Immune activation 
tests, as well as 
transferrin and 
albumin as markers 
of nutritional status 
among children with 
and without PD 
Dhaka, Bangladesh 
 
7-12 mo olds with 
6-8 days of watery 
diarrhea attending 
the International 
Centre for Diarrheal 
Disease Research.  
 
Cases were those 
who went on to 
develop PD, 
controls were those 
who did not.  
 
An additional group 
of subjects without 
diarrhea were 
recruited from a 
nutrition follow-up 
Case-control 
 
n=136;  
 
n=38 cases with 
PD 
 
n=98 controls: 
• 85 with AD 
• 13 with no 
diarrhea 
Blood tests: 
• IFN-γ 
• TNF-α 
• WBC (total and differential) 
• IgA 
• IgG 
• IgM 
• Transferrin 
• Albumin 
• Immune function tests: 
• Neutrophil polarization 
response to chemotactic 
factor 
• Neutrophil opsonization 
to yeast 
• Mononuclear cell 
proliferation, 
spontaneous and in 
response to stimuli with 
WBC total and differential, 
immunoglobulin subtypes, 
cytokines, transferrin, and 
albumin did not differ between 
cases with diarrhea or controls, 
nor did stool leukocyte or 
erythrocyte counts.  
 
The percentages of neutrophils 
that polarized in response to 
stimulation were significantly 
higher in subjects with AD or 
PD compared to those without 
diarrhea; there was no 
difference between the two 
diarrhea groups. 
 
Opsonization did not vary 
between any groups. 
 
Some immune and 
inflammatory 
markers were 
associated with 
acute and/or 
persistent diarrhea. 
 
The only marker 
that was 
significantly 
associated with 
progression to PD 
was a negative 
DTH response to 
tuberculin antigen 
(odds ratio=3.8, CI: 
1.4, 9.9). This was 
calculated from a 
logistic regression 
analysis that only 
The number of 
controls was 
relatively small and 
their nutritional 
status was not 
reported. 
Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.  
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
unit.  
 
Prevalence of 
malnutrition was 
high in all groups. 
mitogens 
 
 
Skin Test: 
• Delayed-type 
hypersensitivity response 
(DTH) to tuberculin, 
tetanus, diphtheria, 
Streptococcus, Proteus, 
Candida, and Trichophyton  
 
 
Stool tests: 
• Leukocytes 
• Red blood cells 
Monocyte spontaneous 
proliferation counts were less 
than half among children with 
no diarrhea compared to those 
with AD (p<0.001) or with PD 
(p=0.011); there was no 
difference between the two 
diarrhea groups.  
 
Monocyte proliferation in 
response to stimulation did not 
differ between the 3 groups.  
 
The proportion with DTH 
responses differed among the 
three groups only in response 
to tuberculin (p=0.021). More 
PD subjects had a negative 
tuberculin response than did 
subjects with AD (p=0.024). 
included children 
with diarrhea. 
2007 
 
Bushen OY et al. 
 
Heavy 
cryptosporidial 
infections in children 
in northeast Brazil: 
comparison of 
Cryptosporidium 
hominis and 
Cryptosporidium 
parvum 
 
Fecal lactoferrin as 
a marker of 
intestinal 
inflammation in 
children with 
Cryptosporidium 
Goncalves Dias 
favela in Fortaleza, 
Brazil 
 
All newborns from 
an urban 
shantytown were 
recruited at birth 
and followed for up 
to 4 yr.  
 
This study included 
only children testing 
positive for 
Cryptosporidium. 
Cohort 
 
n=42  
(41 tested) 
 
 
Stools were 
collected at regular 
intervals as well as 
during episodes of 
diarrhea. 
Stool Test: 
Lactoferrin  
 
68.3% were lactoferrin- 
positive; there were no 
differences in positivity 
between subjects with C. 
hominis and C. parvum spp. 
 
67.9% of lactoferrin-positive 
subjects had very high titers. 
 
Younger children were more 
often lactoferrin-positive 
(p=0.03). The difference was 
mediated by C. parvum; 87.5% 
of ≤1 year olds compared to 
40.0% of older children with C. 
parvum were lactoferrin-
positive (p=0.04). There was no 
difference among those 
infected with C. hominis. 
 
Lactoferrin was correlated with 
symptomatic infection among 
those with C. parvum: 78.6% of 
Lactoferrin was 
correlated with 
younger age and 
symptomatic 
infection among 
those infected with 
C. parvum.  
 
Lactoferrin did not 
significantly predict 
growth outcomes. 
 
Cryptosporidium 
species-specific 
differences were 
observed in 
lactoferrin results. 
In contrast to C. 
parvum, there was 
no association 
between lactoferrin 
and symptomatic/ 
asymptomatic C. 
Lactoferrin results 
were graded based 
on agglutination 
reaction positivity 
with increasing 
dilution and were 
considered 
negative if there 
was no reaction at 
1:50 and highly 
positive at >1:400. 
 
Data were part of a 
larger study; 
similar data on 
lactoferrin in 
Giardia-infected 
children was 
published by A. 
Kohli, et al. (also 
included in this 
review), using a 
slightly different 
Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.  
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
symptomatic children 
compared to no asymptomatic 
children had a positive test 
(r=0.67, p=0.0041).  
 
Lactoferrin was not correlated 
with degree of oocyst shedding 
(p=0.28). 
 
Lactoferrin was correlated with 
∆HAZ score among those with 
C. parvum, although this 
observation was not statistically 
significant (r=-0.39, p=0.13). 
hominis infection 
(p=0.231). In 
addition, similar 
proportions of 
asymptomatic 
children with C. 
hominis had high 
fecal lactoferrin 
titers as had 
undetectable 
results. 
grading scale for 
reporting 
lactoferrin results 
[133]. Rather than 
exclude breastfed 
children, Bushen et 
al. stratified results 
on breastfeeding 
status and found 
no difference in 
positive/ negative 
results, including 
when examined 
among younger 
and older children. 
2004 
 
Campbell DI et al. 
 
Intestinal 
inflammation 
measured by fecal 
neopterin in 
Gambian children 
with enteropathy: 
association with 
growth failure, 
Giardia lamblia, and 
intestinal 
permeability 
 
Fecal neopterin and 
L:M as markers of 
intestinal 
inflammation and 
permeability, 
respectively, and 
their correlation with 
growth status and 
Keneba, Gambia 
 
2 mo olds from 
rural area followed 
until 15 mo of age. 
Cohort 
 
n=72 
 
 
Subjects were 
evaluated with 
twice-weekly 
questionnaire to 
determine diarrhea 
morbidity, clinic 
assessments of 
growth, and 
screening 
laboratory tests 
every 2 mo. 
Stool Test: 
Neopterin 
 
 
Urine Tests: 
• Lactulose2  
• Mannitol 
• L:M 
 
Mean neopterin concentration 
was negatively correlated with 
long-term height (r=-0.29, 
p<0.009) and weight (r=-0.36, 
p<0.007) gain, but not with 
giardiasis. 
 
Mean3 L:M (CI): 0.31 (0.26, 
0.34). 
 
Mean excretion of lactulose 
(CI): 0.20 (0.18, 0.23).  
 
Mean excretion of mannitol 
(CI): 3.0 (2.8, 3.2).  
 
Mean L:M was negatively 
correlated with long-term height 
gain (r value not provided, 
p<0.0001), but was not 
correlated with presence of 
Giardia. 
 
L:M and fecal neopterin were 
L:M and mean fecal 
neopterin 
concentration were 
not correlated. 
 
Mean L:M in the 
Gambian children 
was substantially 
higher than normal 
values in children in 
the UK. These high 
L:M ratios appear 
to be driven by 
mannitol excretion. 
Study population 
might have some 
overlap with that of 
Campbell et al. 
also included in 
this review [110]. 
                                                          
1 Reported results were adjusted for confounding variables, unless otherwise noted. 
2 Lactulose and mannitol results were expressed as % of dose administered. 
3 Geometric mean. 
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Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
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Location and  
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Design and 
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Giardia recovery in 
the stool 
not correlated (p=0.11). 
2003 
 
Campbell DI et al. 
 
Chronic T cell-
mediated 
enteropathy in rural 
west African 
children: relationship 
with nutritional 
status and small 
bowel function 
 
 
L:M as a marker of 
intestinal 
permeability, small 
bowl biopsy with 
assessment of 
intestinal immune 
markers, and 
computerized 
morphometric 
analysis among rural 
Gambian children 
with differing 
degrees of 
malnutrition and 
compared to well-
nourished UK 
children 
Fajara and Sibanar, 
The Gambia 
 
6 mo-3 yr old 
hospital- and clinic-
based cases from 
rural communities. 
 
Case groups based 
on differences in 
nutritional status:  
• WAZ score >-2, 
with GI 
complaints other 
than diarrhea  
• Grade I protein 
energy 
malnutrition 
(PEM) (WAZ 
score -2 to -4) 
and 
unresponsive to 
nutritional 
supplements, 
with or without 
diarrhea 
• Grade II PEM 
(WAZ score <-4) 
with or without 
diarrhea  
 
Controls from UK* 
who were well 
nourished children 
with GI complaints 
other than diarrhea 
and with normal 
endoscopy results 
Case-control 
  
n=40 cases: 
• Group 1: n=4  
• Group 2: n=11 (7 
with diarrhea) 
• Group 3: n=25 
(18 with 
diarrhea) 
 
n=34 with case 
tissue samples 
sufficient for 
cytokine 
immunoreactivity 
tests:  
• Group 1: n=3 
• Group 2: n=8 
• Group 3: n=23 
Endoscopic 
small bowel biopsy, site not 
specified: 
• Histopathology 
• Morphometric assessment 
by computer analysis*  
• Intestinal tissue cytokines 
and immune markers:  
• CD-3  
• CD-4 
• CD-8 
• CD-19 
• CD-25 
• HLA-DR 
• Perforin 
• γδ T-cell receptor 
• Syndecan-1 
• TNF-α 
• IFN-γ 
• TGF-β 
• IL-10 
 
 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M 
 
 
* Biopsy involved 
morphometric assessment 
by computer analysis of 
villous height, crypt depth, 
villous:crypt ratio, and 
intraepithelial lymphocyte 
(IEL) density (per 100 
epithelial cells). 
Crypt-hyperplasia and villous 
atrophy were observed among 
all Gambian subjects, and the 
degree of histopathology did 
not differ among cases with 
differing nutritional status, nor 
was there a correlation with 
diarrhea. 
 
IEL2 means were ~3-fold 
higher in Gambian than UK 
children. 
 
Median CD3, CD4, CD8, 
CD19, and CD25 cell counts 
were significantly higher (2-5x 
higher) among each case 
group compared to the UK 
controls.  
 
IEL, γδ, syndecan-1, HLA-DR, 
and perforin were detected 
among the Gambian children in 
varying degrees but were not 
reported for UK controls. 
Syndecan, CD3, and CD8 
displayed a gradient 
proportional to malnutrition 
severity. 
 
All Gambian groups showed 
higher lamina propria cytokine-
immunoreactive mononuclear 
cell density (~200-450/mm2) 
than UK controls (30-80/mm2). 
 
Among subjects with elevated 
cytokines, similar densities 
All Gambian 
subjects had 
evidence of 
enteropathy with 
crypt-hyperplasia 
and villous atrophy, 
and mean IELs >2 
SD above UK 
norms, independent 
of nutritional status 
and diarrhea 
history. 
 
Elevation of cell-
mediated intestinal 
markers and 
mucosal 
proinflammatory 
cytokines was 
present across the 
3 Gambian groups, 
variably correlated 
with nutritional 
status. 
 
L:M ratios were 
elevated in all 
Gambian groups, 
without apparent 
correlation to host 
nutritional status. 
Statistical 
methodology was 
not sufficiently 
detailed to 
determine what 
was compared 
(e.g. type of central 
tendency measure 
and variance 
calculations for 
L:M not stated).  
 
Duration of 
diarrhea not 
specified, but 
assumed to be 
persistent.  
 
Mucosal 
lymphocyte 
densities, cytokine 
immunoreactivity, 
and L:M results 
were not stratified 
by history of 
diarrhea. 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 These figures are presumed to represent IEL means; however, this was not explicitly stated. 
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were also studied. 
 
 
* UK subjects are 
presented in this 
table due to 
comparisons of 
interest made in the 
review. However 
we do not include 
these subjects in 
the sample size for 
this review. 
were seen for both pro-
inflammatory (IFN-γ and TNF-
α) and putative regulatory (IL-
10 and TGF-β) cytokines. 
Epithelial expression of TGF-β 
was also enhanced compared 
to UK controls, but subjects 
with poorer nutritional status 
had lower densities of mucosal 
TGF-β+ cells, with median 
densities of 420 and 250 
cells/mm2 in the grade I and 
grade II PEM groups, 
respectively. 
 
L:M values1:  
• Group 1: 0.53 (0.4-1.3)  
• Group 2: 0.47 (0.02-2.20) 
• Group 3: 0.73 (0.14-2.2) 
• Not assessed among the UK 
controls 
 
Nutritional status was not 
associated with L:M, recoveries 
of lactulose or mannitol.  
 
L:M was correlated with 
mucosal B lymphocyte density 
(r=0.57, p<0.05), IEL (r=0.51, 
p<0.02), and perforin+ IEL (r=-
0.64, p<0.03). 
2001 
 
Kapoor S et al. 
 
Giardiasis--clinical 
and diagnostic 
perspective 
 
Immunoglobulin 
concentrations in 
New Delhi, India 
 
<12 yr olds 
admitted to hospital 
with PD and 
Giardia.  
 
Controls had no 
diarrhea and were 
hospitalized for 
Case-control 
 
n=40;  
 
n=30 cases with 
PD and Giardia 
 
n=10 controls 
without diarrhea 
Duodenal secretion 
aspirates: 
• IgG 
• IgM  
• IgA 
 
 
Blood Tests: 
• IgG 
• IgM 
Higher mean concentrations of 
IgM were found in duodenal 
aspirates of cases compared to 
controls (p<0.05).  
 
Mean concentrations of 
duodenal IgA and IgG did not 
differ between cases and 
controls. 
Differences in 
immunoglobulin 
concentrations 
were limited among 
children with PD 
infected with 
Giardia compared 
to children without 
such conditions. 
 
The number of 
controls was small 
due to constraints 
in obtaining 
duodenal aspirate 
from children 
without GI 
symptoms. 
                                                          
1 Not clearly indicated if these figures represent mean (CI) or another measure of central tendency. 
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duodenal fluid and 
serum among 
children with PD and 
Giardia infection 
compared to those 
without diarrhea 
non-GI conditions. 
 
Most cases were 
<7 yr old, with n=19 
<3 yr old. Ages of 
controls were not 
specified. 
• IgA 
 
2006 
 
Kirkpatrick BD et al. 
 
Childhood 
cryptosporidiosis is 
associated with a 
persistent systemic 
inflammatory 
response 
 
Fecal cytokines and 
lactoferrin as 
markers of intestinal 
mucosal 
inflammation among 
children with and 
without 
Cryptosporidium 
infection 
Port-au-Prince, 
Haiti 
 
<36 month olds 
recruited from 
GHESKIO HIV 
Center1 with 
Cryptosporidium 
infection and 
healthy controls.  
 
Subjects were 
followed-up at 6 
and 9 months after 
infection resolved.  
 
HIV status of 
subjects varied.  
 
There was a high 
prevalence of 
malnutrition in the 
study population. 
Cohort 
 
n=73; 
 
n=42 cases with 
diarrhea and 
Cryptosporidium 
infection  
(18 with PD) 
 
n=31 healthy 
controls without 
diarrhea and 
Cryptosporidium-
negative 
Stool Tests: 
• Lactoferrin 
• Cytokines: 
• IFN-γ 
• TNF-α 
• TGF-β 
• IL-4  
• IL-8  
• IL-10 
Proportion lactoferrin-positive 
at enrollment: 
• Cases: 51.2% 
• Controls: 4.0% 
 
Cases had higher 
concentrations of TNF-α than 
controls at enrollment (p=0.04), 
but no difference was observed 
at follow-up. 
 
Controls had almost 2x higher 
fecal IFN-γ at enrollment 
(p=0.1); the magnitude of 
difference increased (to almost 
3x) and was statistically 
significant at the 6- and 9-
month follow-up (p=0.01 and 
p=0.03, respectively). 
 
No differences in fecal 
concentrations of TGF-β, IL-8, 
IL-4, or IL-10 were noted 
between groups. 
Lactoferrin was 
present among half 
of subjects with 
cryptosporidiosis 
and uncommon 
among those 
without such 
infection.  
 
Fecal TNF-α was 
higher among 
cases at enrollment 
but did not persist 
when infection 
resolved.  
 
Paradoxically, 
controls’ 
comparatively 
higher fecal IFN-γ 
increased in both 
magnitude and 
degree of statistical 
significance at 
follow-up.  
 
Of the remaining 
fecal cytokines 
assessed, there 
were no differences 
between cases and 
controls. 
Cut-off values for 
lactoferrin positivity 
were not provided.  
 
Breastfed children 
(>85% of cases 
and controls) were 
included in testing. 
Proportions at 
follow-up were not 
reported.  
 
The association of 
fecal cytokines and 
lactoferrin with 
growth 
parameters, history 
of PD, and HIV 
status were not 
reported, nor was 
their association 
with each other.  
 
Various markers of 
systemic 
inflammation, 
including serum 
cytokines, were 
measured but their 
relationship with 
markers of 
intestinal 
inflammation was 
not reported. 
                                                          
1 The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections. 
Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.  
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
 
2002 
 
Kirkpatrick BD et al. 
 
Cryptosporidiosis 
stimulates an 
inflammatory 
intestinal response 
in malnourished 
Haitian children 
 
Stool lactoferrin, 
reducing 
substances, 
leukocytes and 
cytokines as 
markers of intestinal 
inflammation of 
children with and 
without 
Cryptosporidium 
infection 
Port-au-Prince, 
Haiti 
 
<18 mo olds from a 
low SES setting 
recruited from the 
rehydration unit of 
GHESKIO HIV 
Center1 with 
diarrhea and 
Cryptosporidium 
infection. Controls 
recruited from an 
outpatient clinic 
without 
Cryptosporidium 
infection included 
those with and 
without diarrhea. 
Case-control 
 
n=49; 
 
n=17 cases with 
Cryptosporidium 
and diarrhea (5 
with PD)  
 
n=32 controls 
without 
Cryptosporidium; 
• 17 with diarrhea 
(5 with PD) 
• 15 healthy 
 
Stool Tests: 
• Reducing substances (RS) 
• Lactoferrin 
• Cytokines: 
• TNF-α receptor I  
• IL-4 
• IL-8 
• IL-10 
• IL-13 
• IFN- γ  
 
 
Blood Test: 
• WBC  
 
Proportion RS-positive:  
• 33.3% cases 
• 64.7% diarrhea controls 
• 46.7% healthy controls, 
(p=0.2) 
 
Proportion lactoferrin-positive:  
• 83.3% cases  
• 60.0% diarrhea controls 
• 28.6% healthy controls, 
(p=0.01) 
 
IFN-γ was not recovered in any 
stools. 
 
All other fecal cytokines were 
significantly associated with 
Cryptosporidium cases 
compared to diarrhea and 
healthy controls.  
 
Additionally, TNF-α receptor I, 
IL-8, and IL-13 were found in 
diarrhea and healthy controls, 
while IL-4 and IL-10 were not.  
 
Fecal lactoferrin was 
associated with the presence of 
TNF-α receptor I (point 
estimate not provided, p=0.03). 
 
Mean WBC counts were within 
normal range in all 3 groups. 
Fecal lactoferrin 
was identified most 
often in children 
with diarrhea, 
especially in those 
with 
Cryptosporidium. 
While some fecal 
cytokines were 
detected in as 
many as 40% of 
healthy controls 
and 70% of controls 
with diarrhea, they 
were generally 
associated with 
Cryptosporidium 
infection. The other 
stool tests did not 
discriminate by 
diarrhea or 
Cryptosporidium 
status. 
Reported results 
were not stratified 
by persistent vs. 
acute diarrhea 
status.  
 
Cut-off values for 
lactoferrin positivity 
were not 
described.  
 
Stools from 
children who were 
breastfeeding were 
not tested for 
lactoferrin. 
2008  
 
Kohli A et al.  
 
Giardia duodenalis 
assemblage, clinical 
presentation and 
Goncalves Dias 
favela in Fortaleza, 
Brazil 
 
All newborns from 
an urban 
shantytown were 
Cohort 
 
n=108 stool 
samples from 47 
children  
 
Stools were 
Stool Test:  
Lactoferrin 
Proportion of positive 
lactoferrin results decreased 
with each new Giardia 
infection, p=0.015: 
1.1st infection: 74.0% (15.2% of 
those testing positive had 
high titers)  
Increased 
concentrations of 
lactoferrin were 
observed more 
frequently with first 
time Giardia 
infections. 
Lactoferrin results 
were graded based 
on agglutination 
reaction positivity 
with increasing 
dilution; the 
following scale was 
                                                          
1 The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections. 
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markers of intestinal 
inflammation in 
Brazilian children 
 
Fecal lactoferrin as 
a marker of 
intestinal 
inflammation in 
Giardia-infected 
children and its 
association with 
persistence of 
diarrhea 
recruited at birth 
and followed for up 
to 4 yr. Those with 
Giardia recovered 
from stools were 
included in this 
study. 
collected at regular 
intervals as well as 
during episodes of 
diarrhea. 
2.2nd infection: 40.0% (5.3% of 
those testing positive had 
high titers)  
3.3rd infection: 1 (20.0%) tested 
positive (at a high titers) 
 
Increasing titers of lactoferrin 
were associated with longer 
duration of diarrhea, p=0.017: 
• Negative: 2.2 days 
• Low: 9.7 days 
• High: 14.6 days 
 
Lactoferrin results did not differ 
between symptomatic and 
asymptomatic children at first 
infection, but those with 
symptoms had positive results 
with recurrent infections with 
greater frequency (75.0% vs. 0 
in asymptomatic repeat 
infections, p=0.017.) 
Concentrations 
were associated 
with longer duration 
of diarrhea, 
although these 
results were not 
presented 
separately for first 
and recurrent 
infections. 
 
Stool lactoferrin 
might be useful in 
predicting duration 
of diarrheal illness 
in G. duodenalis-
infected children. 
used: 
• High = positive 
at 1:400-1:3200 
dilution  
• Low = positive at 
1:25-1:200 
• Negative = no 
reaction at 1:25 
 
Stools from 
children who were 
breastfeeding were 
not tested.  
 
Data were part of a 
larger study; 
similar data on 
lactoferrin in 
Cryptosporidium-
infected children 
were published by 
O.Y. Bushen, et al. 
(also included in 
this review); 
however, Bushen 
et al. used a 
slightly different 
grading scale for 
reporting 
lactoferrin results 
[108]. 
2010 
 
Lima AA et al.  
 
Effects of vitamin A 
supplementation on 
intestinal barrier 
function, growth, 
total parasitic, and 
specific Giardia spp 
Fortaleza, Brazil 
 
2 mo-9 yr olds 
(mean 43 mo) from 
an impoverished 
urban community, 
eligible if HAZ 
score was <median 
for their community. 
 
RCT 
 
n=79;  
 
n=40 received 
placebo 
(tocopherol)  
 
n=39 received 
vitamin A (retinyl 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M  
 
 
Stool Tests: 
• Lactoferrin 
• Cytokines: 
• IFN-γ 
Median L:M at baseline was 
0.089. There was no significant 
change in L:M at 4 mo follow-
up within either treatment 
group. 
 
No significant difference in L:M 
was observed between 
treatment groups. 
 
Frequency of stool 
lactoferrin varied 
between 23%-32%. 
 
While vitamin A 
supplementation 
was associated 
with reduced 
lactulose excretion, 
it was also 
Authors did not 
report testing for 
associations 
between urinary 
markers of 
intestinal 
permeability and 
concentrations of 
fecal cytokines, or 
between these 
                                                          
1 For lactulose and mannitol results, excretion measurement was not specified. 
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infections in 
Brazilian children: a 
prospective 
randomized, double-
blind, placebo-
controlled trial 
 
L:M as a marker of 
intestinal barrier 
function, and stool 
lactoferrin and 
specific intestinal 
immunological 
cytokines as 
markers of intestinal 
inflammation among 
nutritionally at-risk 
children who 
received either 
vitamin A or placebo 
Subjects were 
screened for 
intestinal parasites, 
and longitudinal 
anthropometrics 
were assessed. 
palmitate)  
 
Subjects were 
treated every 4 
mo. 
• TNF-α 
• IL-4 
• IL-10 
Both median lactulose and 
mannitol excretions decreased 
at 4 mo follow-up among the 
vitamin A compared to the 
placebo group: 
• Lactulose: 0.21 to 0.74, 
p=0.042  
• Mannitol: 3.06 to 8.25, 
p=0.008  
 
Overall proportion of lactoferrin 
was 23% initially. At 1 mo 
follow-up, there was no 
difference in prevalence 
between vitamin A (33%) and 
placebo (31%) groups. 
 
Cytokine concentrations did not 
significantly differ between 
placebo and vitamin A groups. 
associated with 
reduced mannitol 
excretion, with no 
overall effect on 
L:M.  
 
Vitamin A 
supplementation 
was not associated 
with presence of 
lactoferrin or 
intestinal cytokine 
response. 
 
 
markers and 
growth parameters 
or parasitosis. 
 
Cut-point values 
for lactoferrin 
positivity and 
abnormal L:M were 
not described.  
 
Exclusively 
breastfed children 
were excluded 
from study 
participation due to 
assessment of 
stool lactoferrin. 
2005 
 
Lima AA et al. 
 
Intestinal barrier 
function and weight 
gain in malnourished 
children taking 
glutamine-
supplemented 
enteral formula 
 
L:M as a marker of 
intestinal 
permeability and 
various stool tests 
among children with 
malnutrition or PD 
who received either 
glycine or glutamine 
Fortaleza, Brazil 
 
2-60 mo olds 
hospitalized with 
WAZ score <-2, 
~70% of whom had 
PD. 
RCT 
 
n=80;         
 
n=53 received 
supplemented 
formula 
• 27 with glycine 
• 26 with glutamine 
 
n=27 received 
nonsupplemented 
formula 
Urine Tests*: 
• Lactulose1 
• Mannitol 
• L:M  
 
 
Stool Tests**: 
• Lactoferrin  
• Leukocytes  
• Occult blood 
• Reducing substances (RS) 
 
 
* n=80 tested at enrollment, 
n=65 tested at day 10. 
 
** n=60 tested. 
Mean2 L:M (SE):  
• Glutamine group: 
• Baseline: 0.31 (0.10) 
(similar in all three 
groups) 
• Day 10: 0.10 (0.02); 
significant decrease, 
(p=0.01) 
• No significant decrease in 
L:M in glycine and 
nonsupplemented formula 
groups at day 10 
 
Mean lactulose (SE):  
• Glutamine group: 
• Baseline: 0.97 (0.46) 
(similar in all three 
groups) 
• Day 10: NS decrease in 
all 3 groups 
L:M significantly 
improved in the 
glutamine group 
only. 
 
>50% of subjects 
had intestinal 
inflammation by 
stool lactoferrin. 
Fecal leukocytes, 
RS, and occult 
blood were 
detected in fewer 
subjects than 
lactoferrin. 
The relationship 
between stool 
markers and L:M 
was not reported.  
 
Data were not 
stratified by history 
of PD. 
 
Fecal fat was 
assessed, but 
results were not 
reported. 
 
Cut-off values for 
lactoferrin positivity 
were not 
described.  
 
Exclusively 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 Type of mean not specified. 
Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.  
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
supplemented 
formula or placebo 
 
Mean mannitol (SE):  
• Glutamine group: 
• Baseline: 3.42 (0.64) 
(similar in all three 
groups) 
• Day 10: NS decrease in 
all 3 groups 
 
Proportion of stool markers at 
baseline among all subjects:  
• Lactoferrin: 53.3% 
• Leukocytes: 11.7% 
• RS: 3.3% 
• Occult blood: 5.0% 
breastfed children 
were excluded 
from study 
participation due to 
assessment of 
stool lactoferrin. 
 
2006 
 
Long KZ et al. 
 
The effect of vitamin 
A supplementation 
on the intestinal 
immune response in 
Mexican children is 
modified by 
pathogen infections 
and diarrhea 
 
Fecal cytokines as 
markers of intestinal 
mucosal immune 
activation in children 
with and without GI 
pathogens receiving 
vitamin A or placebo 
Mexico City, 
Mexico 
 
All 5-15 mo olds 
within a periurban 
community were 
eligible to be 
screened for 
participation. 
RCT 
 
n=505 stool 
samples from 127 
children; 
 
n=243 stool 
samples from 57 
who received 
vitamin A 
supplementation 
 
n=262 stool 
samples from 70 
who received 
placebo 
  
 
Participants were 
followed regularly; 
diarrhea history 
was tracked and 
stool samples were 
tested. 
Stool Tests: 
Cytokines: 
• IL-4 
• IL-6 
• IFN-γ 
Positive tests for fecal 
cytokines: 
• IL-4: ~55% 
• IFN-γ: ~50% 
• IL-6: ~40%  
 
There were no significant 
differences in proportions of 
these fecal cytokines between 
vitamin A-supplemented and 
placebo subjects. 
 
Vitamin A-supplemented 
children with diarrhea had 
lower median IFN-γ 
concentrations (odds 
ratio1=0.51; CI: 0.26, 0.99) and 
higher IL-4 concentrations 
(odds ratio=2.14; CI: 0.94, 
4.87) compared to children with 
diarrhea in the placebo group 
in a nonrandomized analysis. 
IL-6 concentrations did not 
differ in this analysis. There 
were no differences between 
the two groups among those 
Differences in fecal 
cytokine 
concentrations due 
to vitamin A 
supplementation 
were observed only 
in the subset of 
subjects with GI 
infection or 
diarrhea. 
 
 
Pre-intervention 
fecal cytokine 
concentrations 
were not reported. 
Differences in fecal 
cytokines between 
all subjects with 
and without GI 
infections or 
history of diarrhea 
were not directly 
reported; all 
differences were 
described in terms 
of vitamin A 
interaction. 
                                                          
1 The odds ratios represent odds that a cytokine (categorized into three levels: undetectable, <median, >median) will have a higher value among vitamin A-supplemented children.   
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without diarrhea. 
 
Differences in median 
concentrations of fecal 
cytokines by types of enteric 
pathogens were also observed. 
2001 
 
Mahmud MA et al. 
 
Sociodemographic, 
environmental and 
clinical risk factors 
for developing 
persistent diarrhea 
among infants in a 
rural community of 
Egypt 
 
Stool IgE as a 
marker of 
gastrointestinal 
allergy and its 
association with 
persistent vs. acute 
diarrhea 
Bilbeis, Egypt 
 
Newborns recruited 
at birth from a rural 
village and followed 
for the first year of 
life.  
 
Surveillance of 
diarrhea symptoms 
identified 392 
episodes of 
diarrhea, 41 (11%) 
of which were 
persistent. 
Nested case-
control within a 
cohort study  
 
n=392 episodes of 
diarrhea (including 
41 episodes of PD) 
among 152 
infants* ) 
 
 
* Stool samples 
from each PD 
episode were 
counted as a case 
for analysis and 
compared to 
randomly selected 
AD episodes and 
to non-diarrheal 
samples. 
Stool Test: 
IgE 
Fecal IgE was detected more 
frequently in stools from 
episodes of PD compared to 
episodes of AD: odds ratio 
(CI)1=3.3 (1.0, 10.9). 
 
Fecal IgE was detected more 
frequently in stools from 
episodes of PD than in stools 
from children without diarrhea: 
odds ratio (CI)=4.84 (1.1, 21.7). 
Fecal IgE was 
detected 3 times 
more frequently 
during episodes of 
PD than AD and 5 
times more 
frequently in PD 
stools than in stools 
from those without 
diarrhea. 
Sampling was 
based on episodes 
of diarrhea within a 
cohort of infants; 
individual infants 
could have 
contributed more 
than one diarrheal 
episode. 
Additionally, it 
appears that an 
individual could 
also have been 
included as a case 
of PD, a control 
with AD, or a non-
diarrhea stool 
within the same 
analysis.  
 
Study population 
appears to be the 
same as in another 
Mahmud, et al. 
study also included 
in this review 
which reported the 
prevalence of fecal 
IgE by gender and 
age within the 
cohort [143]. 
2001 
 
Mahmud MA et al. 
 
Bilbeis, Egypt        
 
Newborns recruited 
at birth from a rural 
Cohort 
 
n=152 
followed for 29,036 
Stool Test: 
IgE 
Overall incidence of fecal IgE: 
0.39/child-year 
 
By age group:  
Substantial 
incidence of fecal 
IgE was observed 
in this setting in 
Study population 
appears to be the 
same population 
as in another 
                                                          
1 Reported results were adjusted for confounding variables, unless otherwise noted. 
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Increased fecal IgE 
among infants in a 
rural community of 
Egypt: an analysis of 
associated risk 
factors 
 
Fecal IgE as a 
marker of intestinal 
inflammation among 
children with 
diarrhea 
village and followed 
for the first year of 
life. 
infant days  
 
Stools were 
collected during 
episodes of 
diarrhea. 
• < 3 mo: 0.28/child-yr  
•  3-6 mo: 0.42/child-yr  
•  6-9 mo: 0.16/child-yr  
• >9 mo: 0.12/child-yr  
 
Relative risks (CI): 
•  3-6 compared to >9 mo olds: 
3.28 (1.03, 13.60)  
• Male gender: 1.82 (0.83, 
4.18) 
infants. 
 
IgE incidence 
peaked at 3-6 mo 
of age. 
 
Male gender was 
associated with 
fecal IgE. 
Mahmud, et al. 
reference also 
included in this 
review which 
assessed the 
relationship 
between fecal IgE 
and PD [142]. 
2001 
 
Rabbani GH et al. 
 
Increased nitrite and 
nitrate 
concentrations in 
sera and urine of 
patients with cholera 
or shigellosis 
 
To assess and 
compare nitric oxide 
as a marker of 
intestinal 
inflammation among 
children with cholera 
or shigellosis or 
healthy controls. 
Evaluated to assess 
nitric oxide 
production during 
infection of small 
bowel without 
inflammatory lesion 
(e.g., cholera) and 
during infection 
causing colon 
inflammation (e.g., 
shigellosis). 
Dhaka, 
Bangladesh 
 
2-6 yr olds with 
cholera or 
shigellosis admitted 
to the hospital. 
 
Controls were 
recruited from the 
healthy attendants 
of patients or from 
children of hospital 
staff. 
 
Mean age (SD) in 
yr: 
• Shigellosis 
cases: 3.8 (1.2) 
• Cholera cases: 
4.2 (1.4)  
• Controls: 4.7 
(1.8) 
Case-control 
 
n=63; 
 
n=45 cases: 
• 24 with cholera 
• 21 with 
shigellosis 
 
n=18 healthy 
controls 
 
 
Samples were 
collected from 
cases on 
admission 
and upon 
discharge (after 7-
10 days of 
treatment). 
Urine Test: 
Nitric Oxide (NO)* 
 
 
Blood Tests: 
• Nitrite (NO2) 
• Nitrate (NO3) 
• WBC  
 
 
Stool Test: 
Leukocytes 
 
 
* Nitric oxide (NO) is an 
unstable free radical that is 
converted to nitrite and 
nitrate. Urine NO2 + NO3 
were expressed as a ratio 
with urine creatinine in order 
to account for differences in 
urine concentration. 
In children with shigellosis, 
median serum NO was ~8x 
higher at baseline than in 
controls and significantly 
differed from convalescent 
concentrations (p<0.01). 
Concentrations declined by 
52% of baseline during the 
recovery period but did not 
return to values found in the 
controls (measure of statistical 
significance not reported).  
 
In children with cholera, 
median serum NO 
concentrations at baseline 
were ~4x higher than in control 
subjects. Recovery 
concentrations decreased 52% 
from baseline (p<0.01); 
convalescent values did not 
differ from the values in 
controls (p<0.4).  
 
Median urinary NO ratios were 
similar among those with 
Shigella and V. cholerae 
infection, both upon admission 
and discharge. Initial values 
were ~2x higher than upon 
discharge (p<0.05 and 0.01, 
NO as measured 
by both serum and 
urinary NO2 and 
NO3 concentrations 
was significantly 
elevated at 
presentation during 
acute illness 
compared to 7-10 
days after 
hospitalization in 
both cholera and 
shigellosis.  
 
Median serum NO 
concentrations in 
cholera patients 
were ~half of those 
with shigellosis 
both upon 
admission and 
upon discharge and 
concentrations 
were much higher 
in cases than in 
controls, Such 
striking differences 
were not observed 
for urinary NO 
results. 
 
Some values 
reported in table 
format conflict with 
the text; columns 
of data appear to 
be transposed. 
 
Assessment for 
NO correlation with 
fecal leukocyte 
counts was not 
reported, nor was 
the correlation 
between urinary 
NO and total blood 
WBC. 
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respectively). Control median 
NO was of an intermediate 
concentration between cases’ 
admission and discharge 
median concentrations; the 
difference between control and 
case admission values was 
NS. 
 
Mean blood WBC counts (SD): 
• Shigellosis: 19.6 (3.3)  
• Cholera: 8.3 (2.8) 
• Controls: 7.1 (1.8) 
 
Mean fecal WBC/high power 
field (SD): 
• Shigellosis: 38 (17) 
• Cholera: 5 (2) 
• Controls: 3 (1)  
 
Serum NO correlated with 
blood WBC count in shigellosis 
cases at baseline (r2=0.92, 
p<0.01), but only to a slight 
degree upon discharge 
(r2=0.26, no p-value reported) 
and there was no correlation 
among the cholera cases. 
Serum NO correlated with stool 
volume at presentation 
(r2=0.85, statistically significant 
per authors, p-value not 
reported). 
Serum NO 
concentrations 
correlated with total 
blood WBC in 
shigellosis cases. 
2006  
 
Samie A et al. 
 
Cryptosporidium 
species: preliminary 
descriptions of the 
prevalence and 
genotype distribution 
among school 
Vhembe, South 
Africa 
 
0.1-88 yr olds from 
semi-urban 
community included 
patients 
hospitalized with 
diarrhea or other GI 
complaints as well 
Cross-sectional 
 
n=26 <5 yr old: 
• 22 hospital-
based subjects 
• 4 school-based 
subjects 
Stool Test: 
Lactoferrin 
16/22 patients and 0/4 students 
were lactoferrin positive. 
 
While examination of lactoferrin 
association with history of 
diarrhea or with 
Cryptosporidium infection was 
not reported, only 3/22 and 
16/22 hospitalized patients and 
2/4 and 3/4 school children 
Lactoferrin 
prevalence was 
high among 
children 
hospitalized with 
diarrhea or other GI 
symptoms, 
regardless of 
Cryptosporidium 
status.  
Among the entire 
study cohort of all 
ages, lactoferrin 
results were similar 
among 
hospitalized 
patients regardless 
of Cryptosporidium 
status (influence of 
HIV infection was 
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children and hospital 
patients in the 
Venda region, 
Limpopo Province, 
South Africa 
 
Stool lactoferrin as a 
marker of intestinal 
inflammation among 
hospitalized patients 
and school children 
as students 
attending nearby 
schools. 
were positive for 
Cryptosporidium and had a 
history of diarrhea, 
respectively. 
 
Lactoferrin was not 
found among 
school-recruited 
children, most of 
whom did have a 
history of diarrhea. 
Two of the four 
school children 
were 
Cryptosporidium-
positive. 
not reported). 
Among school 
children, lactoferrin 
was more 
frequently found to 
be positive among 
those infected with 
Cryptosporidium; 
statistical testing 
was not reported. 
 
Lactoferrin results 
were graded based 
on agglutination 
reaction positivity 
with increasing 
dilution and was 
considered 
negative if there 
was no reaction at 
1:25.  
 
Some subjects 
were breastfed and 
were tested for 
lactoferrin. 
2008 
 
Vieira MM et al. 
 
Carotenoids, retinol, 
and intestinal barrier 
function in children 
from northeastern 
Brazil 
 
L:M as marker of 
intestinal barrier 
function, fecal 
lactoferrin and 
leukocytes as 
Fortaleza, Brazil 
 
2 mo-9 yr olds 
(mean age 41 mo) 
from an 
impoverished urban 
community, eligible 
if HAZ score 
<median  
for their community. 
Cross-sectional 
 
n=102 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M  
(97 tested) 
 
 
Stool Tests: 
• Lactoferrin 
(93 tested) 
• Leukocytes 
 
 
lood Tests: 
• C-reactive protein (CRP)  
48.5% had abnormal L:M.  
 
L:M and excretion of each 
sugar separately did not vary 
with retinol concentration. 
 
L:M was associated with levels 
of common dietary carotenoids, 
primarily driven by lactulose. 
However, the association was 
not always statistically 
significant, and the direction of 
association varied depending 
on precursor.  
 
Almost half of 
subjects had 
increased L:M, and 
~40% of subjects 
had increased 
lactoferrin. 
 
While serum retinol 
concentrations 
were not 
associated with 
L:M, serum 
carotenoids were; 
authors suggest 
that these retinol 
L:M threshold for 
abnormal values 
was defined as 
>0.0864 [214]. Cut-
off values for 
lactoferrin positivity 
were not 
described.  
 
Relationships 
between acute 
phase proteins and 
measures of 
intestinal 
permeability or 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.  
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
markers of intestinal 
inflammation, and 
CRP and AGP as 
acute phase 
reactants among 
children with varying 
vitamin A status 
• α-1-acid glycoprotein 
(AGP) 
40% of stool samples were 
positive for lactoferrin. 
 
1% of stool samples were 
positive for fecal leukocytes. 
 
30% of stool samples were 
positive for parasites but this 
had no impact on L:M results, 
lactoferrin, or acute phase 
reactants. 
precursors might be 
more sensitive 
predictors of 
impaired intestinal 
function. However, 
the reported 
direction of 
association varied, 
making 
interpretation of 
these results 
unclear. 
inflammation were 
not reported. 
Relationships 
between L:M and 
lactoferrin or fecal 
leukocytes as well 
as those between 
retinol or 
carotenoids and 
lactoferrin or fecal 
leukocytes were 
not reported.  
 
Exclusively 
breastfed children 
were excluded 
from study 
participation due to 
assessment of 
stool lactoferrin. 
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. 
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s. 
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting. 
 
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval, 
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins, 
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G, 
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent 
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium 
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score), 
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s) 
 
 
Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.  
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
5.5.1 Fecal Lactoferrin 
Fecal lactoferrin reflects infiltration of intestinal mucosa by polymorphonuclear 
neutrophils. The lactoferrin test might be more sensitive than assays for detection of leukocytes 
in stool because the former does not rely on the detection of whole cells, or on visualizing 
technology and trained observers. Its usefulness as a marker is enhanced by its relative stability 
in feces at room temperature. 
We reviewed nine studies that utilized stool lactoferrin as a measure of intestinal 
inflammation. Populations in two of these studies appear to overlap [108, 133].  
5.5.1.1 Prevalence of Fecal Lactoferrin 
The proportion of lactoferrin-positive stools varied widely across publications whose 
study populations also varied in terms of nutritional status and health conditions such as 
diarrhea symptoms and infection with enteric parasites. The proportion of subjects whose stools 
tested positive for lactoferrin ranged from 13 to 74% [132, 133]. 
Two studies assessed stools of children whose HAZ scores were below the median and 
found that 23 to 40% were lactoferrin-positive [137, 169]. Another study found that 53% of 
subjects with malnutrition or persistent diarrhea had lactoferrin in their stools [138]. Samie et al. 
measured lactoferrin in 26 stools of children hospitalized with diarrhea or other gastrointestinal 
complaints and in stools of four primary school children, three of whom had diarrhea at the time 
of testing [162]. None of the schoolchildren and 73% of the inpatients had lactoferrin in their 
stools. 
Several studies measured stool lactoferrin in children with parasitic infections. The 
proportion of Brazilian children infected with Giardia whose stools tested lactoferrin-positive 
decreased with each subsequent infection [133]. At first infection, 74% of subjects’ stools were 
lactoferrin positive, 15% of which had high lactoferrin concentrations, defined as 1:400-1:3200 
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dilution in an agglutination reaction. At second infection, 40% were positive, of which 5% had 
high concentrations of this marker. At third infection, 20% tested positive, all of which had a high 
concentration of lactoferrin. Interestingly, lactoferrin results did not differ between symptomatic 
and asymptomatic children at first colonization by these parasites, but those with symptoms 
were more likely to produce stools that tested positive with recurrent infections. In a study 
among children from an impoverished Brazilian community with HAZ scores less than the 
median, nearly one-third of stools were positive for parasites, but parasitic infection was not 
associated with presence of stool lactoferrin [169].  
Four studies measured stool lactoferrin in children with Cryptosporidium infection. One 
study tested stool lactoferrin in infants and children with Cryptosporidium parvum diarrhea, 
controls with diarrhea of different etiology, and healthy controls [132]. Lactoferrin was detected in 
60% of stools from C. parvum-infected cases, 35% of diarrhea control stools, and 13% of 
healthy control stools. This difference across groups was statistically significant. Two other 
studies also found that the proportion of subjects with lactoferrin-positive stools was about 50 
percentage points higher among cases compared to controls [101, 131]. Bushen et al. reported 
lactoferrin results only on Cryptosporidium-infected children; 68% were positive for lactoferrin 
and 68% of these subjects tested positive at a high titer, defined as positive at >1:400 dilution 
[108]. There were no differences in prevalence of lactoferrin-positivity between subjects with C. 
hominis and C. parvum spp. 
5.5.1.2 Associations between Fecal Lactoferrin and Growth or Other 
Outcomes 
Fecal lactoferrin did not significantly predict growth outcomes in the one study that 
assessed this relationship [108]. This was also the only study to assess the marker’s relationship 
to breastfeeding and age. While there was no association with breastfeeding, younger subjects’ 
stools were significantly more likely to be lactoferrin-positive. This difference, however, was 
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mediated by C. parvum; there was no age-associated difference among those infected with C. 
hominis. 
Three studies found significant associations between fecal lactoferrin and 
cryptosporidiosis [101, 131, 132]. A fourth study reported a high proportion of positive stools 
from infected subjects but did not enroll uninfected children, so assessment of association with 
presence of infection was not possible [108]. That study did, however, test the relationship of 
fecal lactoferrin with oocyst shedding and found no association. A fifth study that had a small 
proportion of subjects infected with Cryptosporidium species did not report examining for 
association with fecal lactoferrin and infection, but based on the numerical data presented such 
an association was not mathematically possible [162].  
Fecal lactoferrin was used as an outcome measure in one intervention trial testing the 
efficacy of vitamin A supplementation on intestinal barrier function, growth, and intestinal 
parasite infections [137]. No difference was observed in fecal lactoferrin results among treatment 
and placebo groups.  
5.5.1.3 Association between Fecal Lactoferrin and Other Markers 
Despite the number of studies that utilized fecal lactoferrin, only one study examined the 
association between fecal lactoferrin and another biomarker and found that fecal lactoferrin was 
significantly associated with the presence of tumor necrosis factor-α receptor I (TNF-αRI). 
Although the investigators also tested for other fecal cytokines, leukocytes and reducing 
substances, they did not report attempts to associate lactoferrin presence or concentration and 
these other markers in these subjects [132].  
5.5.1.4 Methodological Issues with the Fecal Lactoferrin Test 
The stool lactoferrin assay was generally performed with commercial kits. Methods 
described were similar across studies and results graded based on agglutination reaction 
positivity with increasing dilution. Six studies did not clearly report their cutoff for a positive test 
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[131, 132, 137, 138, 162, 169]. Two studies defined a positive threshold as a titer of >1:50 [101, 
108], another as >1:25 [133]. Two studies defined high titers of positivity to be values >1:400 
[108, 133].  
Ingestion of breast milk might cause lactoferrin to be detected in the stool, in the absence 
of intestinal inflammation. Most of the lactoferrin studies in this review did not discuss this 
potential issue within the context of their research. One study that tested a wide age range of 
subjects did not mention the breastfeeding status of those being tested [162]. Five of the studies 
excluded breastfeeding subjects from lactoferrin testing [132, 133, 137, 138, 169]. Several 
studies, however, tested fecal lactoferrin in subjects known to be breast feeding [101, 108, 131], 
and one of these studies assessed the association between breastfeeding and stool lactoferrin 
but found none [108]. 
5.5.2 Fecal Cytokines 
Five studies [101, 131, 132, 137, 140] measured concentrations of stool cytokines as 
indicators of intestinal inflammation; four of these studies investigated fecal cytokines in relation 
to gastrointestinal infection [101, 131, 132, 140]. The most commonly measured fecal cytokines 
were IFN-γ, TNF-α or TNF-αRI, and IL-4; each was assessed in four studies. IL-8 and IL-10 
were each measured in three studies, while TGF-β, IL-6 and IL-13 were each measured in one.  
5.5.2.1 Prevalence of Fecal Cytokines 
Three of the five studies of fecal cytokines reported the proportion of subjects with 
positive tests. The proportion of samples with detectable cytokines in stool varied widely by 
cytokine and by study, ranging from 3% for IL-4 [132] to 55%, also for IL-4 [140]. In a study of 
children with and without gastrointestinal pathogens, about half of the stool samples were 
positive for IL-4, IFN-γ, and/or IL-6, respectively [140]. In contrast, in a study that measured a 
panel of cytokines in the stools of children with and without diarrhea, IFN-γ was not recovered in 
any stools and IL-4 was only detected in 3% of samples [132]. Only IL-13 and TNF-αRI were 
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detected in a substantial proportion of these subjects’ stools; the former was detected in 32% 
and the latter in 52%. IL-8 was detected in 15% and IL-10 in 12% of stools. At 4-month follow-up 
in a subset of subjects, IL-8 was found in 6% and IFN-γ, IL-4, and IL-10 were not found in any 
stools. Among subjects in whom TNF-αRI was detected in stool during acute infection, this 
cytokine persisted at lower concentrations in stools of 50% of cases but was not detected in 
stools of controls. Some subjects previously negative for fecal TNF-αRI were positive at follow-
up. In a study of fecal IL-8 and TNF-α in children with or without C. parvum infection, IL-8 was 
detectable in 31% of subjects without significant differences based on infection status [101]. 
TNF-α was only investigated in infected children and was detected in stools of 40%, all of whom 
had acute diarrhea; however, none had high fecal concentrations of the cytokine.  
5.5.2.2 Associations between Fecal Cytokines and Growth or Other 
Outcomes 
None of the studies of fecal cytokines reported assessment of their relationship to growth 
outcomes in the children studied.  
Three studies investigated the relationship between fecal cytokines and Cryptosporidium 
infection. While IFN-γ was not identified in any stools in a Haitian study, fecal TNF-αRI, IL-8, IL-
13, IL-4 and IL-10 were significantly associated with C. parvum infection [132]. Interestingly, 
some of these cytokines (TNF-αRI, IL-8, IL-13) were found in children with non-Cryptosporidium 
diarrhea and in children without diarrhea while other cytokines (IL-4 & IL-10) were not. Fecal 
cytokines were not associated with presence of co-pathogens in the stool. A subsequent study 
by the same investigators measured concentrations of IFN-γ, TNF-α, TGF-β, IL-4, IL-8, and IL-
10 at multiple time points over nine months in stools of children with and without 
Cryptosporidium infection [131]. In contrast to their previous study, there were no differences in 
fecal concentrations of TGF-β, IL-8, IL-4 or IL-10 between those children with and without 
Cryptosporidium infection. Also, in contrast to their previous study, IFN-γ was detected and 
concentrations in stools of controls were almost double those of cases at enrollment, but this 
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difference was not statistically significant. At six- and nine-month follow-up, however, 
concentrations in stools of controls increased to almost triple that of cases and the difference 
was significant. Fecal TNF-α was only assessed in the second study; those with 
cryptosporidiosis had significantly higher concentrations at enrollment, but this did not persist at 
follow-up, i.e., after infection had resolved. A Brazilian study only measured TNF-α among 10 C. 
parvum-infected children and found no samples with elevated concentrations. IL-8 was 
measured among those with and without C. parvum infection, but the proportions of those with 
detectable serum concentrations did not differ between the groups [101].  
Two randomized, controlled trials of vitamin A supplementation used fecal cytokines as 
outcome measures [137, 140]. In one, IL-4, IL-6 and IFN-γ were measured as the primary 
endpoints of the intervention in children with and without gastrointestinal pathogens [140]. 
Overall no significant difference was observed in stool cytokine concentrations between vitamin 
A-supplemented and placebo subjects. However the relationship between fecal cytokine 
concentrations and vitamin A supplementation was modified by both gastrointestinal infection 
and diarrhea. Similarly in the second study, vitamin A supplementation was not associated with 
an intestinal cytokine response [137]. 
5.5.2.3 Associations between Fecal Cytokines and Other Markers 
Fecal cytokines were compared to other markers in only one of these studies, finding that 
TNF-αRI was significantly associated with fecal lactoferrin [132]. 
5.5.3 Fecal Leukocytes 
Four studies collected data on stool leukocytes. Two of these studies reported the 
proportion of tests positive for the presence of leukocytes. These values ranged from 1% among 
children with HAZ scores below the local median [169] to 11.7% among children hospitalized 
with malnutrition or persistent diarrhea [138]. Two studies compared fecal leukocytes across 
subject groups with different gastrointestinal conditions. In one study, where neither proportions 
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of positive nor fecal leukocyte counts were reported, the investigators found that fecal leukocytes 
did not differ between children with acute diarrhea, some of whom went on to develop persistent 
diarrhea, and controls without diarrhea [104]. The second of these two studies found that mean 
fecal leukocyte counts were nearly eight times higher in shigellosis cases than in cholera cases 
and nearly 13 times higher in shigellosis than in healthy controls [158].  
5.5.4 Fecal Neopterin 
One study measured fecal neopterin as an indicator of intestinal inflammation, following 
subjects from 2-15 months of age [15]. No association was observed between L:M and fecal 
neopterin. Mean neopterin concentrations were negatively associated with long-term height gain, 
but were not associated with Giardia recovery in stools.  
5.5.5 Fecal IgE 
Two studies assessed fecal IgE as a marker of intestinal inflammation; both appear to 
have been conducted on the same population. The first was a community-based cohort study 
that investigated incidence of fecal IgE by gender and age group [143]. The incidence of fecal 
IgE was substantial, at 0.39/child-years, and peaked at 3-6 months of age. The second study 
assessed the relationship between stool IgE and persistent and/or acute diarrhea [142]. Fecal 
IgE was detected greater than three times more frequently among stools from episodes of 
persistent diarrhea compared to stool from episodes of acute diarrhea (OR (95% CIs) =3.3 (1.0, 
10.9)) and nearly five times more frequently in persistent diarrhea stools than in stools from 
those without diarrhea (OR (95% CIs) =4.8 (1.07, 21.7)).  
5.5.6 Inflammatory Intestinal Cell Markers 
One study assessed inflammatory cell markers in intestinal tissue [103]. Densities of cell 
proteins and inflammatory markers in the lamina propria and crypt epithelium in Zambian 
children with persistent diarrhea and different forms of malnutrition were compared across 
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groups and to those in healthy controls from the UK. Immunohistochemistry was performed on 
intestinal tissue obtained by endoscopic biopsy. The intestinal cell proteins studied were 
glycosaminoglycans (GAG), heparan sulfate proteoglycan (HSPG), and syndecan-1. The 
inflammatory cell markers measured were CD3+ intraepithelial lymphocytes (IEL), human 
leukocyte antigen DR-1 (HLA-DR), and Ki67, a crypt epithelial nuclear proliferative marker.  
Inflammatory markers were observed at higher concentrations in the Zambian subjects 
than in the UK controls. There were significant differences in specific types of inflammatory 
markers across malnutrition groups. There was a significant reduction in intestinal GAG and 
HSPG in the kwashiorkor group compared to UK children, but there were no significant 
differences in these values between the children with kwashiorkor and those with other types of 
malnutrition. There was no difference in epithelial syndecan-1 protein expression between the 
malnutrition groups; data for this marker were not reported for the UK controls.  
These markers were not compared to other types of markers of intestinal function. 
5.5.7 Intestinal Tissue Cytokines and Immune Markers 
 While scintigraphy and counts of intraepithelial white blood cells (WBCs) and leukocyte 
presence in the lamina propria provide assessments of intestinal inflammation, scintigraphy can 
be used more broadly to study intestinal pathology and as such is listed in section VII on 
nonspecific markers of intestinal injury. Because WBCs are sought in biopsies along with 
assessments of intestinal architecture, histopathology, including assessment of WBC infiltration, 
is listed in section VII as well.  
Only one study assessed intestinal tissue cytokines and immune markers. Markers were 
compared between rural Gambian children with differing degrees of malnutrition and UK control 
subjects with normal endoscopic results [111]. They assessed cytokine immunohistochemistry of 
intestinal tissue using antibodies against syndecan-1, perforin, γδ T-cell receptor, CD-3, CD-4, 
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CD-8, CD-19, CD-25, HLA-DR, TNF-α, IFN-γ, TGF-β, and IL-10. Median CD3+, CD4+, CD8+, 
CD19+, and CD25+ cell counts were 2-5 times higher among each case group compared to the 
UK controls; these differences were statistically significant. IEL, γδ, syndecan-1, HLA-DR, and 
perforin were detected among the Gambian children in varying degrees but were not reported for 
UK controls. Syndecan, CD3, and CD8 displayed a gradient proportional to malnutrition severity. 
All Gambian groups had greater density of cytokine-immunoreactive mononuclear cells in the 
lamina propria than UK controls. Among subjects with elevated cytokines, similar densities were 
seen for both pro-inflammatory (IFN-γ and TNF-α) and putative regulatory (IL-10 and TGF-β) 
cytokines. Epithelial expression of TGF-β in Gambian subjects was also enhanced compared to 
UK controls, but subjects with poorer nutritional status had lower densities of mucosal TGF-β+ 
cells. A marker of intestinal permeability, L:M was significantly associated with mucosal B 
lymphocyte, IEL, and perforin-positive IEL densities. 
5.5.8 Duodenal Aspirates for Immunoglobulins 
One study measured immunoglobulin concentrations in duodenal fluid as a marker of 
intestinal inflammation [128]. Concentrations of duodenal immunoglobulin were compared in 
hospitalized children with both persistent diarrhea and Giardia infection and controls without 
diarrhea or gastrointestinal infection. Significantly higher mean concentrations of IgM were found 
in duodenal aspirates of cases compared to controls. Mean concentrations of duodenal IgA and 
IgG did not differ between cases and controls, however. 
5.5.9 Summary of Markers of Intestinal Inflammation 
A variety of markers were assessed with a preponderance of studies using fecal 
lactoferrin. Lactoferrin was measured among study populations with varying characteristics. 
Lactoferrin results varied considerably as did results of other measures of intestinal 
inflammation.  
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Of note, among studies that met our review inclusion criteria, there was a complete 
absence of research utilizing fecal calprotectin (a protein produced by neutrophils and 
monocytes). This marker has been found in stools of patients with inflammatory bowel diseases 
in developed country settings during the time period of this review [262-264], but we found no 
analyses of its prevalence and potential role as a diagnostic tool in children with EED.  
A threshold for normal for tests of intestinal inflammation was often not defined by 
authors. Generally data on these markers were not collected longitudinally so it is not clear how 
much intra-individual variation exists. Only one study statistically compared markers of intestinal 
inflammation to each other, and found a relationship between TNF-αR1 and lactoferrin [132]. 
None of the intestinal inflammation studies compared these markers to biopsy results or to other 
tests of intestinal dysfunction such as permeability or absorption. 
An important consideration in evaluating these tests is the overall feasibility of performing 
them, especially in resource-limited settings. For example, stool is a somewhat easier analyte to 
obtain than blood (especially non-capillary assessments) and even urine among young children. 
Duodenal aspirates are, of course, more invasive tests and examination of intestinal tissue can 
only be performed on biopsy specimens, limiting their feasible use. Nonetheless, stool is an 
imperfect analyte. Production of sample cannot be scheduled, and the mechanics of obtaining 
the specimen are sometimes challenging, necessitating using adhesive bags or collection from 
diapers. In addition, stool is probably more biohazardous than blood, and certainly more than 
urine, and often elicits handling concerns by laboratory staff and couriers. 
5.6 Markers of Systemic Inflammation and Systemic 
Immune Activation 
Markers of systemic immune function and inflammatory response might provide 
informative indirect evidence of precursors to, or consequences of, small intestinal injury. 
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Indeed, the hypothesis that local inflammation could be reflected in systemic markers is 
intriguing. There is precedent for associations between markers of organ-specific inflammation 
and systemic inflammation, with the best studied being coronary artery and inflammatory bowel 
diseases. The atherosclerotic lesion in coronary artery disease and the small and/or large bowel 
inflammation in Crohn’s disease and ulcerative colitis are characterized by acute and chronic 
inflammatory changes, and, as such, could be analogous to the lesions found in EED. By 
extension, there is ample evidence of an association between systemic markers of inflammation 
and acute coronary artery events, including myocardial infarction, sudden cardiac death, and 
cerebrovascular accidents, and of intestinal disease activity in inflammatory bowel diseases. 
Concentrations of circulating C-reactive protein (CRP) have, indeed, emerged as strong 
predictors of such events in adults, and complement the use of lipid profiles, which are a more 
specific biomarker of coronary artery disease [265-267]. Systemic CRP or erythrocyte 
sedimentation rates are indices of inflammatory bowel disease activity [268, 269].  
In the case of EED, there is justification for seeking evidence of systemic inflammation as 
a biomarker, based on the precedent of coronary artery disease and inflammatory bowel 
diseases. However, there are additional justifications: the pathophysiology of environmental 
enteric dysfunction might result in, or be associated with, a hyperpermeable gut. Such increased 
bowel permeability would expose the host to a variety of injurious substances, most particularly 
microbial inflammatory drivers, and the host response could either be a surrogate for 
inflammation, or reflect the process that leads to enteric dysfunction. For example, one or more 
bacterial molecules could be absorbed, leading to a pro-inflammatory host response, as 
manifested by elevated CRP, but such a response could be an appropriate reaction to the gut 
that enables the molecules to be absorbed.  
To hone in on assessments of systemic inflammation and immune function that could be 
helpful as markers of enteric dysfunction, we reviewed those studies that examined the markers 
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among children with presentations such as persistent diarrhea, or investigations of the markers 
in relationship to markers of intestinal inflammation or dysfunction.  
It should be noted that there can be considerable overlap between the primary 
assignment of many of these markers of systemic inflammation and nutrient testing (e.g., serum 
albumin, total protein, hemoglobin, and blood counts.) For example, while hypoalbuminemia, 
hypo- or hypergammaglobulinemia, and impaired erythropoiesis are indicators of nutritional 
status, they can also reflect systemic immune activation [270-273]; as such, they were assigned 
to this section. For purposes of this review, if a test could be related to inflammatory activation 
and measured the product of a nutrient (such as hemoglobin) and not the nutrient itself (such as 
iron), then we included the test in our review. 
We identified a diverse set of markers from 23 studies that we assigned to the category 
of systemic inflammation but which could serve as biomarkers for intestinal inflammation. 
Relevant data for each of the studies in this category can be found in Evidence Table 5. The 
most commonly employed markers were CRP, albumin, hemoglobin, transferrin, and varying 
total and immunoglobulin class concentrations. Additional markers included circulating cytokines 
and/or chemokines, total oxidant status, circulating α-1-acid glycoprotein (AGP), serum 
mannose-binding lectin, and urinary neopterin. Three studies assessed nitric oxide [43, 158] and 
plasma endotoxin and IgG endotoxin-core antibody [110], which are markers that could reflect 
systemic inflammation driven by intestinal processes. One study also included data on multiple 
markers of cellular, as well as humoral, immunity [104].  
Although we did not systematically seek studies that assessed systemic marker 
association with nutritional status, among the studies that used markers of systemic 
inflammation or immune activation that were included in this review, seven assessed systemic 
inflammatory markers in relation to anthropometric indices [43, 110, 122, 123, 130, 150, 151]. 
The relationships varied widely across markers and sometimes across different growth 
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parameters for the same marker. Some data associated circulating markers of systemic 
inflammation and stunting; the markers with the strongest associations were albumin and α-1-
acid glycoprotein, each in an inverse relationship [123].  
Six studies investigated association of systemic markers with persistent diarrhea [104, 
106, 107, 114, 130, 166]. Those identified at significantly lower concentrations in children with 
persistent diarrhea relative to children without diarrhea included: serum total protein [106, 107], 
hemoglobin [106, 166], mean corpuscular volume (MCV) and mean corpuscular hemoglobin 
(MCH) [166], lymphocyte counts [166], and anti-oxidant concentrations [107]. Albumin 
concentrations were also lower in children with persistent diarrhea; this relationship was 
statistically significant in one study [106] but not in another [166]. Sample size differences could 
explain the effect discrepancy with six 6-24 month olds with persistent diarrhea in the latter [166] 
compared to 96 6-36 month olds in the former [106]. While albumin concentrations are known to 
increase with increasing age, the slightly older cohort in the study that found an association is 
unlikely to explain the discrepancy in results. 
Markers found at higher levels in children with persistent diarrhea compared to those with 
no diarrhea were total oxidant status, thiobarbituric reactive substances, and DNA damage 
[107]. In addition, assays of neutrophil polarization and monocyte spontaneous proliferation 
showed increased responsiveness in children with acute or persistent diarrhea relative to those 
without diarrhea [104]. A negative delayed-type hypersensitivity response to tuberculin antigen 
was also associated with progression from acute to persistent diarrhea [104]. 
Only one study utilizing markers of systemic inflammation investigated both growth 
outcomes and persistent diarrhea; this was in relation to serum mannose-binding lectin [130], 
which was not significantly associated with either.  
Five studies investigated the relationship of systemic inflammatory markers to gut 
permeability. Associations were found between IgG, IgA, IgM, and IgG endotoxin core antibody 
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and intestinal function as measured by the L:M ratio [110] and between hemoglobin 
concentration and the lactose:creatinine ratio [151]. Additionally a correlation was observed 
between urinary nitric oxide and the serum L:R ratio [43]. In contrast, anemia and mean 
corpuscular volume (MCV) were not associated with serum L:R [58], and associations were not 
found between the L:M ratio and other markers such as α-1-acid glycoprotein (AGP), total IgG, 
albumin, or hemoglobin concentrations [123]. Furthermore, only one of these studies included 
biopsy, but the authors did not report assessing the relationship between markers of systemic 
inflammation and histology [146]. 
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Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
2000 
 
Azim T et al. 
 
Immune response of 
Bangladeshi children 
with acute diarrhea 
who subsequently 
have persistent 
diarrhea 
 
Immune response 
tests, as well as 
transferrin and 
albumin as markers 
of nutritional status 
among children with 
and without PD 
Dhaka, Bangladesh 
 
7-12 mo olds with 6-
8 days of watery 
diarrhea attending 
the International 
Centre for Diarrheal 
Disease Research.  
 
Cases were those 
who went on to 
develop PD, controls 
were those who did 
not.  
 
An additional group 
of subjects without 
diarrhea were 
recruited from a 
nutrition follow-up 
unit.  
 
Prevalence of 
malnutrition was high 
in all groups. 
Case-control 
 
n=136;  
 
n=38 cases with 
PD 
 
n=98 controls: 
• 85 with AD 
• 13 with no 
diarrhea 
Blood tests: 
• IFN-γ 
• TNF-α 
• WBC (total and 
differential) 
• IgA 
• IgG 
• IgM 
• Transferrin 
• Albumin 
• Immune function 
tests: 
• Neutrophil 
polarization 
response to 
chemotactic factor 
• Neutrophil 
opsonization to 
yeast 
• Mononuclear cell 
proliferation, 
spontaneous and 
in response to 
stimuli with 
mitogens 
 
 
Skin Test: 
• Delayed-type 
hypersensitivity 
response (DTH) 
to tuberculin, 
tetanus, 
diphtheria, 
Streptococcus, 
Proteus, 
Candida, and 
Trichophyton  
 
Stool tests: 
• Leukocytes 
• Red blood cells 
WBC total and differential, 
immunoglobulin subtypes, cytokines, 
transferrin, and albumin did not differ 
between cases with diarrhea or 
controls, nor did stool leukocyte or 
erythrocyte counts.  
 
The percentages of neutrophils that 
polarized in response to stimulation 
were significantly higher in subjects 
with AD or PD compared to those 
without diarrhea; there was no 
difference between the two diarrhea 
groups. 
 
Opsonization did not vary between 
any groups. 
 
Monocyte spontaneous proliferation 
counts were less than half among 
children with no diarrhea compared 
to those with AD (p<0.001) or with 
PD (p=0.011); there was no 
difference between the two diarrhea 
groups.  
 
Monocyte proliferation in response to 
stimulation did not differ between the 
3 groups.  
 
The proportion with DTH responses 
differed among the three groups only 
in response to tuberculin (p=0.021). 
More PD subjects had a negative 
tuberculin response than did 
subjects with AD (p=0.024). 
Some immune and 
inflammatory 
markers were 
associated with 
acute and/or 
persistent diarrhea. 
 
The only marker that 
was significantly 
associated with 
progression to PD 
was a negative DTH 
response to 
tuberculin antigen 
(odds ratio=3.8, CI: 
1.4, 9.9). This was 
calculated from a 
logistic regression 
analysis that only 
included children 
with diarrhea. 
The number of 
controls was 
relatively small and 
their nutritional 
status was not 
reported. 
Evidence Table 5. Markers of systemic inflammation and systemic immune activation.  
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2003 
 
Bitarakwate E et al. 
 
Serum zinc status of 
children with 
persistent diarrhoea 
admitted to the 
diarrhoea 
management unit of 
Mulago Hospital, 
Uganda 
 
Serum protein, 
albumin, and 
hemoglobin among 
children with and 
without PD 
Kampala and Mpigi, 
Uganda 
 
6-36 mo olds with 
PD, recruited from 
hospital, and healthy 
controls recruited 
mainly from the local 
population. 
Case-control 
 
n=192; 
  
n=96 cases with 
PD 
 
n=96 healthy 
controls 
Blood Tests: 
• Albumin 
• Total protein 
• Hemoglobin 
PD cases:  
7.47.9% low serum protein  
8.69.7% low serum albumin 
9.Low mean hemoglobin (10.5 g/dL) 
 
For controls, means of all three 
laboratory values were within normal 
range; percent of subjects with 
abnormal values are not reported. 
 
All three test results were 
significantly lower in children with PD 
than in controls (p< 0.01 for each 
comparison). 
Decreased albumin, 
serum total protein 
and hemoglobin 
concentrations were 
associated with PD. 
 
2010 
 
Bukhari AS et al. 
 
DNA damage and 
plasma 
homocysteine 
concentrations are 
associated with 
serum metabolites 
and mineral 
constituents' profiles 
in children with 
persistent diarrhea 
 
Serum proteins, 
metabolites, and 
levels of DNA 
damage among 
children with and 
without PD 
Faisalabad, Pakistan 
 
3-6 yr olds admitted 
to hospital with PD 
and healthy controls. 
Case-control  
 
n=72; 
 
n=36 cases with 
PD 
 
n=36 healthy 
controls 
Blood Tests: 
Serum proteins and 
metabolites:  
• Albumin 
• Globulin 
• Homocysteine 
• Total protein 
• Total cholesterol, 
HDL, LDL, 
triglycerides 
• AST, ALT 
• T3, T4 
• Total oxidant 
status (TOS), Total 
anti-oxidant status 
(TAS), and 
thiobarbituric 
reactive 
substances 
(TBARS) 
• DNA damage to 
lymphocytes 
Mean values significantly higher 
among PD cases than in healthy 
controls:  
10.LDL 
11.Homocysteine 
12.TOS 
13.TBARs 
14.DNA damage 
 
Mean values significantly lower 
among PD cases than in healthy 
controls:  
15.Total protein 
16.T4 
17.TAS 
Multiple serum 
markers were 
associated with PD, 
especially DNA 
damage to 
lymphocytes 
(p=0.0001).  
 
The authors 
speculate that zinc 
deficiency, more 
commonly found in 
the children with PD, 
might be responsible 
for increased 
homocysteine 
concentrations and 
play an important 
role in mediating 
DNA damage. 
Control recruitment 
strategy was not 
well described. 
 
TOS, TBARS and 
TAS were 
incompletely 
defined. 
 
Some values 
differed by gender 
in both the case 
and control groups:  
18.Triglycerides 
19.Total cholesterol 
20.HDL 
21.T3  
 
Multiple markers 
studied; analyses 
did not appear to 
address potential 
confounding. 
Evidence Table 5. Markers of systemic inflammation and systemic immune activation.  
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
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2003 
 
Campbell DI et al. 
 
Growth faltering in 
rural Gambian 
infants is associated 
with impaired small 
intestinal barrier 
function, leading to 
endotoxemia and 
systemic 
inflammation 
 
L:M as a marker of 
intestinal 
permeability and its 
relationship with 
various inflammatory 
markers and 
endotoxin 
Keneba, The 
Gambia 
 
All 2-11 mo olds 
were recruited from 
this rural village and 
followed up to 14 mo 
of age. 
Cohort 
 
n=71 
Urine Tests: 
• Lactulose1  
(53 tested) 
• Mannitol 
(52 tested) 
• L:M 
(52 tested) 
 
 
Blood tests: 
• Albumin 
• CBC 
• C-reactive  
protein (CRP) 
• IgA  
• IgM  
• IgG 
• Plasma endotoxin 
• IgG endotoxin-
core antibody 
At 8 wk of age:  
• Mean2 L:M: 0.169 (CI: 0.145, 
0.198; range: 0.058-0.657) 
• Mean lactulose recovery: 0.202 
(SD=0.159; range: 0.009-0.640) 
• Mean mannitol recovery: 3.80 
(SD=2.35; range: 0.52-8.58) 
 
L:M more than doubled between 12 
wk-1 yr of age (r=0.44, p<0.001) and 
was driven by both increasing 
lactulose (r=0.18, p<0.001) and 
decreasing mannitol (r=-0.14, 
p<0.01) excretion with age.  
 
WAZ and HAZ scores were 
negatively correlated with L:M (r=-
0.41, p<0.001), and primarily driven 
by lactulose excretion (r=-0.39, 
p<0.001). 
 
Laboratory values were consistent 
with chronic, low level 
immunostimulation: 
• 50% of platelet and 39% of 
leukocyte counts were elevated, 
especially mean lymphocyte 
counts which were almost twice 
expected values [198]. 
• While the mean3 CRP was within 
the normal range, 25% of values 
were above the upper limit of 
normal (5 mg/L), and 17% were 
>10 mg/L [198]. 
• Mean IgG, IgA and IgM 
concentrations were near normal 
at 8 wk of age, but increased 
rapidly; all three were elevated 
above expected values in all other 
Mean L:M ratios 
were elevated at 8 
weeks of age, and 
more than doubled 
in the first year of 
life. 
 
Many markers of 
inflammation and 
endotoxin release 
were significantly 
correlated with L:M 
and lactulose 
recovery.  
 
Poor growth was 
significantly 
correlated with L:M 
ratios, primarily due 
to lactulose 
excretion. 
 
Authors postulate 
that while general 
markers of 
inflammation cannot 
be specifically 
ascribed to a gut 
source, endotoxin 
and its related core 
antibody are 
potentially a direct 
measure of intestinal 
inflammation due to 
gut gram negatives 
as a primary source 
of endotoxin release 
among subjects 
without sources of 
Presence of malaria 
parasites was 
assessed by blood 
smear at each 
study visit; the only 
parameter 
associated with 
malaria was CRP.  
Authors did not 
report investigating 
relationships 
between certain 
serum parameters 
(blood counts, CRP 
concentrations) and 
L:M. 
 
Study population 
might have overlap 
with that of 
Campbell et al. 
2004 also included 
in this review [15]. 
                                                          
1 For lactulose and mannitol results, excretion measurement was not specified. 
2 Geometric mean. 
3 Geometric mean. 
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age groups [198, 199]. 
• Mean1 free plasma endotoxin 
concentration was twice the upper 
limit of normal [200] and IgG 
endotoxin-core antibody 
concentrations were also elevated 
[198]. 
• However, mean albumin 
concentrations (and 
concentrations within SD) were 
generally within normal range 
[198]. 
 
L:M was correlated with 
IgG and IgA (r=0.41 and 0.41, 
respectively, p<0.001), and IgM 
(r=0.28, p<0.02). 
 
IgG and IgA were also correlated 
with lactulose recovery (r=0.26 and 
0.25, respectively, p<0.02). 
 
IgG endotoxin core antibody 
concentration was correlated with 
L:M and driven by lactulose 
recovery, (r=0.35, p<0.005 for both).  
 
Endotoxin concentrations were 
correlated with lactulose recovery 
(r=0.36, p<0.02) only. 
extra-intestinal gram 
negative infection. 
2002 
 
Clark TD et al. 
 
Risk factors and 
cumulative incidence 
of anaemia among 
human 
immunodeficiency 
virus-infected 
children in Uganda 
Kampala, Uganda 
 
9 mo old HIV-
infected children 
followed at Mulago 
hospital until 36 mo 
of age.  
 
More than 40% were 
stunted and/or 
underweight at 
Cohort 
 
n=225 
Blood Test: 
Hemoglobin 
While chronic diarrhea was 
associated with moderate anemia in 
a univariate analysis (odds ratio=2.5, 
CI: 1.0, 6.3), it was either not 
associated with moderate anemia 
(hemoglobin <9 g/dL) in a 
multivariate model or not included in 
the model 
While there was a 
high prevalence of 
anemia (<11 g/dL) 
and moderate 
anemia (<9 g/dL) 
(92% and 35% at 9 
months, 
respectively) among 
this cohort of HIV-
infected children, 
chronic diarrhea 
The association 
between chronic 
diarrhea and other 
assessed 
hematologic 
markers (any 
degree of anemia, 
mean corpuscular 
volume, and mean 
corpuscular 
hemoglobin 
                                                          
1 Geometric mean. 
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Association of 
chronic diarrhea with 
moderate anemia in 
HIV-infected children 
enrollment. 
 
appears to have not 
been associated 
with anemia in the 
multivariate analysis. 
However, the text 
did not specifically 
state whether 
chronic diarrhea was 
tested in the 
multivariate model. 
concentration) was 
not reported. 
2008 
 
Goto R et al. 
 
Impact of anti-
Giardia and 
anthelminthic 
treatment on infant 
growth and intestinal 
permeability in rural 
Bangladesh: a 
randomised double-
blind controlled 
study 
 
L:M as a marker of 
intestinal 
permeability, IgG as 
a marker of chronic 
immune stimulation, 
and α-1-acid 
glycoprotein as an 
acute phase reactant 
among children 
undergoing anti-
parasitic 
presumptive 
treatment vs. 
placebo. Also 
assessed markers’ 
associations with 
Dhamrai Upazila, 
Bangladesh 
 
3-15 mo olds from a 
rural area were 
enrolled and 
followed in a 9-mo 
trial.  
 
There was a high 
prevalence of 
malnutrition in the 
study population. 
RCT 
 
n=222* 
 
n=75 received 
anti-Giardia and 
anthelminthic 
treatment 
 
n=59 received 
anti-Giardia 
treatment only 
 
n=88 received 
placebo 
 
 
* Those who fully 
participated and 
for whom data 
were analyzed 
are included in 
this review. 
Urine Test: 
L:M 
 
 
Blood Tests:  
• α-1-acid 
glycoprotein 
(AGP) 
• IgG 
• Albumin 
Mean L:M1 (SD) at baseline was 
0.18 (0.24) in treatment groups, with 
no significant difference in placebo 
group or in testing post-intervention. 
 
Proportion with elevated L:M at any 
study time point varied between 
58%-74%. >57% consistently 
elevated L:M ratios. 
 
Seasonal variation in L:M was 
observed (p <0.001), with highest 
mean values in the monsoon 
season.  
 
L:M was associated with ∆WAZ and 
∆WHZ scores at 24 weeks (p=0.001 
and p<0.001, respectively, point 
estimates not provided.) 
 
Serum immune marker values were 
similar in all groups and did not 
change substantially with 
interventions. 
 
AGP concentrations were negatively 
associated with ∆WAZ score at 24 
weeks (p=0.004, point estimate not 
provided), and were associated with 
∆WHZ score at 12 weeks but not at 
24 weeks. 
High L:M ratios 
overall with 
substantial seasonal 
and within-infant 
variability.  
 
Interventions did not 
impact L:M or serum 
immune markers. 
 
There was 
improvement in 
weight with better 
L:M values, the 
degree to which this 
occurred was not 
reported. 
High L:M ratios 
were defined as 
greater than the 
upper CI for UK 
infants. 
 
Same study 
population as 
reported by this 
group in another 
study also included 
in this review [123]. 
                                                          
1 Geometric mean. 
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growth parameters. 
2008 
 
Goto R et al. 
 
Impact of intestinal 
permeability, 
inflammation status 
and parasitic 
infections on infant 
growth faltering in 
rural Bangladesh 
 
L:M as a marker of 
intestinal 
permeability, IgG as 
a marker of chronic 
immune stimulation, 
and α-1-acid 
glycoprotein as an 
acute phase 
reactant. Also 
assessed laboratory 
values’ associations 
with giardiasis and 
growth parameters. 
Dhamrai Upazila, 
Bangladesh 
 
3-15 mo olds from a 
rural area were 
enrolled and 
followed in a 9-mo 
trial.  
 
There was a high 
prevalence of 
malnutrition in the 
study population. 
Longitudinal data 
extracted from an 
RCT [123]  
 
n=298 
 
 
Urine and blood 
samples were 
collected every 3 
mo and 
anthropometric 
measurements 
were collected 
monthly. 
Urine Test: 
L:M 
 
 
Blood Tests: 
• α-1-acid 
glycoprotein 
(AGP) 
• IgG 
• Albumin 
• Hemoglobin 
 
Mean1 L:M: 0.15 
 
L:M showed a decreasing trend with 
age (p=0.003), and was associated 
with female gender (p=0.004), HAZ 
score (p=0.039), and WAZ score 
(p=0.019), but not with giardiasis or 
any of the serum immune markers. 
 
IgG, AGP, and albumin were 
associated with giardiasis, but 
hemoglobin was not. 
 
Mean circulating albumin 
concentration was normal for age 
[203]. Compared to UK age-matched 
reference [199], rate of rise in IgG 
with increasing age was similar, but 
concentrations were consistently 
~3g/L higher.  
 
IgG was not associated with growth 
parameters. Albumin was associated 
with HAZ score only (p=0.016). AGP 
was inversely associated with HAZ 
(p=0.011) and WAZ (p=0.005) 
scores 
Mean L:M was 
elevated. L:M was 
not associated with 
any of the tested 
serum markers of 
inflammation or with 
giardiasis. 
 
IgG rose with 
increasing age at the 
rate expected 
(compared to UK 
norms) [199] but at 
higher 
concentrations 
across all ages. 
 
Helminthiasis 
prevalence was 
very low; testing for 
association with 
markers was not 
performed.  
 
Giardiasis was 
defined as 
presence of a 
Giardia-specific IgM 
response. 
 
Same study 
population as 
reported by this 
group in another 
study also included 
in this review [122]. 
 
Cut-off values 
representing 
elevated 
concentrations 
have not been 
determined for 
AGP. UK norms for 
10 mo olds-adults 
are 0.88 g/L mean 
(0.21 SD) [204]. 
2007 
 
Jain S et al. 
 
Fecal occult blood 
screening in children 
with severe 
malnutrition 
 
Fecal occult blood 
Delhi, India 
 
Children (ages 
unspecified) 
admitted with severe 
malnutrition and age-
matched healthy 
controls recruited 
from an 
immunization clinic. 
Case-control 
 
n=80; 
 
n=50 cases with 
severe 
malnutrition 
 
n=30 healthy 
controls 
Stool Test: 
Occult blood  
 
 
Blood Test: 
Hemoglobin 
 
Fecal occult blood test was positive 
in 30/50 (60%) cases and 0/30 
controls.  
 
Among cases positive for fecal 
occult blood, 20 (66.7%) were found 
to have hemoglobin <8 g/dL.  
 
Enteric infections: 
• Parasitic infections were detected 
A high proportion of 
severely 
malnourished 
children had a 
positive fecal occult 
blood test, 
compared with no 
positives among 
healthy controls.  
 
Among cases, half 
had a presenting 
complaint of 
diarrhea (duration 
not specified), but 
the authors did not 
report results 
stratified by 
diarrhea duration.  
 
                                                          
1 Geometric mean. 
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among severely 
malnourished 
children compared to 
healthy controls 
 
 in 14/50 (28%) of cases, 12 
(85.7%) of whom tested positive for 
fecal occult blood.  
• Bacterial infections were detected 
in 18/50 (36%) of cases, 13 
(72.2%) of whom tested positive for 
fecal occult blood. 
• Of the remaining 18 for whom an 
enteric pathogen was not 
identified, 5 (27.8%) tested positive 
for fecal blood. 
 
Among the 30 cases with fecal 
occult blood, 16 were breastfed, 11 
were fed cow’s milk, and 3 were fed 
formula. 
Malnourished 
children with 
identifiable 
pathogens more 
often tested positive 
for fecal occult 
blood, although 
approximately 25% 
of those without an 
identifiable pathogen 
also tested positive.  
 
Presence of fecal 
blood did not appear 
to vary by feeding 
mode (e.g. breast 
milk, cow’s milk, or 
formula), although 
data presented were 
limited. 
Authors did not 
provide differences 
in proportions of 
occult blood among 
those with and 
without specific 
enteric pathogens. 
 
Statistical analysis 
was not provided; 
data were reported 
as proportions only.  
 
Matching scheme 
was not defined. 
2001 
 
Kapoor S et al. 
 
Giardiasis--clinical 
and diagnostic 
perspective 
 
Immunoglobulin 
concentrations in 
duodenal fluid and 
serum among 
children with PD and 
Giardia infection 
compared to those 
without diarrhea 
New Delhi, India 
 
<12 yr olds admitted 
to hospital with PD 
and Giardia.  
 
Controls had no 
diarrhea and were 
hospitalized for non-
GI conditions. 
 
Most cases were <7 
yr old, with n=19 <3 
yr old. Ages of 
controls were not 
specified. 
 
Case-control 
 
n=40;  
 
n=30 cases with 
PD and Giardia 
 
n=10 controls 
without diarrhea 
 
Duodenal secretion 
aspirates: 
• IgG 
• IgM  
• IgA 
 
 
Blood Tests: 
• IgG 
• IgM 
• IgA 
 
Higher mean concentrations of IgM 
were found in duodenal aspirates of 
cases compared to controls 
(p<0.05).  
 
Mean concentrations of duodenal 
IgA and IgG did not differ between 
cases and controls. 
 
Differences in 
immunoglobulin 
concentrations were 
limited among 
children with PD 
infected with Giardia 
compared to 
children without 
such conditions. 
The number of 
controls was small 
due to constraints 
in obtaining 
duodenal aspirate 
from children 
without GI 
symptoms. 
2006 
 
Kirkpatrick BD et al. 
 
Serum mannose-
binding lectin 
Port-au-Prince, Haiti 
 
<36 mo old inner-city 
residents recruited 
from the rehydration 
unit at the State 
Case-control 
 
n=99; 
 
n=49 cases with 
Cryptosporidium 
Blood Test: 
Mannose-binding 
lectin (MBL) 
Serum MBL concentrations were 
lower in cases than in healthy 
controls (p=0.002) and diarrhea 
controls (p=0.045). 
 
Percentage MBL-deficient: 
While 
cryptosporidiosis 
was associated with 
MBL deficiency, 
MBL concentrations 
were not significantly 
MBL deficiency was 
defined as 
concentrations <70 
ng/mL. 
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deficiency is 
associated with 
cryptosporidiosis in 
young Haitian 
children 
 
Mannose-binding 
lectin as a marker of 
innate immune 
activation among 
children with and 
without 
Cryptosporidium 
infection 
University Hospital 
or from GHESKIO 
HIV Center1.  
 
All subjects were 
HIV-negative. 
infection  
(22 with PD) 
 
n=9 diarrhea 
controls negative 
for 
Cryptosporidium  
 
n=41 healthy 
controls without 
diarrhea and 
Cryptosporidium-
negative 
• 36.7% cases 
• 9.8% healthy controls 
• 0 diarrhea controls 
 
Cryptosporidiosis was associated 
with MBL deficiency (odds 
ratio=22.4; CI: 3.1, 160.82). 
 
Among cases, the proportion of 
those with PD was nearly double 
among those with MBL deficiency 
compared to those without MBL 
deficiency, but these results were 
not significant (p=0.13). MBL 
deficiency was not associated with 
duration of diarrhea (p=0.37) among 
those with cryptosporidiosis nor with 
anthropometric status among either 
cases or controls. 
associated with 
mean duration of 
diarrhea or history of 
PD. 
2002 
 
Kirkpatrick BD et al. 
 
Cryptosporidiosis 
stimulates an 
inflammatory 
intestinal response 
in malnourished 
Haitian children 
 
Stool lactoferrin, 
reducing 
substances, 
leukocytes and 
cytokines as 
markers of intestinal 
inflammation of 
children with and 
without 
Port-au-Prince, Haiti 
 
<18 mo olds from a 
low SES setting 
recruited from the 
rehydration unit of 
GHESKIO HIV 
Center3 with 
diarrhea and 
Cryptosporidium 
infection. Controls 
recruited from an 
outpatient clinic 
without 
Cryptosporidium 
infection included 
those with and 
without diarrhea. 
Case-control 
 
n=49; 
 
n=17 cases with 
Cryptosporidium 
and diarrhea (5 
with PD)  
 
n=32 controls 
without 
Cryptosporidium; 
• 17 with 
diarrhea (5 with 
PD) 
• 15 healthy 
 
Stool Tests: 
• Reducing 
substances (RS) 
• Lactoferrin 
• Cytokines: 
• TNF-α receptor 
I  
• IL-4 
• IL-8 
• IL-10 
• IL-13 
• IFN-γ  
 
 
Blood Test: 
• WBC 
Proportion RS-positive:  
• 33.3% cases 
• 64.7% diarrhea controls 
• 46.7% healthy controls, (p=0.2) 
 
Proportion lactoferrin-positive:  
• 83.3% cases  
• 60.0% diarrhea controls 
• 28.6% healthy controls, (p=0.01) 
IFN-γ was not recovered in any 
stools. 
 
All other fecal cytokines were 
significantly associated with 
Cryptosporidium cases compared to 
diarrhea and healthy controls.  
 
Additionally, TNF-α receptor I, IL-8, 
IL-13 were found in diarrhea and 
healthy controls, while IL-4 and IL-10 
Fecal lactoferrin was 
identified most often 
in children with 
diarrhea, especially 
in those with 
Cryptosporidium. 
While some fecal 
cytokines were 
detected in as many 
as 40% of healthy 
controls and 70% of 
controls with 
diarrhea, they were 
generally associated 
with 
Cryptosporidium 
infection. The other 
stool tests did not 
discriminate by 
diarrhea or 
Reported results 
were not stratified 
by persistent vs. 
acute diarrhea 
status.  
 
Cut-off values for 
lactoferrin positivity 
were not described.  
 
Stools from children 
who were 
breastfeeding were 
not tested for 
lactoferrin. 
                                                          
1 The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections. 
2 Reported results were adjusted for confounding variables, unless otherwise noted. 
3 The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections. 
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Cryptosporidium 
infection 
were not.  
 
Fecal lactoferrin was associated with 
the presence of TNF-α receptor I 
(point estimate not provided, 
p=0.03). 
 
Mean WBC counts were within 
normal range in all 3 groups. 
Cryptosporidium 
status. 
2003 
 
Kukuruzovic R et al. 
 
Increased nitric 
oxide production in 
acute diarrhea is 
associated with 
abnormal gut 
permeability, 
hypokalemia and 
malnutrition in 
tropical Australian 
aboriginal children 
 
Nitric oxide (NO) as 
a marker of intestinal 
permeability and 
inflammation, and 
lactulose:rhamnose 
ratio (L:R) as a 
marker of intestinal 
permeability and the 
relationship between 
NO and L:R, growth 
parameters, mean 
corpuscular volume 
(as a surrogate of 
iron deficiency), and 
stool reducing 
substances among 
children with and 
without diarrhea 
Darwin, 
Australia 
 
1-6 yr old Aboriginal 
and non-Aboriginal 
hospital inpatients.  
 
Subjects were 
grouped as follows: 
• Children with AD 
• Children with no 
diarrhea but with 
non-GI infectious 
conditions  
• Children without GI 
or infectious 
conditions 
Case-control  
 
n=318; 
 
n=169 cases with 
AD  
(154 Aboriginal) 
 
n=149 controls: 
• 73 with non-GI 
infections (49 
Aboriginal)  
76 with no 
infections (29 
Aboriginal) 
Urine Test: 
Nitric Oxide (NO)* 
 
 
Blood Tests: 
•  L:R  
•  Mean 
corpuscular 
volume (MCV)  
 
 
Stool Test: 
Reducing substances 
(RS)**  
(169 cases tested)  
 
 
* NO is an unstable 
free radical and is 
converted to nitrite 
and nitrate. Urine 
nitrate (NO3)+ nitrite 
(NO2) was expressed 
as a ratio with urine 
creatinine (NO2 + 
NO3:Cr) in order to 
account for 
differences in urine 
concentration. 
 
** Measured only 
among children with 
profuse diarrhea. 
NO among Aboriginal children with 
diarrhea was >3x higher than any 
other group and >5x higher than in 
non-Aboriginal controls. 
• NO was >3x and >2x higher 
among Aboriginal than non-
Aboriginal children in the 
diarrhea (p<0.001) and no 
infections groups (p<0.001), 
respectively, but there was no 
difference between them in the 
non-GI infections group.  
• NO was >3x and ~2x higher in 
the diarrhea compared to the no 
infections group among 
Aboriginals (p<0.001) and non-
Aboriginals (p<0.03), 
respectively.  
• NO was virtually the same 
among the Aboriginal non-GI 
infections and no infections 
groups, as well as among the 
non-Aboriginal diarrhea and 
non-GI infections groups.  
 
112/152 (74%) and 31/169 (18%) of 
children with AD had abnormal L:R 
ratios and positive stool RS, 
respectively. 
 
NO and L:R were measured at 
“convalescence” on Day 5 among 
those with diarrhea: the mean 
improvement in NO was 21.7% 
NO2 + NO3:Cr ratio, 
as a measure of 
endogenous nitric 
oxide production, 
was used as a 
marker of gut 
permeability and 
inflammation, with 
an attempt to identify 
how much more it 
reflects as response 
to inflammation from 
GI vs. non-GI 
infections. 
 
Among non-
Aboriginal controls, 
NO production was 
the same among 
those with diarrhea 
and non-GI 
infections (and 
higher compared to 
controls). NO was 
highest by far 
among Aboriginal 
children with 
diarrhea compared 
to any other group. 
Authors suggest that 
high basal 
concentrations of 
NO among 
Aboriginal children 
Positive stool RS 
was defined as 
>0.5%.  
 
Abnormal L:R was 
defined as >7.6; no 
reference or 
derivation was 
provided for this 
cut-point. 
 
Study population 
appears to be the 
same as in another 
Kukuruzovic, et al. 
study also included 
in this review which 
assessed serum 
lactulose:rhamnose 
as a marker of 
intestinal 
permeability [58]. 
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compared with 54.6% for L:R 
(p=0.01). 
 
NO and L:R were correlated (n=193, 
r=0.37, p<0.001)1; the correlation 
was stronger for lactulose (effect 
ratio=1.47, p<0.001) than for 
rhamnose (effect ratio=0.80, 
p=0.022).  
 
NO was not correlated with stool 
RS3 or MCV, but was correlated with 
lower WAZ score (effect ratio=0.88, 
p=0.05). 
due to (clinically 
silent) enteropathy 
could explain the 
concentrations seen 
among Aboriginal 
controls in this 
study. 
 
NO appeared to 
decrease 
significantly more 
slowly than L:R 
among children 
recovering from 
diarrhea. 
NO was found to 
correlate with L:R. 
NO was more 
strongly correlated 
with lactulose than 
rhamnose. 
2002 
 
Kukuruzovic RH et 
al.  
 
Small bowel 
intestinal 
permeability in 
Australian Aboriginal 
children 
 
Serum lactulose: 
rhamnose ratio 
(L:R), serum lactose, 
and stool reducing 
substances as 
markers of intestinal 
Darwin, Australia 
 
Cases were 
Aboriginal and non-
Aboriginal children 
admitted to hospital 
with diarrhea. 
Controls were 
Aboriginal and non-
Aboriginal children 
admitted without GI 
illnesses. 
Case-control 
 
n=375 admissions 
for 306 children; 
 
n=285 case 
admissions for 
AD (264 
Aboriginal) 
 
n=90 control 
admissions with 
no diarrhea (74 
Aboriginal) 
Blood Tests: 
• Lactose 
• Lactulose4 
• Rhamnose 
• L:R  
• Hemoglobin  
• Mean corpuscular 
volume (MCV) 
 
 
Stool Test: 
Reducing substances 
(RS)*  
 
 
L:R testing was 
27/75 (36%) of Aboriginal controls 
and 0 non-Aboriginal controls had 
abnormal L:R ratios. 
 
Mean5 L:R at baseline: 
Cases: 
• Aboriginal: 16.4  
• Non-Aboriginal: 7.9, p=0.002 
compared to Aboriginal cases 
Controls: 
1.Aboriginal: 4.6 
2.Non-Aboriginal: 2.5, p=0.02 
compared to Aboriginal controls  
 
Mean improvement1 in L:R (CI) at 
day 5 among those with repeat 
testing: 
Mean L:R ratios of 
Aboriginal children 
were approximately 
double those of non-
Aboriginal children 
both among those 
with and without 
diarrhea, consistent 
with authors’ 
suggestion that 
clinically silent 
enteropathy is 
prevalent among 
Aboriginal children.  
 
Mean L:R 
significantly 
Positive stool RS 
was defined as 
>0.5%.  
 
Abnormal L:R was 
defined as >5.6, 
derived from 2 SD 
above the 
arithmetic mean for 
non-Aboriginal 
controls in this 
study. The rationale 
for the choice of 2 
SD above the 
arithmetic, instead 
of the geometric, 
mean is not clear. 
                                                          
1 Reported results appear to have been adjusted for age and race. 
2 Reported results were adjusted for age and race. 
3 Reported results among children with diarrhea were adjusted for age and race. 
4 Lactulose and rhamnose results were expressed as % of dose administered. 
5 Geometric mean. 
Evidence Table 5. Markers of systemic inflammation and systemic immune activation.  
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
permeability among 
Aboriginal and non-
Aboriginal children 
with and without 
diarrhea 
repeated on day 5 for 
a subset of Aboriginal 
subjects: 
• 174/264 admissions 
for acute diarrhea  
• 25/74 control 
admissions 
 
 
* Measured only 
among children with 
profuse diarrhea 
when “clinically 
indicated." Number 
tested not provided. 
• Aboriginal cases: 14.6 (11.2, 
18.0)  
• Aboriginal controls: -0.63 (-4.0, 
2.7)  
 
Mean lactulose recovery2: 
• Cases day 1: 0.085 (0.070–
0.103)  
• Cases day 5: 0.039 (0.033–
0.046) 
• Controls: 0.024 (0.019–0.029) 
All 3 values significantly differed 
from one another. 
 
Mean rhamnose recovery: 
• Cases day 1: 0.479 (0.424–0.542) 
• Cases day 5: 0.555 (0.498–0.616) 
• Controls: 0.585 (0.500–0.685) 
These values did not significantly 
differ from one another. 
 
Confidence intervals (CIs) in the 
authors' graphical representation of 
mean L:R at admission did not 
overlap, and the difference in means 
was particularly evident between 
Aboriginal and non-Aboriginal 
subjects. 
 
Factors associated with L:R among 
cases were3:  
• Acidosis (p=0.007) 
• Hypokalemia (p=0.035) 
• Diarrhea severity (p=0.001)  
 
Age and malnutrition were not 
associated with L:R. 
 
improved over 5 
days among 
Aboriginal cases. 
Children with severe 
diarrhea had higher 
mean L:R. 
 
Higher case L:R was 
driven more by high 
lactulose than by low 
rhamnose.  
Similarly, 
improvement in L:R 
among cases was 
primarily due to 
decreased lactulose.  
 
Stool RS and serum 
lactose were found 
in approximately 
one-quarter and 
one-third of 
Aboriginal cases, 
respectively. The 
latter was weakly 
associated with 
increased lactulose. 
Proportions of 
cases with 
abnormal 
concentrations 
were not reported. 
 
Analysis included 
data for 69 children 
with repeat 
admissions; this 
might violate 
independence 
assumptions for 
their statistical 
analysis methods.  
Repeat L:R testing 
was conducted on 
controls of both 
racial groups, but 
among cases it was 
only conducted on 
Aboriginal cases. 
 
This study appears 
to report on the 
same population as 
in the Kukuruzovic, 
et al. 2003 
reference also 
included in this 
review, which 
assessed nitric 
oxide excretion 
[43]. 
 
Authors reiterate 
the advantages of 
serum over timed 
                                                                                                                                                                                                                                                                                               
1 Improvement in L:R appears to have been calculated as baseline L:R minus repeat L:R, as described in another publication in this review; however, this was not expressly stated. 
Reference 134. Kukuruzovic RH, Brewster DR. Milk formulas in acute gastroenteritis and malnutrition: a randomized trial. J Paediatr Child Health. 2002. 38(6):571-577. 
2 Figures reported parenthetically after the mean percent recoveries of lactulose and rhamnose were not specified as ranges or CIs. 
3 Reported results were adjusted for confounding variables, unless otherwise noted. 
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38% and 27% of Aboriginal cases 
had positive serum lactose and stool 
RS, respectively. 12% of Aboriginal 
and non-Aboriginal controls 
combined had lactosemia.  
 
Presence of lactosemia was 
associated with L:R, adjusted 
relative risk (CI)=1.06 (1.03, 1.10)1. 
Stool RS, anemia, and MCV were 
not associated with L:R. 
urine collection for 
assessment of L:R, 
as discussed in 
another publication 
in this review [125]. 
2001 
 
Mittal SK et al. 
 
Tropical sprue in 
north Indian children 
 
D-xylose and 
duodenal biopsy as 
markers of TS 
New Delhi, 
India 
 
0-15 yr old 
gastroenterology 
clinic patients with 
PD.  
 
Those with abnormal 
morphology on 
biopsy, abnormal D-
xylose test, and 
clinical response to 
antibiotics were 
diagnosed as having 
TS.  
 
Those with abnormal 
morphology and 
response to gluten-
free diet were 
diagnosed with CD. 
We include data on 
these subjects for 
comparative 
reasons. 
Case-series 
 
n=94; 
(38 with repeat 
biopsies) 
 
<5 yr old: n=44 
Duodenal biopsy, 
method not specified: 
Histopathology 
 
 
Blood Tests: 
•  Hemoglobin 
•  D-xylose*  
 
 
* Not specified 
whether from urine or 
serum, and units of 
measurement not 
provided. 
36 (38.3%) were diagnosed with TS 
including 14/44 (31.8%) who were 
under 5 years of age.  
 
18 (19.1%) were diagnosed with CD.  
 
Degree of villous atrophy among TS 
vs. CD patients:  
• Mild in 8/36 (22.2%) vs. 0 
• Moderate in 23/36 (63.9%) vs. 4/18 
(22.2%) 
• Severe in 5/36 (13.9%) vs. 14/18 
(77.8%)  
 
Mean hemoglobin concentration 
(range) among TS patients was 8.3 
g/dL (5.5-11) and did not differ from 
values of those with CD.  
 
Among the 22 TS patients, repeat 
biopsies showed: 
• 16 with normalization 
• 5 with improvement  
• 1 worsened despite marked clinical 
improvement  
 
The D-xylose test was abnormal in 
all TS patients by diagnostic 
definition. 
More than half of the 
GI clinic patients 
with PD had some 
degree of villous 
atrophy.  
 
More than one-third 
and almost one-fifth 
of subjects were 
diagnosed with TS 
and CD, 
respectively.  
 
By study diagnostic 
definition, all TS 
patients improved 
with treatment.  
Among those who 
had repeat biopsies, 
almost three-
quarters showed 
normalization of 
histology, while 23% 
had partial 
improvement and 1 
patient had 
worsened pathology. 
Biopsy results were 
not provided for 
patients without TS 
or CD.  
 
It was unclear if 
there were patients 
with abnormal D-
xylose and 
histology who did 
not respond to 
antibiotic therapy 
and therefore were 
not diagnosed with 
TS. 
 
Cut-off points used 
to define abnormal 
D-xylose tests were 
not provided. 
                                                          
1 Reported results were adjusted for severity of diarrhea, acidosis, hypokalemia, and age. 
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2001 
 
Northrop-Clewes CA 
et al. 
 
Anthelmintic 
treatment of rural 
Bangladeshi 
children: effect on 
host physiology, 
growth, and 
biochemical status 
 
L:M as a marker of 
intestinal 
permeability, and α 
1-antichymotrypsin 
as a marker of 
inflammation and 
immune activation to 
treatment among 
children randomized 
to bimonthly 
antihelminthics or 
placebo. 
Jamalpur district, 
northern Bangladesh 
 
2-5 yr olds from poor 
rural villages, 
sampled randomly 
from a larger cohort 
study. 
 
Stools were 
assessed for 
helminthiasis and 
giardiasis. Growth 
was followed 
longitudinally. 
RCT* 
 
n=109; 
 
n=54 received 
bimonthly empiric 
antihelminthic 
treatment 
 
n=55 received 
placebo 
 
 
* Randomized at 
the village level. 
Blood Tests: 
• α 1-
antichymotrypsin 
(ACT) 
• Albumin  
• Total protein  
 
 
Urine Test: 
L:M  
 
 
Among 93 subjects 
with L:M at baseline:  
• 46 received 
treatment 
• 47 received 
placebo 
 
Among 66 subjects 
with repeated L:M 
testing: 
• 34 received 
treatment 
• 32 received 
placebo 
Mean L:M1 at baseline: 
• Treatment: 0.22 
• Placebo: 0.25 
 
Seasonal variation in L:M was 
observed, with highest values 
following the monsoon season.  
 
Within-subject L:M analysis showed 
no significant association with 
intestinal helminthiasis and no 
significant improvement in treatment 
or placebo groups over 1 yr. L:M 
was generally not associated with 
giardiasis (with the exception of one 
group at one study interval). 
 
L:M was inversely correlated with 
∆HAZ and ∆WAZ scores at some of 
the follow-up intervals (r=-0.22, 
p<0.02 and r=-0.21, p<0.05, 
respectively, at 12 mo follow-up 
visit).  
 
Mean serum ACT, albumin and total 
protein were within normal ranges 
and were not associated with growth 
parameters. ACT and albumin 
concentrations did not significantly 
change with treatment, whereas total 
protein concentrations did (p<0.001). 
L:M ratios were high 
overall and 
demonstrated 
seasonal variation.  
 
Intra-individual L:M 
values did not 
change significantly 
over time, nor were 
they associated with 
helminthiasis or 
consistently 
associated with 
giardiasis.  
 
Inverse correlations 
were seen between 
L:M and growth 
parameters. 
 
Serum markers were 
within normal range. 
The only significant 
change in these 
markers was a 
decrease in total 
protein in the 
treatment group 
without concomitant 
change in albumin; 
this suggested a 
decrease in 
globulins (not 
directly measured), 
perhaps due to 
decreased 
inflammation. 
Baseline study data 
were lost, so 
analysis began with 
samples taken at 
month 2. 
 
The relationship 
between the serum 
markers and 
intestinal 
permeability was 
not reported. 
2009 
 
Panter-Brick C et al. 
Kathmandu, Nepal 
 
3-18 mo olds in two 
Cohort 
 
n=86; 
Urine Test: 
Lactose:Cr  
 
Mean2 Lactose:Cr (CI): 
• Squatter: 0.14 (0.12, 0.16) 
• Middle Class: 0.08 (0.07, 0.10) 
Authors speculate 
that Lactose:Cr 
accounted for less of 
Specific sugar 
excretion was 
normalized to 
                                                          
1 Geometric mean. 
2 Geometric mean. 
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Pathways leading to 
early growth 
faltering: An 
investigation into the 
importance of 
mucosal damage 
and 
immunostimulation 
in different socio-
economic groups in 
Nepal 
 
Lactose:creatinine 
ratio (Lactose:Cr) as 
a marker of intestinal 
permeability and 
hemoglobin, 
albumin, α-1-acid 
glycoprotein, and 
IgG as markers of 
immunostimulation. 
The latter were also 
assessed for their 
relationship to 
nutritional status. 
cohorts: 
• All children in 
target age range 
from four squatter 
settlements  
• Randomly 
selected, age-
matched cohort 
from lower middle-
class, periurban 
households 
 
n=48 in squatter 
cohort  
 
n=38 in lower 
middle-class 
cohort 
 
Blood Test: 
Hemoglobin 
 
• Statistically significant difference 
between the 2 groups among the 
6-12 mo olds (p=0.007) and 18-24 
mo olds (p=0.002), but not among 
12-18 mo olds.  
• For both SES groups, Lactose:Cr 
values decreased with increasing 
age (p<0.001). 
 
HAZ, WAZ, WHZ, and ∆WAZ scores 
were strongly associated with mean 
Lactose:Cr (p<0.001 each) as was 
∆HAZ score (p=0.004); ∆WHZ score 
was not. The strength and 
magnitude of association between 
∆WAZ score and Lactose:Cr was 
most pronounced among the 
wealthier cohort and there was no 
association between ∆HAZ score 
and Lactose:Cr among the squatter 
children.  
 
Hemoglobin concentrations were 
inversely related to Lactose:Cr 
(r2=0.018, p<0.001). 
the deterioration in 
nutritional status 
among the squatter 
children because of 
several factors, 
including poorer 
nutritional intake, 
that impact the 
nutritional status of 
children with lower 
socio-economic 
status. 
urinary creatinine to 
control for variation 
in renal function.  
 
Authors suggest 
that while 
Lactose:Cr might 
not be as accurate 
as L:M, it might be 
a more field-friendly 
assessment of 
mucosal damage 
compared to L:M, 
requiring only spot 
urine collection and 
no substrate 
dosing. However, 
L:M was not 
assessed in this 
study; direct 
comparison of the 
two tests was not 
possible.  
 
While hemoglobin 
concentration was 
inversely related to 
Lactose:Cr, testing 
for associations of 
other measured 
blood markers (IgG, 
AGP and albumin) 
with Lactose:Cr 
was not reported. 
2001 
 
Rabbani GH et al. 
 
Increased nitrite and 
nitrate 
concentrations in 
sera and urine of 
patients with cholera 
Dhaka, 
Bangladesh 
 
2-6 yr olds with 
cholera or shigellosis 
admitted to the 
hospital. 
 
Controls were 
Case-control 
 
n=63; 
 
n=45 cases: 
• 24 with cholera 
• 21 with 
shigellosis 
 
Urine Test: 
Nitric Oxide (NO)* 
 
 
Blood Tests: 
• Nitrite (NO2) 
• Nitrate (NO3) 
• WBC  
 
In children with shigellosis, median 
serum NO was ~8x higher at 
baseline than in controls and 
significantly differed from 
convalescent concentrations 
(p<0.01). Concentrations declined by 
52% of baseline during the recovery 
period but did not return to values 
found in the controls (measure of 
NO as measured by 
both serum and 
urinary NO2 and NO3 
concentrations was 
significantly elevated 
at presentation 
during acute illness 
compared to 7-10 
days after 
Some values 
reported in table 
format conflict with 
the text; columns of 
data appear to be 
transposed. 
 
Assessment for NO 
correlation with 
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or shigellosis 
 
To assess and 
compare nitric oxide 
as a marker of 
intestinal 
inflammation among 
children with cholera 
or shigellosis or 
healthy controls. 
Evaluated to assess 
nitric oxide 
production during 
infection of small 
bowel without 
inflammatory lesion 
(e.g., cholera) and 
during infection 
causing colon 
inflammation (e.g., 
shigellosis). 
recruited from the 
healthy attendants of 
patients or from 
children of hospital 
staff. 
 
Mean age (SD) in yr: 
• Shigellosis cases: 
3.8 (1.2) 
• Cholera cases: 4.2 
(1.4)  
• Controls: 4.7 (1.8) 
n=18 healthy 
controls 
 
 
Samples were 
collected from 
cases on 
admission 
and upon 
discharge (after 
7-10 days of 
treatment). 
 
Stool Test: 
Leukocytes 
 
 
* Nitric oxide (NO) is 
an unstable free 
radical that is 
converted to nitrite 
and nitrate. Urine 
NO2 + NO3 were 
expressed as a ratio 
with urine creatinine 
in order to account 
for differences in 
urine concentration. 
statistical significance not reported).  
 
In children with cholera, median 
serum NO concentrations at 
baseline were ~4x higher than in 
control subjects. Recovery 
concentrations decreased 52% from 
baseline (p<0.01); convalescent 
values did not differ from the values 
in controls (p<0.4).  
 
Median urinary NO ratios were 
similar among those with Shigella 
and V. cholerae infection, both upon 
admission and discharge. Initial 
values were ~2x higher than upon 
discharge (p<0.05 and 0.01, 
respectively). Control median NO 
was of an intermediate concentration 
between cases’ admission and 
discharge median concentrations; 
the difference between control and 
case admission values was NS. 
 
Mean blood WBC counts (SD): 
• Shigellosis: 19.6 (3.3)  
• Cholera: 8.3 (2.8) 
• Controls: 7.1 (1.8) 
 
Mean fecal WBC/high power field 
(SD): 
• Shigellosis: 38 (17) 
• Cholera: 5 (2) 
• Controls: 3 (1)  
 
Serum NO correlated with blood 
WBC count in shigellosis cases at 
baseline (r2=0.92, p<0.01), but only 
to a slight degree upon discharge 
(r2=0.26, no p-value reported) and 
there was no correlation among the 
cholera cases. Serum NO correlated 
with stool volume at presentation 
hospitalization in 
both cholera and 
shigellosis.  
 
Median serum NO 
concentrations in 
cholera patients 
were ~half of those 
with shigellosis both 
upon admission and 
upon discharge and 
concentrations were 
much higher in 
cases than in 
controls, Such 
striking differences 
were not observed 
for urinary NO 
results. 
 
Serum NO 
concentrations 
correlated with total 
blood WBC in 
shigellosis cases. 
fecal leukocyte 
counts was not 
reported, nor was 
the correlation 
between urinary NO 
and total blood 
WBC. 
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(r2=0.85, statistically significant per 
authors, p-value not reported). 
2009 
 
Ritchie BK et al. 
 
13C-sucrose breath 
test: novel use of a 
noninvasive 
biomarker of 
environmental gut 
health 
 
Sucrose breath test 
(SBT) as a marker of 
small bowel mucosal 
damage vis a vis 
sucrase activity 
among an Australian 
Aboriginal 
population. Also 
compared SBT with 
serum 
lactulose:rhamnose 
ratio (L:R) 
Darwin and 
Adelaide, Australia 
 
4 mo-5 yr old 
Aboriginal children 
admitted to hospital 
with diarrhea. 
 
Two control groups: 
• Aboriginal controls 
admitted to 
hospital with non-
GI symptoms 
(50% had 
pneumonia) 
Healthy, non-
Aboriginal controls 
recruited from 
community 
Case-control 
 
n=43;  
 
n=18 Aboriginal 
cases with AD 
 
n=25 controls: 
• 18 Aboriginal, 
without diarrhea 
• 7 non-
Aboriginal, 
healthy 
Blood Tests: 
• L:R 
(32 Aboriginal 
cases and controls 
tested) 
• C-reactive protein 
(CRP) 
• Mean Corpuscular 
Volume (MCV) 
• Hemoglobin 
 
 
Breath Test: 
13C sucrose breath 
test (SBT) 
20/32 (63%) of Aboriginal children 
had abnormal L:R ratios. 
 
Mean1 L:R (CI): 
• Diarrhea cases: 31.8 (24.9, 
40.7)  
• Aboriginal controls without 
diarrhea: 11.4 (8.5, 15.5),  
• significant difference 
(p<0.0001) 
 
SBT Mean (CI): 
• Diarrhea cases: 1.9% (0.9, 
3.0), p<0.0001 compared to 
non-Aboriginal controls and 
p=0.004 compared to 
Aboriginal controls 
• Aboriginal controls: 4.1% 
(3.0, 5.2), p=0.032 
compared to non-Aboriginal 
controls 
• Non-Aboriginal controls: 
6.1% (4.8, 7.3) 
• Significant differences were 
observed between all three 
groups.  
 
SBT results were not associated with 
wasting or with patient age or 
breastfeeding status. 
 
SBT and L:R were inversely 
correlated (r=0.67; CI: 0.42, 0.62; 
p<0.0001). L:R explained 45% of the 
variance in SBT; diarrhea explained 
28% of variance. 
 
SBT was associated with increased 
MCV, relative risk (CI)=3.9 (2.8, 5.0). 
SBT values were 
significantly lower 
and L:R values were 
significantly higher 
among Aboriginal 
children with 
diarrhea than among 
those without GI 
symptoms. SBT was 
also significantly 
lower among 
Aboriginal controls 
than among non-
Aboriginal children 
without diarrhea. 
This is consistent 
with previous reports 
of high prevalence of 
clinically silent TE in 
this population.  
 
SBT was 
significantly 
inversely correlated 
with L:R. 
Abnormal L:R ratios 
were defined as 
>16; no reference 
or derivation was 
provided for this 
cut-point.  
 
L:R test was not 
conducted among 
the non-Aboriginal 
controls. 
 
SBT/L:R correlation 
analysis was based 
on data for 
Aboriginal cases 
and controls 
combined; stratified 
analysis was not 
reported and could 
be of interest 
considering the 
large difference in 
L:R observed 
between these 
groups. 
 
Associations of 
MCV, CRP, and 
hemoglobin with 
SBT after adjusting 
for potentially 
confounding 
variables were not 
reported. 
                                                          
1 Geometric mean. 
Evidence Table 5. Markers of systemic inflammation and systemic immune activation.  
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and 
Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
SBT was not associated with 
hemoglobin or CRP. 
2001 
 
Rollins NC et al. 
 
Feeding mode, 
intestinal 
permeability, and 
neopterin excretion: 
A longitudinal study 
in infants of HIV-
infected South 
African women 
 
L:M as a marker of 
gut mucosal integrity 
and urinary 
neopterin excretion 
as a marker of cell-
mediated immunity 
in infants with and 
without HIV infection 
Durban, South Africa 
 
1, 6, and 14 wk old 
infants born to HIV-
infected mothers. 
Cohort 
 
n=272 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M  
• Neopterin 
Mean2 L:M (CI): 
• HIV-infected subjects: 
• 1 wk: 0.12 (0.06, 0.27)  
• 6 wk: 0.24 (0.15, 0.38) 
• 14 wk: 0.24 (0.14, 0.44) 
• Uninfected subjects:  
• 1 wk: 0.13 (0.09, 0.19) 
• 6 wk: 0.08 (0.06, 0.11) 
• 14 wk: 0.09 ( 0.07, 0.13) 
 
HIV-infection by 14 wk of age was 
significantly associated with 
increased L:M. 
 
A non-significant, positive trend in 
neopterin excretion was observed 
among HIV-infected infants. 
L:M was generally 
normal (compared to 
UK values) for non-
HIV-infected infants, 
but significantly 
increased among 
HIV-infected 
subjects, especially 
after 6 weeks. 
 
The increased L:M 
in HIV-infected 
infants was primarily 
driven by lactulose 
rather than mannitol. 
 
Higher neopterin 
excretion by HIV-
infected infants was 
observed but this 
was not statistically 
significant. 
Assessment of 
association 
between L:M and 
neopterin was not 
reported. 
2000 
 
Rollins NC et al. 
 
Vitamin A 
supplementation of 
South African 
children with 
diarrhea: optimum 
timing for improving 
biochemical and 
clinical recovery and 
subsequent vitamin 
A status 
Durban, South Africa 
 
6-60 mo old 
inpatients or 
outpatients with 
severe diarrhea. 
 
RCT 
 
n=139; 
 
n=66 received 
vitamin A on 
admission (group 
1) 
 
n=73 received 
vitamin A after 
clinical 
improvement 
(group 2) 
Urine Tests: 
• Lactulose3 
• Mannitol 
• L:M  
• Neopterin  
 
 
Blood Tests: 
• C-reactive protein 
(CRP) 
• α-1 acid 
glycoprotein 
(AGP) 
 
Mean4 L:M: 
• Group 1:  
• Day 0: ~1.8 
• Day 3: ~2.4  
• Group 2:  
• Day 0: ~1.2 
• Day 3: ~0.7 
 
There were no differences in mean 
L:M between groups or within groups 
between days 0 and 3, although 
there was a significant difference in 
paired analysis within individuals at 
the two time points (data not 
Mean L:M ratios 
were very high 
(~10x) (at baseline 
and at day 3 in both 
groups) compared to 
other studies in this 
review. Study 
authors suggested 
(via personal 
correspondence) 
that this could have 
been due to the 
severity of illness in 
the sample 
Urine testing could 
only be conducted 
in the laboratory on 
certain days; hence 
only a subset of 
subjects underwent 
those tests.  
 
Group 2 patients 
had significantly 
higher CRP, non-
significantly higher 
WBCs and AGP, 
and lower retinol 
                                                          
1 Lactulose and mannitol results were expressed in mg. 
2 Geometric mean. 
3 For lactulose, mannitol, and neopterin results, excretion measurement was not specified. 
4 Geometric mean. 
Evidence Table 5. Markers of systemic inflammation and systemic immune activation.  
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
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Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
 
L:M as a marker of 
intestinal 
permeability and 
urinary neopterin, 
serum α-1 acid 
glycoprotein, and C-
reactive protein as 
markers of 
inflammation among 
children with severe 
diarrhea 
 
 
Treatment 
involved vitamin A 
supplementation 
either on the day 
of admission or 
after acute 
diarrheal 
symptoms had 
resolved. 
49 subjects received 
urine testing: 
• Group 1: n=25 
• Group 2: n=24  
 
 
Blood and urine were 
tested on days 0 and 
3. 
presented, and direction, magnitude 
and degree of significance not 
reported). 
  
Lactulose and mannitol excretion 
were assessed only in the paired 
analysis. Lactulose excretion 
decreased between days 0 and 3 
(magnitude of effect and degree of 
significance not reported), while 
mannitol excretion showed no 
change.  
 
Mean1 neopterin and AGP 
concentrations did not differ between 
groups or within groups on the 
different study days or in the paired 
analysis. When initial CRP (~2x 
higher in Group 2 compared to 
Group 1, p<0.004) was taken into 
account, mean CRP on day 3 did not 
differ between the 2 groups. 
However in the paired analysis, CRP 
concentrations were significantly 
different between days 0 and 3. 
population (children 
hospitalized for 
diarrhea). 
 
Vitamin A 
administration did 
not result in 
significant 
improvement in L:M, 
neopterin, or AGP 
regardless of timing 
of vitamin A 
administration. 
and retinol-binding 
protein 
concentration 
compared to group 
1 at baseline. 
Authors note that 
these parameters 
suggest that Group 
2 patients might 
have been more ill 
at baseline. For the 
subset of 49 
patients undergoing 
urine testing, the 
mean2 L:M and 
neopterin 
concentrations 
were lower among 
Group 2 than Group 
1 subjects (NS). 
However, baseline 
differences in acute 
phase and vitamin 
A markers at 
baseline were not 
reported separately 
for these 49 
subjects. 
 
Data for lactulose 
and mannitol 
excretion were not 
reported separately. 
Rationale for 
additional analyses 
of these molecules 
expressed as ratios 
with creatinine was 
not explained.  
 
                                                          
1 Geometric mean. 
2 Geometric mean. 
Evidence Table 5. Markers of systemic inflammation and systemic immune activation.  
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Authors suggest 
that their 3-day 
testing period 
(based on their 
previous work in a 
different setting 
[207] might have 
been too short to 
identify effect as 
demonstrated by 
McCullough et al. at 
10 days after 
presentation [208]. 
2003 
 
Soliman SM et al. 
 
Role of micronutrient 
mixture in acute and 
persistent diarrhea in 
infants and its 
impact on nutritional 
status 
 
Blood cell and 
albumin markers 
among infants with 
acute, persistent or 
no diarrhea, and 
effects on these 
markers after 10 
days of 
supplementation 
with micronutrient 
mixture (containing 
vitamin A, zinc and 
other micronutrients) 
among subjects with 
and without diarrhea 
 
Cairo, Egypt 
 
6-24 mo olds with 
diarrhea were 
recruited from Al-
Sahel teaching 
hospital malnutrition 
clinic. 
 
5/6 PD cases and 
10/14 AD cases had 
some degree of 
malnutrition.  
 
Infants with PD had 
significantly lower 
vitamin A and zinc 
stores compared to 
controls. Those with 
AD had significantly 
lower vitamin A 
stores. 
Case-control  
 
n=30;  
 
n=20 cases: 
• 6 with PD 
• 14 with AD  
 
n=10 healthy 
controls* 
 
 
* Controls were 
age- and sex-
matched to 
cases. 
Blood Tests: 
• Complete blood 
count and 
differential 
• Red cell measures: 
• Mean 
corpuscular 
volume (MCV) 
• Mean 
corpuscular 
hemoglobin 
(MCH) 
• Mean 
corpuscular 
hemoglobin 
concentration 
(MCHC) 
• Transferrin 
saturation 
• Albumin 
 
Mean baseline hemoglobin was 
significantly lower in infants with AD 
and PD (p<0.05 for each group) than 
in controls  
 
Mean MCV and MCH were lower in 
those with AD (p<0.025 and p<0.01, 
respectively) and PD (p<0.01 for 
both markers) compared to controls.  
 
Mean lymphocyte counts among PD 
cases were low compared to those 
of controls (p<0.01). 
 
Other markers did not vary 
significantly at baseline. However, 
among infants with PD, mean 
albumin was abnormally low, 
although it was not significantly 
different compared to controls or 
those with AD. 
Mean albumin (g/dL) (SE): 
• PD: 2.9 (0.27)  
• AD: 3.29 (0.25)  
• Controls: 3.37 (0.21) 
 
Following micronutrient 
supplementation, mean hemoglobin, 
MCV, lymphocyte counts and 
albumin increased in both diarrhea 
Albumin and many 
hematologic markers 
were low at baseline 
among infants with 
diarrhea, especially 
in those with PD, 
compared to those 
without diarrhea; 
some of these 
differences were 
statistically 
significant. 
Parameters 
generally normalized 
after micronutrient 
supplementation. 
Information on 
control recruitment 
and 
anthropometrics 
were not specified. 
 
Sample size was 
small when 
stratified by 
case/control 
groups, especially 
for PD cases (n=6). 
Controls were 
reported to have 
been matched to 
cases, yet there 
were half the 
number of controls 
than cases and 
statistical testing 
(student’s t-test) 
was not 
commensurate with 
matched case-
control 
methodology. 
Evidence Table 5. Markers of systemic inflammation and systemic immune activation.  
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
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Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
groups to concentrations on par with 
control baseline concentrations 
(albeit increases were NS except 
within the PD group). MCH improved 
to concentrations on par with the 
control group only among the infants 
with AD. 
2008 
 
Vieira MM et al. 
 
Carotenoids, retinol, 
and intestinal barrier 
function in children 
from northeastern 
Brazil 
 
L:M as marker of 
intestinal barrier 
function, fecal 
lactoferrin and 
leukocytes as 
markers of intestinal 
inflammation, and 
CRP and AGP as 
acute phase 
reactants among 
children with varying 
vitamin A status 
Fortaleza, Brazil 
 
2 mo-9 yr olds 
(mean age 41 mo) 
from an 
impoverished urban 
community, eligible if 
HAZ score <median  
for their community. 
Cross-sectional 
 
n=102 
 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M  
(97 tested) 
 
 
Stool Tests: 
• Lactoferrin 
(93 tested) 
• Leukocytes 
 
 
Blood Tests: 
• C-reactive protein 
(CRP)  
• α-1-acid 
glycoprotein 
(AGP) 
 
48.5% had abnormal L:M.  
 
L:M and excretion of each sugar 
separately did not vary with retinol 
concentration. 
 
L:M was associated with levels of 
common dietary carotenoids, 
primarily driven by lactulose. 
However, the association was not 
always statistically significant, and 
the direction of association varied 
depending on precursor.  
 
40% of stool samples were positive 
for lactoferrin. 
 
1% of stool samples were positive 
for fecal leukocytes. 
 
30% of stool samples were positive 
for parasites but this had no impact 
on L:M results, lactoferrin, or acute 
phase reactants. 
Almost half of 
subjects had 
increased L:M, and 
~40% of subjects 
had increased 
lactoferrin. 
 
While serum retinol 
concentrations were 
not associated with 
L:M, serum 
carotenoids were; 
authors suggest that 
these retinol 
precursors might be 
more sensitive 
predictors of 
impaired intestinal 
function. However, 
the reported 
direction of 
association varied, 
making 
interpretation of 
these results 
unclear. 
L:M threshold for 
abnormal values 
was defined as 
>0.0864 [214]. Cut-
off values for 
lactoferrin positivity 
were not described.  
 
Relationships 
between acute 
phase proteins and 
measures of 
intestinal 
permeability or 
inflammation were 
not reported. 
Relationships 
between L:M and 
lactoferrin or fecal 
leukocytes as well 
as those between 
retinol or 
carotenoids and 
lactoferrin or fecal 
leukocytes were not 
reported.  
 
Exclusively 
breastfed children 
were excluded from 
study participation 
due to assessment 
of stool lactoferrin. 
 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
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2007 
 
Williams EA et al. 
 
A double-blind, 
placebo-controlled, 
glutamine-
supplementation trial 
in growth-faltering 
Gambian infants 
 
L:M and plasma 
immunoglobulins 
and acute phase 
reactant proteins 
(albumin, C-reactive 
protein, and alpha-1-
antichymotrypsin) in 
community-based 
Gambian infants 
enrolled in a 
glutamine trial 
 
West Kiang region, 
Gambia 
 
4-10 mo olds from a 
rural area followed 
during the 5-month 
rainy season and for 
6 months afterward. 
Cohort 
 
n=72 
 
Glutamine or 
placebo of 
nonessential 
amino acids was 
orally 
administered 
twice daily during 
rainy season; L:M 
ratio was 
measured 
monthly, and 
plasma samples 
were collected 3 
times. 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M 
 
Blood markers 
• C-reactive protein 
(CRP)  
• Alpha-1 anti-
chymotrypsin 
(ACT) 
• IgA 
• IgG 
• IgM 
• Albumin 
Mean2 L:M (CI):  
• Baseline:  
• Glutamine group: 0.33 (0.25, 
0.43) 
• Placebo group: 0.33 (0.26, 
0.41) 
• Post-intervention: 
• Glutamine group: 0.29 (0.23, 
0.35) 
• Placebo group: 0.26 (0.21, 
0.32) 
 
Mean excretion of lactulose (CI):  
• Baseline:  
• Glutamine group: 0.21 (0.16, 
0.28) 
• Placebo group: 0.20 (0.15, 
0.26) 
• Post-intervention: 
• Glutamine group: 0.17 (0.13, 
0.21) 
• Placebo group: 0.14 (0.11, 
0.18) 
 
Mean excretion of mannitol (CI):  
• Baseline:  
• Glutamine group: 2.65 (2.02, 
3.48) 
• Placebo group: 2.50 (1.87, 
3.36) 
• Post-intervention: 
• Glutamine group: 2.48 (1.99, 
3.11) 
• Placebo group: 2.14 (1.62, 
2.82) 
 
L:M values did not differ significantly 
between treatment groups before or 
following intervention. However, a 
L:M values were 
elevated in this 
population, with no 
significant change 
after the 
intervention.  
 
None of the plasma 
markers differed 
significantly 
between treatment 
and placebo groups, 
either at baseline or 
at the end of 
supplementation. 
 
Growth outcomes 
did not differ 
significantly across 
treatment groups. 
The relationships 
between L:M and 
growth parameters, 
immuno-globulins, 
and acute phase 
proteins were not 
reported. 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 Geometric mean. 
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repeated measures ANOVA showed 
that during supplementation, L:M 
values were borderline elevated 
among the glutamine-supplemented 
group relative to the placebo group 
(p=0.05), counter to expectation. 
 
Neither ACT, CRP, albumin, nor 
immunoglobulins IgA, IgG, or IgM 
differed significantly between 
treatment and placebo groups, either 
at baseline or at the end of 
supplementation. 
 
Mean levels of IgA and IgG 
increased during the study 
(p<0.001), while IgM levels did not. 
Concentrations of each of these 
immunoglobulins did not differ 
between treatment and placebo 
groups. 
 
Plasma albumin, ACT, 
and CRP values showed no change 
over the course of the study. 
 
Proportions of children with elevated 
CRP ranged from 30-41% at 
different collection time points. The 
glutamine intervention had no effect 
on proportion of children with 
elevated CRP. 
 
Treatment and placebo groups 
experienced decreases in WAZ, 
HAZ, and MUAC coinciding with the 
rainy season; however, there was no 
significant difference observed 
between the groups for any of these 
parameters.  
 
Treatment and placebo groups did 
not differ in morbidity indices (i.e. 
Evidence Table 5. Markers of systemic inflammation and systemic immune activation.  
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
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percentage of time reported with a 
particular illness or illness overall). 
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. 
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s. 
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting. 
 
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval, 
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins, 
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G, 
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent 
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium 
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score), 
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s) 
 
 
Evidence Table 5. Markers of systemic inflammation and systemic immune activation.  
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
5.7 Markers of Microbial Drivers 
Markers of microbial environments, such small bowel bacterial overgrowth (SBBO), were 
reviewed, while markers for specific enteric organisms were beyond the scope of this review. The 
data from each of the studies relevant to this review are listed in Evidence Table 6.
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2002 
 
Alves GM et al. 
 
Nutritional status 
and breath hydrogen 
test with lactose and 
lactulose in Terena 
Indian children 
 
Lactose hydrogen 
breath test (HBT) as 
a marker of lactase 
activity, and 
lactulose HBT as a 
marker of SBBO 
Limão Verde and 
Córrego Seco, Mato 
Grosso du Sul, Brazil 
 
All children <10 yr 
old were recruited 
from these rural 
villages. 
Cross-sectional 
 
n=264;  
 
<5 yr old: n=145  
 
(However results 
were provided by 
<4 and >4 yr old 
age groups.) 
Breath Tests: 
• Lactose HBT 
(251 tested) 
• Lactulose HBT  
(252 tested) 
Lactose HBT: 
• Elevated: 27.1% among all 
subjects 
• Borderline: 43.0% among all 
subjects 
• 0% of subjects <4 yr had elevated 
or borderline results 
 
Lactulose HBT positive: 
• 11.5% of all subjects 
• 8.6% of subjects <4 yr 
The prevalence of 
lactase deficiency as 
measured by lactose 
HBT was >25%, but 
non-existent among 
those <4 yr of age. 
 
Prevalence of SBBO 
as assessed by 
lactulose HBT was 
~10%. 
Assessment of 
association 
between lactulose 
and lactose 
absorption was not 
reported. 
2000 
 
Fagundes-Neto U et 
al. 
 
Studies of the small 
bowel surface by 
scanning electron 
microscopy in infants 
with persistent 
diarrhea 
 
Scanning electron 
microscope (SEM) 
and light microscope 
(LM) analyses of 
small intestinal 
biopsy among 
infants with PD with 
and without SBBO 
Sao Paulo, Brazil 
 
2-10 mo olds with 
PD and protein 
calorie malnutrition 
consecutively 
admitted to Sao 
Paulo Hospital. 
Case-series  
 
n=16 
Jejunal secretions 
aspirate: 
Bacterial 
concentrations 
 
 
Jejunal tethered 
capsule biopsy: 
Histopathology by LM 
and SEM 
 
 
Rectal tethered 
capsule biopsy: 
Histopathology 
68.7% had bacterial overgrowth 
(concentration >104 colonies/mL): 3 
had enteropathogenic E. coli while 
the rest had colonic microflora. 
 
All small intestine specimens had 
morphological abnormalities on LM: 
• 43.7% moderate villous atrophy 
• 56.3% subtotal villous atrophy  
 
SEM revealed abnormalities of 
varying intensity:  
• Among the 11 with SBBO, villous 
atrophy ranged from Grade II 
(n=4), Grade III (n=2), to Grade IV 
(n=3).  
• For the 5 subjects without SBBO, 
villous atrophy ranged from Grade 
I (n=1) to Grade 2 (n=4).  
• A mucous-fibrinoid pseudo-
membrane over enterocytes was 
noted in 7 of the 11 with SBBO 
and none of the others.  
 
• Other abnormalities noted on 
SEM included:  
• Mucus and debris covered large 
Histological 
abnormalities were 
noted in all subjects 
by LM and SEM.  
 
Degree of villous 
atrophy noted on 
SEM seemed to be 
correlated with 
SBBO (no statistical 
tests were reported).  
 
Authors speculate 
that the mucous-
fibrinoid pseudo-
membrane partially 
covering enterocytes 
is consistent with a 
malabsorptive 
process, with the 
findings of fat 
droplets on 
enterocytes 
surfaces, and with 
the state of 
malnutrition of the 
subjects. 
Inconsistent 
reporting of 
proportions of 
histopathologic 
findings among all 
subjects and by 
SBBO status; 
assessment of 
potential 
relationship with 
SBBO between 
different histologic 
findings was not 
possible. 
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areas of the villous surface 
• Derangement of the enterocytes 
(in some cases cell borders were 
not clearly defined)  
• Reduced height and number (or 
absence in some places) of 
microvilli  
• Lymphocytes and fat droplets 
were observed over the surface of 
enterocytes (18%)1 
 
10 subjects had colitis on rectal 
biopsy; this was not associated with 
SBBO or degree of small intestinal 
pathology on SEM. 
2002 
 
Murphy JL et al. 
 
Maldigestion and 
malabsorption of 
dietary lipid during 
severe childhood 
malnutrition 
 
Stool recovery of 
radiolabeled 
products as markers 
of lipid digestion and 
absorption, and bile 
salt deconjugation 
as a marker of 
SBBO among 
children with severe 
malnutrition 
Kingston, Jamaica 
 
5-23 mo olds 
admitted to the 
Tropical Metabolism 
Research Unit of the 
University of the 
West Indies with 
severe malnutrition. 
Case-series 
 
n=24 
 
 
Subjects were 
divided into 3 
groups of 8 
children, each 
group receiving a 
different labeled 
triglyceride. 
 
Data were 
collected in three 
separate phases 
as described 
above in JL 
Murphy et al. 
2001 [149]. 
Stool Tests: 
• Total and 
fractionated 13C 
following ingestion 
of one of three 13C 
labeled triglycerides 
(TG): trilaurin, 
triolein, or 
trilinolein*  
• 13C stool assay 
following 
administration of 
labeled fatty acid 
13C glycocholate**  
 
 
* To assess fat 
excretion as a % of 
dose administered. 
Also assessed 
proportion of 13C in 
triglyceride (TG) and 
fatty acid (FA) 
fractions to 
distinguish excretion 
Median total stool excretion of 13C in 
phase 1 was 9% (range: 1%-29%) 
and did not vary between TG 
groups.  
Median 13C excretion dropped 33%-
99% in phase 2 and 86%-95% in 
phase 3 compared to phase 1 
(p<0.05 each). 
 
Over the study period, there were 
significant associations between 
total lipid and the amount of 13C 
labeled TGs in stool for some 
groups, but not for others. 
 
Median 13C in TG and FA was 
similar across TG groups in all 
phases. 13C FA recovery was 
similar and reduced by ~2/3 
compared to Phase 1. 13C TG was 
not detectable in Phases 2 or 3. 
Statistical comparisons between 
phases were not reported.  
 
13C after radiolabeled glycocholate 
High concentrations 
of 13C (compared to 
healthy UK children) 
[190] were observed 
in half of the 
subjects at 
admission, reflecting 
impaired digestion or 
absorption.  
 
The differences in 
stool 13C were wide 
but not as extreme 
as in a previous 
study by same 
investigators (also 
examined in this 
review) using a 
different TG 
(tripalmitin) 
substrate [149]. 
 
13C excretion did not 
significantly differ 
between TG groups 
Authors state that 
the study was not 
powered to 
compare the 
different TGs, but 
they contend that 
medium chain 
trilaurin did not 
appear to be 
processed 
differently than the 
longer chain TGs 
triolein and 
trilinolein. 
 
Authors did not 
describe the 
method used to 
assign subjects to 
different TG groups.  
 
While it was noted 
that some subjects 
had positive stool 
cultures, details 
                                                          
1 These SEM results were not presented separately for those with and without SBBO. 
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caused impaired 
digestion (presence 
of TG) vs. poor 
absorption (presence 
of FA). 
 
** To assess bile salt 
deconjugation in the 
bowel caused by 
SBBO; conducted 
after the TG 
assessment and a 3 
day washout period. 
administration was detected in stool 
at quantities considered to be in 
excess of the 7% recovery of dose 
administered upper limit of normal in 
U.S. adults in [189]: 
• Phase 1: 13/24 (54%) 
• Phase 2: 5/24 (20.8%)  
• Phase 3: 3/24 (12.5%) 
and declined with 
improving clinical 
course. 
 
Similar to their 
previous study, 
significantly more 
13C in stool was 
recovered as FA 
than TG, reflecting 
impaired absorption 
over poor lipid 
digestion/ hydrolysis. 
Unlike in their 
previous study, there 
was evidence of 
SBBO as measured 
post-ingestion of 13C 
glycocholate. 
were not provided 
on the nature of the 
enteric infections. 
2001 
 
Murphy JL et al. 
 
Gastrointestinal 
handling and 
metabolic disposal of 
13C-labelled 
tripalmitin during 
rehabilitation from 
childhood 
malnutrition 
 
Fecal fat, stool 
recovery of 
radiolabeled 
products, and breath 
tests as markers of 
lipid digestion and 
absorption and bile 
salt deconjugation 
as a marker of 
SBBO among 
children with severe 
Kingston, Jamaica 
 
7-23 mo olds with 
malnutrition admitted 
to the University of 
the West Indies. 
Case-series 
 
n=8  
 
 
Data were 
collected in three 
separate phases 
(each lasting 9 
days): 
• Within 48 hours 
of admission 
• During early 
rehabilitation 
• During late 
rehabilitation 
Stool Tests: 
• Fecal fat* 
• Total and 
fractionated 13C 
assay after 
administration of 
13C tripalmitin 
(TP)** 
• 13C assay after 
administration of 
13C glycocholate 
(GCA)*** 
 
Breath Tests: 
• 13CO2 after 
administration of 
13C glycocholate 
(GCA)*** 
• 13CO2 after 
administration of 
13C TP**** 
 
 
* In 72 hour stool 
Mean fecal fat (SD): 
• Phase 1: 2.4 g/day (3.6) or 5.9% 
(9.4) of dietary lipid intake 
• Phase 2: 1.7 (0.9) g/day, or 3.3% 
(2.4) of intake  
• Phase 3: 0.9 (0.6) g/day, or 1.4% 
(0.7) of intake 
• Differences between phases were 
not statistically significant. 
 
Total excretion of 13C in stool also 
varied widely across patients (0%-
44%) and did not differ between 
study phases.  
 
Correlation between fecal fat and 13C 
(r=0.48; p<0.05) was observed.  
 
Lack of lipid digestion and 
absorption were assessed by 
measuring TG and FA fractions, 
respectively. Mean 13C TG recovery 
(SD) (% of administered dose), 
number of patients excreting TG: 
Mean fecal fat was 
not elevated 
compared to 
published norms 
[191, 192] during 
any study phase.  
 
There was wide 
variation in fecal fat 
at presentation, and 
wide variations in 
stool 13C across 
subjects. Authors 
indicate that this is 
the first such 
assessment in 
malnourished 
children; previous 
studies on healthy 
children from the UK 
demonstrated 
average excretion of 
6% [190]. 
 
Statistical methods 
might be 
inappropriate for a 
small sample. 
 
All subjects were 
treated with 
antibiotics including 
metronidazole for 
presumptive SBBO; 
this might have 
affected GCA 
testing. 
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malnutrition collection (measured 
as total grams and as 
% of dietary fat 
intake). 
 
** To assess fat 
excretion as a % of 
dose administered. 
Also assessed 
proportion of 13C in 
triglyceride (TG) and 
fatty acid (FA) 
fractions to 
distinguish excretion 
caused by impaired 
digestion (presence 
of TG) vs. poor 
absorption (presence 
of FA). 
 
*** To assess bile 
salt deconjugation in 
the bowel caused by 
SBBO; conducted 
after the TG 
assessment and a 3 
day washout period. 
 
**** Expressed as a 
percentage of 
absorbed label (dose 
administered - label 
recovered in stool) to 
assess oxidation for 
acute energy needs. 
• Phase 1: 0.7% (1.6), n=3 
• Phase 2: 0.9% (2.8), n=1  
• Phase 3: no recovery from any 
subjects, differences between 
phases were NS 
 
13C FA fraction in stool declined 
during rehabilitation. 
Mean 13C FA recovery (SD): 
• Phase 1: 6.0% (7.3)  
• Phase 2: 4.8% (3.7)  
• Phase 3: 3.3% (3.8),  
differences between phases were 
NS 
  
Mean FA values were ~9x (NS), 5x 
(p<0.001), and 3x (p<0.05) higher 
than mean TG values in Phases 1, 
2, and 3, respectively. 
  
Following administration of labeled 
TP, absorbed 13C label by breath 
analysis was ~5% (range 0%-21.2%) 
and similar across study phases.  
 
Following the administration of 
labeled GCA, there was either no or 
minimal recovery of 13C in stool and 
13CO2 on breath (as % of dose 
administered) in all phases. 
The majority of 
excreted 13C was in 
the form of FA rather 
than TG. Authors 
interpreted this to 
reflect failure of lipid 
absorption in the 
face of adequate 
digestion/hydrolysis. 
Each form (FA and 
TG) was found in 
decreasing values 
as the study phases 
progressed, 
suggesting improved 
digestion and 
absorption, although 
results did not differ 
significantly.  
 
Fecal fat was 
correlated with 
concentrations of 
13C in stool.  
There was no 
evidence of SBBO 
or bile acid 
malabsorption.  
 
13CO2 excretion 
following 
administration of 13C 
TP was minimal, 
suggesting a 
propensity for 
deposition in 
adipose tissues 
rather than oxidation 
for immediate 
energy needs. The 
authors report that 
this breath test has 
not been widely 
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used, but that 
healthy UK children 
have breath 
excretion values 
from 15%-43% 
[190], compared to a 
mean of 5% and 
range 0%-21% in 
this cohort; the latter 
findings were more 
similar to results 
from kwashiorkor 
patients where 13C-
labeled oleic acid 
was used as 
substrate [193]. 
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. 
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s. 
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting. 
 
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval, 
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins, 
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G, 
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent 
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium 
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score), 
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s) 
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5.7.1 Lactulose Hydrogen Breath Test (HBT) 
Alves et al. utilized the lactose hydrogen breath test (HBT) to measure of lactose absorption 
and the lactulose HBT as a measure of SBBO in a community-based study of indigenous children in 
Brazil [102]. Prevalence of SBBO in the study subjects was 12% among subjects below four years of 
age, and overall 9% had SBBO. The authors did not report on the relationship between lactulose and 
lactose absorption. 
In a study of intestinal function among well-nourished children with asymptomatic giardiasis 
and healthy controls in Mexico, Moya-Camarena et al. utilized the lactulose HBT and the indican test 
to exclude subjects with SBBO. No further data were reported on results of the lactulose HBT; 
therefore we did not include this study in this section of our review [147]. 
5.7.2 13CO2 in Breath or Stool after Administration of                       
13C Glycocholate as Marker for SBBO 
Murphy et al. [149] assessed gastrointestinal function by stool tests with [149] or without [148] 
breath tests in children hospitalized for rehabilitation of malnutrition. The 13CO2 breath test was 
performed after administering 13C glycocholate (GCA) to assess bile salt deconjugation in the bowel 
caused by SBBO. The test was conducted after a similar assessment with triglyceride and a 
subsequent 3-day washout period. Results were expressed as percent of administered dose. In their 
initial study, following the administration of labeled GCA, there was no or minimal recovery of 13C in 
stool and 13CO2 on breath in all study phases. The authors interpreted these results to indicate that 
the GCA was not malabsorbed and that the subjects did not show evidence of bile salt 
deconjugation. In the subsequent larger study, however, 13C from labeled GCA was recovered in the 
stool in more than one-third of the children, indicating the presence of SBBO [148].  
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5.7.3 Intestinal Aspirates for Bacterial Concentrations 
Fagundes-Neto et al. analyzed jejunal aspirates and small intestinal biopsies of hospitalized 
infants with persistent diarrhea and malnutrition by scanning electron microscopy (SEM) and light 
microscopy [118]. Based on bacterial concentration in jejunal aspirates, more than two-thirds of 
subjects had bacterial overgrowth (concentration >104 colonies/mL), and three were infected with 
enteropathogenic E. coli while the rest had colonic microflora in their small bowel. Histological 
abnormalities were noted in all subjects by light microscopy and SEM. The degree of villous atrophy 
noted on SEM seemed to correlate with SBBO, but statistical testing was not provided.  
Fagundes-Neto et al. also reported a mucous-fibrinoid pseudo-membrane that partially 
covered enterocytes [118]. They speculated that it could indicate a malabsorptive process, based on 
the findings of fat droplets on enterocyte surfaces and the malnourished condition of the subjects. 
Reporting of proportions of histopathologic findings among all subjects and by SBBO status, 
as well as statistical assessment of potential correlation with SBBO between different histologic 
findings, would have benefitted the analysis. 
5.8 Markers of Nonspecific Intestinal Injury 
The matter of small bowel biopsies and EED is complex. From initial investigations nearly five 
decades ago, the histopathologic appearance of the small bowel defined the entity. Sentinel papers 
from Southeast Asia and elsewhere formed the basis of our understanding of the entity on which we 
have focused in this review [274, 275]. Also, there is an extensive tradition of pathological 
assessments of the bowel and other organs in a variety of syndromes and diseases, and histological 
assessment is often considered the gold standard to which biomarkers are compared. Histology 
certainly can inform the nature of lesions. In the digestive system, microscopic evaluation of tissue 
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can often help differentiate infectious from noninfectious inflammations, assess the degree of allergic 
reaction if present, suggest the principal effector cells, and identify malignant potential (rare in these 
subjects). Specific diagnoses can also be made by histologic evaluation of the small bowel; well-
known examples are celiac disease and Crohn’s disease.  
In view of the potential value of relating biopsies to biomarkers, we sought to find any relation 
between this putatively definitive test (small bowel biopsy) and any laboratory test or abnormality. 
The data relevant to this review are listed for each of these 18 biopsy studies in Evidence Table 7. 
We also include other markers of non-specific intestinal injury in Evidence Table 7, including three 
studies utilizing fecal occult blood or red blood cells and one employing Tc-99m dextran scintigraphy. 
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Study Outcomes of  
Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
2009 
 
Amadi B et al. 
 
Reduced production 
of sulfated 
glycosaminoglycans 
occurs in Zambian 
children with 
kwashiorkor but not 
marasmus 
 
Duodenal biopsy 
including 
assessments of 
intestinal markers in 
children with PD and 
different forms of 
malnutrition 
Lusaka, Zambia 
 
12.2-19.8 mo olds 
with PD and 
malnutrition 
admitted to the 
malnutrition ward of 
a teaching hospital. 
Case-control  
 
n=41*; 
 
n=41 cases with 
PD and 
malnutrition:  
• 18 with 
marasmus 
• 8 with marasmic 
kwashiorkor 
• 15 with 
kwashiorkor  
 
n=19 healthy 
control children 
from UK  
 
 
* UK subjects are 
presented in this 
table due to 
comparisons of 
interest made in 
the review. 
However we do not 
include these 
subjects in the 
sample size for this 
review. 
Endoscopic duodenal 
biopsy: 
• Histopathology 
• Densities in lamina 
propria and crypt 
epithelium: 
• Cell proteins:  
• Glycosaminoglyca
n (GAG) 
• Enterocyte heparan 
sulfate 
proteoglycan 
(HSPG) 
• Syndecan-1  
• Inflammatory cell 
markers: 
• CD3 IEL 
• Ki67 
• Human leukocyte 
antigen DR-1 (HLA-
DR) 
Biopsy findings among the 
Zambian compared to the UK 
children: 
• Villous height reduced 
• Crypt depth increased  
• ~50% reduction in crypt:villous 
ratio 
• Values for lamina propria cell 
densities were not reported for 
UK subjects 
 
No significant differences in crypt 
or villous measures or lamina 
propria cell densities were 
observed between nutritional 
groups or after nutritional 
rehabilitation. 
 
Intestinal markers: 
• Inflammatory markers were 
seen in higher densities 
compared to the UK children. 
There were significant 
differences between the 
different nutritional groups in 
the specific types of 
inflammatory markers. 
• There was a significant 
reduction in GAGs and HSPG 
in the kwashiorkor group 
compared to UK children, but 
no significant differences 
between kwashiorkor and other 
presentations of malnutrition.  
• There was no difference in 
epithelial syndecan-1 protein 
expression between the 
malnutrition groups (data not 
available for UK controls). 
Mucosal 
architecture was 
markedly abnormal 
compared to UK 
controls but did not 
vary between 
marasmus and 
kwashiorkor 
presentations of 
malnutrition.  
 
Inflammatory cell 
densities were 
generally higher 
compared to UK 
children and 
showed different 
patterns across the 
malnutrition 
presentations.  
 
Tissue 
concentrations of 
HSPG and GAG 
were reduced 
especially amongst 
children with 
kwashiorkor. 
Intestinal protein 
markers did not 
differ amongst the 
malnutrition groups. 
27 subjects were 
HIV positive; 
incidence was 
lower in the 
kwashiorkor group. 
2000 
 
Azim T et al. 
 
Dhaka, Bangladesh 
 
7-12 mo olds with 6-
8 days of watery 
Case-control 
 
n=136;  
 
Blood tests: 
• IFN-γ 
• TNF-α 
• WBC (total and 
WBC total and differential, 
immunoglobulin subtypes, 
cytokines, transferrin, and 
albumin did not differ between 
Some immune and 
inflammatory 
markers were 
associated with 
The number of 
controls was 
relatively small and 
their nutritional 
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Immune response of 
Bangladeshi children 
with acute diarrhea 
who subsequently 
have persistent 
diarrhea 
 
Immune activation 
tests, as well as 
transferrin and 
albumin as markers 
of nutritional status 
among children with 
and without PD 
diarrhea attending 
the International 
Centre for Diarrheal 
Disease Research.  
 
Cases were those 
who went on to 
develop PD, 
controls were those 
who did not.  
 
An additional group 
of subjects without 
diarrhea were 
recruited from a 
nutrition follow-up 
unit.  
 
Prevalence of 
malnutrition was 
high in all groups. 
n=38 cases with 
PD 
 
n=98 controls: 
• 85 with AD 
• 13 with no 
diarrhea 
differential) 
• IgA 
• IgG 
• IgM 
• Transferrin 
• Albumin 
• Immune function tests: 
• Neutrophil polarization 
response to 
chemotactic factor 
• Neutrophil opsonization 
to yeast 
• Mononuclear cell 
proliferation, 
spontaneous and in 
response to stimuli with 
mitogens 
 
 
Skin Test: 
• Delayed-type 
hypersensitivity 
response (DTH) to 
tuberculin, tetanus, 
diphtheria, 
Streptococcus, Proteus, 
Candida, and 
Trichophyton  
 
 
Stool tests: 
• Leukocytes 
• Red blood cells 
cases with diarrhea or controls, 
nor did stool leukocyte or 
erythrocyte counts.  
 
The percentages of neutrophils 
that polarized in response to 
stimulation were significantly 
higher in subjects with AD or PD 
compared to those without 
diarrhea; there was no difference 
between the two diarrhea 
groups. 
 
Opsonization did not vary 
between any groups. 
 
Monocyte spontaneous 
proliferation counts were less 
than half among children with no 
diarrhea compared to those with 
AD (p<0.001) or with PD 
(p=0.011); there was no 
difference between the two 
diarrhea groups.  
 
Monocyte proliferation in 
response to stimulation did not 
differ between the 3 groups.  
 
The proportion with DTH 
responses differed among the 
three groups only in response to 
tuberculin (p=0.021). More PD 
subjects had a negative 
tuberculin response than did 
subjects with AD (p=0.024). 
acute and/or 
persistent diarrhea. 
 
The only marker 
that was 
significantly 
associated with 
progression to PD 
was a negative 
DTH response to 
tuberculin antigen 
(odds ratio=3.8, CI: 
1.4, 9.9). This was 
calculated from a 
logistic regression 
analysis that only 
included children 
with diarrhea.  
 
status was not 
reported. 
 
2005 
 
Bhatnagar S et al. 
 
Celiac disease with 
mild to moderate 
histological changes 
Delhi, India 
 
1-18 yr olds with a 
presentation 
consistent with CD 
(combination of 
chronic diarrhea, 
Case-series 
 
n=107 
Endoscopic duodenal 
biopsy: 
Histopathology 
70 had normal histology (defined 
as crypt:villous ratio 1:2-3, 
absence of lymphoid lamina 
propria infiltration, and minimal 
intraepithelial lymphocytes (IEL). 
 
37 had mild changes (defined as 
More than one 
quarter of children 
with chronic 
diarrhea had 
normal small 
intestinal mucosa; 
at follow-up their 
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is a common cause 
of chronic diarrhea 
in Indian children 
 
Duodenal biopsy 
among children with 
chronic diarrhea 
 
abdominal 
distension, and 
growth failure), 
recruited from a 
pediatric 
gastroenterology 
clinic.  
 
Subjects negative 
for CD-specific 
antibodies were of 
interest for this 
review. 
mild blunting of villi with 
crypt:villous ratio of 1:1*). A 
specific etiology was identified in 
only n=5: 
• 2 with giardiasis 
• 1 with lymphangiectasia 
• 2 with chronic pancreatitis 
 
Only children with CD had 
moderate or severe histologic 
changes. 
 
* Along with increased IEL and 
lymphocytic lamina propria 
infiltration. 
growth had 
improved and their 
diarrhea had 
resolved.  
 
No definitive 
diagnosis was 
reached for 86% of 
subjects with 
abnormal histology 
(albeit most had 
mild findings). 
2003 
 
Bustos M et al. 
 
Disaccharidase 
deficiency in Bolivian 
children with 
persistent diarrhea 
 
Jejunal biopsy and 
disaccharidase 
activities in children 
with PD and different 
forms of malnutrition 
Cochabamba, 
Bolivia 
 
3-34 mo old 
Amerindians 
hospitalized with PD 
and moderate or 
severe malnutrition 
in an urban setting. 
Cohort 
 
n=42 cases with 
PD and 
malnutrition: 
• 2 with 
kwashiorkor 
• 20 with 
marasmus 
• 20 with 
marasmic- 
kwashiorkor  
 
 
Children were 
assessed on 
admission and at 
three weeks, after 
diarrhea had 
resolved and 
anthropometrics 
were improving. 
Jejunal tethered capsule 
biopsy: 
• Histopathology 
• Disaccharidase activity:  
• Lactase 
• Sucrose-Isomaltase 
• Maltase 
 
 
Histology was scored on a 
scale of 1 (normal) to 4 
(severe morphological 
damage or flat mucosa). 
Most subjects had mild to 
moderate (score of 2-3) 
histological abnormalities, with 
one kwashiorkor patient having 
completely flat villi.  
 
Second biopsy showed a trend 
of improved mucosa, but 
difference was not significant 
based on histology score, 
intraepithelial lymphocyte 
density, or degree of infiltration 
of lamina propria. 
 
Percentages with enzymatic 
activity below normal at baseline, 
discharge:  
• Lactase: 64%, 59% 
• Sucrase-isomaltase: 97%, 90% 
• Maltase: 45%, 52% 
All changes were statistically 
significant.  
 
Lactase recovery was 
associated with admission HAZ 
(p=0.05) and WAZ (p=0.03) 
scores.  
 
Patients had 
diminished 
intestinal 
disaccharidase 
activity and 
substantial 
pathology on 
biopsy at admission 
and at three weeks, 
despite clinical 
improvements and 
tolerance of 
lactose-containing 
formula. 
Spanish language 
article. 
 
Values for 
subnormal 
disaccharidase 
activity were not 
provided. 
 
The magnitude of 
lactase inverse 
association with 
growth parameters 
was not reported. 
Authors did not 
report whether they 
had tested for 
associations 
between maltase 
or sucrose-
isomaltase and 
growth parameters. 
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Despite continued high 
disaccharidase deficiency 
prevalence at discharge, all 
children tolerated the lactose-
containing formula challenge. 
2003 
 
Campbell DI et al. 
 
Chronic T cell-
mediated 
enteropathy in rural 
west African 
children: relationship 
with nutritional 
status and small 
bowel function 
 
 
L:M as a marker of 
intestinal 
permeability, small 
bowl biopsy with 
assessment of 
intestinal immune 
markers, and 
computerized 
morphometric 
analysis among rural 
Gambian children 
with differing 
degrees of 
malnutrition and 
compared to well-
nourished UK 
children 
Fajara and Sibanar, 
The Gambia 
 
6 mo-3 yr old 
hospital- and clinic-
based cases from 
rural communities. 
 
Case groups based 
on differences in 
nutritional status:  
1. WAZ score >-2, 
with GI complaints 
other than diarrhea  
2. Grade I protein 
energy malnutrition 
(PEM) (WAZ score -
2 to -4) and 
unresponsive to 
nutritional 
supplementation, 
with or without 
diarrhea 
3. Grade II PEM 
(WAZ score <-4) 
with or without 
diarrhea  
 
Controls from UK* 
who were well 
nourished children 
with GI complaints 
other than diarrhea 
and with normal 
endoscopy results 
Case-control 
  
n=40 cases: 
• Group 1: n=4  
• Group 2: n=11 (7 
with diarrhea) 
• Group 3: n=25 
(18 with diarrhea) 
 
n=34 with case 
tissue samples 
sufficient for 
cytokine 
immunoreactivity 
tests:  
• Group 1: n=3 
• Group 2: n=8 
• Group 3: n=23 
Endoscopic 
small bowel biopsy, site 
not specified: 
• Histopathology 
• Morphometric 
assessment by 
computer analysis*  
• Intestinal tissue 
cytokines and immune 
markers:  
• CD-3  
• CD-4 
• CD-8 
• CD-19 
• CD-25 
• HLA-DR 
• Perforin 
• γδ T-cell receptor 
• Syndecan-1 
• TNF-α 
• IFN-γ 
• TGF-β 
• IL-10 
 
 
Urine Tests: 
• Lactulose1 
• Mannitol 
• L:M 
 
 
* Biopsy involved 
morphometric assessment 
by computer analysis of 
Crypt-hyperplasia and villous 
atrophy were observed among 
all Gambian subjects, and the 
degree of histopathology did not 
differ among cases with differing 
nutritional status, nor was there 
a correlation with diarrhea. 
 
IEL2 means were ~3-fold higher 
in Gambian than UK children. 
 
Median CD3, CD4, CD8, CD19, 
and CD25 cell counts were 
significantly higher (2-5x higher) 
among each case group 
compared to the UK controls.  
 
IEL, γδ, syndecan-1, HLA-DR, 
and perforin were detected 
among the Gambian children in 
varying degrees but were not 
reported for UK controls. 
Syndecan, CD3, and CD8 
displayed a gradient proportional 
to malnutrition severity. 
 
All Gambian groups showed 
higher lamina propria cytokine-
immunoreactive mononuclear 
cell density (~200-450/mm2) than 
UK controls (30-80/mm2). 
 
Among subjects with elevated 
cytokines, similar densities were 
seen for both pro-inflammatory 
All Gambian 
subjects had 
evidence of 
enteropathy with 
crypt-hyperplasia 
and villous atrophy, 
and mean IELs >2 
SD above UK 
norms, independent 
of nutritional status. 
 
Elevation of cell-
mediated intestinal 
markers and 
mucosal 
proinflammatory 
cytokines was 
present across the 
3 Gambian groups, 
variably correlated 
with nutritional 
status. 
 
L:M ratios were 
elevated in all 
Gambian groups, 
without apparent 
correlation to host 
nutritional status. 
Statistical 
methodology was 
not sufficiently 
detailed to 
determine what 
was compared 
(e.g. type of central 
tendency measure 
and variance 
calculations for L:M 
not stated)  
 
Duration of 
diarrhea not 
specified, but 
assumed to be 
persistent.  
 
Mucosal 
lymphocyte 
densities, cytokine 
immunoreactivity, 
and L:M results not 
stratified by history 
of diarrhea. 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 These figures are presumed to represent IEL means, however, this was not explicitly stated. 
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were also studied. 
 
 
* UK subjects are 
presented in this 
table due to 
comparisons of 
interest made in the 
review. However we 
do not include these 
subjects in the 
sample size for this 
review. 
villous height, crypt depth, 
villous:crypt ratio, and 
intraepithelial lymphocyte 
(IEL) density (per 100 
epithelial cells). 
(IFN-γ and TNF-α) and putative 
regulatory (IL-10 and TGF-β) 
cytokines. Epithelial expression 
of TGF-β was also enhanced 
compared to UK controls, but 
subjects with poorer nutritional 
status had lower densities of 
mucosal TGF-β+ cells, with 
median densities of 420 and 250 
cells/mm2 in the grade I and 
grade II PEM groups, 
respectively. 
 
L:M values1:  
• Group 1: 0.53 (0.4-1.3)  
• Group 2: 0.47 (0.02-2.20) 
• Group 3: 0.73 (0.14-2.2) 
• Not assessed among the UK 
controls 
 
Nutritional status was not 
associated with L:M, recoveries 
of lactulose or mannitol.  
 
L:M was correlated with mucosal 
B lymphocyte density (r=0.57, 
p<0.05), IEL (r=0.51, p<0.02), 
and perforin+ IEL (r=-0.64, 
p<0.03). 
2006 
 
El Mouzan MI et al. 
 
Endoscopic 
duodenal biopsy in 
children 
 
Duodenal biopsy 
among children with 
suspected intestinal 
disease 
Riyadh, Saudi 
Arabia 
 
1.5 mo-18 yr olds 
referred to hospital 
for endoscopy with 
duodenal biopsy. 
 
78% of subjects 
were <12 yr old; 
results not 
presented by age. 
Retrospective 
case-series 
 
n=241 cases: 
• 102 with PD 
• 116 with 
unexplained 
short stature  
• 11 with refractory 
rickets 
• 12 with other 
conditions 
Endoscopic duodenal 
biopsy: 
• Gross endoscopic 
visualization 
• Histopathology 
14% had abnormalities on 
endoscopic visualization: 
• 1% had esophagitis 
• 6% had gastritis, 7 (47%) of 
which were H. pylori positive 
• 7% had duodenitis 
 
Biopsy results: 
• PD:  
• 26% normal 
• 29% chronic non-specific 
duodenitis 
Villous atrophy was 
identified not only 
among 40% of 
children with PD, 
but also among 
22%, 9%, and 17% 
of those with short 
stature, rickets, and 
other conditions, 
respectively. 
 
Authors argue that 
Specific results for 
the 2 patients with 
protein losing 
enteropathy were 
not reported. 
 
For 27% of cases, 
the only 
histopathology 
finding was chronic 
non-specific 
duodenitis; the 
                                                          
1 Not clearly indicated if these figures represent mean (CI) or another measure of central tendency. 
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(including 2 with 
protein losing 
enteropathy) 
• 40% villous atrophy 
• 5% other* 
 
• Short stature: 
• 56% normal 
• 22% chronic non-specific 
duodenitis 
• 22% villous atrophy 
 
• Rickets: 
• 55% normal 
• 36% chronic non-specific 
duodenitis 
• 9% villous atrophy 
 
• Other: 
• 25% normal 
• 50% chronic non-specific 
duodenitis 
• 17% villous atrophy 
• 8% other* 
 
* 3 lymphangiectasia, 2 Giardia, 
1 Mycobacterium avium 
intracellulare. Findings were 
reported according to presenting 
symptoms. 
endoscopic biopsy 
is superior to “blind” 
capsule biopsy in 
developing country 
settings and allows 
for visualization of 
the intestine.  
 
Endoscopic 
visualization results 
were not reported 
by condition nor in 
relation to 
histopathology 
results; it is difficult 
to assess the value 
added compared to 
biopsy alone. 
diagnostic, 
prognostic, and 
therapeutic utility of 
identification is 
unclear. 
2000 
 
Fagundes-Neto U et 
al. 
 
Studies of the small 
bowel surface by 
scanning electron 
microscopy in 
infants with 
persistent diarrhea 
 
Scanning electron 
microscope (SEM) 
and light microscope 
(LM) analyses of 
Sao Paulo, Brazil 
 
2-10 mo olds with 
PD and protein 
calorie malnutrition 
consecutively 
admitted to Sao 
Paulo Hospital. 
Case-series  
 
n=16 
 
Jejunal secretions 
aspirate: 
Bacterial concentrations 
 
 
Jejunal tethered capsule 
biopsy: 
Histopathology by LM 
and SEM 
 
 
Rectal tethered capsule 
biopsy: 
Histopathology 
68.7% had bacterial overgrowth 
(concentration >104 
colonies/mL): 3 had 
enteropathogenic E. coli while 
the rest had colonic microflora. 
 
All small intestine specimens 
had morphological abnormalities 
on LM: 
• 43.7% moderate villous 
atrophy 
• 56.3% subtotal villous atrophy  
 
SEM revealed abnormalities of 
varying intensity:  
• Among the 11 with SBBO, 
Histological 
abnormalities were 
noted in all subjects 
by LM and SEM.  
 
Degree of villous 
atrophy noted on 
SEM seemed to be 
correlated with 
SBBO (no 
statistical tests 
were reported).  
 
Authors speculate 
that the mucous-
fibrinoid pseudo-
Inconsistent 
reporting of 
proportions of 
histopathologic 
findings among all 
subjects and by 
SBBO status; 
assessment of 
potential 
relationship with 
SBBO between 
different histologic 
findings was not 
possible. 
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small intestinal 
biopsy among 
infants with PD with 
and without SBBO 
villous atrophy ranged from 
Grade II (n=4), Grade III (n=2), 
to Grade IV (n=3).  
• For the 5 subjects without 
SBBO, villous atrophy ranged 
from Grade I (n=1) to Grade 2 
(n=4).  
• A mucous-fibrinoid pseudo-
membrane over enterocytes 
was noted in 7 of the 11 with 
SBBO and none of the others.  
 
Other abnormalities noted on 
SEM included:  
• Mucus and debris covered 
large areas of the villous 
surface 
• Derangement of the 
enterocytes (in some cases cell 
borders were not clearly 
defined)  
• Reduced height and number 
(or absence in some places) of 
microvilli  
• Lymphocytes and fat droplets 
were observed over the 
surface of enterocytes (18%)1 
 
10 subjects had colitis on rectal 
biopsy; this was not associated 
with SBBO or degree of small 
intestinal pathology on SEM. 
membrane partially 
covering 
enterocytes is 
consistent with a 
malabsorptive 
process, with the 
findings of fat 
droplets on 
enterocytes 
surfaces, and with 
the state of 
malnutrition of the 
subjects. 
2001  
 
Gandolfi L et al. 
 
Antiendomysial 
antibody test 
reliability in children 
with frequent 
Brasilia, Brazil 
 
6 mo-13 yr olds with 
acute, persistent or 
chronic diarrhea, 
and/or malnutrition 
being seen at the 
pediatric 
Cross-sectional 
 
n=31 
Jejunal capsule biopsy: 
Histopathology 
30/31 (96.8%) had abnormal 
histopathology: 
• Suggesting non-specific 
inflammatory abnormalities in 
27 (87.1%) subjects. 
• Demonstrating grade 3 
mucosal abnormalities in all 
malnourished 1 yr olds 
The vast majority of 
children with 
clinically severe 
diarrhea and/or 
malnutrition had 
some degree of 
abnormality on 
jejunal biopsy. 
Biopsies of interest 
were not provided 
in subject-specific 
detail (e.g. 
characteristics of 
the 27 children with 
non-specific 
inflammation were 
                                                          
1 These SEM results were not presented separately for those with and without SBBO. 
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diarrhea and 
malnutrition: is it 
celiac disease 
 
Jejunal biopsy 
among children with 
PD and/or 
malnutrition 
gastroenterology 
service of a 
university hospital 
and determined to 
have disease 
severity warranting 
biopsy. 
 
Subjects negative 
for CD-specific 
antibodies were of 
interest for this 
review. 
negative for enteric parasites. not detailed (e.g. 
presence of 
parasites, degree 
of malnutrition 
and/or diarrhea). 
2000 
 
Hafeez A et al. 
 
An audit of pediatric 
upper 
gastrointestinal 
endoscopies 
 
Duodenal biopsy 
among children with 
PD or growth 
problems 
Islamabad, Pakistan 
 
2 mo-12 yr olds 
referred from 
various hospitals to 
KRL Hospital 
Islamabad for 
abdominal pain, PD, 
short stature, FTT, 
GI bleeding, or 
anemia. The 
subjects of interest 
for this review were 
those with PD or 
growth problems. 
Case-series 
 
n=41; 
• 28 with PD 
• 9 with FTT 
• 4 with short 
stature 
 
Endoscopic duodenal 
Biopsy: 
• Gross endoscopic 
visualization 
• Histopathology 
 
Positive histopathologic findings 
were identified in:  
• 21/28 with PD  
• 7/9 with FTT 
• 3/4 with short stature 
 
More abnormalities were found 
via histology than visualization, 
and findings did not necessarily 
correlate. 
75% of the PD and 
77% and the short 
stature/FTT 
patients had 
abnormalities by 
endoscopy. 
 
Authors assert the 
importance of 
biopsies among 
children with 
indications for 
endoscopy, due to 
lack of correlation 
between them and 
increased 
identification of 
abnormalities by 
biopsy. 
There was possible 
bias in the manner 
of selection for 
endoscopy. 14 
biopsies were 
unable to be 
analyzed (from 100 
endoscopies). 
 
Authors did not 
report the 
endoscopic 
appearance of the 
mucosa.  
 
Histology findings 
were reported by 
specimen (with 
multiple specimens 
from some 
patients), not by 
condition or by 
patient, so specific 
results could not be 
interpreted in 
regards to this 
review. 
2007 
 
Jain S et al. 
Delhi, India 
 
Children (ages 
Case-control 
 
n=80; 
Stool Test: 
Occult blood  
 
Fecal occult blood test was 
positive in 30/50 (60%) cases 
and 0/30 controls.  
A high proportion of 
severely 
malnourished 
Among cases, half 
had a presenting 
complaint of 
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Fecal occult blood 
screening in children 
with severe 
malnutrition 
 
Fecal occult blood 
among severely 
malnourished 
children compared 
to healthy controls 
unspecified) 
admitted with 
severe malnutrition 
and age-matched 
healthy controls 
recruited from an 
immunization clinic. 
 
n=50 cases with 
severe malnutrition 
 
n=30 healthy 
controls 
 
Blood Test: 
Hemoglobin 
 
Among cases positive for fecal 
occult blood, 20 (66.7%) were 
found to have hemoglobin <8 
g/dL.  
 
Enteric infections: 
• Parasitic infections were 
detected in 14/50 (28%) of 
cases, 12 (85.7%) of whom 
tested positive for fecal occult 
blood.  
• Bacterial infections were 
detected in 18/50 (36%) of 
cases, 13 (72.2%) of whom 
tested positive for fecal occult 
blood. 
• Of the remaining 18 for whom 
an enteric pathogen was not 
identified, 5 (27.8%) tested 
positive for fecal blood. 
 
Among the 30 cases with fecal 
occult blood, 16 were breastfed, 
11 were fed cow’s milk, and 3 
were fed formula. 
children had a 
positive fecal occult 
blood test, 
compared with no 
positives among 
healthy controls.  
 
Malnourished 
children with 
identifiable 
pathogens more 
often tested 
positive for fecal 
occult blood, 
although 
approximately 25% 
of those without an 
identifiable 
pathogen also 
tested positive.  
 
Presence of fecal 
blood did not 
appear to vary by 
feeding mode (e.g. 
breast milk, cow’s 
milk, or formula), 
although data 
presented were 
limited. 
diarrhea (duration 
not specified), but 
the authors did not 
report results 
stratified by 
diarrhea duration.  
 
Authors did not 
provide differences 
in proportions of 
occult blood among 
those with and 
without specific 
enteric pathogens. 
 
Statistical analysis 
was not provided; 
data were reported 
as proportions 
only.  
 
Matching scheme 
was not defined. 
2002  
 
Kapoor, S et al. 
 
Detecting protein 
losing enteropathy 
by Tc-99m dextran 
scintigraphy: A novel 
experience 
 
Tc-99m dextran 
scintigraphy as a 
marker of protein-
New Delhi, India 
 
2-12 yr olds 
selected from 
hospitalized patients 
with symptoms 
suspicious for 
protein-losing 
enteropathy 
(hypoalbuminemia 
and edema). 
Case-series 
 
n=3 <5 yr old 
Tc-99m dextran 
scintigraphy 
Abnormal Tc-99m dextran 
uptake was positive in one child 
found to have subtotal villous 
atrophy on biopsy and another 
thought to have abdominal 
tuberculosis. 
  
The child with the negative scan 
had marasmus and partial villous 
atrophy on biopsy. 
 
Scintigraphy might 
be a useful, 
noninvasive 
method for 
detecting intestinal 
pathology. 
This pilot study had 
a small sample 
size of 8 children, 
and only 3 were 
younger than 5 
years. 
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losing enteropathy 
or intestinal 
inflammation 
2004 
 
Laadhar A et al. 
 
Determination of 
anti-
transglutaminase 
antibodies in the 
diagnosis of celiac 
disease in children: 
results of a five year 
prospective study 
 
Duodenal biopsy 
among patients with 
suspected CD 
Sfax, Tunisia 
 
Children admitted 
for endoscopic 
biopsy for 
symptoms of CD 
(not specified).  
 
Subjects of interest 
for this review were 
those who tested 
negative for CD-
specific serology 
and who did not 
meet the study 
diagnostic criteria 
for CD--subtotal or 
total villous atrophy 
consistent with 
Marsh stages 3 or 4. 
 
Controls were aged 
3 mo-17 yr (mean 
4.5 yr). 
Case-control 
 
n=99 
Endoscopic duodenal 
biopsy: 
Histopathology 
 
Of 99 subjects not meeting 
diagnostic criteria for CD, 
endoscopic biopsies revealed: 
• 76 had normal morphology of 
the intestinal mucosa 
• 7 had elevated densities of 
intraepithelial lymphocytes  
• 10 had partial villous atrophy 
(Marsh stage 2)  
• 6 had various other conditions 
such as giardiasis or gastritis 
Among 169 
children with 
symptoms of CD, 
41% had subtotal 
or total villous 
atrophy, 10% had 
partial villous 
atrophy or 
inflammatory 
findings, and 45% 
had normal 
biopsies. 
Article in French. 
 
Prevalence of CD 
antibodies did not 
clearly align with 
case/control 
designation. 
Because of the 
way the results 
were reported, we 
could not extract 
data on those who 
tested negative for 
CD-specific 
serology and who 
had Marsh stages 
3 or 4 
histopathology. 
 
Methods section 
described obtaining 
duodenal biopsies, 
while results and 
conclusion sections 
specify that jejunal 
specimens were 
obtained. 
2006 
 
Leite CA et al. 
 
Functional, 
microbiological and 
morphological 
intestinal findings 
among human 
immunodeficiency 
virus infected 
children 
 
Sao Paulo, Brazil 
 
5 mo-12 yr old 
(median 24 mo) 
HIV-infected 
subjects recruited 
from a hospital and 
clinic. 
 
All subjects had 
some degree of 
protein-energy 
malnutrition. 
Cohort 
 
n=11; 
 
n=5 patients with 
current or recent 
episode of diarrhea  
 
n=6 patients with 
no diarrhea in the 
30 days preceding 
enrollment 
 
Blood Test: 
D-xylose 
(9 tested) 
 
 
Biopsy of small intestine 
by tethered capsule or 
endoscopy: 
Histopathology 
(10 tested)  
 
 
Rectal biopsy: 
100% had low D-xylose 
absorption: 
• Mean: 15.6 mg/dL 
• SD: 5 
• Range: 8.9-24.4 
• Median: 14.2  
 
Small intestinal biopsy:  
• 100% had some degree of 
villous atrophy based on a I-IV 
grading system: 
• Grade I: 3 
• Grade I/II: 2  
There was a high 
prevalence (100%) 
of abnormal D-
xylose results 
among HIV-infected 
children, regardless 
of diarrhea status.  
 
All patients also 
had cellular 
infiltration of the 
lamina propria and 
varying degrees of 
Portuguese 
language article.  
 
D-xylose <25 
mg/dL was defined 
as indicative of 
malabsorption. 
This value is higher 
than what some 
references have 
noted as a cut-
point [186].  
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Small intestinal and 
rectal biopsy to 
assess morphology 
and D-xylose as a 
marker of 
malabsorption 
among HIV-infected 
children 
Histopathology 
(6 tested) 
• Grade II: 1 
• Grade II/III: 1 
• Grade III/IV: 1 
• 2 samples were too 
superficial to assess 
• Intraepithelial lymphocytes 
were increased in half of the 
biopsies. 
• Lymphocytic and 
polymorphonuclear (PMN) 
infiltration of the lamina 
propria were present in 10/10 
and 7/10 biopsies, 
respectively. 
 
Rectal biopsy: 
• 100% had normal architecture 
• Lymphocytic and PMN 
infiltration were present in 6/6 
and 4/6, respectively. 
villous atrophy. 
 
There was no 
correlation between 
D-xylose and 
degree of villous 
atrophy on biopsy. 
Investigators used 
a well-articulated 
system of grading 
villous atrophy.  
 
Results were not 
presented by 
diarrhea status, 
perhaps due to 
small sample size. 
2005 
 
Lima AA et al. 
 
Intestinal barrier 
function and weight 
gain in malnourished 
children taking 
glutamine-
supplemented 
enteral formula 
 
L:M as a marker of 
intestinal 
permeability and 
various stool tests 
among children with 
malnutrition or PD 
who received either 
glycine or glutamine 
Fortaleza, Brazil 
 
2-60 mo olds 
hospitalized with 
WAZ score <-2, 
~70% of whom had 
PD. 
RCT 
 
n=80;         
 
n=53 received 
supplemented 
formula 
• 27 with glycine 
• 26 with glutamine 
 
n=27 received 
nonsupplemented 
formula 
Urine Tests*: 
• Lactulose1 
• Mannitol 
• L:M  
 
 
Stool Tests**: 
• Lactoferrin  
• Leukocytes  
• Occult blood 
• Reducing substances 
(RS) 
 
 
* n=80 tested at 
enrollment, n=65 tested at 
day 10. 
 
** n=60 tested. 
Mean2 L:M (SE):  
• Glutamine group: 
• Baseline: 0.31 (0.10) 
(similar in all three groups) 
• Day 10: 0.10 (0.02); 
significant decrease, 
(p=0.01) 
• No significant decrease in L:M 
in glycine and 
nonsupplemented formula 
groups at day 10 
 
Mean lactulose (SE):  
• Glutamine group: 
• Baseline: 0.97 (0.46) 
(similar in all three groups) 
• Day 10: NS decrease in all 
3 groups 
 
L:M significantly 
improved in the 
glutamine group 
only. 
 
>50% of subjects 
had intestinal 
inflammation by 
stool lactoferrin. 
Fecal leukocytes, 
RS, and occult 
blood were 
detected in fewer 
subjects than 
lactoferrin. 
The relationship 
between stool 
markers and L:M 
was not reported.  
 
Data were not 
stratified by history 
of PD. 
 
Fecal fat was 
assessed, but 
results were not 
reported. 
 
Cut-off values for 
lactoferrin positivity 
were not 
described.  
 
Exclusively 
                                                          
1 Lactulose and mannitol results were expressed as % of dose administered. 
2 Type of mean not specified. 
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supplemented 
formula or placebo 
Mean mannitol (SE):  
• Glutamine group: 
• Baseline: 3.42 (0.64) 
(similar in all three groups) 
• Day 10: NS decrease in all 
3 groups 
 
Proportion of stool markers at 
baseline among all subjects:  
• Lactoferrin: 53.3% 
• Leukocytes: 11.7% 
• RS: 3.3% 
•  Occult blood: 5.0% 
breastfed children 
were excluded 
from study 
participation due to 
assessment of 
stool lactoferrin. 
2001 
 
Mishra OP et al. 
 
Endoscopic and 
histopathological 
evaluation of 
preschool children 
with chronic diarrhea 
 
Duodenal biopsy 
among patients with 
chronic diarrhea 
 
 
Varanasi, India 
 
1-5 yr olds with PD 
selected randomly 
from an outpatient 
population in a 
urban setting. 
 
A high proportion of 
the children had 
varying degrees of 
protein energy 
malnutrition. 
 
 
Case-series  
 
n=30 with 
endoscopy 
performed 
Endoscopic duodenal 
biopsy: 
• Gross endoscopic 
visualization 
• Histopathology 
 
 
7 (23.3%) had grossly abnormal 
endoscopic findings: 
• 5 (16.7%) with chronic 
duodenitis  
• 1 with duodenitis with multiple 
erosions  
• 1 with duodenitis with 
hemorrhagic gastritis  
 
22 (73.3%) had abnormal 
histopathology: 
1. 17 (56.7%) with villous atrophy 
with mononuclear cell 
infiltration  
• 1 (3.3%) with villous atrophy 
and eosinophilic infiltration  
• 2 (6.7%) with villous atrophy 
and mononuclear and 
eosinophilic infiltration 
• 2 (6.7%) with only 
mononuclear cell infiltration 
 
Mean duration of diarrhea (SD) 
was not associated with gross 
endoscopic findings but did vary 
by histopathology: 
• Normal histopathology: 9.0 wk 
(6.0), n=8 
• Mononuclear cell infiltration: 
9.0 wk (6.0), n=2 
Grossly abnormal 
endoscopic 
appearance was 
found in one-
quarter of children 
with chronic 
diarrhea assessed 
by endoscopy. 
Three-quarters had 
abnormal histology. 
More than half had 
villous atrophy with 
mononuclear cell 
infiltration; these 
patients had >1 
month longer 
duration of diarrhea 
than those with 
either normal 
histology or 
mononuclear cell 
infiltration without 
villous atrophy.  
 
Age, 
enteropathogen 
recovery, and 
degree of 
malnutrition were 
not associated with 
Authors do not 
report assessing 
relationship 
between gross 
endoscopic 
findings and 
histopathology. 
 
Number of patients 
with villous atrophy 
and both 
mononuclear and 
eosinophilic 
infiltration was very 
small (n=2), yet 
authors report a 
significant 
difference in their 
duration of diarrhea 
relative to those 
with normal 
histopathology. 
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• Villous atrophy with 
mononuclear cell infiltration: 
14.9 wk (5.3), n=17, p<0.02 
compared to normal 
histopathology 
• Villous atrophy with 
mononuclear and eosinophilic 
infiltration: 21.5 wk (2.1), n=2, 
p<0.02 compared to normal 
histopathology 
• Villous atrophy with 
eosinophilic infiltration: 6.0 wk, 
n=1 
 
No consistent pattern was 
observed between gross 
endoscopic findings or 
histopathological lesions and 
age, WFA, or type of 
enteropathogen recovered in 
stools.  
gross endoscopic 
or histopathological 
findings.  
2001 
 
Mittal SK et al. 
 
Tropical sprue in 
north Indian children 
 
D-xylose and 
duodenal biopsy as 
markers of TS  
 
 
New Delhi, 
India 
 
0-15 yr old 
gastroenterology 
clinic patients with 
PD.  
 
Those with 
abnormal 
morphology on 
biopsy, abnormal D-
xylose test, and 
clinical response to 
antibiotics were 
diagnosed as 
having TS.  
 
Those with 
abnormal 
morphology and 
response to gluten-
Case-series 
 
n=94; 
(38 with repeat 
biopsies) 
 
<5 yr old: n=44  
 
 
 
 
Duodenal biopsy, method 
not specified: 
Histopathology 
 
 
Blood Tests: 
• Hemoglobin 
• D-xylose*  
 
 
* Not specified whether 
from urine or serum, and 
units of measurement not 
provided. 
36 (38.3%) were diagnosed with 
TS including 14/44 (31.8%) who 
were under 5 years of age.  
 
18 (19.1%) were diagnosed with 
CD.  
 
Degree of villous atrophy among 
TS vs. CD patients:  
• Mild in 8/36 (22.2%) vs. 0 
• Moderate in 23/36 (63.9%) vs. 
4/18 (22.2%) 
• Severe in 5/36 (13.9%) vs. 
14/18 (77.8%)  
 
Mean hemoglobin concentration 
(range) among TS patients was 
8.3 g/dL (5.5-11) and did not 
differ from values of those with 
CD.  
 
Among the 22 TS patients, 
More than half of 
the GI clinic 
patients with PD 
had some degree 
of villous atrophy.  
 
More than one-third 
and almost one-fifth 
of subjects were 
diagnosed with TS 
and CD, 
respectively.  
 
By study diagnostic 
definition, all TS 
patients improved 
with treatment.  
Among those who 
had repeat 
biopsies, almost 
three-quarters 
showed 
Biopsy results were 
not provided for 
patients without TS 
or CD.  
 
It was unclear if 
there were patients 
with abnormal D-
xylose and 
histology who did 
not respond to 
antibiotic therapy 
and therefore were 
not diagnosed with 
TS. 
 
Cut-off points used 
to define abnormal 
D-xylose tests 
were not provided. 
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Study Outcomes of  
Diagnostic Interest 
Location and  
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Design and 
Sample Size Biomarker Results Conclusion Comments 
free diet were 
diagnosed with CD. 
We include data on 
these subjects for 
comparative 
reasons. 
repeat biopsies showed: 
• 16 with normalization 
• 5 with improvement  
• 1 worsened despite marked 
clinical improvement  
 
The D-xylose test was abnormal 
in all TS patients by diagnostic 
definition. 
normalization of 
histology, while 
23% had partial 
improvement and 1 
patient had 
worsened 
pathology.  
 
2000 
 
Nichols B et al. 
 
Contribution of 
villous atrophy to 
reduced intestinal 
maltase in infants 
with malnutrition 
 
Jejunal biopsy, 
maltase activity, and 
enzyme messenger 
RNAs among 
malnourished and 
well-nourished 
children. Assessed 
association between 
maltase and villous 
atrophy and other 
mucosal intestinal 
markers indicative of 
loss of enterocytes 
and enterocytic 
function.  
 
Sao Paulo, Brazil 
 
Cases were children 
(mean age 9.9 mo, 
SD 8.1) hospitalized 
with malnutrition 
refractory to dietary 
rehabilitation.  
 
Controls were 
children (mean age 
3.6 mo, SD 1.0) with 
HAZ and WAZ 
scores >-2 and 
normal intestinal 
mucosa on biopsy, 
hospitalized for 
Kasai procedure for 
biliary atresia.  
 
 
Case-control 
 
n=33; 
 
n=24 cases  
 
n=9 controls  
 
 
Subjects were 
matched on height 
and weight; ages 
differed within 
matched sets. 
 
  
Jejunal capsule biopsy: 
• Histopathology* 
• Maltase activity  
• Intestinal messenger 
RNA (mRNA) 
abundances: 
• Maltase-
glucoamylase (MGA) 
• Sucrase-isomaltase 
(SI) 
• Villin, a structural 
protein expressed 
only in enterocytes 
• Sodium-activated 
luminal glucose-
galactose 
transporter 1 
(SGLT), a functional 
protein expressed 
only in enterocytes 
• β-actin 
 
 
* Mucosal atrophy was 
scored on a scale of 1 
(absence of atrophy 
compared to an organ 
donor) to 4 (similar to 
children with active CD). 
 
Histology among controls 
was on surgically resected 
tissue.  
 
Mean villous atrophy score (SD): 
• Cases: 2.6 (0.8) 
• Controls: 1.2 (0.5), p=0.006) 
 
WAZ score was correlated with 
villous atrophy (r=0.65, p- value 
not reported).  
 
13/25 [sic] cases and 0/5 
controls had subnormal (defined 
as <94 U/g protein) of maltase 
activity; mean maltase was 34% 
lower among cases (p=0.11). 
Maltase activity did not appear to 
decrease with WAZ score 
(further details not provided). 
 
However, in sub-analyses 
among those samples with an 
adequate β-actin, a 
housekeeping gene message, 
(n=10 cases, n=9 controls), 
cases’ findings expressed as a 
mean percent of controls' (SD) 
included: 
• Villous length (reciprocal of 
atrophy score): 38.9 (41.6), 
p=0.004 
• Maltase activity: 37.1 (23.2), 
p=0.001 
• MGA mRNA: 45.1 (36.4), 
p=0.016 
• Villin mRNA: 52.5 (22.6), 
p=0.003 
The malnourished 
children had 
significantly greater 
villous atrophy than 
the younger 
controls. 
 
Among the subset 
tested for mRNA 
messages, maltase 
activity as well as 
the mRNA 
abundances for 
MGA, villin and 
SGLT were 
significantly 
correlated with 
case status and 
were correlated 
with villous atrophy. 
 
While maltase 
deficiency has been 
reported in 
malnutrition in other 
studies, authors 
assert that these 
are the first results 
that directly support 
the hypothesis that 
reductions in 
maltase activity are 
due to villous 
atrophy. This study 
Tissue from 
patients requiring 
intestinal resection 
as part of their 
biliary atresia 
management 
provides an 
opportunity to 
assess presumably 
“normal” intestinal 
architecture.  
However, unless 
they mocked up ex 
vivo mucosal 
biopsies in these 
controls, resections 
will have lower 
proportions of 
villous to 
submucosa tissue 
compared to cases’ 
samples derived 
from mucosal 
biopsies. While this 
probably doesn’t 
affect histology, it 
might affect 
enterocyte 
functional assays 
and mRNA 
determination, as 
transmural tissue 
will bring in more 
diverse populations 
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• SGLT mRNA: 66.6 (23.1), 
p=0.057 
• β-actin: 88.2 (15.8), p=0.189 
 
Both villous length and maltase 
activity in a subset of cases were 
less than 40% of control values.  
 
MGA, villin, and SGLT mRNA 
abundances were correlated with 
villous atrophy score (r=0.73), 
(r=0.76), and (r=0.54), 
respectively (p-values not 
reported)1.  
 
MGA mRNA abundance was 
correlated with maltase activity 
(r=0.32). 
 
 
 
also nicely 
correlates mRNA 
relative abundance 
with function.  
 
 
of cells; only some 
of them might have 
transcripts of 
interest. However, 
the bias is likely in 
a direction that 
would reduce effect 
size. 
 
It was unclear if 
control inclusion 
criteria included 
absence of atrophy 
or if all potential 
controls lacked 
atrophy.  
 
Statistical methods 
might not have 
adequately taken 
into account the 
small sample size 
and matching 
scheme.  
 
Subsets of subjects 
were investigated 
for various tests. 
For example, 10 
cases had mRNA 
analyses based on 
β-actin adequacy. 
Another instance of 
selected testing 
was the subset of 
22 and 15 cases 
that had WAZ 
score to histology 
and mRNA 
correlation 
analyses, 
                                                          
1 Villin and SGLT1 were assessed as a ratio with housekeeper gene β-actin. 
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respectively. 
Rationale for 
subset selection 
was not thoroughly 
described. 
2003 
 
Pires AL et al. 
 
Digital morphometric 
and stereologic 
analysis of small 
intestinal mucosa in 
well-nourished and 
malnourished 
children with 
persistent diarrhea 
 
Computerized 
morphometric and 
stereologic 
assessments in 
proximal small 
intestine biopsy in 
subjects with PD 
Porto Alegre, Brazil 
 
6 mo-5 yr old 
inpatients from an 
urban setting who 
underwent biopsy 
as part of a work-up 
for PD. 
 
There was a high 
proportion of 
children with 
malnutrition in this 
study population. 
Cross-sectional, 
retrospective 
 
n=65 
Small intestinal biopsies, 
site and method not 
specified*:  
• Mucosal morphometric 
assessment by computer 
analysis (62 tested):  
• Villous height 
• Crypt depth  
• Villous:crypt ratio 
• Mucosal thickness 
• Digital assessment (500x 
magnification) (65 
tested): 
• Enterocyte height  
• Enterocyte nucleus 
height 
• Brush border 
height  
• Stereological analysis 
to assess mucosal 
surface area (62 tested) 
 
 
* From stored specimens 
previously assessed by 
micrometer. 
Computerized mucosal 
measures were similar to those 
by micrometer and were not 
associated with nutritional status. 
 
Digitally assessed enterocyte 
height, enterocyte brush border, 
and enterocyte nucleus height 
correlations:  
• WAZ score: r=0.25 (p=0.038), 
r=0.26 (p=0.03), and r=0.24, 
(p=0.05), respectively  
• WHZ score: r=0.29 (p=0.02), 
r=0.27 (p=0.03), and r=0.16 
(p=0.19), respectively 
• HAZ score: r=0.16 (0.18), 
r=0.23 (p=0.06), r=0.23 (0.06)  
 
There was no correlation 
between mucosal surface area 
and growth parameters.  
Enterocyte 
measures show 
some correlation 
with WAZ and WHZ 
scores, but not with 
HAZ score. 
However, surface 
area and 
villous:crypt ratios 
were not correlated 
with any growth 
parameter. 
 
 
 
2008 
 
Poddar U et al.  
 
Is tissue 
transglutaminase 
autoantibody the 
best for diagnosing 
celiac disease in 
children of 
developing countries 
 
Chandigarh, India 
 
<14 yr (mean age 
6.9 yr) presenting 
with symptoms 
consistent with CD 
(PD, FTT, and/or 
pallor) 
 
Subjects negative 
for CD were of 
interest for this 
Case-control 
 
n=28 controls; 
• 22 with giardiasis  
• 1 with TS 
• 5 with SBBO 
Endoscopic duodenal 
biopsy: 
Histopathology 
Duodenal biopsy of those with 
giardiasis showed nonspecific 
chronic inflammation of lamina 
propria; there was no evidence 
of villous atrophy. 
Duodenal biopsy 
demonstrated 
histological 
changes 
accompanying 
Giardia infection. 
Authors did not 
report the biopsy 
findings in the TS 
or SBBO patients. 
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Duodenal biopsies in 
controls with 
giardiasis, TS, and 
SBBO 
review. 
2002 
 
Poddar U et al. 
 
Celiac disease in 
India: Are they true 
cases of celiac 
disease 
 
Duodenal biopsy, D-
xylose, and fecal fat 
in children with 
symptoms of CD but 
normal mucosal 
biopsy results  
Chandigarh, India 
 
18 mo-14 yr olds 
with PD, FTT, or 
pallor from a 
hospital pediatric 
gastroenterology 
unit.  
Subjects with 
normal crypt:villous 
ratio on biopsy were 
of interest for this 
review. 
Case-control 
 
n=47     
Endoscopic duodenal 
biopsy: 
Histopathology  
 
 
Stool Tests: 
• Fecal fat* 
• D-xylose** 
 
 
 
* In 72-hour stool 
collection. 
 
** Not specified whether 
from urine or serum, and 
units of measurement not 
provided. 
 
 
38% had chronic inflammatory 
cell infiltrates in the lamina 
propria.  
 
55% had abnormal D-xylose 
concentrations. 
 
20% had abnormal fecal fat test. 
 
No results beyond proportion 
positive were reported for any of 
the above markers. 
 
Among controls 
with normal 
mucosal 
architecture by 
biopsy, more than 
one-third had PD. 
 
D-xylose and fecal 
fat might not 
correlate well with 
duodenal biopsy 
results. 
Relationships 
between fecal fat, 
D-xylose and 
biopsy results were 
not reported. 
 
While 38% of 
controls had PD, 
results for the 
markers studied 
were not stratified 
by PD for this 
group.  
 
Seven children with 
biopsies consistent 
with CD did not 
respond to gluten-
free diet and were 
excluded from the 
study.  
 
Cut-off points used 
to define abnormal 
D-xylose tests 
were not provided. 
 
2008 
 
Sherwani K et al. 
 
Prevalence of iron 
deficiency anemia in 
chronic diarrhoea 
and celiac disease - 
A western UP 
experience 
 
Duodenal biopsy in 
Aligarh, India  
 
1-12 yr olds (mean 
age 51.2 mo) from 
an urban setting 
with PD recruited 
from pediatric 
outpatient and 
inpatient units.  
 
Those with negative 
CD work-up were 
Cross-sectional 
 
n=19 
 
Duodenal biopsy, method 
not specified: 
Histopathology 
Six patients had partial villous 
atrophy and non-specific 
duodenitis by biopsy. 
Biopsy identified 
abnormal 
histopathology in 
approximately 1/3 
of patients who did 
not have CD, but 
did not identify PD 
etiology in the 
remainder who did 
not have CD. 
The 6 children with 
partial villous 
atrophy were 
thought to have 
SBBO as they 
recovered after 
treatment with 
broad spectrum 
antibiotics. 
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patients with PD  subjects of interest 
for this review. 
2003 
 
Tassara O et al. 
 
Gastrointestinal 
diseases in children 
infected with the 
human 
immunodeficiency 
virus 
 
Endoscopy and 
biopsy among HIV-
infected children 
Santiago, Chile 
 
0-12 yr old (median 
9 mo) HIV-infected 
children treated in 
hospital. A high 
proportion had PD. 
Cross-sectional 
 
n=11 
 
 
Endoscopic 
upper GI biopsy including 
esophagus, stomach, 
and/or duodenum: 
• Gross endoscopic 
visualization 
• Histopathology 
 
  
Macroscopic inflammatory 
changes were observed on 
endoscopy in the esophagus, 
stomach or duodenum in 2 
subjects.  
 
Biopsies of esophagus, stomach 
or duodenum showed 
inflammatory changes of varying 
degree in all 11 subjects. 
Biopsy results 
might show 
inflammatory 
damage in cases 
with no 
macroscopic 
damage visible. 
Spanish language 
article. 
 
Inflammatory 
changes identified 
in the digestive 
system were not 
specified by site 
(i.e. esophagus, 
stomach or 
duodenum). 
 
Results were not 
stratified by 
presenting 
symptoms, 
including PD. 
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. 
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s. 
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting. 
 
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval, 
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins, 
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G, 
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent 
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium 
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score), 
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s) 
 
 
Evidence Table 7. Markers of non-specific intestinal injury.  
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Our findings indicate a profound lack of enteric histologic data on pediatric populations in 
resource-limited settings. Specifically, only 18 of the 77 studies that we reviewed contained any 
biopsy materials, and only three of these 18 publications also included any non-intestinal tissue 
candidate biomarkers [111, 136, 155]. Furthermore, only two [111, 136] of these three studies 
attempted to statistically relate the less invasive, non-intestinal markers to histologic findings; 
the only significant association reported was between L:M and intestinal tissue inflammation on 
histopathology. Moreover, only 718 subjects aged 0-18 years were represented among the 18 
biopsy studies. Ages were mixed in many studies, such that it was impossible to discern which 
subjects were in the age range of maximal interest in this review (i.e., under five years of age), 
and indications for the biopsies were quite diffuse (e.g., diarrhea, poorly specified abdominal 
symptoms). Therefore, the subject population and data availability were suboptimal for the 
purposes of this review. In addition, none of the studies that included biopsies related the 
findings to the outcome of most considerable interest, i.e., stunting. 
Prospectively collected small bowel biopsies may provide useful data, guide biomarker 
development and validation, and reveal information about the cause(s) and pathophysiology of 
EED. Appropriate conditions are necessary for biopsy studies to be illuminating. For example, 
the context in which subjects and controls are selected is vital. Regarding cases, a rigorous 
clinical case definition must be established that defines growth faltering and minimal extent of 
intestinal functional abnormalities. Exclusion criteria should also be established for disorders 
that might mimic EED, such as celiac disease or inflammatory bowel disease. The pathology 
associated with these disorders, however, could inform biomarker association with intestinal 
dysfunction not specific to, but nevertheless relevant to and sensitive for EED. Such markers 
could be part of a set of markers used to diagnose EED. However, the usefulness of a biopsy to 
guide biomarker development and validation depends on several factors. Ideally, the lesion 
should be from treatment-naïve hosts; this does bring up an ethical dilemma, however. For 
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example, placement of a patient on gluten free diet, even briefly, or treating a patient with 
possible inflammatory bowel disease, prior to biopsies can obscure findings and render the 
histopathologic evaluation less valuable. Second, biopsies obtained under protocol must take 
into account the distribution of the lesion, so as to confirm the negative predictive value of any 
set of biopsies. Two disorders provide some guidance in this realm. For celiac disease, the 
lesion is surprisingly non-uniform [276-279], and multiple biopsies must be sought to avoid beta 
error. A similar situation applies to gastric biopsies for Helicobacter pylori detection [280-286]. A 
comparison group is also necessary, and to date, most “normal” or “control” tissues were from 
children in developed country settings. Hence, the abnormalities noted in children’s biopsies 
cannot be attributed to the disease process (enteropathy), or its consequences (stunting, most 
particularly), rather than to residence in an area in which such disorders are common. In other 
words, biopsy association with disease is, based on the available literature, no more strong than 
EED association with geography. 
A case could be made that biopsies are part of a routine evaluation of a child with failure 
to thrive, and a recent publication from North America suggests that this diagnostic modality is 
commonly employed in the evaluation of stunting disorders [287]. However, the precise 
diagnostic yield of a biopsy is not stated in this publication, nor are the data weighted by the 
symptoms or the age of the children. At this time, it remains uncertain how generalizable the 
utility of these recommendations is in settings where EED is common. 
The safety of a biopsy also needs to be considered in pondering the value of tissue 
assessment, or of biomarker discovery or validation. If a biopsy is obtained as part of an 
evaluation of poor growth, then the small risk of the biopsy usually is less than the potential 
benefit. However, this calculus assumes that substantial pre-procedure and post-procedure care 
is available to mitigate the likelihood of complications. The use of anesthesia in inpatient or 
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outpatient settings is safe, but should conform to the highest grade of safety [288]. An additional 
concern is that endoscopy of the duodenum carries a risk of causing intramural hematomas, 
estimated at 0.08% of upper endoscopic procedures in the United States [289, 290]. This 
complication results in small bowel obstruction, severe pain, and Ampulla of Vater obstruction 
and requires management involving prolonged hospitalization and total parenteral nutrition 
and/or or naso-enteral feeds. Coagulopathies such as von Willebrand Disease, other platelet 
disorders, and vitamin K deficiency (the risk of which is increased in chronic diarrhea and 
malabsorption) [291, 292] are thought to contribute to approximately half of endoscopy-related 
duodenal hematomas [289, 290, 293-307]. Among von Willebrand Disease variants, only severe 
(type 3) disease can be readily identified by available screening tests (prothrombin time) 
although such assessments can be used to pre-endoscopically identify treatment-responsive 
vitamin D deficiency. 
If biopsies are obtained as part of a research protocol to identify markers that predict 
clinically consequential EED (and even if biopsies are only used for clinical care), it is necessary 
to assemble a panel of individuals whose tissues are evaluated in parallel, but who do not have 
the most consequential of the complications of putative enteropathy, namely, stunting 
(assuming this remains the outcome of greatest concern). It would not be possible to recruit 
healthy control children for biopsies, because the procedure would offer limited benefit—
especially in relation to potential harm. However, some surrogate controls might arise as 
adventitiously obtained tissue becomes available either during operations or other endoscopic 
procedures, and the use of small bowel obtained at time of portoenterostomy is a particularly 
inspired choice [53].  
Caveats must be attached to any histologic assessment of the guts in children being 
evaluated for enteropathy as part of a care plan. It is very unlikely that intestinal biopsies would 
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be used as a diagnostic procedure at the beginning of an evaluation for malnutrition or poor 
growth. More likely, it would be a procedure of last resort, after less invasive evaluation failed to 
establish an etiology, and after attempts at nutritional and intestinal rehabilitation are undertaken 
and prove unsuccessful. However, as noted above, the empiric treatment of consequential 
intestinal dysfunction might change the pathology, and thereby diminish the diagnostic value of 
the procedure. Also, if biopsies are obtained, and subjected to analysis, it is critical that the 
materials be handled in a systematic manner, and processed per protocol, so as to maximize 
the data that they generate.  
In summary, there is no evidence to date that biopsies have been used to define the 
entity of childhood EED, because inadequate controls have been studied (children without 
evidence of functional impairment of gut function living in the same environment). There is no 
evidence that the biopsies relate to the outcome of greatest concern, namely, stunting. The data 
obtained from biopsies could be falsely normal, because of attempts at intestinal rehabilitation 
that will presumably precede the endoscopy. This negative assessment does not mean that 
biopsies are without worth, only that their value as providing case-defining information, or 
guiding biomarker discovery or validation, has yet to be made. However, if biopsies are 
obtained, it is critical that they be performed in a rigorous, disciplined and ethical manner, and 
that the data to be obtained are maximized.  
5.9 Markers of Extra-Small Intestinal Function 
We included markers of non-small intestinal organ function as these might provide 
important indirect assessments of precursors to or resultants of small intestinal injury. We 
reviewed those markers that were examined among children with presentations potentially 
consistent with enteropathy, such as persistent diarrhea, or were examined in relationship to 
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markers of intestinal inflammation or dysfunction. The data relevant to this review are listed for 
each of these studies in Evidence Table 8. 
263
Reference and 
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Diagnostic Interest 
Location and  
Target Population 
Design and 
Sample Size Biomarker Results Conclusion Comments 
2010 
 
Bukhari AS et al. 
 
DNA damage and 
plasma 
homocysteine 
concentrations are 
associated with 
serum metabolites 
and mineral 
constituents' profiles 
in children with 
persistent diarrhea 
 
Serum proteins, 
metabolites, and 
levels of DNA 
damage among 
children with and 
without PD 
Faisalabad, Pakistan 
 
3-6 yr olds admitted 
to hospital with PD 
and healthy controls. 
Case-control  
 
n=72; 
 
n=36 cases with 
PD 
 
n=36 healthy 
controls 
Blood Tests: 
Serum proteins and 
metabolites:  
• Albumin 
• Globulin 
• Homocysteine 
• Total protein 
• Total cholesterol, 
HDL, LDL, 
triglycerides 
• AST, ALT 
• T3, T4 
• Total oxidant status 
(TOS), Total anti-
oxidant status (TAS), 
and thiobarbituric 
reactive substances 
(TBARS) 
DNA damage to 
lymphocytes 
Mean values significantly higher 
among PD cases than in healthy 
controls:  
• LDL 
• Homocysteine 
• TOS 
• TBARs 
• DNA damage 
 
Mean values significantly lower 
among PD cases than in healthy 
controls:  
• Total protein 
• T4 
• TAS 
Multiple serum 
markers were 
associated with PD, 
especially DNA 
damage to 
lymphocytes 
(p=0.0001).  
 
The authors 
speculate that zinc 
deficiency, more 
commonly found in 
the children with PD, 
might be 
responsible for 
increased 
homocysteine 
concentrations and 
play an important 
role in mediating 
DNA damage. 
Control recruitment 
strategy was not 
well described. 
 
TOS, TBARS and 
TAS were 
incompletely 
defined. 
 
Some values 
differed by gender 
in both the case 
and control groups:  
• Triglycerides 
• Total cholesterol 
• HDL 
• T3  
 
Multiple markers 
studied; analyses 
did not appear to 
address potential 
confounding. 
2000 
 
Fagundes-Neto U et 
al. 
 
Studies of the small 
bowel surface by 
scanning electron 
microscopy in infants 
with persistent 
diarrhea 
 
Scanning electron 
microscope (SEM) 
and light microscope 
(LM) analyses of 
small intestinal 
biopsy among 
infants with PD with 
and without SBBO 
Sao Paulo, Brazil 
 
2-10 mo olds with 
PD and protein 
calorie malnutrition 
consecutively 
admitted to Sao 
Paulo Hospital. 
Case-series  
 
n=16 
 
Jejunal secretions 
aspirate: 
Bacterial 
concentrations 
 
 
Jejunal tethered 
capsule biopsy: 
Histopathology by LM 
and SEM 
 
 
Rectal tethered 
capsule biopsy: 
Histopathology 
 
68.7% had bacterial overgrowth 
(concentration >104 colonies/mL): 3 
had enteropathogenic E. coli while 
the rest had colonic microflora. 
 
All small intestine specimens had 
morphological abnormalities on LM: 
• 43.7% moderate villous atrophy 
• 56.3% subtotal villous atrophy  
 
SEM revealed abnormalities of 
varying intensity:  
• Among the 11 with SBBO, villous 
atrophy ranged from Grade II 
(n=4), Grade III (n=2), to Grade IV 
(n=3).  
• For the 5 subjects without SBBO, 
villous atrophy ranged from Grade 
I (n=1) to Grade 2 (n=4).  
• A mucous-fibrinoid pseudo-
Histological 
abnormalities were 
noted in all subjects 
by LM and SEM.  
 
Degree of villous 
atrophy noted on 
SEM seemed to be 
correlated with 
SBBO (no statistical 
tests were reported).  
 
Authors speculate 
that the mucous-
fibrinoid pseudo-
membrane partially 
covering 
enterocytes is 
consistent with a 
malabsorptive 
Inconsistent 
reporting of 
proportions of 
histopathologic 
findings among all 
subjects and by 
SBBO status; 
assessment of 
potential 
relationship with 
SBBO between 
different histologic 
findings was not 
possible. 
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membrane over enterocytes was 
noted in 7 of the 11 with SBBO 
and none of the others.  
 
Other abnormalities noted on SEM 
included:  
• Mucus and debris covered large 
areas of the villous surface 
• Derangement of the enterocytes 
(in some cases cell borders were 
not clearly defined)  
• Reduced height and number (or 
absence in some places) of 
microvilli  
• Lymphocytes and fat droplets 
were observed over the surface of 
enterocytes (18%)1 
 
10 subjects had colitis on rectal 
biopsy; this was not associated with 
SBBO or degree of small intestinal 
pathology on SEM. 
process, with the 
findings of fat 
droplets on 
enterocytes 
surfaces, and with 
the state of 
malnutrition of the 
subjects. 
2005 
 
Galpin L et al. 
 
Effect of 
Lactobacillus GG on 
intestinal integrity in 
Malawian children at 
risk of tropical 
enteropathy 
 
L:M and sucrose: 
lactulose ratio 
(SUC:L) as markers 
of intestinal and 
gastric permeability, 
respectively, in 
Mwenye, Malawi  
 
36-60 mo olds 
recruited from a rural 
community, 
excluding children 
with severe acute 
malnutrition or 
severe chronic 
illnesses. 
 
Subjects were 
considered at risk for 
EED due to 
residence in a 
location with high 
prevalence of EED. 
RCT 
 
n=164;  
 
n=81 received 
Lactobacillus GG 
(80 completed the 
study) 
 
n=83 received 
placebo 
(81 completed the 
study) 
 
 
Subjects received 
30-days of 
Urine Tests: 
• Lactulose2 
• Mannitol 
• Sucrose (SUC) 
• L:M  
• SUC:L 
 
At enrollment: 
• 73% had L:M >0.10  
• 40% had L:M >0.20 
• Mean3 L:M (SD): 
• Treatment: 0.18 (0.16) 
• Placebo: 0.22 (0.20)  
• Mean lactulose (SD) in treatment 
group: 0.25 (0.17) 
• Mean mannitol (SD) in treatment 
group: 8.0 (4.5)  
• Mean SUC:L (SD):  
• Treatment: 0.58 (0.64)  
• Placebo: 0.60 (0.64) 
 
Mean excretion of sucrose (SD) 
increased from 0.057 (0.042) to 
0.078 (0.058) in the treatment group 
A high baseline 
prevalence of 
abnormal L:M was 
observed, with no 
change after 
intervention. 
  
High mannitol 
excretion (relative to 
UK norms) drove 
the abnormal L:M. 
 
There was little 
effect on SUC:L with 
intervention; 
sucrose excretion 
increased in both 
Difficult to interpret 
sucrose tests 
because there are 
limited data on 
laboratory values 
for these tests in 
young children. 
                                                          
1 These SEM results were not presented separately for those with and without SBBO. 
2 Lactulose, mannitol, and sucrose results were expressed as % of dose administered. 
3 Arithmetic mean. 
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asymptomatic 
children presumed at 
risk of EED 
Presumed that if 
SBBO is etiology for 
EED, treatment with 
Lactobacillus will 
result in improved 
gut integrity. 
Lactobacillus GG 
or placebo. Only 
the 161 subjects 
who completed 
the study had 
repeat testing. 
(p=0.01), but similar results were 
observed in the placebo group. 
Otherwise there were no changes in 
lactulose, mannitol, L:M, or SUC:L 
after treatment or placebo. 
treatment and 
control groups. 
2006 
 
Leite CA et al. 
 
Functional, 
microbiological and 
morphological 
intestinal findings 
among human 
immunodeficiency 
virus infected 
children 
 
Small intestinal and 
rectal biopsy to 
assess morphology 
and D-xylose as a 
marker of 
malabsorption 
among HIV-infected 
children 
Sao Paulo, Brazil 
 
5 mo-12 yr old 
(median 24 mo) HIV-
infected subjects 
recruited from a 
hospital and clinic. 
 
All subjects had 
some degree of 
protein-energy 
malnutrition. 
Cohort 
 
n=11; 
 
n=5 patients with 
current or recent 
episode of 
diarrhea  
 
n=6 patients with 
no diarrhea in the 
30 days 
preceding 
enrollment 
Blood Test: 
D-xylose 
(9 tested) 
 
 
Biopsy of small 
intestine by tethered 
capsule or endoscopy: 
Histopathology 
(10 tested)  
 
 
Rectal biopsy: 
Histopathology 
(6 tested) 
100% had low D-xylose absorption: 
• Mean: 15.6 mg/dL 
• SD: 5 
• Range: 8.9-24.4 
• Median: 14.2  
 
Small intestinal biopsy:  
• 100% had some degree of villous 
atrophy based on a I-IV grading 
system: 
• Grade I: 3 
• Grade I/II: 2  
• Grade II: 1 
• Grade II/III: 1 
• Grade III/IV: 1 
• 2 samples were too superficial 
to assess 
• Intraepithelial lymphocytes were 
increased in half of the biopsies. 
• Lymphocytic and 
polymorphonuclear (PMN) 
infiltration of the lamina propria 
were present in 10/10 and 7/10 
biopsies, respectively. 
 
Rectal biopsy: 
• 100% had normal architecture 
Lymphocytic and PMN infiltration 
were present in 6/6 and 4/6, 
respectively. 
There was a high 
prevalence (100%) 
of abnormal D-
xylose results 
among HIV-infected 
children, regardless 
of diarrhea status.  
 
All patients also had 
cellular infiltration of 
the lamina propria 
and varying degrees 
of villous atrophy. 
 
There was no 
correlation between 
D-xylose and 
degree of villous 
atrophy on biopsy. 
Portuguese 
language article.  
 
D-xylose <25 
mg/dL was defined 
as indicative of 
malabsorption. This 
value is higher than 
what some 
references have 
noted as a cut-point 
[186].  
 
Investigators used 
a well-articulated 
system of grading 
villous atrophy.  
 
Results were not 
presented by 
diarrhea status, 
perhaps due to 
small sample size. 
2003 
 
Tassara O et al. 
 
Gastrointestinal 
diseases in children 
infected with the 
Santiago, Chile 
 
0-12 yr old (median 
9 mo) HIV-infected 
children treated in 
hospital. A high 
proportion had PD. 
Cross-sectional 
 
n=11 
 
Endoscopic 
upper GI biopsy 
including esophagus, 
stomach, and/or 
duodenum: 
• Gross endoscopic 
visualization 
Macroscopic inflammatory changes 
were observed on endoscopy in the 
esophagus, stomach or duodenum 
in 2 subjects.  
 
Biopsies of esophagus, stomach or 
duodenum showed inflammatory 
Biopsy results might 
show inflammatory 
damage in cases 
with no macroscopic 
damage visible. 
Spanish language 
article. 
 
Inflammatory 
changes identified 
in the digestive 
system were not 
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human 
immunodeficiency 
virus 
 
Endoscopy and 
biopsy among HIV-
infected children 
• Histopathology changes of varying degree in all 11 
subjects. 
specified by site 
(i.e. esophagus, 
stomach or 
duodenum). 
 
Results were not 
stratified by 
presenting 
symptoms, 
including PD. 
2009  
 
Trehan I et al. 
 
A randomized, 
double-blind, 
placebo-controlled 
trial of rifaximin, a 
nonabsorbable 
antibiotic, in the 
treatment of tropical 
enteropathy 
 
L:M,  
sucrose:lactulose, 
and  
sucralose:lactulose 
as markers of small 
intestinal, gastric, 
and colonic 
permeability, 
respectively, among 
those receiving 
rifaximin or placebo 
Limela, Malawi 
 
All 3-5 yr olds from 
the village were 
recruited. 
RCT 
 
n=144;  
 
n=72 received 
rifaximin for 7 
days 
 
n=72 received 
placebo  
 
It was presumed 
that if SBBO is 
the etiology for 
enteropathy, 
treatment with 
rifaximin would 
result in improved 
intestinal integrity. 
Urine Tests 
• Lactulose1 
• Mannitol 
• Sucrose (SUC) 
• Sucralose (SCL) 
• L:M  
• Sucrose:lactulose 
ratio (SUC:L) 
• Sucralose:lactulose 
ratio (SCL:L)  
 
 
Subjects were tested 
before and after 
treatment. 
At enrollment: 
• Mean mannitol (SD):  
• Treatment: 9.57 (5.24)  
• Placebo: 10.29 (6.62) 
• Mean lactulose (SD): 
• Treatment: 0.30 (0.18) 
• Placebo: 0.34 (0.25) 
• Mean SUC (SD):  
• Treatment: 0.062 (0.04)  
• Placebo: 0.074 (0.058) 
• Mean SCL (SD):  
• Treatment: 0.51 (0.29)  
• Placebo: 0.58 (0.53) 
• Mean L:M (SD): 
• Treatment: 0.18 (0.12) 
• Placebo: 0.17 (0.09) 
• Mean SUC:L (SD): 
• Treatment: 0.50 (0.34) 
• Placebo: 0.64 (0.90) 
• Mean SCL:L (SD): 
• Treatment: 0.42 (0.32) 
• Placebo: 0.39 (0.23) 
• For both groups combined:  
• 76% had L:M >0.10 
• 34% had L:M >0.20 
 
No significant post- intervention 
differences were observed in any 
fractional sugar excretion or dual 
sugar test, including among children 
There was a high 
proportion with 
elevated L:M which 
did not change with 
rifaximin treatment. 
 
Baseline L:M 
measurements in 
this study resembled 
those of another 
Malawian population 
in similar 
environmental 
conditions [120]. 
 
SCL excretion in this 
population was 
similar to that found 
in healthy American 
children (0.4%), 
while SCL:L was 
comparatively lower 
(0.8) and driven by 
lactulose [210]. 
SCL:L might be a 
better marker of 
colonic permeability 
[211-213]. Results 
from this study 
potentially indicate 
that colonic 
Methodological 
differences in 
specimen collection 
and testing, in 
particular for SCL 
excretion, might 
account for some 
differences in 
values compared to 
other studies.  
 
This was the first 
use of SCL for site-
specific absorption 
testing in a 
developing country 
setting. 
                                                          
1 Lactulose, mannitol, SUC, and SCL results were expressed as % of dose administered. 
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with elevated pre-intervention L:M. permeability was 
normal. 
  
Few data exist on 
SUC excretion. 
Results in this trial 
are similar to those 
found in another 
Malawian population 
(0.06% SUC 
excretion) [120] and 
high compared to 
healthy older 
children from 
developed country 
settings (0.02-
0.03%) [210, 212]. 
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. Where these 
studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s. 
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting.  
 
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval, 
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins, 
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G, 
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent 
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium 
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score), 
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s) 
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One study assessed markers of liver and thyroid function among hospitalized persistent 
diarrhea cases and healthy controls [107]. These authors found that thyroid hormones were 
significantly lower in children with diarrhea than in controls. Liver tests showed associations in 
conflicting directions.  
The remaining five studies examined tests related to segments of the gastrointestinal 
tract outside of the small bowel [13, 118, 120, 136, 167]. Three of these performed endoscopy 
and/or biopsy on the esophagus, stomach, and/or rectum [118, 136, 167]. In a study of 11 HIV-
infected malnourished children rectal biopsy tissue uniformly demonstrated normal architecture, 
but increased lymphocytic and neutrophilic infiltration. Duodenal biopsies were also infiltrated 
with these cells but all subjects had additionally some degree of abnormal architecture [136]. 
Another case series found macroscopic inflammatory changes in 18% of endoscopies and 
100% of biopsies of the upper gastrointestinal tract in eight children with HIV infection, many of 
whom had persistent diarrhea [167]. However, the investigators did not report whether these 
findings were identified in the esophagus, stomach and/or duodenum. A third study in this 
category found that nearly two-thirds of subjects had evidence of colitis based on rectal biopsy; 
this was not associated with small bowel bacterial overgrowth or degree of small intestinal 
pathology observed by scanning electron microscope [118].  
Tests of small intestinal permeability have been described in a previous section (5.3), 
but certain dual-sugar permeability tests are more specific for evaluating colonic or gastric 
function. These markers include urinary sucrose, urinary sucralose, the urinary 
sucrose:lactulose ratio (SUC:L), and the urinary sucralose:lactulose ratio (SCL:L). Sucrose 
excretion and sucrose:lactulose (SUC:L) were components of a panel of urinary excretion tests 
that comprised the clinical endpoints as measures of gastric permeability for two community-
based intervention studies, one of which additionally tested sucralose excretion and 
sucralose:lactulose (SCL:L) as measures of colonic permeability. The first of these studies was 
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a randomized, controlled trial of Lactobacillus GG [120]. The mean excretion of sucrose 
increased in the treatment group following treatment, but similar results were observed in the 
placebo group. Following the intervention, there was no change in the mean SUC:L in either 
group. The second of these studies was a randomized, controlled trial that assessed L:M, 
SUC:L, and SCL:L responses to treatment with rifaximin, a nonabsorbable antibiotic. The 
investigators hypothesized that if small bowel bacterial overgrowth played an etiologic role in 
enteropathy, treatment with the antibiotic would result in improvements in measurements of 
permeability [13]. Sucralose excretion in this population was similar to that found in healthy 
American children while SCL:L was comparatively lower and driven by lactulose [210]. These 
results were similar to those found in another Malawian population [120] in where excretion 
values were 2-3 fold greater than those excreted by healthy older children from developed 
countries [210, 212]. No significant post-intervention differences were observed for any of these 
markers. The authors asserted that this was the first use of sucralose for site-specific absorption 
testing in a developing country setting. Few data exist on sucrose excretion, but overall values 
for sucrose excretion were similar across the two studies.  
5.10 Relationships between Markers of EED, 
Including Histopathology 
Biomarkers provide, by definition, “read-outs” or values that are related to one or more 
host processes. Here we review inter-marker relationships, independent of host outcomes 
(which are reviewed below).  
Only four studies included assessments of “noninvasive” biomarkers (i.e., those not 
requiring the introduction of an endoscope or tube into the small bowel (e.g., for visualization, to 
obtain duodenal fluid or biopsy tissue) as well as intestinal histopathology [111, 136, 155]; only 
two of these studies compared histopathology to less invasive markers. Leite et al. assessed 
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the relationship of D-xylose and the degree of villous blunting and found no association [136]. 
Campbell et al. found that L:M was associated with various findings on scanning electronic 
microscopy (SEM) and was correlated with mucosal B lymphocyte density, intraepithelial 
lymphocyte (IEL) density, and the presence of perforin-positive IELs [111].  
An additional three studies compared endoscopic visualization or markers in intestinal 
tissue obtained by biopsy to standard light microscopic histopathology [53, 118, 126]. Neither 
endoscopic [126] nor SEM [118] findings were associated with histopathology on light 
microscopy. However, intestinal maltase activity, as well as intestinal mRNA abundances for 
maltase-glucoamylase and the enterocyte-specific proteins villin and sodium-activated luminal 
glucose-galactose transporter 1, were correlated with villous atrophy [53]. 
Twelve studies [15, 43, 58, 110, 123-125, 132, 149, 151, 158, 159] compared 15 
different non-intestinal tissue markers to each other. Four of these studies assessed serum L:R 
to other markers and found relationships with sucrose breath values [159], serum lactose [58], 
urinary nitrites [43], and urinary L:R [125], but did not demonstrate associations with stool 
reducing substances [58] or serum red blood cell markers [58]. Three other studies assessed 
urinary L:M to other markers and found no associations with fecal neopterin [15], urinary lactose 
or lactose:lactulose [124], or a variety of systemic immune/inflammatory markers including AGP, 
total IgG, albumin, and hemoglobin [123]. However, one additional study did find that L:M was 
associated with not only total serum IgM and IgA levels, but also IgG [110]. This study also 
found a correlation between L:M values and IgG endotoxin core antibody concentrations, and 
additionally found urinary lactulose excretion to correlate with circulating IgG endotoxin core 
antibody and endotoxin concentrations. Other studies found that urinary lactose:creatinine was 
inversely related to hemoglobin [151] and that fecal lactoferrin was related to TNF-α receptor I 
[132]. Others found no relationship between urinary nitrite and stool reducing substances [43] or 
between sucrose breath test and hemoglobin or C-reactive protein [159].  
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5.11 Relationships between EED Biomarkers and 
Growth or Other Outcomes of Interest  
We sought to find biomarkers of processes relevant to consequential outcomes in the 
host. In the context of EED, the outcome of greatest proximate interest is growth failure, 
specifically linear growth failure, but other potential injuries (e.g., persistent diarrhea) and distal 
consequences (e.g., delayed cognitive development) were also considered.  
Eight studies attempted to associate various markers with persistent diarrhea, six of 
which found such an association. In five of the six studies, these were systemic markers such 
as serum proteins or indices of serum white or red blood cells [106, 107, 142, 166, 308]. A sixth 
study found that concentrations of immunoglobulin in duodenal aspirates were associated with 
persistent diarrhea among children infected with Giardia [128]. A study of mannose-binding 
lectin (MBL) found that while a deficiency of the marker was associated with cryptosporidiosis, 
MBL concentrations were not significantly associated with either duration of diarrhea or 
persistent diarrhea [130]. While the eighth study did assess for hemoglobin association with 
persistent diarrhea, it was not clear from the reporting of their multivariate results if there was an 
association [114].  
Fourteen studies [101, 103, 111, 113, 117, 121, 126, 131-133, 138, 154, 155, 167] 
included subjects with and without persistent diarrhea but did not statistically assess 
relationships between markers and this outcome, although five of these studies [101, 103, 117, 
126, 155] did present data stratified by the outcome of persistent diarrhea. 
While acute diarrhea is not a cardinal EED symptom, we included it as an outcome of 
interest when looking at studies that sought its association with biomarkers of enteric 
dysfunction. Our rationale was that intestinal damage or pathophysiology resulting from acute 
enteric processes might still provide meaningful insights into the utility of various markers in 
272
representing pathologic gut processes. Eight studies [43, 58, 116, 124, 125, 159, 166, 308] 
investigated the relationship between markers and acute diarrhea. It should be noted that some 
of these studies included children with persistent diarrhea, but did not stratify results according 
to acute or persistent presentations; we include all of these studies under the heading “acute 
diarrhea”. Most of these studies found associations between acute diarrhea and the markers 
investigated. One of these studies [125] found a relationship between acute diarrhea and both 
urinary and serum L:R while another [58], a study limited to serum L:R testing, found 
associations between diarrhea and serum L:R and lactulose. However, Goto et al. [124] did not 
find an association between the L:M ratio and acute diarrhea.  
Studies also found associations between acute diarrhea and other tests specific for 
intestinal function, such as the sucrose breath test [159], and fecal fat [116]. Association was 
also observed for two markers of innate immunity, neutrophil polarization in response to a 
chemotactic factor and monocyte spontaneous proliferation assays [104], as well as nitric oxide 
production [43]. While one study found associations between acute diarrhea and various red 
blood cell parameters [166], another [104] found a lack of association between acute diarrhea 
and other systemic markers such as white blood cells, transferrin, serum albumin, cytokines, 
and immunoglobulin subtypes.  
Sixteen [15, 101, 108, 121, 130-134, 136, 140, 152, 158, 162, 168, 172] studies had 
subjects with and without acute diarrhea but did not statistically analyze the relationship 
between markers and acute diarrhea, although three [101, 152, 162] presented data stratified by 
acute diarrhea status. In two studies [101, 162], a high proportion of those with acute diarrhea 
were lactoferrin positive. One of these studies [101] also found that a low proportion of cases 
with acute diarrhea were positive for stool IL-8, but all of the individuals positive for stool IL-8 
had acute diarrhea. The study [152] utilizing the D-xylose test found that of the eight children 
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with abnormal results, one had diarrhea and of 19 children with diarrhea, only one had an 
abnormal result for D-xylose.  
Thirteen studies included children with symptomatic or clinically silent giardiasis [15, 
105, 116, 117, 122-124, 128, 133, 137, 147, 150, 154]; diagnostic methods to identify Giardia 
varied between microscopy and antigen testing. Seven of these studies investigated the 
relationship between markers and giardiasis [15, 116, 123, 124, 128, 147, 150] and five found 
an association between at least one marker and the infection [116, 123, 124, 128, 147], 
although the studies commonly reported associations between one biomarker and not others. 
Some studies found serum total IgG and AGP [123], and lactose hydrogen breath test results 
[147] were significantly higher in asymptomatic, Giardia-infected children than in uninfected 
controls. Significantly higher mean concentrations of total IgM were found in duodenal aspirates 
of Giardia cases with persistent diarrhea compared to controls without diarrhea [128]. In a study 
that included subjects with and without diarrhea, giardiasis was associated with the presence of 
fecal fat, and this association held across four testing methods [116]. In contrast, a study of a 
fecal marker of inflammation, neopterin, did not find an association with Giardia infection [15]. 
The relationship between Giardia infection and a urinary marker of intestinal permeability 
differed across studies. While Goto et al. found an association between giardiasis and mean 
urinary L:M value in one study [124], they did not find this association in a subsequently 
published study [123]. Campbell et al. did not find an association between Giardia infection and 
urinary L:M [15], and another report found that urinary L:M was not consistently associated with 
giardiasis [150]. The relationship between circulating markers and Giardia infection varied by 
marker; specifically, an association was observed between infection and serum albumin but not 
hemoglobin concentrations [123]. Six studies [105, 117, 122, 133, 137, 154] that included both 
infected and uninfected subjects did not statistically investigate the relationship between Giardia 
infection and these markers, although two [105, 117] of these studies did present data stratified 
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by infection status and a third [154] provided a general description of the histopathology in 
infected subjects. These three studies investigated cases with intestinal symptoms consistent 
with celiac disease and referred for duodenal biopsy. Among the children that were not 
diagnosed as having celiac disease, the studies reported widely varying percentages of subjects 
with Giardia infection: 0.8% [117], 5.4% [105], and 78.6% [154].  
Eight studies presented data on children with asymptomatic and/or symptomatic 
cryptosporidiosis. Five of these [101, 130-132, 172] tested the association of Cryptosporidium 
infection with various markers, three of which were conducted in Haiti by the same group [130-
132]. Fecal lactoferrin [101, 132] serum mannose-binding lectin deficiency [130], and mean 
urinary L:M [172] were associated with cryptosporidiosis. A sixth study tested longitudinally 
collected stools of Brazilian children for Cryptosporidium and presented the results for the 
children with infection, finding that stool lactoferrin was strongly associated with symptomatic 
infection in children with C. parvum but not C. hominis [108].  
In the three cryptosporidiosis studies that included testing for various fecal cytokines, 
results were mixed. For example, two studies found no association between infection and IL-8 
[101, 131], IL-4 [131], or IL-10 [131], while associations were identified with each of these 
cytokines, as well as with IL-13, in one of the studies from Haiti [132]. One of the studies from 
Haiti found an association between fecal IFN-γ and control status rather than among those with 
Cryptosporidium infection [131], while the other did not detect IFN-γ in the stools of any subjects 
[132].  
In two additional studies of subjects with and without Cryptosporidium infection, 
abnormal D-xylose results were found more often among infected children [152], while fecal 
lactoferrin did not appear to be related to infection status based on the numbers reported in the 
study, although statistical testing of the relationship was not described [162].  
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Sixteen studies assessed the association of markers of intestinal function with nutritional 
status outcomes [15, 43, 53, 108-112, 122-124, 139, 145, 150, 151, 153]. The anthropometric 
assessments used in these investigations varied, and the results for given measures were 
mixed. We describe the results of the eight studies that measured the relationship between L:M 
and anthropometrics above (see Table 15) [15, 110-112, 122-124, 150].  
Urinary lactose:creatinine [151], stool neopterin [15], and intestinal lactase activity [109] 
were associated with all anthropometric indices investigated while stool lactoferrin [108] and 
intestinal maltase activity were not [53]. Results for urinary nitric oxide and WAZ correlation 
were of borderline statistical significance (effect ratio 0.88, p=0.05) [43].  
Four studies examined the association between histopathology and growth parameters 
[53, 111, 145, 153]; two studies identified no relationship between weight-for-age measures 
[111, 145], while one reported that WAZ score was correlated with degree of villous atrophy 
[53]. Examination of tissue by digital morphometry in another study produced ambiguous results 
[153]. One of these studies also examined the relationship of weight-for-age with endoscopic 
visualization of the intestine and found no association [145]. Campbell et al. found varying 
results when assessing the relationship of different intestinal tissue cytokines and immune 
markers with WAZ score [111].
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